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Summary  III 
Summary 
The human gastrointestinal tract is covered by a simple epithelium that operates as a 
selective permeable barrier and allows the uptake of essential nutrients while 
simultaneously preventing the entry of macromolecules and pathogens from the gut 
lumen. Several types of intercellular junctions tightly connect the epithelial cells and thus 
establish a functional barrier. While tight junctions (TJ) as well as adherens junctions 
(AJ) have been studied extensively, less information is available for desmosomes. For a 
long time, desmosomes were considered to provide primarily the mechanical strength to 
intercellular cohesion. However, growing evidence suggest a role in regulating signaling 
cascades. Desmosomal cadherins constitute the adhesive core of desmosomes with 
extracellular domains (ED) binding to adjacent cadherins and a cytoplasmic tail that 
anchors the junctional complex to the intermediate filament cytoskeleton. In the human 
intestine, only two desmosomal cadherins are present, desmoglein 2 (Dsg2) and 
desmocollin 2 (Dsc2), of which Dsg2 has been reported to be crucial for barrier function 
and to play a critical role in the pathogenesis of inflammatory bowel disease (IBD).  
The main objective of this study was to investigate the adhesive and signaling functions 
of Dsg2 in human intestinal cells. At first, I characterized cultured enterocytes regarding 
their ability to establish a functional barrier that is suitable as model for the intestinal 
epithelium. Here, cultured cells showed mature barrier properties with fully formed 
apical junctional complexes and characteristic microvilli on the cell surface similar as 
observed in human tissue.  Furthermore, I identified that Dsg2 is present additionally 
outside of desmosomes on the surface of polarized enterocytes. To characterize Dsg2 
binding properties, I established atomic force microscopy (AFM) on living enterocytes, 
which was then used to investigate the effect of several signaling mediators on Dsg2 
binding. An antibody targeting the ED of Dsg2 was able to inhibit binding events in 
AFM measurements and activated p38MAPK but did not influence cell cohesion under 
same conditions. To elucidate the signaling properties of Dsg2 more in detail, I 
compared WT and Dsg2-deficient enterocytes and found a deregulated p38MAPK 
signaling pathway. Using transepithelial resistance (TER) measurements, I further 
showed that the interrelationship of p38MAPK and Dsg2 regulates barrier properties.  
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Moreover, I identified EGFR as direct interaction partner of Dsg2 and that this 
interaction inhibits the proliferative function of EGFR. In Dsg2-deficient cells, EGFR 
is absent at cell-cell borders and proliferation is increased. Co-localization of Dsg2 and 
EGFR was also observed in human tissue samples, indicating that this newly discovered 
mechanism is universal. Further, I characterized the heterophilic binding and 
demonstrated that EGFR mediators inhibit the interaction. In addition, EGFR 
mediators impaired barrier establishment and reduced cell adhesion, suggesting that the 
Dsg2-EGFR complex regulates barrier properties of intestinal epithelial cells.  
Since impaired barrier function and in particular Dsg2 function is implicated in the 
pathogenesis of Crohn’s disease (CD), I participated in studies investigating the 
mechanisms leading to loss of barrier function in IBD. Here, I analyzed human tissue 
samples from CD patients and showed changes in desmosome ultrastructure. 
 Furthermore, comparison of Dsg2 and Dsc2 deficient cells revealed a differential 
biological relevance of these cadherins. More specifically, Dsg2 had a more profound 
impact on barrier properties than Dsc2. In addition, I investigated the effect of the 
neurotrophic factor GDNF on Dsg2 binding, because GDNF has been reported to have 
a protective function in IBD patients. Here, using AFM, I showed that GDNF increases 
the binding properties of Dsg2 at cell borders and protects Dsg2 from cytokine-induced 
reduction at cell borders.   
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1 Introduction 
 
1.1 Function and structure of the human intestinal epithelial barrier 
The human gastrointestinal tract has amazing skills. Consisting of the oesophagus, 
stomach, small and large intestine, it is designed to fulfill a variety of functions such as 
storage as well as propulsive transport of food, digestion, absorption of nutrients and 
elimination of solid food waste. At the same time, it forms an important interface 
between the body interior and external environment that contains trillions of 
microorganisms that live in symbiotic and mutualistic relationship with the host as well 
as enteric pathogens that are usually co-ingested with food (Cerf-Bensussan and 
Gaboriau-Routhiau, 2010; Rodriguez et al., 2015). Hence, different types of response are 
required, dependent on whether the antigen is profitable or harmful to the host (Mowat, 
2003). How is it possible to stay permeable for the uptake of nutrients but simultanously 
preventing the entry of commensal bacteria, pathogens and harmful macromolecules? 
This remarkable function is achieved by a dynamic, selective permeable barrier. While 
the oesophagus is lined by a multilayered stratified squamous epithelium (Grace et al., 
1985), the remaining parts of the gastrointestinal tract are covered by a single layer of 
polarized columnar epithelial cells that are tightly connected by a set of intercellular 
junctional complexes (Capaldo et al., 2014; Farquhar and Palade, 1963a). The major part 
of digestion and absorption of nutrients takes place in the small intestine, divided into 
the sections duodenum, jejunum and ileum, as well as in the large intestine (Helander 
and Fandriks, 2014; Moog, 1981). In order to achieve a high efficiency in digestion and 
absorption, the intestinal epithelium is organized in a three-dimensional structure 
consisting of crypts and villi in the small intestine and crypts in the colon, which enlarges 
the surface area to approximately 32 m2 (Helander and Fandriks, 2014). To carry out the 
diversity of functions, four major types of intestinal epithelial cells (IECs) are present in 
the intestinal epithelium (Fig.1). Enterocytes make up the largest portion and are created 
primarily for specific digestive functions and absorption of nutrients such as ions, water, 
sugar, peptides and lipids (Clevers, 2013; van der Flier and Clevers, 2009). Goblet cells 
secrete highly glycosylated mucins into the intestinal lumen, thereby creating a thick fluid 
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that protects the intestinal wall from digestive enzymes and forms the first line of defense 
against microorganisms from the gut (Johansson et al., 2013; Kim and Ho, 2010). The 
major intestinal mucin produced by goblet cells is MUC2 that belongs to the gel-forming 
mucins. This group of mucins forms large polymers consisting of glycosylated mucin 
domains that are resistant to endogenous proteases, which allows the intestine to digest 
food without digesting itself (Johansson et al., 2013). In addition, transmembrane mucins 
that are produced by enterocytes, as well, form a thin layer called the glycocalyx that 
covers the apical side of IECs. Beyond their assumed role in protection, transmembrane 
mucins are also believed to be involved in apical cell surface sensing and signaling 
(Hattrup and Gendler, 2008; Singh and Hollingsworth, 2006). Paneth cells, which are 
present only in the small intestine, produce antimicrobial peptides (AMPs) including 
alpha-defensins, lysozymes and Reg3 proteins (Bevins and Salzman, 2011; Clevers and 
Bevins, 2013). AMPs have bactericidal activity and eradicate bacteria, thereby shaping 
the composition of the commensal microbiota and protecting against infections (Muniz 
et al., 2012). Moreover, AMPs function in recruiting and activating immune cells as well 
as modulate their maturation and differentiation (Funderburg et al., 2007; Navid et al., 
2012; Rodriguez-Garcia et al., 2009). Enteroendocrine cells function as chemoreceptors 
and following stimulation, they release intestinal hormones like gastrin, motilin or 
somatostatin directly into the bloodstream (Cox, 2016; Noah et al., 2011). In addition, 
progenitor stem cells reside in the crypt base, also called crypts of Lieberkühn, and 
differentiate into mature IECs while migrating up along the crypt-villus axis, thereby 
renewing the intestinal epithelium every 4-5 days (Clevers, 2013). Together, these 
specialized IECs lineages form a dynamic, physical and biochemical barrier.  
Lamina propria, which is present in close contact below the intestinal epithelium, 
contains blood vessels, immune cells such as intra-epithelial lymphocytes, macrophages, 
dentritic cells, B- and T-cells and connects the epithelium to the smooth muscle layer 
which is responsible for gut movement such as peristaltis (Collins and Bhimji, 2018). 
Muscle contractions and digestive functions are coordinated by the enteric nervous 
system (ENS) that cooperates with the central nervous system (CNS) and consists of the 
myenteric and submucosal plexus (Furness, 2012). Of note here are the enteric glial cells 
(EGCs), which are located also in proximity to the IECs (Yu and Li, 2014). They release 
specific mediators such as glial cell-derived neurotrophic factor (GDNF) or 
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transforming growth factor (TGF) β1 and play an important role in the maintance of 
both, ENS and epithelial barrier integrity (Abdo et al., 2010; Neunlist et al., 2014).  
 
Figure 1: Schematic overview of the cellular composition and three-dimensional organization of 
the epithelium in the small intestine. The intestinal epithelium includes absorptive enterocytes, mucus 
secreting goblet cells, hormone releasing enteroendocrine cells, antimicrobial peptides (AMPs) -
producing paneth cells and proliferating stem cells, which together form a dynamic barrier that seperates 
the mucosal tissue from the luminal gut microbiota. A three-dimensional structure consisting of crypts 
and villi increases the surface area and ensures highly efficient digestion and absorption. The epithelium 
is in close contact to the lamina propria that connects the epithelial cells to the muscle layer and contains 
blood vessels and immune cells. 
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1.2 Intestinal epithelial intercellular junctions 
In order to achieve a functional barrier, the paracellular space between IECs must be 
sealed. Three different types of intercellular junctions namely tight junctions (TJs), 
adherens junctions (AJs) and desmosomes hold the IECs together and form the 
“terminal bar” by sealing the paracellular space (Capaldo et al., 2014; Farquhar and 
Palade, 1963a) (Fig.2). In addition, clusters of intercellular plasma membrane channels 
called gap junctions (GJ) allow communication between adjacent cells through a passage 
route for ions and small metabolites of less than 2 kilodalton (kDa)(Staehelin, 1972).  
 
Figure 2: Structure of intercellular junctional complexes in the intestinal epithelium. Intestinal 
epithelial cells (IEC) are connected through a set of adhesion complexes including tight junctions (TJ), 
adherens junctions (AJ), desmosomes and gap junctions (GJ). TJ and AJ are tethered to the acto-myosin 
cytoskeleton, while desmosomes are linked to the intermediate filament cytoskeleton and provide strong 
intercellular cohesion.   
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1.2.1 Tight junctions 
TJs are the most apical junctional complexes and besides restricting paracellular diffusion 
based on size and charge, they maintain apicobasal cell polarity through their function 
as fence that restricts diffusion of lipids and proteins between the apical and basolateral 
sides of the cell (Cereijido et al., 1998; Tsukita and Furuse, 2000). The main protein 
components of tight junctions include the small tetraspan proteins of the claudin family, 
three MARVEL domain proteins including occludin, tricellulin and MARVELD3 as well 
as the junctional adhesion molecules (JAMs) (Furuse et al., 1996; Kubota et al., 1999; 
Martin-Padura et al., 1998; Tsukita and Furuse, 2000). The cytoplasmic C-terminal 
domains of the transmembrane proteins bind to the junctional plaque that is composed 
of adaptor proteins such as zonula occludens 1 (ZO1), which contain multiple protein-
protein interaction motifs and connect the junctional membrane proteins with F-actin 
and microtubules (Stevenson et al., 1986; Van Itallie and Anderson, 2014). Claudins are 
the most well understood TJ proteins. They comprise at least 27 members with sizes 
ranging from 20 to 27 kDa and are expressed in a tissue specific manner (Mineta et al., 
2011; Tsukita et al., 2001). According to their channel- and barrier-forming properties, 
claudins are grouped into either anion- or cation-selective paracellular channels and 
further into tight claudins when increasing barrier tightness such as claudin 4 (Cld4) and 
leaky claudins when increasing paracellular permeability such as claudin 2 (Cld2) 
(Amasheh et al., 2002; Krug et al., 2014). As they can oligomerize in cis and trans, diverse 
combinations are possible that influence barrier function (Koval, 2013).  
 
1.2.2 Adherens junctions 
AJs are located directly beneath TJs and due to their close structural and functional 
proximity, both together are also referred to as the apical junctional complex (AJC). AJs 
are calcium-dependent multiprotein complexes, consisting of classical cadherins such as 
E-cadherin (Ecad), N-cadherin (Ncad), VE-cadherin (VEcad) and P-cadherin (Pcad), 
which initiate intercellular contacts through homo- or heterophilic binding of cadherins 
on opposing cells (Adams et al., 1998; Pokutta et al., 1994). Classical cadherins are 
expressed in tissue specific manner. For instance Ncad is present in muscle cells and 
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neurons, while VEcad can be found in endothelial cells and Ecad is the key 
transmembrane protein in epithelial cells (Niessen et al., 2011). Their binding is essential 
for the differentiation into an epithelial cell, as loss of Ecad binding results in an epithelial 
to mesenchymal transition and thus impairs barrier function (Pal et al., 2018). Cadherin-
cadherin interaction occur via their extracellular domains (EDs) and is highly dependent 
on extracellular Ca2+ that rigidifies the ED and allows interaction (Nagar et al., 1996). 
The occurrence of several Ca2+ binding pockets with different affinities, enables 
cadherins to respond dynamically to changes in junctional Ca2+ levels (Prasad and 
Pedigo, 2005). Moreover, a highly conserved tryptophan residue that is present in the 
first ED and inserts into the hydrophobic pocket of the partner cadherin influences 
binding by forming a so-called strand-swapped dimeric structure (Shapiro et al., 1995). 
The cytoplasmic domain of these transmembrane proteins interact with catenins such as 
α-catenin, β-catenin and p120ctn, which couple the cadherin complex to the actin 
cytoskeleton (Perez-Moreno and Fuchs, 2006). With this, AJs confer mechanical 
strength to adjacent epithelial cells and stabilize cell-cell adhesion. Additionally, through 
interaction with numerous other cytoskeletal linker molecules as well as adaptor proteins 
(Padmanabhan et al., 2015), AJs regulate the actin cytoskeleton and are involved in 
intracellular signaling as well as transcriptional regulation (Rubsam et al., 2017a). 
 
1.2.3 Desmosomes 
Desmosomes (which is a composition of the Greek words “desmos”, meaning bond and 
“soma”, meaning body) are the least studied type of intercellular junctions and 
considered to provide primarily the mechanical strength to intercellular cohesion (Green 
and Simpson, 2007). Similar to AJs, they are composed of transmembrane glycoproteins 
of the cadherin family that mediate calcium-dependent cell-cell adhesion via their EDs 
in a homo- or heterophilic manner. In human epithelial tissues, seven isoforms of 
desmosomal cadherins, desmoglein 1-4 (Dsg1-4) and desmocollin 1-3 (Dsc1-3) are 
expressed in a tissue- and differentiation- specific pattern. While stratified epithelia such 
as the human epidermis, express all desmosomal cadherin isoforms, the simple columnar 
epithelium of the human intestine contains Dsg2 and Dsc2 only (Holthofer et al., 2007; 
Introduction  7 
Koch et al., 1992). A common feature shared by all desmosomal cadherins is their 
molecular organization (Fig. 3). Their ED consists of four extracellular cadherin repeats 
(ECs 1-4) and a membrane proximal extracellular anchor (EA) sequence, followed by a 
single-pass transmembrane (TM) domain. While the extracellular repeats of the cadherin 
superfamily are pretty well conserved in classical and desmosomal cadherins, unique 
features are attributed to the cytoplasmic tails (Hulpiau and van Roy, 2009). Both, 
desmogleins and desmocollins, contain a membrane proximal intracellular anchor (IA) 
domain and an intracellular cadherin-like sequence (ICS) that associates with the 
armadillo family plaque proteins plakoglobin (PG) and plakophilin (Pkp). These proteins 
in turn interact with desmoplakin (DP) that anchors the multiprotein complex to the 
intermediate filament cytoskeleton (Holthofer et al., 2007; Koch et al., 1990; Owen and 
Stokes, 2010). Desmocollins occur in two isoforms, of which one contains a truncated 
ICS domain. In addition, desmogleins contain an extended C-terminal unique region 
(DUR) with unknown features that is composed of an intracellular proline-rich linker 
(IPL), a repeat unit domain (RUD) and a desmoglein terminal domain (DTD) (Koch et 
al., 1990). 
 
Figure 3: Molecular composition of a desmosome. (A) Electron micrograph of a desmosome from 
cultured Caco2 cells. (B) Desmosomal cadherins consist of four extracellular cadherin repeats (EC), a 
single pass transmembrane domain (TM) and a cytoplasmic tail that comprises an intracellular anchor 
(IA) and an intracellular cadherin-like sequence (ICS) that associates with plaque proteins. Desmogleins 
have an additional desmoglein unique region (DUR) composed of an intracellular proline-rich linker 
(IPL), a repeat unit domain (RUD) and a desmoglein terminal domain (DTD). 
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1.2.4 Gap junctions 
GJs allow direct communication between two cells through providing a conduit for the 
passage of small metabolites and ions. They are constructed of transmembrane proteins 
called connexins (Cxs) that interact in a homo- and heterophilic way and can form homo- 
and heterotypic channels. Two hemichannels consisting of six Cxs each form a GJ, of 
which permeability is determined by the composition of Cxs isoforms (De Maio et al., 
2002; Segretain and Falk, 2004). Furthermore, Cxs interact with numerous proteins such 
as cytoskeletal components, junctional molecules from AJ or TJ and enzymes like kinases 
or phosphatases (Giepmans, 2004). Intercellular communication via GJ is required for 
maintaining epithelial cell homeostasis and function (Vinken et al., 2006). Furthermore, 
they are assumed to play an important role in several pathophysiological processes. A 
recent study demonstrates that hetero-cellular communication via GJ between IECs and 
inflammatory cells such as macrophages contributes to the dysregulation of intestinal 
epithelial barrier in inflammatory bowel disease (IBD) (Al-Ghadban et al., 2016). 
  
Introduction  9 
1.3 Regulation of the intestinal barrier and intercellular adhesion 
The intestinal epithelial tissue renews every 4-5 days and thus shows the highest turnover 
rate in adult mammals (Clevers, 2013; Mayhew et al., 1999). Within the crypt, progenitor 
stem cells proliferate and differentiate into mature IECs that migrate along the crypt-
villus axis toward the villus tip region, or surface epithelial cuff in the colon, where dying 
epithelial cells are shed, a process that is called cell extrusion (Rosenblatt et al., 2001). 
Cell proliferation and shedding must be tightly regulated to assure the integrity of the 
intestinal barrier and maintain its properties. Hence, it is reasonable that under 
inflammatory conditions, when epithelial proliferation and cell turnover are enhanced, 
an increased risk of barrier leakage is observed (Cliffe et al., 2005). However, how can 
adherent cells in an epithelium proliferate and extrude without compromising the 
epithelial barrier function? The key lies in the regulation of intercellular junctions. Here, 
several strategies are conceivable.  
 
1.3.1 Regulation of intercellular adhesion via specific expression and turnover 
of adhesion molecules 
First, the type and amount of expressed adhesion molecules determines the strength of 
cell-cell adhesion. It is widely recognized that a huge number of narrow tight junctions 
is present in intestinal villi with a mature barrier, while more leaky junctions are found 
in the crypts where cell proliferation takes place (Hollander, 1999). Altered expression 
of tight junction proteins is also observed in a variety of gastrointestinal disorders that 
are characterized by a leaky barrier (Oshima and Miwa, 2016). For instance, expression 
of occludin as well as sealing claudins 5 and 8 is reduced in colon biopsies from patients 
with Crohn’s disease (CD) (Zeissig et al., 2007), whereas the pore-forming claudin 2 has 
been shown to be upregulated in samples from patients suffering from ulcerative colitis 
(UC) and CD (Heller et al., 2005; Zeissig et al., 2007). The same holds true for the 
expression of components from other intercellular junctions. Dsg2 was found to be 
reduced in the mucosa of CD patients (Spindler et al., 2015) and loss of Ecad is nowadays 
commonly considered as a hallmark of epithelial to mesenchymal transition in tumor 
progression (Pal et al., 2018). However, transcriptional regulation of adhesion molecules 
10  Introduction 
 
accounts rather for long-term changes and cannot induce rapid changes in intercellular 
adhesion, since the metabolic half-life of adhesion proteins ranges from approximately 
4 hours for claudins to around five to ten hours for cadherins and up to 12 hours for 
occludin (McCrea and Gumbiner, 1991; Shore and Nelson, 1991; Van Itallie et al., 2004; 
Wong and Gumbiner, 1997). A more dynamic regulation of available amount of 
adhesion molecules is achieved through endocytosis and degradation. In line with this, 
deregulated cadherin internalization has been demonstrated to play a role in various 
diseases associated with loss of epithelial integrity (Kowalczyk and Nanes, 2012). While 
desmosomal cadherins show a rapid turnover, as shown for Dsc2 with a fluorescence 
recovery time of only 30 min after photobleaching, their cytoplasmic plaques seem to be 
exceptionally stable (Windoffer et al., 2002). Furthermore, the composition of 
desmosomal plaques also regulates desmosome dynamics. While Pkp3 renders 
desmosomes to be more dynamic and is found at early desmosomes for instance during 
wound healing, incorporation of Pkp1 results in stable and hyperadhesive desmosomes 
to stabilize intercellular adhesion (Keil et al., 2016; Tucker et al., 2014). A recent study 
shows, that this incorporation is regulated through association of Pkp1 and Pkp3 with 
14-3-3 proteins, which depends on the Pkp phosphorylation status (Rietscher et al., 
2018). 
 
1.3.2 Regulation of intercellular adhesion via the extracellular domain of 
transmembrane adhesion proteins 
A second strategy for regulation of intercellular adhesion involves modulation of the 
existing adhesion complexes including direct inhibition of binding between 
transmembrane proteins through conformational changes, steric hindrance or cleavage 
of extracellular domains (Fig.4). Several studies using adhesion proteins with mutations 
in their extracellular domains report decreased adhesion properties, highlighting the 
importance of a functional ED for proper adhesion (Buck et al., 2018; Dieding et al., 
2017; Gunzel and Yu, 2013; Samuelov and Sprecher, 2015). 
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 Inhibition of binding through conformational changes 
The importance of cadherin ED conformation is obvious regarding the fact that calcium 
binding-induced conformational changes are required for cadherin-cadherin interaction 
(Pokutta et al., 1994). Furthermore, several Ca2+ binding pockets with different affinities 
allow adjustment of binding properties dependent on junctional Ca2+ levels (Prasad and 
Pedigo, 2005). However, for desmosomes, this approach of regulation plays rather a role 
in wound healing, since desmosomes in mature tissues appear in a so-called hyper-
adhesive Ca2+-independent state and thus are resistant to disruption by reduced Ca2+ 
concentration (Garrod et al., 2005). A recent study, reporting that arryhthmogenic 
cardiomyopathy related mutations in Dsg2 ED influence the cadherin binding kinetics 
(Dieding et al., 2017), underlines the importance of proper ED function for adhesive 
properties of cadherins. Modulation of ED conformational changes plays also a role in 
TJ adhesion. For instance, an enterotoxin produced by the food-poisoning bacterium 
Clostridium perfringens, has been reported to target the extracellular domain of Cld4, 
thereby inducing a conformational change that disrupts the claudin assembly in TJ, 
which causes diarrhea (Shinoda et al., 2016).  
 Inhibition of binding through steric hindrance 
Binding inhibition through steric hindrance is well known from the autoimmune disease 
pemphigus, whereby autoantibodies targeting the adhesive domains of Dsg1 and Dsg3 
interfere with desmoglein trans-interaction, leading to skin blisters (Amagai and Stanley, 
2012). However, beside steric hindrance, autoantibody-mediated signaling events are 
required to induce impaired keratinocyte cohesion in pemphigus (Waschke and Spindler, 
2014). Furthermore, multifunctional modulators such as Galectins inhibit cell adhesion 
through steric hindrance when binding monovalently to one of the interacting domains, 
albeit bivalent galectin might also enhance adhesion by cross-linking the ED (Hughes, 
2001). For instance, binding of Galectin-3 to the ED of Dsg2 has been shown to stabilize 
the desmosomal cadherin and intercellular adhesion in intestinal epithelial cells (Jiang et 
al., 2014).  
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 Inhibition of binding through extracellular cleavage of ED 
Regulation of intercellular junctions through extracellular cleavage of the 
transmembrane domains is on the one hand a vital mechanism to regulate epithelial 
homeostasis through loosening intercellular junctions for modulation of cell migration, 
induction of cell proliferation or to prevent the formation of unintended cell aggregates 
(Huguenin et al., 2008; Lochter et al., 1997; McCawley and Matrisian, 2001). On the 
other hand, bacterial proteases target junctional proteins thereby disrupting barrier 
integrity and in pathological states including inflammation and cancer, many proteases 
for junctional proteins are misregulated, which underlines the importance of this 
regulatory mechanism (Nava et al., 2013). For instance, a serine protease released by 
Staphylococcus aureus cleaves the ED of Dsg1, which disrupts cell-cell adhesion and results 
in Staphylococcal scalded skin syndrome or bullous impetigo (Amagai et al., 2000; 
Hanakawa et al., 2002). A zinc-containing metalloprotease produced by Vibrio cholerae 
targets TJs and disrupts epithelial barrier function through cleavage of the occludin ED 
(Wu et al., 2000). Also AJ are targeted by bacterial proteases such as the HtrA protease 
from Helicobacter pylori that cleaves the ED of Ecad (Hoy et al., 2012). By now, a huge 
number of proteases has been identified for all types of intercellular junctions present in 
the intestinal epithelium and many of them are upregulated in IBD (Menzel et al., 2006; 
Ravi et al., 2007). For instance, matrixmetalloproteinase (MMP) as well as a disintegrin 
and metalloproteinase domain-containing protein (ADAM) can cleave classical 
cadherins as well as Dsg2 (Bech-Serra et al., 2006; Lochter et al., 1997; Maretzky et al., 
2005; Nava et al., 2013; Noe et al., 2001) and their activities are upregulated in several 
pathological conditions including inflammation, cancers, vascular disorders and 
autoimmune diseases (Gialeli et al., 2011; Rocks et al., 2008). However, beside disruption 
of adhesion, cleavage of the ED releases a functional ectodomain fragment that 
additionally modulates cellular processes. In this context, Dsg2 ectodomain shedding 
has been shown to compromise the mucosal barrier and to enhance IEC proliferation 
through activation of growth factor receptors (Kamekura et al., 2015). Also in skin 
epithelium, shed cadherin fragments have been reported to inhibit intercellular adhesion 
(Klessner et al., 2009; Lorch et al., 2004; Maretzky et al., 2005; Reiss et al., 2005). 
Moreover, increased soluble fragments of Ecad, Ncad and nectin are detected in cancer 
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tissues of patients and thus are meanwhile considered as biomarkers (Chung et al., 2011; 
Derycke et al., 2006; Fabre-Lafay et al., 2005; Katayama et al., 1994).  
 
Figure 4. Regulation of intercellular adhesion through direct inhibition of binding between ED 
of adhesion molecules. Transmembrane adhesion molecules interact via their ED in a homo- or 
heterophilic manner, thereby mediating strong intercellular adhesion. Interaction is inhibited through 
conformational changes of the ED, protease-mediated cleavage of the ED, whereby the cleaved 
fragment also exerts biological functions and steric hindrance for example through autoantibodies or 
small molecules such as lectins. 
 
 
 
1.3.3 Regulation of intercellular adhesion via the cytoplasmic tail of adhesion 
proteins 
Although it is the ED of the transmembrane junctional proteins that mediates interaction 
with their respective binding partners on adjacent cells, also the cytoplasmic tail is an 
important site for regulation of intercellular adhesion (Fig. 5). To provide mechanical 
strength, adhesion complexes are associated with the cytoskeleton, which in case of TJ 
and AJ is the actin cytoskeleton and in case of desmosomes, the intermediate filament 
cytoskeleton. Hence, the cytoskeletal anchorage is a favorable target site for regulation 
of the adhesive strength and for opening of the intercellular space by contraction of the 
cytoskeleton. Important to mention here are the Rho family GTPases that modulate 
actin cytoskeleton dynamics and have emerged as crucial regulators of intestinal barrier 
function (Citalan-Madrid et al., 2013). Both, barrier stabilizing and destabilizing effects 
for these GTPases have been shown such as RhoA and Cdc42 mediated support of TJ 
formation as well as barrier disruption through RhoA induced myosin light chain 
phosphorylation and actin-myosin contraction (Itoh et al., 2012; Terry et al., 2011; 
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Yamada and Nelson, 2007). Along this line, reduced barrier function in CD is assumed 
to be induced by increased expression of myosin light chain kinase (MLCK) in response 
to TNFα (Turner, 2006). Moreover, retraction of the keratin intermediate filament 
network is a hallmark of the autoimmune disease pemphigus vulgaris that is 
characterized by skin blisters, which result from loss of cell-cell adhesion (Spindler et al., 
2018). Furthermore, keratinocytes deficient of all keratin filaments showed impaired 
Dsg3 binding properties and membrane stability (Vielmuth et al., 2018). In this context, 
another important signaling molecule, p38 mitogen-activated protein kinase 
(p38MAPK) has been shown to regulate the anchorage of the desmosomal complex to 
the keratin filament cytoskeleton and its activation is linked to keratin retraction 
(Berkowitz et al., 2005; Spindler et al., 2013; Waschke et al., 2006). In addition, 
p38MAPK is also involved in regulation of intercellular adhesion in the intestinal 
epithelium and is supposed to play an important role in the pathogenesis of CD. In this 
regard, TNFα, the central cytokine in CD, has been shown to increase the activity of 
p38MAPK, which was accompanied by loss of Dsg2 and TJ remodeling (Spindler et al., 
2015). The p38MAPK signaling pathway and its interrelationship with desmosomal 
cadherins is described in detail below. Finally, the cytoplasmic tails modulate intercellular 
adhesion through regulation of cadherin turnover as tail-tail interactions have been 
demonstrated to stabilize the protein and inhibit endocytosis (Chen et al., 2012). 
 
1.3.4 Regulation of intercellular adhesion via receptor tyrosine kinase signaling 
Regulation of intercellular adhesion is required for proper cell homeostasis and has to 
be adjusted dynamically in response to environmental stimuli. Central in transmitting 
extracellular stimuli, are the receptor tyrosine kinases (RTK) that have emerged as key 
regulators of fundamental cellular processes including differentiation, proliferation and 
migration (Ullrich and Schlessinger, 1990). In humans, 58 RTKs are expressed, with all 
having a similar molecular architecture consisting of an extracellular region with ligand 
binding domains, a single transmembrane helix and a cytoplasmic region containing a 
protein tyrosine kinase domain as well as further carboxy terminal and juxtamembrane 
regulatory regions (Lemmon and Schlessinger, 2010). A growing number of studies 
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provide evidence that RTKs associate with intercellular junctions and influence cell-cell 
adhesion but vice versa also junctional proteins control RTKs (McClatchey and Yap, 
2012; McCrea et al., 2015; McLachlan and Yap, 2007). Mechanisms how RTKs regulate 
intercellular adhesion, include phosphorylation of multiple components of the adhesion 
complex in a direct manner or via activation of kinases such as Src, Abl, PAK and CK1/2 
(Bertocchi et al., 2012; Escobar et al., 2015; Hoschuetzky et al., 1994; Ji et al., 2009; 
Shibamoto et al., 1994). It is assumed, that this modification weakens cell adhesion by 
disrupting the cytoskeleton anchorage (Bertocchi et al., 2012; McCrea et al., 2015) or by 
inducing protein endocytosis (Cadwell et al., 2016). In this study, particular attention is 
given to the epidermal growth factor (EGF) receptor (EGFR) that has been 
demonstrated to regulate function of desmogleins (Klessner et al., 2009; Lorch et al., 
2004) and is described in detail below. 
 
 
Figure 5. Modulation of the transmembrane adhesion protein cytoplasmic tail regulates 
intercellular adhesion. Adhesion proteins are tethered to the cytoskeleton via their cytoplasmic tail, 
which provides mechanical strength to the intercellular junction. Contraction of the cytoskeleton as well 
as disruption of cytoskeleton anchorage, both mediated by a range of signaling molecules, weakens 
intercellular adhesion. Tail-tail interaction of desmosomal cadherins stabilizes the proteins and prevents 
internalization. RTKs regulate intercellular adhesion via direct or indirect phosphorylation of the 
junctional proteins, which results in disruption of cytoskeleton anchorage or internalization.   
 
 
 
Thus far, many signaling molecules have been identified to interact with intercellular 
junctions. In general, junctional complexes are meanwhile accepted as signaling 
platforms that are targeted by various signaling mechanisms but also themselves 
modulate epithelial homeostasis including cell proliferation, differentiation, migration 
and regulated shedding (Chiasson-MacKenzie and McClatchey, 2018; Muller et al., 2008; 
Rubsam et al., 2017a).  
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1.3.5 Desmosomes as signaling hubs 
There is increasing evidence that desmosomes do not only provide mechanical strength 
to intercellular adhesion but also integrate mechanical and biochemical pathways to 
regulate cellular functions. Although cells are held together by three types of intercellular 
junctions, inactivation of desmosomal components such as Dsg2, Dsc3 or DP are 
embryonic lethal in mice, indicating their important function in tissue morphogenesis 
(Den et al., 2006; Eshkind et al., 2002; Gallicano et al., 1998). Over the last years, 
desmosomal contacts have emerged as critical signaling hubs (Spindler and Waschke, 
2014). Since to date no enzymatic activity has been accredited to the intracellular tail of 
desmogleins, interaction with signaling components is required for signal transduction. 
In keratinocytes, extradesmosomal Dsg3 has been reported to strengthen cell cohesion 
via modulation of p38MAPK through the formation of a signaling complex together 
with Ecad, β-catenin and Src (Rotzer et al., 2015). Activation of p38MAPK through 
desmosomal signaling is also a well-known event in the autoimmune disease pemphigus, 
where autoantibody binding to the ED of Dsg1 and Dsg3 induces phosphorylation of 
p38MAPK (Berkowitz et al., 2008b; Berkowitz et al., 2005). Furthermore, several other 
signaling molecules have been shown to be activated by pemphigus autoantibodies such 
as the protein kinase C (PKC), Src, Erk and cAMP signaling (Esaki et al., 1995; Seishima 
et al., 1995; Walter et al., 2017), suggesting that desmosomal cadherins transmit 
extracellular stimuli and trigger signaling inside the cell (Muller et al., 2008). A well-
known environmental stimulus are for instance inflammatory cytokines like interferon-
γ (IFNγ) and TNFα, which are released during mucosal inflammation as known for the 
pathogenesis of IBD (Koch and Nusrat, 2012; Nava et al., 2010; Rogler and Andus, 
1998). In respond to inflammatory cytokines, Dsg2 ED cleavage has been reported. 
Here, the cleaved fragments bind to human epidermal growth factor receptor family 
members HER2 and HER3, which results in activation of MAPK and Akt/mTOR 
downstream signaling pathways (Kamekura et al., 2015). 
However, signaling occurs also independently of the extracellular portion, as shown for 
Dsg1, where direct interaction of the Dsg1 cytoplasmic tail and EGFR suppress EGFR 
activation and subsequent Erk1/2 signaling, to promote differentiation (Getsios et al., 
2009). Further, the release and translocation of otherwise tied desmosomal components 
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regulates signaling pathways, as shown for PG that inhibits the expression of β-catenin 
genes in the nucleus, thereby controlling the canonical Wnt pathway (Ben-Ze'ev et al., 
2000; Garcia-Gras et al., 2006). Likewise, the plakophilins, in addition to their role as 
architectural component in desmosomal plaques, are known to be present in the 
cytoplasm or nucleus, where they influence translational as well as transcriptional 
processes through direct interaction with RNA binding proteins or transcription factors, 
respectively (Hofmann et al., 2006; Mertens et al., 1996; Munoz et al., 2014). In addition, 
the release of cleaved fragments from the intracellular desmoglein domains are able to 
induce signaling as shown recently for Dsg2, of which intracellular fragments regulate 
apoptosis in IECs (Yulis et al., 2018). Similarly, the cleaved intracellular fragments of 
Dsg1 and Dsg3 have been reported to regulate apoptosis (Dusek et al., 2006; Weiske et 
al., 2001). Furthermore, the intracellular C-terminal fragment of Dsg2 has been found 
to be enriched in extracellular vesicles secreted by keratinocytes, thus influencing 
intercellular signaling. Moreover, Dsg2 modulated biogenesis of the extracellular vesicles 
via caveolin-1 and lipid rafts (Overmiller et al., 2017). Previously, Dsg2 has already been 
demonstrated to displace caveolin-1, EGFR and Src from lipid rafts leading to their 
enhanced activity (Overmiller et al., 2016).  
Given their tight association with the cytoskeleton, it is easily comprehensible that 
desmosomes control also the cytoskeletal network and thereby integrate mechanical 
pathways to attune tissue structure and function (Rubsam et al., 2017a). However, this 
involves not only regulation of the directly associated intermediate filament cytoskeleton, 
but also includes regulation of the actin cytoskeleton and actin-based junctions. For 
instance, keratinocytes deficient for DP have a reduced number of desmosomes that are 
not linked to keratins anymore and in addition, they have less AJs (Vasioukhin et al., 
2001b). Vice versa, loss of classical cadherins from AJ or α-catenin also impairs AJ as 
well as desmosome assembly (Michels et al., 2009; Tinkle et al., 2008; Vasioukhin et al., 
2001a). In addition, extradesmosomal Dsg3 signaling complexes have been shown to 
bind to actin and recruitment of DP to the desmosomal plaque requires actomyosin, 
which raises the possibility that actin is important for desmosome assembly (Godsel et 
al., 2010; Tsang et al., 2012). Desmosome-mediated regulation of the actin organization 
involves inter ilia the plaque protein Pkp2 that regulates actin remodeling and 
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localization of active RhoA to cell-cell contacts (Godsel et al., 2010). Furthermore, it can 
be concluded that TJ are under control of desmosomes. DP was demonstrated to 
regulate claudin expression (Sumigray et al., 2014) and an antibody targeting the ED of 
Dsg2 induced increased permeability accompanied with alterations of TJ component 
distribution, while Ecad was unaltered (Schlegel et al., 2010). However, the underlining 
mechanism remains unclear, so far. 
 
1.3.6 p38MAPK signaling pathway 
The p38MAPK is an important player involved in the regulation of intercellular adhesion 
(Spindler and Waschke, 2014) and has been associated with a variety of vital functions 
(Fig. 6). So far, four splice variants of p38MAPK are known, of which p38α and p38β 
are ubiquitously expressed whereas p38γ as well as p38δ expression is dependent on the 
type of tissue (Hanks and Hunter, 1995). Activation of p38MAPK includes extracellular 
stimuli such as UV light, heat, osmotic shock, inflammatory cytokines and growth factors 
(Foltz et al., 1997; Han et al., 1994; Lee et al., 1994; Raingeaud et al., 1995; Rouse et al., 
1994). Further complexity comes from the vast number of extracellular activators, of 
which some can do both, activate as well as inactivate the kinase dependent on the type 
of cell. For instance, insulin activates p38MAPK in adipocytes but downregulates the 
kinase in chick forebrain neuron cells (Heidenreich and Kummer, 1996; Sweeney et al., 
1999). Moreover, several upstream kinases regulate p38MAPK activity (Zarubin and 
Han, 2005) with MKK3 and MKK6 from the MAP kinase kinase (MAPKK) family 
being the two main kinases known to activate p38MAPK (Enslen et al., 1998). 
Furthermore, a MAPKK-independent mechanism of p38MAPK activation has been 
reported, involving autophosphorylation of p38MAPK upon binding to transforming 
growth factor-β-activated protein kinase 1 binding protein (TAB1) (Ge et al., 2002). In 
addition, Rho family GTP-binding proteins such as RhoA, Rac1 and Cdc42 also 
contribute to p38MAPK activation (Bagrodia et al., 1995; Kyriakis and Avruch, 2001; 
Zhang et al., 1995). Downregulation of p38MAPK activity is achieved by 
dephosphorylation through phosphatases from the MAP kinase phosphatase (MPK) 
family as well as some other types of phosphatases such as serine/threonine protein 
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phosphatase type 2C (PP2C) (Sun et al., 1993; Takekawa et al., 1998). Substrates of 
p38MAPK include downstream kinases, transcription factors as well as components of 
the cytoskeleton such as keratins and regulate cell metabolism, apoptosis, survival, 
migration, inflammation, cell growth, proliferation and cell differentiation (Daly et al., 
1999; Dieckgraefe et al., 1997; Sharma et al., 2003; Xia et al., 1995; Zarubin and Han, 
2005). Furthermore, a growing number of studies reports a role for p38MAPK in 
regulating cell adhesion. Thus, p38MAPK-mediated keratin retraction paralleled with 
decreased cell cohesion, is a well-known phenomenon in pemphigus (Berkowitz et al., 
2005; Spindler et al., 2013). This process involves EGFR activation and inhibition of 
RhoA activity, which results in reduced insertion of keratin filaments at cell junctions 
(Bektas et al., 2013; Waschke, 2008). Furthermore, p38MAPK is also known to bind 
directly to Dsg3 and PG and activation of p38MAPK has been associated with increased 
desmosomal turnover in a clathrin- and dynamin-independent manner (Delva et al., 
2008; Mao et al., 2009; Saito et al., 2012; Schulze et al., 2012; Spindler et al., 2013). In 
addition, increased activity of p38MAPK upon stimulation with TNFα induced loss of 
cell cohesion and increased permeability in cultured IECs (Spindler et al., 2015).  
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Figure 6. The p38MAPK signaling pathway and associated functions. Activation of the p38MAPK 
signaling pathway includes stimulation with UV light, cytokines, growth factors, oxidative stress or DNA 
damage. Upon stimulation, a cascade of several kinases is activated resulting in phosphorylation of 
p38MAPK, which in turn regulates a variety of cellular functions. Among others, activation of 
p38MAPK inhibits anchorage of the keratin filament cytoskeleton via RhoA and MK2, resulting in 
impaired cell adhesion. In addition, active p38MAPK promotes Dsg3 depletion, further destabilizing cell 
adhesion. 
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1.3.7 EGFR signaling pathway 
Beside its plethora of functions including cell growth, differentiation, proliferation and 
motility (Ceresa and Peterson, 2014), increasing evidence indicate that EGFR plays a 
central role in regulating intercellular adhesion. Moreover, EGFR has already been 
shown to regulate function of desmogleins and vice versa (Blay and Brown, 1985; 
Getsios et al., 2009; Kamekura et al., 2014; Klessner et al., 2009; Lorch et al., 2004; 
Overmiller et al., 2016). The EGFR belongs to the ErbB/HER protein-tyrosine kinase 
family, of which four members are known in vertebrates, HER1-4 that are expressed at 
the cell surface of numerous cell types (Hynes and Lane, 2005). The extracellular region 
comprises four domains I-IV, of which the domains I and III bind to activating ligands. 
Domain II contains a dimerization arm that is masked through intramolecular 
interactions with domain IV resulting in a tethered conformation that inhibits 
dimerization (Bouyain et al., 2005; Burgess et al., 2003; Cho and Leahy, 2002; Ferguson 
et al., 2003). Ligand binding induces a conformational change that unmask the 
dimerization arm and allows homophilic as well as heterophilic interaction with a second 
ligand-bound receptor molecule to form functional dimers or oligomers (Burgess et al., 
2003; Roskoski, 2014). So far, seven different ligands are known to bind to EGFR, of 
which EGF is considered to bind with high affinity (Harris et al., 2003; Wilson et al., 
2009). All ligands are produced as transmembrane precursor proteins and have to be 
cleaved by cell surface proteases to be released as mature growth factors that bind to 
EGFR (Harris et al., 2003). Since production of EGF is controlled locally, in contrast to 
being delivered systematically like it is the case for hormones, it is possible that different 
organs execute their own EGF-mediated programs (Conte and Sigismund, 2016; Singh 
and Harris, 2005). Receptor dimerization induces activation of the EGFR tyrosine kinase 
domain (TKD) and succeeding cross-phosphorylation of cytoplasmic receptor domains 
that serve as docking sites for several adaptor proteins containing Src homology-2 (SH2) 
and phosphotyrosine-binding (PTB) domains (Honegger et al., 1989; Kaplan et al., 2016; 
Ogiso et al., 2002; Shoelson, 1997; Sudol, 1998; Ullrich and Schlessinger, 1990). 
Recruited proteins include for example Src homology domain-containing adaptor 
protein C (Shc), growth factor receptor-bound protein 2 (Grb2) phospholipase C γ 
(PLCγ) or kinases such as Src, phosphatidylinositol-3-kinase (PI3K), phosphatases such 
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as PTP1B, SHP1 and SHP2 and ubiquitin ligases such as Cbl (Olayioye et al., 2000). The 
kinase Src has additionally been shown to phosphorylate EGFR on tyrosine residue 845 
(Y845) in a ligand independent manner (Moro et al., 2002). Over hundred interaction 
partners for EGFR have been identified so far and the number is still growing 
(Morandell et al., 2008). Specificity of the docking site is defined by the phosphorylated 
tyrosine residue, of which approximately twenty residues have been identified as docking 
sites that trigger various signaling cascades. The major signaling cascades involve 
Ras/Raf/MEK/ERK/MAPK and PI3K/Akt pathways (Singh and Harris, 2005) but 
further pathways have been reported such as PLCγ/PKC, signal transducer and activator 
of transcription (STAT), c-Jun terminal kinase (JNK) as well as p38MAPK (Andl et al., 
2004; Johnson et al., 2005; Kloth et al., 2002) (Fig. 7). Vice versa, p38MAPK is also a 
feedback regulator of EGFR and controls its expression (Frey et al., 2006; 
Vergarajauregui et al., 2006). Furthermore, EGFR is internalized upon ligand binding via 
clathrin-coated endocytic vesicles that fuse with early endosomes where the EGFR is 
sorted for recycling or degradation (Bakker et al., 2017). While trafficking, signaling 
continues and EGFR is also known to function as transcription factor in the nucleus 
(Brand et al., 2013; Francavilla et al., 2016; Haugh et al., 1999; Kamio et al., 1990; Vieira 
et al., 1996; Wu et al., 2012). The EGFR pathway controls a series of biological functions 
such as cell proliferation, differentiation, survival, migration, angiogenesis and cell 
adhesion (Baselga and Hammond, 2002; Laskin and Sandler, 2004; Morandell et al., 
2008; Yarden and Sliwkowski, 2001). Moreover, EGFR is suggested to regulate cell 
extrusion, wound healing and migration in the intestinal epithelium (Blay and Brown, 
1985; Miguel et al., 2017; Polk, 1998). These processes require precise regulation of 
intercellular adhesion and thus it comes as no surprise that several studies linked the 
EGFR to desmosomal function. In keratinocytes, Dsg1 was shown to co-localize with 
EGFR, thus suppressing its activity to promote differentiation (Getsios et al., 2009). 
Another study reported positive regulation of EGFR by Dsg2 thereby stimulating cell-
growth and migration (Overmiller et al., 2016) and Dsg2 turnover is under control of 
EGFR signaling (Klessner et al., 2009). There is also evidence for direct interaction of 
Dsg2 and EGFR (Tong et al., 2014). In addition, desmosomal plaque proteins have been 
linked to the EGFR pathway, such as Pkp2 that enhances ligand-dependent as well as 
ligand-independent receptor dimerization and activation (Arimoto et al., 2014).  
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Figure 7. The EGFR signaling pathway and associated functions. The EGFR appears as monomer 
in a tethered conformation that is opened upon ligand binding, which allows receptor dimerization 
followed by cross-phosphorylation of the cytoplasmic tail tyrosine residues. Several adaptor proteins as 
well as kinases, phosphatases and ubiquitin ligases are recruited dependent on the type of 
phosphorylation that results in activation of various signaling cascades controlling vital cellular functions. 
Ligand binding also induces receptor internalization. Besides, EGFR is also linked to desmosomal 
components. 
 
 
 
 
1.3.8 Glial cell-derived neurotrophic factor 
The intestinal epithelial barrier function is additionally regulated by the ENS, which is a 
network of glial and neuronal cells and through sympathetic and parasympathetic 
pathways liaises closely with the CNS (Furness, 2012). Increasing evidence attribute a 
key role in regulating barrier function to the EGCs that release specific mediators such 
as GDNF or TGFβ1 hence controling the maintance of both, ENS and epithelial barrier 
integrity (Abdo et al., 2010; Neunlist et al., 2014). Ablation of EGCs has been 
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demonstrated to impair intestinal barrier function in mice (Bush et al., 1998; Cornet et 
al., 2001) and functional as well as morphological abnormalities similar to inflammatory 
bowel diseases were observed in mice with reduced GDNF levels (Brun et al., 2013; von 
Boyen et al., 2004; Zhang et al., 2010b). GDNF is a growth factor belonging to the 
cysteine-knot superfamily and signals through a receptor complex consisting of the RTK 
RET (rearranged during transfection) and one of four GDNF familiy receptors (GFRα 
1-4) (Takahashi, 2001). Downstream targets of the activated receptor complex include 
p38MAPK, Erk, Akt and PKA (Allen et al., 2013; Granholm et al., 2000; Takahashi, 
2001). In general, GDNF influences the proliferation of glial cells as well as neurons 
during development of the ENS (Wang et al., 2010), but additionally GDNF is reported 
to have strong anti-apoptotic effects on colonic epithelial cells (Steinkamp et al., 2003; 
Zhang et al., 2010b). Moreover, GDNF is suggested to directly affect junctional proteins 
such as claudin 5 that is upregulated by the growth factor in the blood-brain barrier 
(Shimizu et al., 2012). Along this line, a recent study demonstrated a positive effect on 
barrier maturation and wound healing in IECs involving enhanced maturation of TJ and 
on top, suggests enterocytes to represent another source for GDNF in the intestine 
(Meir et al., 2015b). However, it is unclear what stimulus induces GDNF expression in 
enterocytes. Here, toll-like receptor 2 (TLR-2) that is activated by pathogen-associated 
molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), has 
been shown to be required for secretion of GDNF in EGCs (Walsh et al., 2013). Hence, 
it can be envisioned that GDNF regulates the intestinal barrier properties in 
pathophysiological inflammatory states such as IBD. 
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1.4 Inflammatory bowel disease 
Dysfunction of the intestinal epithelial barrier is a hallmark of IBD including ulcerative 
colitis (UC) and CD, which affect mostly young people (Martini et al., 2017). While CD 
can impact any part of the gastrointestinal tract, UC is limited to the mucosa of the colon 
(Feakins, 2014). Up to 40% of first-degree relatives of patients suffering from CD display 
an altered permeability in the small intestine without showing symptoms of IBD, 
indicating that multiple genetic as well as environmental factors contribute to a complex 
pathogenesis (Geremia et al., 2014; Hollander et al., 1986; Peeters et al., 1997; Uhlig, 
2013). Due to an uncontrolled immune response to gut microbiota, which results from 
compromised barrier functions, IBD was classified as an autoimmune disease, for a long 
time. However, nowadays the disturbed adaptive immunity is considered rather as 
consequence than as cause of intestinal inflammation (Jager et al., 2013). An increased 
secretion of the inflammatory cytokine TNFα is believed to be a critical factor that links 
the observed increased intestinal permeability and immune reaction (Sanders, 2005). 
However, TNFα also affects junctional components such as Dsg2 that has been shown 
to disappear from cell borders upon stimulation with TNFα. In addition, claudins were 
deregulated with a reduction of Cld1 and upregulation of Cld2 (Spindler et al., 2015). At 
least in part, these effects were triggered by activation of p38MAPK. Alterations in TJ 
integrity is a well-known phenomenon in patients suffering from CD (Mankertz and 
Schulzke, 2007; Zeissig et al., 2007). Likewise, AJ are affected in CD with an observed 
dislocation of Ecad (Muise et al., 2009). Furthermore, several signaling molecules such 
as RhoA or MLCK that are linked to regulation of intercellular adhesion, have been 
reported to be dysregulated in patients with IBD (Blair et al., 2006; Lopez-Posadas et al., 
2016). Hence, not only changes in composition of intercellular junctions play a key role 
in the pathogenesis of IBD but also signaling related to intercellular junctions. Treatment 
of IBD is currently focused on immunomodulators and anti-inflammatory agents to 
control the inappropriate immune response as well as inflammation that harms the 
intestinal epithelium (Cohen et al., 2012). However, there are considerable side-effects 
and not all patients respond to the therapy, which underlines the need for new 
therapeutic approaches (MacDonald et al., 2012; Rutgeerts et al., 2009). Hence, a deeper 
knowledge on the pathophysiology of IBD might provide new therapeutic options.  
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1.5 Aim of this study 
For a long time, desmosomes have been considered to provide primarily the mechanical 
strength to intercellular cohesion. However, a growing number of studies point also 
towards a role in regulating signaling cascades. Especially tissues with a high turnover 
rate such as the human intestinal epithelium require a precise regulation of intercellular 
adhesion to allow cell extrusion and proliferation, while maintaining the epithelial barrier 
function. Many signaling pathways are known to be central during intestinal tissue 
homeostasis, however only little is known about their interplay with desmosomal 
components. Thus, the main objective of this PhD thesis was to explore whether the 
desmosomal cadherin Dsg2 modulates signaling pathways beside its adhesive properties 
in simple epithelia of the intestine. 
For this purpose, WT as well as Dsg2 deficient cultured enterocytes were analyzed 
regarding deregulated signaling pathways as well as their intercellular cohesion and 
barrier properties. To ascertain the suitability of cultured enterocytes as a model for the 
intestinal epithelium, cells were characterized concerning the establishment of junctional 
complexes and compared to human tissue from the intestine using transmission as well 
as scanning electron microscopy.  
Although, being the core adhesive molecule of desmosomes, the appearance of 
extradesmosomal cadherins has been reported. Thus, another goal was to clarify the 
question whether extradesmosomal Dsg2 is present in IECs, which was addressed 
utilizing high resolution microscopy as well as biochemical approaches.  
To elucidate binding properties of Dsg2, atomic force microscopy (AFM) was 
established on living enterocytes. Using this approach several modulators of different 
signaling cascades were tested regarding their ability to influence Dsg2 binding.  
A crucial regulator of the intestinal homeostasis is EGFR that has already been linked to 
regulation of junctional complexes. Hence, a further aim was to explore a putative 
cooperation of Dsg2 and EGFR in intestinal barrier regulation. For this, co-localization 
studies, biochemical assays, interaction studies and functional assays were performed in 
cultured cells as well as human tissue samples.  
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Since Dsg2 is assumed to contribute to the pathogenesis of CD, another goal was to 
elucidate its role in this context. To this end, human tissue samples from CD patients 
were analyzed with regard to ultrastructural changes of desmosomes. Moreover, the 
interrelationship of Dsg2 and GDNF, which is a potential key player in IBD, was 
characterized with AFM. 
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Desmoglein 2 regulates the 
intestinal epithelial barrier via p38 
mitogen-activated protein kinase
Hanna Ungewiß1, Franziska Vielmuth1, Shintaro T. Suzuki2, Andreas Maiser3, Hartmann 
Harz3, Heinrich Leonhardt3, Daniela Kugelmann1, Nicolas Schlegel4 & Jens Waschke1
Intestinal epithelial barrier properties are maintained by a junctional complex consisting of tight 
junctions (TJ), adherens junctions (AJ) and desmosomes. Desmoglein 2 (Dsg2), an adhesion molecule 
of desmosomes and the only Dsg isoform expressed in enterocytes, is required for epithelial 
barrier properties and may contribute to barrier defects in Crohn’s disease. Here, we identified 
extradesmosomal Dsg2 on the surface of polarized enterocytes by Triton extraction, confocal 
microscopy, SIM and STED. Atomic force microscopy (AFM) revealed Dsg2-specific binding events along 
the cell border on the surface of enterocytes with a mean unbinding force of around 30pN. Binding 
events were blocked by an inhibitory antibody targeting Dsg2 which under same conditions activated 
p38MAPK but did not reduce cell cohesion. In enterocytes deficient for Dsg2, p38MAPK activity 
was reduced and both barrier integrity and reformation were impaired. Dsc2 rescue did not restore 
p38MAPK activity indicating that Dsg2 is required. Accordingly, direct activation of p38MAPK in Dsg2-
deficient cells enhanced barrier reformation demonstrating that Dsg2-mediated activation of p38MAPK 
is crucial for barrier function. Collectively, our data show that Dsg2, beside its adhesion function, 
regulates intestinal barrier function via p38MAPK signalling. This is in contrast to keratinocytes and 
points towards tissue-specific signalling functions of desmosomal cadherins.
The internal surface of the gut is covered by a single layer of polarized enterocytes, forming the intestinal epi-
thelium that operates as a selective barrier which protects the organism against luminal pathogens but allows 
uptake of nutrients. Barrier properties are established by three types of intercellular junctions, tight junctions 
(TJ), adherens junctions (AJ) and desmosomes which together form the “terminal bar” by sealing the paracellular 
space1, 2. TJ composed of claudins, occludin and a range of additional transmembrane proteins, are located in 
the most apical part where they seal the intercellular cleft3. Beneath, AJ formed by E-cadherin (E-cad) and a set 
of associated proteins mediate mechanical strength between epithelial cells and in addition are also involved in 
epithelial polarization, differentiation, migration and tissue morphogenesis4. The third and least studied type of 
intercellular junctions are the desmosomes, composed of the cadherin family members desmoglein (Dsg) and 
desmocollin (Dsc), which interact in homo- and heterophilic fashion via their extracellular domains (ED) and 
are associated with the intermediate filament cytoskeleton through specific desmosomal plaque proteins, namely 
plakoglobin (PG), plakophilins (Pkp) and desmoplakin (DP)5. Desmosomal cadherins are expressed as multiple 
isoforms in a tissue- and differentiation-specific manner. Layer specific expression pattern of all human isoforms 
(Dsg1-4 and Dsc1-3) can be observed in stratified epithelia such as the human epidermis whereas desmosomes in 
the simple columnar epithelium of the human intestine are composed of Dsg2 and Dsc2 only6–9.
Desmosomes are assumed to play the leading role in intercellular cohesion10. Beyond, they are also implicated 
in modulating fundamental cellular processes such as proliferation, apoptosis or organization of the cytoskele-
ton11. We have previously shown that desmosomal adhesion is required for intestinal epithelial barrier function12. 
The maintenance and turn-over of junctional complexes has to be regulated tightly during the rapid cell renewal 
of every 4–5 days in the intestinal epithelium13. On the other hand, increased intestinal permeability is associated 
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with severe inflammatory disorders such as Crohn’s disease (CD)14–17. Especially, Dsg2 has already been shown to 
play a role in inflammation18 and in the pathogenesis of CD as it was strongly reduced in the mucosa of patients 
suffering from CD whereas the AJ molecule E-cadherin was unaffected19. Tumor necrosis factor-α (TNF-α), 
which is a central cytokine in CD, resulted in impaired barrier properties whereas a tandem peptide stabiliz-
ing desmosomal adhesion rescued barrier function. Interestingly, similar to TNF-α, a Dsg2-specific antibody 
targeting the ED of Dsg2 increased permeability12. However, it is unclear how this effect is achieved. It is likely 
that some amount of antibody permeates across TJs and directly inhibits transinteraction of Dsg2 within desmo-
somes, which compromises barrier integrity.
Another possibility could be that Dsg2 is expressed outside of desmosomes on the cell surface, accessible to 
the Dsg2-specific antibody and binding resulted in activation of signalling pathways. Desmogleins have already 
been shown to mediate signalling events20, however, nothing is known about extradesmosomal Dsg2 on the cell 
surface of enterocytes. In contrast, in keratinocytes extradesmosomal Dsg3 but not Dsg2 has been found in a 
signalling complex together with E-cadherin, β-catenin and Src21 where Dsg3 strengthens cell cohesion via mod-
ulation of mitogen-activated protein kinase (p38MAPK)22.
Bearing in mind that Dsg2 is the only Dsg isoform expressed in enterocytes and in view of our previous 
finding that it may contribute to the pathogenesis of CD, we investigated whether Dsg2 plays a role in modu-
lating signalling cascades and cell cohesion in enterocytes, in this study. For the recent study, we used DLD1 
cells deficient for Dsg2 and or Dsc2 under conditions where they were polarized similar to the well-established 
model of Caco2 cells used in our previous studies. Here, we show for the first time that extradesmosomal Dsg2 
is expressed on the surface of polarized cultured enterocytes. Moreover, our data identify a novel role for Dsg2 
in regulating p38MAPK as this kinase was activated after application of the Dsg2-specific antibody and reduced 
levels of p38MAPK activity were detected in Dsg2 knockout cells. Furthermore, activation as well as inhibition of 
p38MAPK led to barrier-destabilization, suggesting that a well-balanced level of p38MAPK activity is crucial for 
barrier properties. Collectively, our data provides evidence that Dsg2 regulates barrier properties in enterocytes 
via modulating the p38MAPK signalling cascade.
Results
Polarized cultured enterocytes displayed extradesmosomal Dsg2 at the cell surface. To explore 
the adhesive and signalling function of Dsg2 in the intestine, we used Caco2 and DLD1 cell lines. Both form an 
enterocyte-like epithelial cell monolayer with fully formed junctional complexes and characteristic microvilli on 
the cell surface (Fig. S1A) resembling a human specimen from the terminal ileum (Fig. S1B). Immunostaining 
of the junctional components Dsg2 and Claudin4 (Cld4) revealed linear localization at the cell border with junc-
tional complexes being present at the most apical part of the intercellular cleft (Fig. 1A and S1C). Moreover, con-
stant protein levels of junctional components (Fig. S1D) as well as constant transepithelial resistance (TER) values 
(Fig. S1E) revealed mature barrier properties. By using structured illumination microscopy (SIM), we observed 
that Dsg2 is also located at the free cell surface which is characterized by microvilli (Fig. 1B). Furthermore, 
SIM allowed distinguishing between desmosomal Dsg2 which is in close proximity to DP and extradesmosomal 
Dsg2 which is found solitary. Sandwich-like arrangement of Dsg2 and DP was observed at the lower lateral cell 
borders whereas apically, Dsg2 was found primarily separate from DP (Fig. 1C). Additionally, by using stimu-
lated emission depletion microscopy (STED), we identified clusters on the cell surface consisting of Dsg2 and 
DP molecules as well as single Dsg2 molecules (Fig. 1D). These results were confirmed biochemically by triton 
extraction which separates the cell lysate into a soluble fraction and an insoluble fraction which is considered to 
be cytoskeleton-bound and to contain desmosomal components. In contrast to DP, which was detected in the 
insoluble fraction only, Dsg2 was found in both the insoluble as well as the soluble fraction (Fig. 1E) in line with 
extradesmosomal localization of Dsg2. Taking together, our findings reveal that Dsg2 is present outside of des-
mosomes on the cell surface in addition to its typical localization to serve as adhesion molecule in desmosomes.
Dsg2-specific binding events were detected on the surface of living enterocytes. Since immu-
nostaining revealed Dsg2-specific spots on the cell surface, we next applied AFM on living cells to characterize 
Dsg2-specific binding events similar as shown recently for Dsg323, 24. The AFM topography image of DLD1 cells 
closely resembled the scanning electron microscopy (SEM) image of these cells (Fig. S2A) and allows specific 
measurements at cell borders which appeared elevated in the topography image. For each experiment, 2–3 areas 
at cell borders were selected for each condition, with 1000 recorded force-distance curves for each area. Under 
control conditions, binding events with a frequency of around 14,5% were detected which were more prominent 
close to the cell border (Fig. 2A). Peak fit analysis of unbinding force in DLD1 cells revealed a distribution-peak 
at 30,4 pN (Fig. 2B). To demonstrate specificity of binding events, an inhibitory Dsg2-specific antibody was 
added after control measurements12, 25. The antibody significantly reduced the binding frequency by around 40% 
(Fig. 1C). Specificity of the Dsg2-specific antibody was verified in a cell-free AFM setup, where it significantly 
blocked homophilic Dsg2 interaction to a similar extent (Fig. 2D). Similarly, siRNA-mediated silencing of Dsg2 
expression resulted in significantly reduced binding frequency (Fig. S2B). Next, the antibody was applied in a 
dispase-based cell dissociation assay to investigate its effect on cell adhesion. Application for 24 h resulted in 
increased cell monolayer fragmentation compared to controls in both DLD1 and Caco2 monolayers (Fig. 2E and 
S2C). Depletion of Dsg2 using siRNA yielded similar results in both DLD1 and Caco2 cells (Fig. S2D). These 
observations further confirm the presence of extradesmosomal Dsg2 on the cell surface which specifically can be 
targeted by an anti Dsg2 antibody which is capable of reducing cell cohesion.
Inhibition of Dsg2 binding activated p38MAPK which is critical for enterocyte cohesion. In 
addition to their adhesive functions, desmosomal cadherins have already been shown to regulate p38MAPK sig-
nalling in keratinocytes22, 26, 27. Hence, we investigated the effect of inhibited Dsg2 binding on p38MAPK activity 
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in enterocytes. After incubation with the Dsg2-specific antibody for 30 min, we observed activation of p38MAPK 
(Fig. 3A and B). Depletion of Dsg2 by siRNA did not cause p38MAPK activation but rather resulted in reduced 
level of p38MAPK activity (Fig. S3A), which is similar to DLD1 cells lacking Dsg2 (see below). Next, we exam-
ined whether the activity of p38MAPK is important for cell cohesion. Blocking of p38MAPK with the inhibitor 
SB202190 as well as activation of p38MAPK with anisomycin resulted in increased cell monolayer fragmenta-
tion (Fig. 3C). Moreover, application of the p38MAPK inhibitor together with the Dsg2-specific antibody also 
increased fragmentation (Fig. 3C). Intriguingly, short incubation with the Dsg2-specific antibody for 30 min was 
sufficient to activate p38MAPK but not to reduce cell cohesion (Fig. S3B), suggesting that binding to extrades-
mosomal Dsg2 may induce p38MAPK signalling. In contrast, incubation for 24 h increased cell monolayer frag-
mentation and was accompanied with elevated p38MAPK activity (Fig. S3C). Together, these data indicate that 
Figure 1. Extradesmosomal Dsg2 is present at the cell surface of polarized cultured enterocytes. Cells were 
grown on coverslips for several days after reaching confluency, fixed with 2% PFA and stained for junctional 
components. (A) Confocal microscopy analysis of Caco2 cells shows linear and apical localization of the 
junctional components Dsg2 and Cld4 at cell borders. Scale bar, 10 µm. (B) Analysis with SIM shows Dsg2 being 
located at same level as microvilli, visualized with Alexa488-phalloidin, at the surface of Caco2 cells. Shown 
is a Z-projection. Bar, 5 µm. (C) Apical fraction of Dsg2 (right panel) is not co-localizing with DP in contrast 
to lower layers (left panel) where both can be found in close proximity as analysed via SIM. Scale bar, 5 µm. 
(D) Both, clusters consisting of Dsg2 and DP as well as single Dsg2 molecules are present on the cell surface 
of DLD1 cells, as revealed by STED. Scale bar, 5 µm (left panel), 1 µm (right panel). (E) Dsg2 was detected in 
both, the Triton X-100-soluble and -insoluble fraction in contrast to DP being present only in the insoluble 
fraction. GAPDH served as loading control. Cropped blots are displayed and full-length blots are included in 
the supplementary information.
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inhibition of Dsg2 binding activates p38MAPK which is critical for enterocyte cohesion and that the level of 
activated p38MAPK has to be well-balanced.
Balance of p38MAPK activity is critical for intestinal barrier function. We have previously shown 
that Dsg2 is required for maintenance of intestinal barrier function12. Therefore, we next sought to explore the 
role of Dsg2 during barrier recovery. To this end, we performed Ca2+-switch experiments which allowed us to 
induce barrier recovery under well-defined conditions28. TER values of confluent monolayers dropped during 
1 h of EGTA-mediated Ca2+ depletion by around 50% and rose immediately after addition of CaCl2 (Fig. 4A and 
S4A). After about two hours of repletion, TER values reached again control levels indicating that reformation 
Figure 2. Dsg2-specific binding events can be detected on the surface of enterocytes. (A) Dsg2 force 
measurements were performed on living DLD1 cells at 37 °C. Cell topography was imaged to select specific 
areas at cell borders (upper panel). Force measurements revealed binding events along the cell border (lower 
panel) Bar, 10 µm (upper panel), 1 µm (lower panels). (B) Peak fit analysis of unbinding force resulted in a 
distribution-peak of 30,4 pN. (C) Application of a Dsg2-specific antibody significantly reduced the amount of 
binding events on living DLD1 cells as well as (D) in a cell-free setup (shown are means ± SE, n = 3, *p < 0,05). 
(E) Dsg2-specific antibody increased cell monolayer fragmentation in a dispase-based cell dissociation assay. 
(Shown is mean ± SE, n = 9, *p < 0,05 compared to control).
Figure 3. Inhibition of Dsg2 binding resulted in increased p38MAPK activity which is critical for enterocyte 
cohesion. (A) Western blot analysis after incubation of DLD1 cells with a Dsg2-specific antibody for 30 min 
revealed increased phosphorylation of p38MAPK. Cropped blots are displayed and full-length blots are 
included in the supplementary information. (B) Band intensity of detected p-p38MAPK was quantified using 
ImageJ and normalized to control (shown is mean ± SE, n = 6, *p < 0,05 compared to control). (C) DLD1 cells 
were treated with the p38MAPK inhibitor SB202190 or the activator anisomycin and analysed in a dispase-
based cell dissociation assay. Both resulted in increased cell monolayer fragmentation. (Shown is mean ± SE, 
n = 3, *p < 0,05 compared to control).
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of junctional complexes is completed. In line with this, immunostaining of Dsg2, E-cad and Cld4 displayed 
fragmentation and reduction at cell borders during depletion accompanied with formation of intercellular gaps 
(Fig. 4B and S4B–D). After two hours of repletion, immunostaining was similar to controls (Fig. 4B and S4C). 
To examine the role of Dsg2 during barrier recovery, we next applied the Dsg2-specific antibody at the end of 
depletion together with CaCl2. Interestingly, barrier recovery was not disturbed (Fig. 4C). In contrast, application 
of an inhibitory E-cad-specific antibody abolished barrier recovery. Next, we applied SB202190 at the end of 
depletion which in DLD1 cells, prevented barrier reformation and moreover also resulted in barrier disruption 
without Ca2+-switch (Fig. 4D). Similarly, in Caco2 cells, inhibition of p38MAPK significantly delayed barrier 
recovery (Fig. S4E and S4F). Activation of p38MAPK via anisomycin had no immediate effect on barrier func-
tion and recovery (Fig. 4D). However, 10 h after application of anisomycin TER values dropped indicating that a 
well-balanced level of activated p38MAPK is crucial for barrier maintenance. In summary, our findings support 
an indispensable role of p38MAPK in barrier reformation and maintenance.
Dsg2 regulates p38MAPK activity which is required for barrier properties. Since the activation of 
p38MAPK via the Dsg2-specific antibody indicated that Dsg2 regulates p38MAPK activity, we hence determined 
alterations in p38MAPK signalling in DLD1 cells lacking desmosomal cadherins. Comparison of baseline TER 
values of wildtype (wt) and knockout cells revealed a significant reduction when desmosomal cadherins were 
absent (Fig. 5A). Interestingly, no difference was observed when both Dsg2 and Dsc2 were missing or when Dsc2 
was re-expressed indicating that Dsg2 was critical for barrier properties. Similarly, in cells lacking Dsg2 chelation 
of Ca2+ had a more severe impact on cell junction disruption with values around 70% lower than wt values at the 
end of depletion (Fig. 5B). Interestingly, in both DLD1 cells missing Dsg2 and Dsc2 as well as in cells with Dsc2 
rescue levels of p-p38MAPK but not total p38MAPK were reduced (Fig. 5D and E). This is similar to DLD1 cells 
where Dsg2 expression was suppressed by siRNA (Fig. S3A). This indicates that Dsg2 but not Dsc2 regulates the 
activity of p38MAPK. Finally, we investigated how the loss of desmosomal cadherins affects barrier recovery. 
Time for repletion was about 4–5 times higher in cells lacking Dsg2 and Dsc2 compared to wildtype (Fig. 5F 
and G). However, anisomycin to activate p38MAPK during Ca2+-switch experiments facilitated repletion in 
Figure 4. Well-balanced p38MAPK activity is critical for intestinal barrier function. Ca2+-switch assay with 
confluent DLD1 cells. (A) TER values decrease during depletion with 4 mM EGTA for 1 h and increase to 
back to control values during 2 h of repletion with 8 mM CaCl2. (B) Immunostaining of Dsg2 and Cld4 shows 
reduced and fragmented staining as well as gaps after 1 h depletion and similar staining to control condition 
after 2 h repletion. (C) Barrier reformation is not disturbed after application of a Dsg2-specific antibody but is 
impaired after addition of an inhibitory anti E-cadherin antibody. (D) TER values decrease after inhibition of 
p38MAPK with SB202190 and also barrier reformation is impaired in the Ca2+-switch experiment. Activation 
of p38MAPK via anisomycin has no effect in the short run but also induces reduction of TER values after about 
10 h. (shown are representative graphs for at least three independent experiments).
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∆Dsg2∆Dsc2 cells resulting in times to recovery similar to wt cells (Fig. 5F and G). In summary, these data iden-
tify a new role for Dsg2 in regulating p38MAPK activity which is required for barrier properties in enterocytes.
Discussion
In this study we demonstrate that Dsg2 is required for cell cohesion of enterocytes and maintenance of intestinal 
epithelial barrier function. For this function, regulation of p38MAPK appears to be critical, especially for barrier 
recovery. We detected reduced levels of activated p38MAPK in enterocytes deficient for Dsg2 and Dsc2 which 
was accompanied by both impaired barrier integrity as well as delayed barrier reformation. Reduced activity of 
p38MAPK was not restored with a Dsc2 rescue indicating that Dsg2 is required. However, barrier reformation 
was accelerated with direct activation of p38MAPK demonstrating that Dsg2-mediated activation of p38MAPK 
is crucial for barrier function. Furthermore, we identified extradesmosomal Dsg2 on the surface of polarized 
enterocytes. Application of an antibody targeting the ED of Dsg2 reduced binding events in AFM experiments 
Figure 5. Dsg2 regulates p38MAPK activity which is required for barrier properties. (A) Comparison of 
baseline TER values between wildtype and knockout cells revealed reduced TER in DLD1 cells lacking Dsg2 
(shown is mean ± SE, n ≥ 10, *p < 0,05 compared to control, n.s not significant). (B) During Ca2+ depletion 
for 1 h TER values of Dsg2-deficient cells decreased stronger compared to wildtype cells. (Shown is mean ± SE, 
n ≥ 6, *p < 0,05 compared to control, n.s not significant). (C) Wildtype and knockout cells grown on coverslips 
were stained for Dsg2 and Dsc2 to confirm knockout. Scale bar, 10 µm (D). Level of p-p38MAPK in Dsg2 
and Dsc2 knockout cells was analysed via Western blot. Loss of Dsg2 and Dsc2 resulted in reduced level of 
p-p38MAPK which was not restored by Dsc2 rescue. α-Tubulin served as loading control. Cropped blots are 
displayed and full-length blots are included in the supplementary information. (E) Band intensity of detected 
p-p38MAPK was quantified using ImageJ and normalized to control (shown is mean ± SE, n ≥ 3, *p < 0,05 
compared to control, n.s not significant). (F) Time for complete repletion during Ca2+-switch experiments was 
compared between wildtype and double knockout of Dsg2 and Dsc2. Loss of desmosomal cadherins resulted in 
a prolonged repletion time which was rescued by activation of p38MAPK via anisomycin (shown is mean ± SE, 
n ≥ 6, *p < 0,05 compared to wildtype under control conditions, #p < 0,05 compared to ∆Dsg2∆Dsc2 under 
control conditions, n.s not significant). (G) Treatment with anisomycin reduced repletion time in ∆Dsg2∆Dsc2 
knockout cells. Representative graph for at least four independent Ca2+-switch experiments is shown.
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and under same conditions activated p38MAPK but was not effective to reduce cell cohesion, indicating that 
extradesmosomal Dsg2 may be involved in the regulation of p38MAPK signalling.
In previous studies, we have characterized mechanisms regulating desmosomal adhesion in keratinocytes. 
However, desmosomal cadherins show tissue-specific expression patterns6–9, which implies that they may have 
distinct functionally properties within different tissues. In keratinocytes we found that Dsg2 is less important for 
cell cohesion compared to Dsg329 and beyond that, activated p38MAPK reduces intercellular cohesion and forms 
a complex with Dsg3 but not Dsg222, 30. In line with this, depletion of Dsg2 did not cause p38MAPK activation. 
In contrast, this study reveals that in enterocytes active p38MAPK is indispensable for barrier reformation and 
maintenance. Moreover, Dsg2 appears to regulate the activity of this kinase. However, by immunoprecipitation 
we did not find Dsg2 being associated with p38MAPK (data not shown).
Previously, we have shown that Dsg2 is required for intestinal barrier properties. Both, an antibody directed 
against Dsg2 as well as siRNA-mediated Dsg2 depletion resulted in loss of cell cohesion and reduced barrier 
function12, 19, 22. Since Dsg2 was missing at cell junctions in patients suffering from CD and a Dsg-specific tandem 
peptide ameliorated barrier dysfunction in response to TNF-α, which is regarded as a central cytokine in CD 
pathogenesis, we concluded that impaired Dsg2 may contribute to pathogenesis of inflammatory bowel diseases 
(IBD)19. This is supported by the finding that cytokines in IBD via matrix metalloproteinase 9 (MMP9) and a 
disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) cause ectodomain cleavage of Dsg2, 
the products of which further compromised barrier integrity18. Thus, we were surprised that the Dsg2-specific 
antibody was not effective to inhibit barrier reformation in Ca2+-switch experiments, in contrast to an inhibi-
tory E-cad-specific antibody which prevented barrier recovery completely. With this, it can be speculated that 
homophilic Dsc2 interactions can compensate for inhibited Dsg2 binding and are sufficient to restore barrier 
properties. Otherwise, it is also possible that AJ account for barrier establishment while desmosomes have rather 
regulatory function during epithelial homeostasis via p38MAPK. Studies from the literature showing that E-cad 
is clearly present at cell borders already at beginning of confluency12 support this hypothesis.
As outlined above, previous studies have shown that a specific antibody binding the ED of Dsg2 disrupted 
intestinal epithelial barrier properties12. Although, it is likely that this effect is to some extend caused by direct 
interference of Dsg2 binding within desmosomes, it is also possible that the Dsg2-specific antibody bound to 
extradesmosomal Dsg2 thereby inducing signalling events leading to reduced barrier properties. This is espe-
cially intriguing since extradesmosomal Dsg molecules have been proposed to serve as signalling hubs31. In this 
study, we demonstrated for the first time that Dsg2 is present outside of desmosomes on the surface of polarized 
cultured enterocytes. Using SIM and STED, we identified distinct Dsg2 spots on the cell surface as well as clusters 
consisting of Dsg2 and DP. Moreover, specific interaction between Dsg2-coated tips and the surface of living 
enterocytes was measured with AFM and application of the Dsg2-specific antibody resulted in decreased binding 
frequency, under conditions where it did not reduce cell cohesion in a dispase-based cell dissociation assay but 
significantly increased p38MAPK phosphorylation. Collectively, these findings suggest that the Dsg2-specific 
antibody binds to extradesmosomal Dsg2 on the cell surface thereby inducing p38MAPK signalling. However, 
incubation for 24 h reduced cell cohesion, indicating that it most likely interfered with desmosomal Dsg2 binding 
under these conditions. Along with a possible signalling function, Dsg2 is known to be a receptor for adenovi-
ruses of which binding triggers intracellular signalling32, 33 also pointing towards the appearance of extradesmo-
somal Dsg2 on the cell surface as desmosomal Dsg2 is inaccessible for adenoviruses in polarized epithelial cells. 
Interestingly, Adenovirus 3 is supposed to bind to the ED 3 and 4 leading to an activation of members of the 
MAPK pathway32, 33. This is in accordance with our data, since the Dsg2-specific antibody is also directed against 
the ED 3 and induced p38MAPK activation, which was paralleled by reduced cell cohesion in a dispase-based 
cell dissociation assay. Considering that there is no enzymatic activity of the intracellular tail of Dsg2 known to 
date, the question arises how signalling cascades can be activated. A recent study demonstrated that soluble Dsg2 
fragments activate the Akt/mTor and MAPK pathway through binding to HER2 and HER3 receptors18. In this 
line shedding of the Dsg2 ED upon binding to the virus was reported32, supporting the idea of Dsg2 fragments 
acting as ligands for other receptors. An alternative mechanism for activating signalling pathways may involve 
displacing proteins from lipid rafts as it has just been reported for Dsg2 in keratinocytes34. Furthermore, our 
data demonstrate that activity of p38MAPK has to be regulated tightly. Inhibition of p38MAPK impaired barrier 
reformation during Ca2+-switch experiments and augmented cell monolayer fragmentation. Direct activation 
of p38MAPK with anisomycin facilitated barrier recovery in Dsg2-deficient cells, in which baseline p38MAPK 
activity was reduced. However, in the course of several hours treatment with anisomycin impaired barrier func-
tion also. This is in line with our previous data, as treatment with TNFα activated p38MAPK which resulted in 
loss of cell cohesion and increased permeability as well as reduction of Dsg2 at the cell borders19.
Finally, our experiments also may give some insight into the pathogenesis of CD. As previously shown, Dsg2 is 
decreased in samples from patients suffering from CD19. However, it is unclear whether this is primary or second-
ary to lesion formation in CD and nothing is known about the underlying mechanisms leading to reduction of 
Dsg2. Our findings that extradesmosomal Dsg2 is present on the cell surface of enterocytes and Dsg2 modulates 
the p38MAPK signalling cascade could uncover a new mechanism in the development of CD. Dsg2 may act as 
a sensor to transmit extracellular stimuli thereby controlling intestinal barrier maintenance. In this scenario, it 
can be speculated that inappropriate transmission of environmental signals could lead to severe inflammatory 
responses and facilitate the development of CD. Further studies are necessary to prove this hypothesis.
Materials and Methods
Cell Culture. The two human intestinal epithelial cell lines Caco2 (ATTC, LGC Standards, Wesel, Germany) 
and DLD1 (kind gift of Shintaro T. Suzuki, Kwansei Gakuin University, Japan) were used. Caco2 cells were cul-
tured in Eagle’s minimal essential medium (ATCC) and DLD1 cells were maintained in Dulbecco’s modified 
Eagle medium (Life Technologies, Carlsbad, CA) with both media being supplemented by 10% fetal bovine serum 
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(Biochrom, Berlin, Germany), 50 U/ml penicillin and 50 U/ml streptomycin (both AppliChem, Darmstadt, 
Germany). Both cell lines were cultivated in a humidified atmosphere containing 5% CO2 at 37 °C and used for 
experiments after reaching full confluence.
Test Reagents. SB202190 (Calbiochem, Darmstadt, Germany) was used to inhibit p38MAPK at 30 µM for 
24 h and anisomycin (Sigma-Aldrich, Munich, Germany) was applied at 60 µM for 24 h to activate p38MAPK. 
For inhibition of Dsg2 binding a specific monoclonal mouse antibody directed against the second and third 
ED of Dsg2 (clone 10G11, Acris, Herford, Germany) without sodium azide was applied at 1:50. Following pri-
mary antibodies were used: mouse anti Dsg2 (clone 10G11) and rabbit anti Dsg2 (rb5, both Progen, Heidelberg, 
Germany), rabbit anti DP (NW6, USA, self-made), mouse anti Dsc2/3 (clone 7G6, Life Technologies, Carlsbad, 
CA), rabbit anti Claudin-4, rabbit anti Claudin-1 and rabbit anti Claudin-2 (all from Life Technologies, Carlsbad, 
CA), mouse anti E-cadherin (clone 36, BD Bioscience, Heidelberg, Germany,) mouse anti GAPDH (Santa Cruz 
Biotechnology, Santa Cruz, CA), mouse anti α-tubulin (Abcam, Cambridge, UK), rabbit anti p38MAPK, rabbit anti 
phospho-Thr180/182 p38MAPK, (Cell Signaling, Danvers, MA, USA),. As secondary antibodies HRP-conjugated 
goat anti-mouse or goat anti-rabbit (Dianova, Hamburg, Germany) were used for western blot analysis, Cy2-, Cy3- 
or Alexa488-labeled goat anti-mouse or goat anti-rabbit antibodies (Dianova, Hamburg, Germany) were used for 
confocal microscopy, Alexa488-labeled goat anti-mouse (Dianova, Hamburg, Germany) and Alexa594-labeled 
goat anti-rabbit (Life Technologies, Carlsbad, CA) were used for SIM and Star580- and Star635P-labeled antibod-
ies (Abberior) were used for STED. For visualization of F-Actin Alexa488-labeled phalloidin (Life Technologies, 
Carlsbad, CA) was applied and nuclei were counterstained with DAPI (Sigma-Aldrich, Munich, Germany).
Immunofluorescence. After grown to confluency on glass coverslips, cells were fixed with 2% paraform-
aldehyde in PBS for 10 min and subsequently permeabilized with 0,5% TritonX-100 in PBS containing 0,02% 
Tween20 (PBS-T) for 10 min. After blocking in 2% BSA in PBS-T for 1 h cells were incubated with primary anti-
bodies for 1 h (all steps were performed at room temperature) and subsequently after 3 washing steps with PBS-T 
with secondary antibodies also for 1 h. For confocal microscopy coverslips were mounted on glass slides with 60% 
glycerol in PBS, containing 1,5% N-propyl gallate (Serva, Heidelberg, Germany) and images were acquired using 
a Leica SP5 confocal microscope with a 63 x NA 1.4 PL APO objective (both Leica, Wetzlar, Germany).
Structured illumination microscopy (SIM). After immunostaining, cells were mounted in 
VECTASHIELD (Vector Laboratories) and SIM images were acquired with a DeltaVisionOMX V3 microscope sys-
tem (General Electric) equipped with a 100 × 1.4 oil immersion objective UPlanSApo (Olympus), 405 nm, 488 nm 
and 593 nm laser (DIC) and Cascade II camera (Photometrics). Reconstruction was done with the SoftWorx soft-
ware (Vers. 6.0 Beta 19, unreleased) and additionally images were aligned with a self-written Fiji macro.
Stimulated emission depletion microscopy (STED). After immunostaining, cells were mounted in 
2,5% DABCO in MOWIOL/HEPES (self-made solution) and imaged with an Abberior 3D STED confocal micro-
scope. Star580 and Star635P (both from Abberior) were excited at 594 nm and 638 nm respectively using pulsed 
diode lasers (PDL 594, Abberior Instruments; PiL063X, Advanced Laser Diode Systems). Fluorescent molecules 
were depleted at 775 nm with a pulsed fibre laser (PFL-P-30-775B1R, MPB Communications) and emission was 
detected with an avalanche photodiode detector at 605-625 and 650-720 nm range.
Western Blot. Cells were grown in 24-well plates and after treatment with respective reagents lysed using SDS 
lysis buffer containing (containing 25 mM HEPES, 2 mM EDTA, 25 mM NaF and 1% SDS) supplemented with 
a protease-inhibitor cocktail (Roche, Mannheim, Germany) and subsequently sonicated. After protein amount 
determination using a BCA Protein Assay Kit (Pierce/Thermo Scientific, Waltham, MA, USA) cell lysates were 
mixed with 3x Laemmli buffer and resolved by reducing SDS-PAGE. Following, proteins were transferred to a 
nitrocellulose membrane (Life Technologies, Carlsbad, CA) according to the standard protocols and membranes 
were probed with primary antibodies. Afterwards, HRP-conjugated secondary antibodies (Dianova, Hamburg, 
Germany) were applied and detected with an ECL reaction system (self-made solution).
TritonX-100 Protein Extraction. Cell monolayer grown in 6-well plates were washed with ice cold PBS 
and incubated in a Triton buffer (containing 0.5% Triton X-100, 50 mM MES, 25 mM EGTA and 5 mM MgCl2) 
for 15 min on ice under gentle shaking. To separate the cytoskeletal protein fraction (Triton-insoluble) from the 
non-cytoskeletal protein fraction (Triton-soluble), cell lysates were centrifuged at 13,000 rpm for 5 min. After 
resuspending the pellets in SDS lysis buffer followed by sonication, protein concentration of both fractions was 
defined as described above and lysates were analysed via Western blot.
Atomic Force Microscopy (AFM). Dsg2 interactions on the surface of living enterocytes were analysed with 
atomic force microscopy (AFM), using a Nanowizard III AFM (JPK Instruments, Berlin, Germany) mounted on 
an optical microscopy (Carl Zeiss, Jena, Germany). The principle of AFM force spectroscopy was described in 
detail before23. Briefly, the sharp tip on a flexible cantilever was functionalized with recombinant Dsg2-Fc con-
taining the complete ED of Dsg2 using a flexible polyethylene glycol linker (Gruber Lab, Institute of Biophysics, 
Linz, Austria) as outlined elsewhere35. While measurements, the tip is repetitively lowered onto the enterocyte cell 
monolayer and retracted again. Thereby binding events between the molecule on the tip and a molecule on the 
cell surface can be detected as the tip is hold back near the cell surface during the retraction movement in case of 
interaction. When the retraction force overcomes the binding strength of the interaction the tip jumps back into 
neutral position. AFM topography images of 50 × 50 µm were acquired at the beginning of each experiment in 
a force curve-based imaging mode (QI- mode) with a setpoint adjusted to 0,5 nN, a z-length of 1500 nm and a 
pulling speed of 50 µm/s. For force mapping to detect specific binding events a small area of 2 × 5 µm was chosen 
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and a map consisting of 20 × 50 pixels with each pixel representing one force-distance curve was recorded. Hereby, 
relative setpoint was set to 0,5 nN, a z-length of 2 µm was used for the DLD1 cells and 3 µm for the Caco2 cells 
with a pulling speed of 4 µm/s for the DLD1 cells and 5 µm/s for Caco2 cells. Measurements were performed in 
respective cell culture medium at 37 °C. For cell-free AFM measurements Dsg2 coated mica sheets (SPI Supplies, 
West Chester, USA) were used instead of cell monolayers. Setpoint was adjusted to the same value as for cell-based 
experiments to produce comparable results. The z-length was set to 0,3 µm and a pulling speed of 1 µm/s was used. 
For each condition 400 force-distance curves were measured on an area of 25 µm × 25 µm.
Dispase-based Dissociation Assay. Confluent Caco2 and DLD1 cell monolayer grown in 24-well plates 
were incubated with test reagents, washed with Hank’s buffered saline solution (HBSS; Sigma-Aldrich) and 
treated with 150 µl of the enzyme dispase II (2,4 U/ml in HBSS, Sigma-Aldrich) at 37 °C to detach the whole cell 
monolayer from the well bottom. For Caco2 cells additionally 1% Collagenase I (Thermo Scientific, Waltham, 
MA, USA) was added. DLD1 cell monolayer detached from the well bottom after 30 min and Caco2 cell mon-
olayer after 1,5 h. After stopping the reaction with 200 µl HBSS cell monolayer were sheared by pipetting 3 times 
using an electrical pipet. Finally, resulting fragments were counted under a binocular microscope (Leica). For 
every condition 3–4 wells out of a 24-well plate were counted and each experiment was repeated at least 3 times.
Measurement of transepithelial resistance. To asses epithelial barrier integrity, the transepithelial 
resistance (TER) was measured with an ECIS model Z theta (Applied Biophysics, Troy, NY) as described previ-
ously36. For this, cells were cultured on 8-well electrode arrays (Ibidi, 8W10E) with sensing areas consisting of 
working electrodes at each well bottom and a counter electrode. Via the electrolytes of the cell culture medium 
above the cells, the electrodes are electrically connected. By application of a non-invasive alternating current 
(<1 µA) to the electrodes, the ECIS device measures the associated voltage drop across the system and determines 
the electrical resistance of the cell covered electrodes. A drop in TER values mirrors barrier breakdown. At the 
beginning of measurements medium was exchanged (300 µl) and baseline TER at 400 Hz for Caco2 cells and 
800 Hz for DLD1 cells, was measured until values reached a plateau. Then, different test reagents were added and 
resistance was monitored every minute for the next 24 h.
Calcium Switch Assay. To analyse cell junctional disassembly and reassembly, Caco2 and DLD1 cells were 
grown on 8-well electrode arrays (Ibidi, 8W10E) and TER was monitored every minute. After measurement of 
baseline TER for about 20 min, Ca2+ ions were depleted using 4 mM EGTA for 1 h thereby inducing disruption of 
Ca2+-dependent cell junctions. With the addition of 8 mM CaCl2, reformation of cell junctions was induced and 
validated based on changes in TER values.
Statistics. All experiments were repeated at least 3 times. Quantification of band intensity was performed using 
ImageJ (National Institutes of Health, Bethesda, MD). Statistical analysis was performed using a two-tailed t test 
for 2-sample group analysis and one-way ANOVA followed by bonferroni correction for multiple sample groups.
Human samples. Human specimens were obtained from terminal ileum of patients that required right hem-
icolectomy in which the surgical resection routinely involves a part of the healthy small intestine. All experiments 
were performed in accordance with relevant guidelines and regulations. All patients had given their informed 
consent before surgery, and the study was approved by the Ethical Board of the University of Würzburg (proposal 
numbers 113/13 and 46/11). For TEM analyses samples were fixed with 2.5% glutaraldehyde, cut into ~1mm³ 
pieces and further processed as described above.
Data Availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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Supplemental Material and Methods  
Transmission Electron Microscopy (TEM)  
Cell monolayer were fixed with 1% glutaraldehyde at 37°C for 1 h, then washed three times with PBS 
and incubated with 2% osmiumtetroxid solution for 1 h at 4°C.  Afterwards, samples were dehydrated 
through an ethanol series from 20 to 100% followed by embedding with epon for 24 hours at 80°C. 
Finally, ultrathin sections (60 - 80 nm) were cut with a diamond knife and staining was performed 
with a saturated solution of uranyl acetate for 40 min and lead citrate for 5 min. Images were acquired 
with the transmission electron microscope Libra 120 (Zeiss, Oberkochen, Germany).  
 
Scanning Electron Microscopy (SEM)  
For scanning electron microscopy, cell monolayer were fixed and dehydrated as described for TEM. 
Afterwards, samples were dried with carbon dioxide under excess pressure of around 86 bar (Critical 
point dryer K850, Quorum Technologies, UK) and subsequently sputtered with gold at 30 mA for 60 s 
(Cressington 108auto) under argon atmosphere. Images were acquired using the scanning electron 
microscope Leo 1550 (Zeiss Oberkochen, Germany). 
siRNA-mediated Silencing of Dsg2 
Human siRNA oligo pools specific for Dsg2 as well as non-target controls were purchased from 
Dharmacon/GE Healthcare (Freiburg, Germany). Cells were transfected at 90% confluency using 
Turbofect (Thermo Scientific, Waltham, MA) as a transfection reagent according to manufacturer’s 
protocols. Medium was exchanged after 24 hours and experiments were performed after 48 hours. 
 
Supplementary figure legends 
Figure S1. Caco2 cells were cultured for 2 days, 4 days or 6 days after confluency and analysed via 
transmission and scanning electron microscopy, confocal microscopy, Western blot and TER. (A) 
Characteristic junctional complexes as well as microvilli were present already on day 2. Scale bar, 1 
µm (left and central panels), 2 µm (right panel) (B) Electron microscopy images of human terminal 
ileum specimens show tight junctions (TJ), adherens junctions (AJ) and desmosomes (D) at the apical 
part of the intercellular cleft. Desmosomes can also be found in lower regions of the intercellular cleft. 
Scale bar, 1000 nm (left panel), 500 nm (right panel) (C) Immunostaining of junctional components 
reveals linear localization of Dsg2, Cld1 and Cld4 already on day 2, staining for Cld2 decreases in the 
time course of differentiation. Scale bar, 10 µm. (D) Western blot analysis reveals unaltered protein 
level of junctional components from day 2 till day 6. α-Tubulin serves as loading control. (E) TER 
measurements reveal constant values between day 2 and day 6. (n = 4, n.s not significant) 
Figure S2. (A) AFM topography image and scanning microscopy image of DLD1 cells closely 
resemble each other. Scale bar, 2 µm (left panel), 10 µm (right panel). (B) siRNA-mediated silencing 
of Dsg2 reduces amount of binding events on living DLD1 cells. (siNT = non-target siRNA; shown is 
mean ± SE, n = 4, * p < 0,05) (C) Dsg2-specific antibody increases cell monolayer fragmentation of 
Caco2 cells in a dispase-based cell dissociation assay (shown is mean ± SE, n = 4, * p < 0,05). (D) 
siRNA-mediated silencing of Dsg2 increases cell monolayer fragmentation of DLD1 and Caco2 cells 
in a dispase-based cell dissociation assay. (shown is mean ± SE, n = 4, * p < 0,05) 
Figure S3. (A) siRNA mediated silencing of Dsg2 reduces phosphorylation of p38MAPK. (B) Dsg2-
specific antibody did not increase cell monolayer fragmentation in a dispase-based cell dissociation 
assay after 30 min of incubation (shown is mean ± SE, n = 4, n.s = not significant compared to 
control). (C) Western blot analysis after incubation of DLD1 cells with a Dsg2-specific antibody for 
24 h revealed increased phosphorylation of p38MAPK. Band intensity of detected p-p38MAPK was 
quantified using ImageJ and normalized to control (shown is mean ± SE, n = 3, * p < 0,05 compared 
to control). 
Figure S4. (A) TER values of Caco2 cells decrease during depletion with 4 mM EGTA for 1 h and 
increase back to control values during 2 h of repletion with 8 mM CaCl2. (Representative graph for n > 
3 is shown). (B) Immunostaining of Dsg2 and E-cadherin during Ca2+-switch experiments in DLD1 
cells reveals reduction and fragmentation after 1 h depletion and similar staining to control condition 
after 2 h repletion. Scale bar, 10 µm. (C-D) Immunostaining of junctional components during Ca2+-
switch experiments in Caco2 cells reveals reduction and fragmentation as well as gap formation after 1 
h depletion and similar staining to control condition after 2 h repletion. Scale bar, 10 µm. (E) Barrier 
reformation in Caco2 cells is impaired after inhibition of p38MAPK with SB202190 in the Ca2+-
switch experiment while addition of anisomycin has no effect (Representative graph for 6 independent 
experiments is shown). (D) Time for repletion during Ca2+-switch experiments was compared between 
control condition and application of anisomycin or SB202190. Inhibition of p38MAPK with 
SB202190 significantly delayed the repletion time while application of anisomycin resulted in a 
repletion time similar to control condition (shown is mean ± SE, n=6, * p < 0,05 compared to control 
condition, n.s not significant). 
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Abstract
Rapidly renewing epithelial tissues such as the intestinal epithelium require precise tuning of intercellular adhesion and 
proliferation to preserve barrier integrity. Here, we provide evidence that desmoglein 2 (Dsg2), an adhesion molecule of des-
mosomes, controls cell adhesion and proliferation via epidermal growth factor receptor (EGFR) signaling. Dsg2 is required 
for EGFR localization at intercellular junctions as well as for Src-mediated EGFR activation. Src binds to EGFR and is 
required for localization of EGFR and Dsg2 to cell–cell contacts. EGFR is critical for cell adhesion and barrier recovery. In 
line with this, Dsg2-deficient enterocytes display impaired barrier properties and increased cell proliferation. Mechanisti-
cally, Dsg2 directly interacts with EGFR and undergoes heterotypic-binding events on the surface of living enterocytes via 
its extracellular domain as revealed by atomic force microscopy. Thus, our study reveals a new mechanism by which Dsg2 
via Src shapes EGFR function towards cell adhesion.
Keywords Desmosomes · Desmosomal cadherins · Intestinal barrier · Cell adhesion
Abbreviations
AFM  Atomic force microscopy
AJ  Adherens junction
Cld4  Claudin 4
Dsc2  Desmocollin 2
Dsg2  Desmoglein
DP  Desmoplakin
Ecad  E-cadherin
EGFR  Epidermal growth factor receptor
MAPK  Mitogen-activated protein kinase
PG  Plakoglobin
Pkp  Plakophilin
RTK  Receptor tyrosine kinase
STED  Stimulated emission depletion microscopy
TER  Transepithelial resistance
TJ  Tight junction
WT  Wild type
Introduction
Epithelial tissues represent the interface between the 
organism and the environment, and thus, maintenance of 
epithelial barrier function is indispensable to prevent entry 
of pathogens or harmful macromolecules. This is, in par-
ticular, crucial for the gastrointestinal epithelium, which 
comprises a huge surface and faces a plethora of bacteria 
present in the gut but simultaneously needs to stay perme-
able to enable the uptake of nutrients and essential macro-
molecules [1, 2]. Aggravating this situation, the intestinal 
epithelial tissue shows the highest turnover rate in adult 
mammals and is exposed to notable mechanical stress 
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resulting from gastrointestinal motility [3, 4]. Hence, pre-
cise regulation of intercellular adhesion and proliferation 
is required to preserve barrier integrity. This function is 
achieved by a set of adhesion complexes including tight 
junctions (TJ), adherens junctions (AJ), and desmosomes 
that tightly connect the polarized enterocytes within the 
simple columnar epithelium, thereby sealing the paracel-
lular space [5, 6]. Initially, desmosomes were considered 
to primarily provide the mechanical strength in intercel-
lular cohesion [7]. However, growing evidence suggests 
that desmosomal cadherins beside their adhesive function 
actively coordinate signaling pathways, hence mediat-
ing proliferation, diﬀerentiation, and apoptosis [8–11]. 
Desmosomal cadherins are transmembrane glycoproteins 
which interact via their extracellular domains (ED) in a 
homo- and heterophilic manner, while their tails associ-
ate with the plaque proteins plakoglobin (PG), plakophilin 
(Pkp), and desmoplakin (DP), thereby anchoring the des-
mosomal complex to the intermediate filament cytoskel-
eton. Thus, these components constitute the adhesive core 
of desmosomes [12]. Seven isoforms of desmosomal cad-
herins are expressed in human epithelial tissues, of which 
the intestinal epithelium contains Desmoglein 2 (Dsg2) 
and Desmocollin 2 (Dsc2) only [13–15]. A recent study 
reports that Dsc2 alone is suﬃcient to form a functional 
desmosomal plaque in enterocytes [16]. However, Dsg2 
is required for intestinal epithelial barrier properties and 
abnormal expression of Dsg2 is implicated in colon can-
cer and inflammatory disorders such as Crohn’s disease 
[17–20]. In addition, it was shown that Dsg2 besides its 
role in cellular adhesion has an essential signaling func-
tion in regulating p38 mitogen-activated protein kinase 
(MAPK) signaling in enterocytes [20].
The mechanism by which desmosomal cadherins regu-
late signaling pathways is an emerging focus of research. 
Given that the intracellular tail of desmogleins has no 
enzymatic activity, transduction of signaling requires 
interaction with signaling components such as kinases. 
In this context, several molecular mechanisms have been 
proposed such as matrix metalloprotease-mediated shed-
ding of Dsg2 external domain fragments which may act 
as ligands for receptor tyrosine kinases (RTK) [21] or 
displacing kinases from lipid rafts, thereby promoting 
their activation [22]. The common denominator in both 
scenarios is the involvement of RTK which are already 
known to associate with classical cadherins, and thus, both 
molecules are modulated mutually [23, 24]. Depending on 
the phosphorylation site, specific signaling molecules can 
be recruited which, in turn, modulate a variety of down-
stream signaling cascades [25–29]. Of particular inter-
est to this study is the epidermal growth factor receptor 
(EGFR) which has been shown to modulate function of 
desmogleins [30, 31] as well as to be modulated by des-
mogleins [9, 22, 32]. Furthermore, EGFR is suggested to 
regulate cell migration, wound healing, and cell extrusion 
in intestinal epithelial cells [33–35]. Albeit, all these pro-
cesses require regulation of intercellular junctions; the role 
of desmosomal cadherins in this context has only been 
marginally explored.
In this study, we examined how Dsg2 and EGFR cooper-
ate in regulating intestinal epithelial homeostasis to assure 
barrier integrity. We show that Dsg2 modulates EGFR 
localization as well as protein level and Src-dependent acti-
vation, which both were reduced in Dsg2-deficient DLD1 
and Caco2 cells. Here, we demonstrate, for the first time, 
that Dsg2 and EGFR interact directly using atomic force 
microscopy (AFM) both on living enterocytes as well as in 
a cell-free setup. Moreover, these binding events were inhib-
ited by ligand binding to EGFR and depend on EGFR tyros-
ine kinase activity. In addition, inhibition of EGFR tyrosine 
kinase activity impaired barrier formation and intercellular 
adhesion. Furthermore, loss of Dsg2 increased cell prolif-
eration, which was restored after inhibition of EGFR activ-
ity. Collectively, our data suggest a new signaling complex 
consisting of Dsg2 and EGFR which stabilizes the adhesive 
state of intestinal epithelial cells.
Fig. 1  Dsg2 knockout results in mislocalization and reduced pro-
tein levels of EGFR in intestinal epithelial cells. a Immunostaining 
for Dsg2 (green) and EGFR (red) in patient tissue sections of the 
colon revealed co-localization of both proteins. Four independent 
patient tissue samples were analyzed. Shown is representative image 
of a section from the colon. Bar 10 µm. b Immunostaining for Dsg2 
(green) and EGFR (red) in human enteroids revealed co-localization 
of both proteins along the cell borders as well as on the surface fac-
ing the lumen. Shown is representative image for ten enteroids. Bar 
10 µm. c Confluent cell monolayer of DLD1 cells grown on cover-
slips were immunostained for EGFR, Dsg2, and Dsc2/3. Loss of 
Dsg2 but not Dsc2/3 results in a major loss of EGFR staining at cell 
borders. Bar 10 µm. d Merged images of immunofluorescence stain-
ing of Dsg2, EGFR, and Dsc2/3 show co-localization of Dsg2 and 
EGFR but not Dsc2/3 and EGFR. Bar 10 µm (left panel) and 5 µm 
(right panel). e Evaluation of the Pearson correlation coeﬃcient of 
EGFR confirms a co-localization of EGFR with Dsg2 but not Dsc2. 
Shown are boxplots with each point representing one analyzed area 
along the cell border. *p < 0.05. f STED super resolution microscopy 
analysis of Dsg2 and EGFR co-immunostaining shows co-localiza-
tion. Bar 5 µm. g x–z image of Dsg2 and EGFR co-immunostaining 
shows specific co-localization at the apical site of cell contacts. Bar 
10 µm (left panel) and 5 µm (right panel). h EGFR is absent in the 
Triton X-100 insoluble fraction when Dsg2 is missing in contrast to 
Ecad that is not aﬀected by Dsg2 knockout. GAPDH served as load-
ing control. i Band intensity of detected EGFR was measured from 
five independent experiments, showing a significant reduction of 
EGFR in the insoluble fraction in Dsg2-deficient DLD1 cells. Results 
are shown as mean ± SE. *p < 0.05. j Total protein level of EGFR in 
DLD1 cells were assessed by western blotting that revealed reduced 
EGFR levels in Dsg2-deficient cells. GAPDH served as loading 
control. k Band intensity of detected EGFR was quantified from at 
least ten independent experiments, demonstrating a significant reduc-
tion of total EGFR protein levels upon Dsg2 knockout. Shown are 
mean ± SE. *p < 0.05
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Results
Loss of Dsg2 reduces EGFR levels and prevents its 
localization to cell borders
Increasing evidence suggests that desmosomal cadherins 
beyond their adhesive function are actively involved in reg-
ulating signaling cascades. Previously, we demonstrated 
that Dsg2 regulates barrier integrity in human intestinal 
cells via p38MAPK signaling [20]. In addition, several 
studies on keratinocytes linked desmogleins to diﬀerentia-
tion and proliferation through regulation of growth factor 
signaling cascades [8, 9]. We, therefore, asked how des-
mosomal cadherins influence EGFR signaling in human 
intestinal cells. First, we performed immunostaining for 
Dsg2 and EGFR in human colon samples to investigate 
whether these proteins can be found in close proximity. 
EGFR is assumed to be located primarily in the basolat-
eral membrane of enterocytes, whereas Dsg2 was shown 
to be present as part of desmosomes in the basolateral 
membrane but also outside of desmosomes in the apical 
membrane, at least in cultured enterocytes [20, 36, 37]. 
Interestingly, we observed EGFR staining at the basolat-
eral membrane as well as at the apical surface and distinct 
spots of Dsg2 staining all along the cell borders (Fig. 1a). 
Besides, a small fraction of apical EGFR staining was 
overlapping with immunostaining for Dsg2 resulting in 
yellow spots. Similarly, we observed overlapping stain-
ing for EGFR and Dsg2 in human enteroids with an even 
more pronounced EGFR staining at the apical cell mem-
brane facing the enteroid lumen (Fig. 1b). Using human 
colon carcinoma DLD1 cells deficient for Dsg2 and/or 
Dsc2 [16], we next investigated whether localization and 
protein levels of EGFR are controlled by desmosomal cad-
herins. DLD1 wild-type (WT) cells in immunostaining 
displayed linear localization of EGFR along cell borders 
similar to Dsg2 (Fig. 1c, upper panels) and Dsc2 (Fig. 1c, 
lower panels). To examine whether desmosomal cadher-
ins aﬀect the localization of EGFR, we immunostained 
DLD1 cells deficient for Dsg2, Dsc2, or both cadherins. 
Cells deficient for both, Dsg2 and Dsc2, showed almost 
complete loss of EGFR staining at cell borders (Fig. 1c, 
second column). Similar results were obtained using WT 
and Dsg2-deficient Caco2 cells (Fig. S1A). Reconstitu-
tion of Dsc2 was not suﬃcient to restore this phenotype 
(Fig. 1c, third column), suggesting that Dsg2 is required 
for recruiting EGFR to cell borders. In line with this, 
loss of Dsc2 did not aﬀect EGFR localization (Fig. 1c, 
fourth column). Moreover, merged images of Dsg2 (green) 
and EGFR (red) staining revealed co-localization at cell 
borders with a Pearson correlation coeﬃcient of around 
0.4 pointing towards positive correlation of overlapping 
staining (Fig. 1d, e). In contrast, no correlation between 
EGFR and Dsc2 staining was observed, as indicated by 
a correlation coeﬃcient of 0 (Fig. 1d, e). Using STED 
super resolution microscopy, we analyzed EGFR and Dsg2 
localization more closely and found overlapping stain-
ing for EGFR and Dsg2 even at high resolution (Fig. 1f) 
confirming their close co-localization. Furthermore, we 
observed co-localization all along the cell border but more 
pronounced at the most apical part of the intercellular cleft 
(Fig. 1g). In accordance to the immunostaining, triton 
extraction resulted in a significant reduction of EGFR in 
the insoluble fraction when Dsg2 was absent (Fig. 1h, i) 
raising the possibility of a putative signaling complex con-
sisting of Dsg2 and EGFR maybe at sites of desmosomes. 
Importantly, immunoblotting for Ecad did not result in 
any changes upon loss of Dsg2 or of Dsc2 (Fig. 1h), sug-
gesting that AJ stay unaﬀected. Moreover, total protein 
expression levels of EGFR were reduced significantly in 
cells deficient for Dsg2 but not Dsc2 (Fig. 1j, k), indicating 
that Dsg2 might be important for EGFR stability. Simi-
larly, EGFR protein levels were reduced in Dsg2-deficient 
Caco2 cells (Fig. S1 B–E).
Dsg2 and EGFR interact directly via their 
extracellular domains
Given the first hints pointing towards a signaling complex 
consisting of Dsg2 and EGFR, we next investigated whether 
there is direct interaction. To this end, we conducted AFM 
on living DLD1 cells using an AFM cantilever coated with 
recombinant Dsg2-Fc containing the complete extracellu-
lar domain of Dsg2 similar as shown recently [20]. First, 
AFM topography images were created to select specific 
areas at cell borders for further adhesion measurements 
(Fig. 2a, upper panel). For interaction studies, the function-
alized AFM tip was repetitively lowered on the cell sur-
face, thereby creating an adhesion map consisting of 1000 
force–distance curves for each selected area, with each white 
pixel representing one positive-binding event (Fig. 2a, lower 
panel). Intriguingly, these binding events were blocked sig-
nificantly when applying an inhibitory antibody against the 
extracellular domain of EGFR (Fig. 2a, b), indicating that 
measured binding events under control conditions partly 
reflect heterophilic Dsg2–EGFR interaction. To verify that 
measured binding events were Dsg2-specific, an inhibi-
tory antibody against the extracellular domain of Dsg2 was 
applied, which reduced the binding events to a similar extent 
(Fig. 2b), similar as published previously [20]. In addition, 
we performed cell-free AFM experiments with Dsg2-coated 
AFM tips on mica sheets functionalized with either recom-
binant Dsg2-Fc or recombinant EGFR-Fc containing the 
complete extracellular domain to validate homophilic or het-
erophilic interactions. Binding frequency was similar when 
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measured Dsg2–Dsg2 or Dsg2–EGFR interaction under the 
same conditions (Fig. 2b), suggesting that both interactions 
can occur. Application of the inhibitory EGFR-specific anti-
body did not reduce homophilic Dsg2 interactions (Fig. 2b), 
demonstrating that it does not bind un-specifically to Dsg2. 
In contrast, heterophilic Dsg2–EGFR binding was signifi-
cantly reduced similar to AFM measurements on living cells 
(Fig. 2b) underlining the specificity of measured binding 
events. Bearing in mind that the inhibitory EGFR-specific 
antibody blocks the ligand-binding site of EGFR, these data 
further raise the possibility that this binding site might be 
important for heterophilic EGFR–Dsg2 binding. Applica-
tion of the inhibitory Dsg2-specific antibody reduced both 
homophilic Dsg2–Dsg2 as well as heterophilic Dsg2–EGFR 
interactions (Fig. 2b). Given that the antibody is directed 
against the extracellular domains 3 and 4 of Dsg2, this 
result indicates that these subdomains may be required for 
EGFR–Dsg2 interaction. In addition, we also examined 
endogenous association between EGFR and Dsg2 in DLD1 
cells using co-immunoprecipitation studies. In line with the 
AFM-based adhesion studies, interaction of EGFR and Dsg2 
was detected in DLD1 cells (Fig. 2c). Moreover, we per-
formed a pull-down assay using the recombinant Dsg2-Fc, 
which also resulted in co-precipitation of EGFR and thus 
further indicates an interaction of EGFR with the extracel-
lular domain of Dsg2 (Fig. 2d).
Ligand binding to EGFR prevents its interaction 
with Dsg2 at the cell surface
The canonical EGFR signaling pathway involves binding of 
growth factors to EGFR resulting in receptor dimerization 
and subsequent cross-phosphorylation of cytoplasmic recep-
tor domains [25, 26, 28, 29]. Therefore, we applied EGF 
during AFM measurements on living DLD1 cells result-
ing in a significant reduction of binding frequency (Fig. 3a, 
b). This prompted us to ask whether EGF-mediated recep-
tor dimerization reduced binding to Dsg2 maybe through 
masking the binding site. Alternatively, the subsequent 
auto-phosphorylation might induce decreased Dsg2–EGFR 
interaction. Hence, we treated the cells with erlotinib, a spe-
cific EGFR tyrosine kinase inhibitor to assess whether the 
Fig. 2  Dsg2 and EGFR form heterophilic interactions via their extra-
cellular domains. a AFM cell topography image was created to select 
specific areas along the cell borders for Dsg2 adhesion measure-
ments (upper panel). Adhesion measurements using a Dsg2-coated 
AFM tip generated adhesion maps with each white pixel represent-
ing one binding event (lower panel). b Treatment with an inhibitory 
EGFR-specific antibody significantly reduced the amount of Dsg2 
binding events on living cells similar to an inhibitory anti-Dsg2 
antibody. Cell-free AFM measurements using a Dsg2 coated tip and 
mica sheets coated either with Dsg2 or with EGFR revealed a similar 
binding frequency of homophilic Dsg2–Dsg2 and heterophilic Dsg2–
EGFR interactions, which were significantly blocked by respective 
antibodies applied to the mica sheet. Graph shows fold-change val-
ues from at least three independent experiments ± SE. *p < 0.05. c 
Co-immunoprecipitation was performed with DLD1 cell lysates and 
an anti-Dsg2 antibody for immunoprecipitation (IP) of endogenous 
Dsg2. Immunoblotting for EGFR revealed co-IP of both proteins. 
FT flow through. d Pull-down assay was performed with DLD1 cell 
lysates and a Dsg2-Fc fusion protein. Immunoblotting for EGFR 
revealed co-IP of Dsg2-Fc and EGFR
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tyrosine kinase activity of EGFR aﬀects its binding to Dsg2. 
Indeed, the inhibitor resulted in reduced binding frequency 
(Fig. 3a, b), indicating that EGFR kinase activity is impor-
tant. However, EGF also reduced the binding frequency in 
cell-free AFM measurements with a Dsg2-coated cantilever 
on EGFR-coated mica sheets (Fig. 3b), which raises the pos-
sibility that Dsg2–EGFR interaction might be also inhib-
ited through steric hindrance upon EGF binding to EGFR. 
Results from hanging drop bead aggregation assays that 
revealed a similar inhibitory eﬀect of EGF on interaction 
of Dsg2- and EGFR-coated beads support this hypothesis 
(Fig. 3c, d). Next, we analyzed the measured interactions 
with regard to their unbinding forces to gain insight into 
the molecular interaction mechanism. Peak fit analysis of 
measured unbinding force curves under control conditions 
revealed a distribution peak at 31.56 pN (Fig. 3e) which is 
in accordance with previously measured unbinding forces 
using a Dsg2-coated AFM tip on living enterocytes [20]. 
Interestingly, unbinding forces were similar after applica-
tion of EGF, the inhibitory EGFR-specific antibody or erlo-
tinib (Fig. 3f). Given that, EGFR is internalized following 
ligand binding [38, 39], we hypothesized that reduced bind-
ing frequency might be due to less available EGFR at the 
cell surface. Therefore, we performed surface biotinylation 
assays. As expected, incubation with EGF reduced EGFR 
levels at the cell surface (IP) as well as in total lysate (Input) 
Fig. 3  EGF reduces Dsg2-specific binding events on the cell sur-
face of living DLD1 cells. a Dsg2 adhesion measurements were 
performed on living DLD1 cells under control conditions and after 
incubation with EGF or erlotinib. Shown are topography images of 
selected areas at cell borders and adhesion maps with each white 
pixel representing one binding event. b Quantification shows a sig-
nificant reduction of binding events on living DLD1 cells after incu-
bation with both, EGF or erlotinib. Application of EGF also reduced 
the amount of binding events in the cell-free AFM setup with a 
Dsg2-coated tip and EGFR-coated mica sheets. Graph bars represent 
fold-change values ± SE from at least four independent experiments. 
*p < 0.05. c Peak fit analysis of measured unbinding forces revealed 
a distribution peak of 31.56 pN under control conditions. d Distri-
bution-peak values of unbinding forces measured on DLD1 cells 
under control conditions and after incubation with EGF, anti-EGFR 
antibody, or erlotinib were compared and revealed similar values for 
all conditions. Graph shows distribution-peak values normalized to 
control. e, f Hanging drop bead aggregation assay confirms blockade 
of interaction between Dsg2 and EGFR through EGF. Beads coated 
with a human IgG Fc fragment served as control. *p < 0.05; n.s. not 
significant. g Western blot analysis of surface biotinylation assay 
revealed reduced Dsg2 and EGFR levels on the surface of DLD1 cells 
after incubation with EGF. h Quantification of Dsg2 and EGFR band 
intensity from at least seven independent experiments shows a sig-
nificant reduction of surface protein levels only after incubation with 
EGF. Graph bars represent fold-change values ± SE. *p < 0.05
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(Fig. 3g, h). Interestingly, Dsg2 cell surface levels were also 
reduced after EGF treatment (Fig. 3g, h), indicating that 
EGFR and Dsg2 might stabilize one another at the cell sur-
face. In contrast, the inhibitory EGFR-specific antibody as 
well as Erlotinib had no significant eﬀect on cell surface 
protein levels of Dsg2 and EGFR (Fig. 3g, h), suggesting 
that reduced AFM-binding frequency is attributable to inhi-
bition of direct binding. In summary, our data demonstrate 
that interaction of Dsg2 and EGFR is disrupted upon ligand 
binding to EGFR as well as after inhibition of the tyrosine 
kinase activity, suggesting that both direct binding via their 
extracellular domains as well as ligand-independent activa-
tion of EGFR might be involved in this interaction.
Loss of Dsg2 reduces Src-dependent 
phosphorylation of EGFR
Inhibition of EGFR kinase activity reduced EGFR binding to 
Dsg2. Hence, we asked whether loss of Dsg2 might reduce 
phosphorylation of EGFR. As we hypothesized that ligand-
independent activation of EGFR is involved in Dsg2–EGFR 
complex formation and it has been shown that EGFR is 
phosphorylated on Y845 in an EGF-independent man-
ner [40], we focused on this phosphorylation site. Indeed, 
DLD1 cells deficient for Dsg2 displayed lower levels of 
Y845 phosphorylation (Fig. 4a, b). Similarly, loss of Dsg2 
in Caco2 cells reduced phosphorylation of EGFR at this site 
(Fig. S2A and B). Reconstitution of Dsc2 in DLD1 cells 
deficient for both desmosomal cadherins did not restore the 
level of phosphorylation. Moreover, loss of Dsc2 alone had 
no significant eﬀect on phosphorylation levels (Fig. 4a, b), 
suggesting that Dsg2 and not Dsc2 is required for phospho-
rylation. Usually, the phosphorylation at Y845 is catalyzed 
by the tyrosine kinase Src [41–43], which has already been 
reported to play a role in cell adhesion signaling [40, 44, 
45]. Interestingly, Src localization to cell borders remained 
unchanged upon loss of Dsg2 (Fig. S2C). Furthermore, also 
protein levels of total and phosphorylated Src as well as dis-
tribution in the triton-soluble and -insoluble fractions were 
not aﬀected (Figs. S2D and S2E). However, inhibition of Src 
activity using the Src-specific inhibitors PP2 and KX2-391 
resulted in reduced and fragmented EGFR and Dsg2 immu-
nostaining at cell borders in DLD1 cells (Fig. 4c). Intrigu-
ingly, where remaining both proteins were still co-localizing. 
Since Src is reported to associate with Dsg3 [45], we next 
performed immunoprecipitation to investigate whether it 
also forms a complex with Dsg2 and EGFR. Surprisingly, 
we found Src only associated with EGFR but not Dsg2 in 
DLD1 cells (Fig. 4d). Altogether, these data indicate that Src 
acts upstream of Dsg2 and EGFR; Src activity is required 
Fig. 4  Dsg2 knockout reduces Src-dependent phosphorylation of 
EGFR. a Level of phosphorylated EGFR at Y845 in DLD1 cells defi-
cient for Dsg2 and Dsc2 was analyzed via Western blot. Loss of Dsg2 
resulted in reduced level of pEGFR, which was not rescued by recon-
stitution of Dsc2. b Intensity of bands detected by a pEGFR-specific 
antibody was quantified using ImageJ and normalized to total EGFR. 
Shown are fold-change values ± SE of six independent experiments. 
*p < 0.05; n.s. not significant. c Immunostaining of Dsg2 and EGFR 
in DLD1 cells showed reduced and fragmented staining of both pro-
teins at the cell border after application of the Src inhibitors PP2 and 
KX2-391. Bar 10 µm. d DLD1 cell lysates were used for immunopre-
cipitation of EGFR (upper panels) or Dsg2 (lower panels) and sub-
jected to western blot analysis for Src, revealing a co-IP of Src with 
EGFR but not with Dsg2
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for proper localization of Dsg2 and EGFR to the cell bor-
ders and Src-mediated phosphorylation at Y845 stabilizes 
Dsg2–EGFR interaction.
Dsg2 via EGFR regulates the switch 
between adhesive and proliferative states 
in enterocytes
Finally, we were interested in the functional relevance of 
this new signaling complex. We have previously shown that 
loss of Dsg2 aﬀects barrier properties via impaired down-
stream signaling of p38MAPK [20]. Here, we investigated 
whether EGFR signaling is involved in maintenance of bar-
rier properties in intestinal cells. To explore its role during 
barrier recovery, we performed  Ca2+-switch experiments 
and applied several EGFR-modulating agents at initiation 
of repletion. Treatment of DLD1 WT cells with EGF as well 
as the inhibitory EGFR-specific antibody did not disturb bar-
rier recovery, resulting in similar TER values compared to 
 Ca2+-switch alone (Fig. 5a, b). In contrast, application of 
erlotinib abolished barrier recovery significantly (Fig. 5a, b). 
Since we assume that Src activity is required for localization 
of EGFR to cell borders, we next tested whether inhibition 
of Src using the inhibitor PP2 aﬀects barrier recovery after 
 Ca2+ switch. Similar to the eﬀect of erlotinib, also Src inhi-
bition prevented barrier reformation significantly (Fig. 5a, 
b). Furthermore, inhibition of p38MAPK with the inhibitor 
SB202190 hampered barrier recovery (Fig. 5a, b), similar 
as published previously [20], which led us to the assump-
tion that p38MAPK might be regulated downstream of the 
Dsg2–EGFR signaling complex. We obtained similar results 
using Caco2 cells (Fig. S3A and B). Moreover,  Ca2+-switch 
experiments with DLD1 WT cells grown on filter inserts 
revealed no diﬀerence when applying EGF from apical side 
to basolateral side with both behaving similar to control 
conditions (Fig. S3C and D). Treatment with erlotinib in 
the trans-well system also disturbed barrier under both con-
ditions, but recovery was even more aﬀected by applica-
tion from basolateral side (Fig. S3C and D). Furthermore, 
 Ca2+-switch experiments with DLD1 cells deficient for both 
Dsg2 and Dsc2 also revealed significantly impaired barrier 
recovery after inhibition of EGFR, Src, or p38MAPK, indi-
cating that desmosomal cadherins are not the only target of 
these signaling pathways in the process of barrier recovery 
(Fig. S3E and F). Since barrier properties are maintained 
by TJ, eﬀects on claudins may also be possible. Therefore, 
we performed immunostaining for Claudin 4 (Cld4) after 
2 h repletion together with the respective mediator, which 
revealed linear staining along cell borders similar to control 
condition after repletion without any inhibitor or when sup-
plemented with EGF or a-EGFR, whereas staining appeared 
irregular after repletion in the presence of erlotinib, PP2, 
or SB202190 (Fig. S3G). Next, we analyzed whether the 
stability of newly formed cell junctions diﬀers after reple-
tion with EGFR-modulating agents compared to control, 
using a dispase-based cell dissociation assay. Application 
of EGF and the inhibitory EGFR-specific antibody had no 
eﬀect on cell adhesion after  Ca2+ switch (Fig. 5c) as well as 
when applied on a confluent monolayer (Fig. 5d). However, 
inhibition of EGFR tyrosine kinase activity using erlotinib 
increased the number of fragments significantly after  Ca2+ 
switch (Fig. 5c) and disrupted cell adhesion of a conflu-
ent cell monolayer (Fig. 5d). Similar, inhibition of Dsg2 
binding using the Dsg2-specific antibody and inhibition of 
p38MAPK with SB202190 increased cell monolayer frag-
mentation after  Ca2+ switch as well as under normal condi-
tions (Fig. 5c, d), further indicating that the Dsg2–EGFR 
complex might regulate a downstream signaling cascade 
that includes p38MAPK. Several studies implicate a role 
for Dsg2 in regulating downstream signaling cascades linked 
to proliferation [8, 22, 32]. In addition, the pivotal function 
of the EGFR is to drive cell growth and survival [46–48]. 
Therefore, we investigated whether loss of Dsg2 and, as a 
consequence, disruption of the Dsg2–EGFR complex aﬀect 
cell proliferation. Indeed, DLD1 cells deficient for Dsg2 
and Dsc2 showed significantly increased cell proliferation 
Fig. 5  Dsg2 regulates EGFR activity, thereby suppressing prolifera-
tion and supporting an adhesive state in enterocytes. a Barrier recov-
ery of DLD1 WT cells after  Ca2+ switch was monitored via TER 
measurements showing impaired barrier recovery after inhibition of 
EGFR, Src and p38MAPK activity with respective inhibitors. Inhibi-
tors were applied together with  CaCl2 after 1 h depletion with EGTA. 
b TER values were quantified after 10 h of repletion with respective 
inhibitors and normalized to control repletion with respective vehicle. 
Repletion with erlotinib, PP2, and SB202190 resulted in significantly 
reduced TER values compared to control. Shown are fold-change 
values ± SE of 4–6 independent experiments. *p < 0.05; n.s. not sig-
nificant. c Cell adhesion of DLD1 cells was analyzed in a dispase-
based dissociation assay after  Ca2+ switch and treatment with sev-
eral inhibitors. Treatment with erlotinib, PP2, and SB202190 during 
repletion significantly increased monolayer fragmentation compared 
to control repletion with respective vehicle. Shown is mean ± SE of 
six independent experiments. *p < 0.05; n.s. not significant. d Con-
fluent DLD1 cell monolayer were treated with EGF, a-EGFR, erlo-
tinib, or SB202190, and analyzed for cell adhesion in a dispase-based 
cell dissociation assay. Inhibition of EGFR and p38MAPK activity 
significantly increased number of fragments in contrast to EGF and 
the EGFR-specific antibody. Shown is mean ± SE of five independ-
ent experiments. *p < 0.05; n.s. not significant. e Cell proliferation 
was determined by cell counting. 50,000 cells were seeded for each 
cell line with or without erlotinib and cells were counted after 24, 
48, 72, and 96 h. f Number of cells after 96 h was quantified. Shown 
is mean ± SE of at least five independent experiments. *p < 0.05. g 
Cell proliferation was determined after Dsg2 reconstitution in DLD1 
cells deficient for Dsg2 and Dsc2, 48 h after transfection. Shown is 
mean ± SE of four independent experiments. GFP-ev empty vector, 
*p < 0.05. h Model of Dsg2-mediated regulation of EGFR. Dsg2 
recruits EGFR to cell borders where it is phosphorylated by Src and 
induces downstream signaling, thereby strengthening adhesion maybe 
via p38MAPK. Loss of Dsg2 results in activation of the canonical 
EGFR signaling pathway resulting in proliferation
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compared to WT cells (Fig. 5e, f). Stable reconstitution 
of Dsc2 in cells deficient for both desmosomal cadherins 
did not revert proliferation rate and loss of Dsc2 only did 
not result in increased proliferation compared to WT cells 
(Fig. 5e, f), suggesting that Dsg2 and not Dsc2 mediates this 
eﬀect. Treatment with the EGFR tyrosine kinase inhibitor 
erlotinib diminished cell proliferation under all conditions 
resulting in values similar to WT cells (Fig. 5e, f). A similar 
result was obtained using WT and Dsg2-deficient Caco2 
cells (Fig. S3 H). These data suggest that increased cell 
proliferation caused by loss of Dsg2 was mediated through 
EGFR tyrosine kinase activity. In addition, we performed 
Dsg2 rescue experiments with transient re-expression of 
Dsg2–GFP to corroborate the eﬀect on proliferation upon 
loss of Dsg2. Using confocal microscopy, we confirmed the 
successful expression of Dsg2–GFP that was found linearly 
along cell borders in DLD1 double knockout as well as 
Dsg2-deficient Caco2 cells (Fig. S3I). Analysis of prolif-
eration revealed that transient re-expression of Dsg2 was 
suﬃcient to reduce the increased proliferation rate in Dsg2-
deficient DLD1 and Caco2 cells (Fig. 5g; Fig. S3J).
Altogether, our study has identified a new role for Dsg2 
in regulating EGFR activity in intestinal epithelial cells via 
a novel signaling complex consisting of Dsg2, EGFR, and 
Src. In this model, EGFR binds to Dsg2 and is phosphoryl-
ated by Src, which results in increased adhesion maybe via 
modulating p38MAPK signaling. In cells deficient for Dsg2, 
unbound EGFR is activated by ligand binding that leads to 
dimerization and cross-phosphorylation, thereby inducing 
pro-proliferative signaling pathways (Fig. 5h).
Discussion
Although many cellular processes regulated by EGFR 
require a break-up of intercellular junctions and desmosomes 
are considered to play the leading role in intercellular cohe-
sion, only little is known about the functional interplay of 
EGFR and desmosomal cadherins. In this study, we propose 
a new mechanism of EGFR regulation in intestinal epithelial 
cells via a signaling complex consisting of Dsg2, EGFR, 
and Src. We demonstrate, for the first time, that Dsg2 and 
EGFR interact directly via their extracellular domains and 
that ligand binding as well as inhibition of EGFR tyros-
ine kinase activity prevent this interaction in AFM meas-
urements. In addition, inhibition of EGFR tyrosine kinase 
activity significantly reduced cell adhesion, suggesting that 
the Dsg2–EGFR complex stabilizes desmosomal adhesion. 
Dsg2 is required for EGFR to localize to cell borders where 
it binds to Src. In line with this, we detected reduced level 
of Src-mediated phosphorylation of EGFR at Y845 in Dsg2-
deficient cells. Moreover, inhibition of Src activity impaired 
barrier formation, which was accompanied by fragmented 
immunostaining of Dsg2 and EGFR at cell borders. Fur-
thermore, loss of Dsg2 enhanced cell proliferation that was 
restored by inhibition of EGFR kinase activity, indicating 
that Dsg2 modulates EGFR activity, thereby regulating the 
switch between adhesive and proliferative states in intestinal 
epithelial cells.
Our data are in line with the previous studies reporting 
reduced phosphorylation of EGFR on Y845 upon loss of 
Dsg2 [22, 32]. EGFR phosphorylation at Y845 is usually 
catalyzed by Src and regulates a variety of cellular functions 
through the activation of several downstream events [41–43]. 
Increased levels of Src and EGFR can be found in various 
cancer cells, and Y845 phosphorylation-mediated signal-
ing is linked to higher cancer malignancy due to enhanced 
cell transformation, motility, and invasion [42, 49–52]. 
Moreover, Src-mediated phosphorylation at Y845 has been 
reported to promote anti-apoptotic and pro-proliferative 
cell functions [53–56]. In accordance, recently published 
data show that reduced level of EGFR Y845 phosphoryla-
tion after Dsg2 downregulation suppresses cell proliferation 
[22, 32]. However, our study provides evidence that loss of 
Dsg2 and corresponding reduction of EGFR Y845 phospho-
rylation enhanced cell proliferation of intestinal epithelial 
DLD1 cells as well as of Caco2 cells. One has to consider 
that EGFR signaling highly depends on its spatial compart-
mentalization that determines the biological outcome [57]. 
After ligand-mediated activation at the cell surface, EGFR 
molecules are internalized and traverse diﬀerent routes of 
the endosome network, while signaling continues [58–61]. 
EGFR is also known to act as transcription factor in the 
nucleus [62, 63]. Our data indicate a new mechanism by 
which EGFR directly interacts with Dsg2 at cell borders, 
thereby signaling towards adhesion and suppressing prolif-
eration. We observed that this direct interaction is blocked 
using specific antibodies directed against the extracellular 
domains of EGFR or Dsg2 in cell-free AFM measurements. 
A previous study reported that Dsg2 ectodomains, which are 
capable of binding to the same region as the Dsg2-specific 
antibody used in this study, inhibit intercellular adhesion 
and, in addition, increase intestinal epithelial cell prolifera-
tion [21], which fits well to our proposed model. Particu-
lar attention should be given to the close co-localization of 
Dsg2 and EGFR which we found not only in cell culture, but 
similarly in human enteroids as well as in human samples 
which supports the physiological relevance of direct inter-
action between Dsg2 and EGFR. Several studies reporting 
the presence of EGFR in the apical membrane in intestinal 
cells [64–66] where Dsg2 is located support these obser-
vations. Another study suggests EGFR activation through 
Dsg2-mediated disruption of EGFR association with lipid 
rafts without direct interaction of EGFR and Dsg2 [22]. 
Thus, presumably, a diﬀerent signaling complex is formed, 
resulting in a diﬀerent biological function. However, this 
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study was performed in keratinocytes which express more 
than one desmoglein isoform. This is in contrast to intestinal 
epithelial cells with only Dsg2 and Dsc2 being expressed 
[67, 68]. Hence, it is conceivable that desmosomal cadherins 
exert distinct functions in diﬀerent tissues. In line with this, 
in keratinocytes, EGFR was shown to co-localize with Dsg1 
that suppressed EGFR activity to promote diﬀerentiation 
[9]. A recent study demonstrated a similar mechanism, by 
which the classical cadherin Ecad recruits EGFR to AJ and 
suppresses its activity to foster barrier stability [69]. This 
is in line with our proposed model, where Dsg2 localizes 
EGFR to cell borders, thereby suppressing its proliferative 
activity and strengthening cell adhesion. Similarly, Dsg2 has 
been reported to support diﬀerentiation and thus to act as 
tumor suppressor gene in gastric cancer [70]. Furthermore, 
our data indicate that this eﬀect is mediated by increased 
EGFR phosphorylation at Y845 which appears to be impor-
tant for the formation of the Dsg2–EGFR signaling complex. 
Studies from the literature, demonstrating that Y845 phos-
phorylation induces cell cycle arrest and inhibits growth, 
also support our hypothesis [71, 72]. Interestingly, another 
group demonstrated that downregulation of Dsc2 increases 
proliferation in colon cancer cells, while downregulation of 
Dsg2 reduces proliferation, which is in contrast to our study 
[32, 73]. However, this study was conducted in cancer cells 
harboring a mutation that results in deregulated β-catenin 
signaling and increased expression of pro-proliferative genes 
[74, 75]. Given that the EGFR and β-catenin pathways are 
known to interact at multiple levels ranging from transcrip-
tional to posttranscriptional regulation [76–81], deregulated 
signaling events downstream of these pathways may account 
for the diﬀerent impact on proliferation after Dsg2 downreg-
ulation. Similar to our study, EGFR Y845 phosphorylation 
was reduced upon loss of Dsg2, which points toward compa-
rable EGFR regulation but diﬀerent downstream signaling. 
We observed increased proliferation rate in both DLD1 and 
Caco2 cells upon loss of Dsg2.
Previously, we have shown that Dsg2 regulates intesti-
nal barrier properties via p38MAPK that is activated upon 
loss of Dsg2 [20]. However, it is still an open question how 
Dsg2 regulates this signaling pathway. MAPK cascades are 
known to be downstream targets of the EGFR and increased 
p38MAPK phosphorylation after EGF stimulation has been 
reported previously [82, 83]. Furthermore, Src-dependent 
p38MAPK activation has been shown to modulate the EGF-
stimulated response towards migration instead of prolifera-
tion during wound closure in intestinal epithelial cells [84]. 
Hence, a signaling cascade consisting of Src being upstream 
of the Dsg2–EGFR complex and p38MAPK being regulated 
downstream of this complex, thereby supporting the adhe-
sive state of intestinal epithelial cells, is conceivable. How-
ever, our data do not rule out the possibility that other tar-
gets including adhesion molecules as well as other signaling 
cascades may be coordinated by Dsg2 together with EGFR. 
For instance, EGFR regulation has recently been linked to 
AJ [69] and we observed irregular staining of the TJ pro-
tein Cld4 after EGFR inhibition. Furthermore, it has been 
reported that the apical and basolateral fractions of EGFR 
exert diﬀerential signaling functions [85]. Although we 
observed no diﬀerence in outcome when applying EGFR-
modulating agents from apical side to basolateral side in this 
study, future studies may gain more insight into the molecu-
lar mechanism underlying the EGFR-mediated regulation of 
intestinal barrier properties.
Taken together, we propose a new mechanism of EGFR 
regulation that is important for intestinal epithelial cell 
homeostasis. Deregulation of any of the involved proteins 
has potential to induce intestinal disorders such as inflam-
matory bowel disease (IBD) or cancer. Thus, EGFR signal-
ing has been shown to be reduced in IBD patients, while 
upregulated levels are often found in various types of can-
cers, indicating that a precise regulation of EGFR activity 
is crucial to maintain intestinal barrier integrity [42, 86]. In 
line with this, growth factors such as EGF promote wound 
healing in IBD but are also involved in the formation of 
neoplasia [87–89]. Likewise, Dsg2 is reduced in the mucosa 
of patients suﬀering from Crohn’s disease and is implicated 
in oncogenesis [17, 19]. In addition, tumor necrosis fac-
tor α (TNFα), a cytokine implicated in the pathogenesis 
of Crohn’s disease, has been reported to modulate EGFR 
activity, as well [90, 91]. Hence, understanding the molecu-
lar mechanism of EGFR regulation in intestinal cells might 
provide the molecular basis for new therapeutic approaches 
for the treatment of IBD or cancer in the future.
Materials and methods
Cell culture
DLD1 and Caco2 cells were cultured in Dulbecco’s modi-
fied Eagle medium (Life Technologies, Carlsbad, CA, USA) 
supplemented by 10% fetal bovine serum (Biochrom, Berlin, 
Germany), 50 U/mL penicillin, and 50 U/mL streptomycin 
(both AppliChem, Darmstadt, Germany), and cultivated 
in a humidified atmosphere containing 5%  CO2 at 37 °C. 
Experiments were performed 4 days after reaching full con-
fluence. DLD1 knockout cells were generated in the lab of 
Suzuki (Kwansei Gakuin University, Japan) [16] using the 
CRISPR/Cas9 system with the pX330 vector (Addgene, 
Cambridge, MA, USA) according to the method described 
by Cong et al. [92]. Briefly, human cDNAs for Dsg2 and 
Dsc2 were obtained by polymerase chain reaction (PCR) 
with nucleotide sequences that are published in the Gen-
Bank, and amplified and cloned into the expression vector 
pEF1 (Invitrogen, Carlsbad, CA, USA) accompanied with 
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the introduction of an HA tag at the C-terminus. DLD1 cells 
were co-transfected with the CRISPR/Cas9 construct and the 
expression vector pCAG-Flag-IRESpuro (Addgene, Cam-
bridge, MA, USA) using the lipofectamine LTX protocol. 
Puromycin was used for screening, resultant colonies were 
picked and cultured, and the expression of target protein was 
analyzed by immunoblotting. In addition, deletion of the 
target gene was confirmed by amplification of genomic DNA 
by PCR and subsequent sequencing. For stable expression of 
full-length Dsc2, cells were transfected with the DNA con-
struct using the Lipofectamine LTX protocol and screened 
in the presence of G418 (400 µg/mL) for about 2 weeks, 
followed by immunoblot analysis.
Human tissue samples
Colon samples were obtained from patients who required 
right or left hemi-colectomy due to colon carcinoma in 
which the surgical resection routinely involves a part of the 
healthy small intestine or colon, respectively. All patients 
gave their written informed consent prior surgery to inclu-
sion in the study and ethical approval was given by the Ethi-
cal Board of the University of Würzburg (proposal numbers 
113/13, 46/11, 42/16). Tissue samples were collected in a 
standardized procedure via the Interdisciplinary Bank of 
Biomaterials and Data Würzburg (IBDW) as described in 
detail previously [93]. For immunostaining, tissue samples 
were fixed in 4% paraformaldehyde, embedded in paraﬃn, 
and sectioned (1 μm).
Enteroids
Intestinal epithelial cells (IECs) were isolated from healthy 
human full-wall gut resections, 1 cm2 in size as described 
previously [94]. Briefly, villi were scraped oﬀ the muscle-
free mucosa using a sterile glass slide. The remaining tis-
sue was transferred into a 50 mL falcon tube with 20 mL 
4 °C cold HBSS (Sigma-Aldrich, St. Louis, MO, USA) and 
vortexed for 5 s, and the supernatant discarded. This wash-
ing step was repeated until the supernatant was completely 
cleared of cell debris. Afterward, the tissue was incubated 
in 4 °C cold 2 mM EDTA/HBSS solution (Sigma-Aldrich, 
St. Louis, MO, USA) for 30 min at 4 °C under gentle rota-
tion on a shaker. Subsequently, the tissue was washed once 
in 20 mL HBSS by manually inverting the tube five times. 
The mucosa was transferred in a new tube with 10 mL HBSS 
and manually shaken five times. This shaking procedure was 
repeated four times always using a new tube. Each cell frac-
tion was checked for the amount and size of crypts within 
small drops under the microscope. The supernatants contain-
ing the most vital appearing crypts were pooled and centri-
fuged at 350g for 3 min at room temperature (RT). Pellet was 
resuspended in 10 mL basal medium, DMEM-F12 Advanced 
(Invitrogen, Carlsbad, CA, USA) supplemented with N2, 
B27, Anti–Anti, 10 mM HEPES, 2 mM GlutaMAX-I (all 
from Invitrogen, Carlsbad, CA, USA), and 1 mM N-ace-
tylcysteine (Sigma-Aldrich, St. Louis, MO, USA), and the 
crypt number was estimated in a 10 µL drop by microscopy. 
Crypts were centrifuged in a nonstick 1.5 mL tube at 350g 
for 3 min at RT and the supernatant was removed. The tube 
with the cell pellet was placed on ice until further use. The 
pellet was resuspended in an appropriate amount of cold 
Matrigel (Corning, Hickory, NC, USA), that is, 5000 crypts/
mL. Drops of 50 µL per well were seeded in a 24-well plate 
and incubated for 10–20 min until the Matrigel was well 
solidified. The culture medium contained a mixture of 50% 
fresh basal medium and 50% Wnt3A-conditioned medium.
Furthermore, the following growth factors were added: 
500 ng/mL hR-Spondin 1 (PeproTech, Rocky Hill, NY, 
USA). 100 ng/mL IECs were isolated from human small 
intestinal tissue and expanded as organoid culture for 
3–4 weeks.
Test reagents
Epidermal growth factor receptor activity was inhibited 
using either a specific mouse anti-EGFR antibody (C225, 
sodium azide free, Merck Millipore, Darmstadt, Germany) 
at 0.5 µg/mL for 1 h or the tyrosine kinase activity inhibi-
tor erlotinib (Santa Cruz Biotechnology, Santa Cruz, CA, 
USA) at 2.5 µM for 1 h. For positive stimulation of EGFR 
activity, the growth factor EGF (Sigma-Aldrich, Munich, 
Germany) was used at 20 ng/mL for 1 h. Cells were cul-
tured in serum-free medium for 1 h prior to treatment with 
EGFR-modulating agents. PP2 (Calbiochem, Darmstadt, 
Germany) and KX2-391 (Biozol, Germany) were used at 
10 µM for 1 h to inhibit Src activity and SB202190 (Cal-
biochem, Darmstadt, Germany) was used at 30 µM for 1 h 
to inhibit p38 MAPK. Dsg2 binding was inhibited using 
a specific monoclonal mouse antibody directed against the 
second and third extracellular repeat domains of Dsg2 (clone 
10G11, sodium azide free, Progen, Heidelberg, Germany) 
applied 1:50. For western blot analysis and immunofluo-
rescence staining, following primary antibodies were used: 
mouse anti-Dsg2 (clone 10G11) and rabbit anti-Dsg2 (rb5, 
both Progen, Heidelberg, Germany), mouse anti-Dsc2/3 
(clone 7G6) and rabbit anti Claudin-4 (both Life Technolo-
gies, Carlsbad, CA, USA), rabbit anti-DP I/II (H-300), rabbit 
anti-EGFR (clone 1005-G), mouse anti-EGFR (clone A-10) 
and mouse anti-GAPDH (all from Santa Cruz Biotechnol-
ogy, Santa Cruz, CA, USA), mouse anti-α-tubulin (Abcam, 
Cambridge, UK), and rabbit anti-phospho-EGFR Tyr845 
and rabbit anti-Src (both from Cell Signaling, Danvers, MA, 
USA). HRP-conjugated goat anti-mouse or goat anti-rabbit 
(Dianova, Hamburg, Germany) secondary antibodies were 
used for western blot analysis. Cy3- or Alexa488-labeled 
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goat anti-mouse or goat anti-rabbit antibodies (Dianova, 
Hamburg, Germany) were used for confocal microscopy, 
and Star580- and Star635P-labeled antibodies (Abberior) 
were used for STED. F-actin was visualized using Alexa488-
labeled phalloidin (Life Technologies, Carlsbad, CA, USA) 
and nuclei were counterstained with DAPI (Sigma-Aldrich, 
Munich, Germany).
Immunofluorescence
Cells were grown on 12 mm glass cover slides, fixed with 
2% paraformaldehyde in PBS for 10 min and, subsequently, 
permeabilized with 0.5% TritonX-100 in PBS containing 
0.02% Tween20 (PBS-T) for 10 min following 1 h of block-
ing in 2% BSA in PBS-T. Human tissue samples embedded 
in paraﬃn were sectioned in 1 µm slices and immunostaining 
was performed after removal of paraﬃn using 100% Xylol 
followed by an ethanol series from 100 to 70% and sera dest 
at the end. Then, samples were permeabilized with 0.1% 
TritonX-100 in PBS-T for 30 min followed by blocking in 
2% BSA in PBS-T. Primary and secondary antibodies were 
incubated for 1 h at room temperature each. Paraﬃn sections 
were incubated with primary antibodies at 4 °C over night. 
For confocal microscopy, coverslips were placed on glass 
slides with 60% glycerol in PBS, containing 1.5% N-propyl 
gallate (Serva, Heidelberg, Germany). Image acquisition was 
performed using a Leica SP5 confocal microscope with a 
63× NA 1.4 PL APO objective (both Leica, Wetzlar, Ger-
many. Co-localization analysis was performed by generating 
an intensity plot profile for each channel using the ImageJ 
software and calculating the Pearson’s correlation coeﬃcient 
between the intensity distributions of two molecules of inter-
est. To this end, 35 cell borders from 7 independent experi-
ments were selected.
Stimulated emission depletion microscopy (STED)
After immunostaining, cells were mounted in 2.5% DABCO 
in MOWIOL/HEPES (self-made solution). Images were 
acquired with an Abberior 3D STED confocal microscope. 
Star580 and Star635P (both from Abberior) were excited 
at 594 and 638 nm, respectively, using pulsed diode lasers 
(PDL 594, Abberior Instruments; PiL063X, Advanced 
Laser Diode Systems). Depletion of fluorescent molecules 
was conducted at 775 nm with a pulsed fibre laser (PFL-
P-30-775B1R, MPB Communications) and emission was 
detected with an avalanche photodiode detector at 605–625 
and 650–720 nm range.
Western blot
Cells were lysed with SDS lysis buﬀer (25 mM HEPES, 
2 mM EDTA, 25 mM NaF, and 1% SDS) supplemented 
with a protease-inhibitor cocktail (Roche, Mannheim, 
Germany) followed by sonication and heating to 95 °C 
for 10 min in Laemmli buﬀer with 50 mM dithiothreitol 
(Applichem). Protein amount was determined using a BCA 
Protein Assay Kit (Pierce/Thermo Scientific, Waltham, 
MA, USA) and equivalent protein concentrations were 
resolved by reducing SDS-PAGE. After protein transfer to 
a nitrocellulose membrane (Life Technologies, Carlsbad, 
CA, USA) according to the standard protocols, membranes 
were probed with primary antibodies overnight at 4 °C 
followed by incubation with secondary antibodies for 2 h 
at room temperature. Bands were detected with an ECL 
reaction system (self-made solution) using the Amersham 
Imager 600 (GE Healthcare Life Sciences, Germany).
TritonX-100 protein extraction
Cells were washed with ice-cold PBS and incubated in a 
Triton buﬀer (0.5% Triton X-100, 50 mM MES, 25 mM 
EGTA, and 5 mM  MgCl2) supplemented with 1 mM PMSF 
(Roth, Germany), Aprotinin, Pepstatin A (both Applichem, 
Germany), and Leupeptin (VWR, Germany) for 15 min on 
ice under gentle shaking. Subsequently, cell lysates were 
centrifuged at 13,000 rpm for 5 min to separate the insolu-
ble from the soluble fraction and pellets were resuspended 
in SDS lysis buﬀer followed by sonication. Protein con-
centration of both fractions was calculated as described 
above and equivalent amounts of protein were used for 
western blot analysis.
Cell surface biotinylation
Cells grown in six-well plates were treated with test rea-
gents, washed with ice-cold HBSS, and incubated with 
0.25 mM membrane-impermeable EZ-Link Sulfo-NHS-
Biotin (Thermo Fischer Scientific, Waltham, USA) for 
1 h on ice to prevent internalization. Excess biotin was 
quenched by washing three times with ice-cold 100 mM 
Glycin followed by three times washing with ice-cold 
HBSS. Cells were lysed in lysis buﬀer (50 mM NaCl, 
10 mM PIPES, 3 mM  MgCl2, and 1% Triton X-100) 
for 15 min on ice followed by 5 min centrifugation at 
13,000 rpm and measurement of protein concentration 
of the recovered cell lysate supernatants as described 
above. For precipitation of biotin-labeled proteins, a pro-
tein amount of 500 µg was incubated with NeutrAvidin 
(High Capacity)-agarose beads (Thermo Fischer Scientific, 
Waltham, USA) over night at 4 °C. After four times wash-
ing with lysis buﬀer, cell surface proteins were eluted in 
Laemmli buﬀer containing 50 mM dithiothreitol at 95 °C 
and subjected to Western blot analysis.
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Co-immunoprecipitation
Cell monolayers were washed with ice-cold HBSS and incu-
bated with RIPA buﬀer (50 mM Tris–HCl, 150 mM NaCl, 
0.1% SDS, 1% NP-40, and 0.1 mM EDTA) supplemented 
with a protease-inhibitor cocktail (Roche, Mannheim, Ger-
many) for 30 min on ice while shaking. Cells were scraped 
and centrifuged at 13,000 rpm for 5 min at 4 °C, and pro-
tein concentration of the lysate was determined as described 
above. Cell lysates were precleared with protein-G beads 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 1 h 
at 4 °C, followed by incubation with 1 µg of respective anti-
body or IgG control for 3 h at 4 °C with gentle rotation. 
Subsequently, protein-G beads were added and incubated 
over night at 4 °C. For pull-down assays with Dsg2-Fc, 
beads were incubated with 0.15 mg/mL Dsg2-Fc in HBSS 
at 4 °C over night, washed three times with RIPA buﬀer to 
remove unbound protein, and incubated with cell lysates at 
4 °C again over night. After three times washing with RIPA 
buﬀer, immunocomplexes were boiled in 20 µL Laemmli 
buﬀer containing 50 mM dithiothreitol at 95 °C for 10 min 
and subjected to Western blot analysis.
Atomic force microscopy (AFM)
Atomic force microscopy measurements were performed 
with a Nanowizard III AFM (JPK Instruments, Berlin, Ger-
many) mounted on an optical microscopy (Carl Zeiss, Jena, 
Germany). The whole setup was placed on a Halcyonics i4 
anti-vibration table (Accurion, Goettingen, Germany) in a 
closed hood to protect measurements from environmental 
noise. The application of AFM force microscopy on living 
cells was described in detail before [95]. All measurements 
were conducted in cell culture medium at 37 °C. For Dsg2 
adhesion studies, recombinant Dsg2-Fc (self-made) contain-
ing the complete extracellular domain (ED) of Dsg2 was 
linked to flexible Si3N4 AFM cantilevers (MLCT probes, 
Bruker, Calle Tecate, CA, USA) via a flexible bifunctional 
polyethylene glycol linker (Gruber Lab, Institute of Bio-
physics, Linz, Austria) as described elsewhere [96]. Prior 
to adhesion measurements on living cells, AFM topogra-
phy images of 50 × 50 µm and 128 × 128 pixels were cre-
ated using a force curve-based imaging mode (QI-mode) 
with a setpoint adjusted to 0.5 nN, a z length of 1500 nm, 
and a pulling speed of 50 µm/s. Adhesion measurements 
were performed in the force spectroscopy mode with a rela-
tive setpoint of 0.5 nN, a z length of 2 µm, and a pulling 
speed of 4 µm/s. The same cantilever was used under con-
trol conditions and after incubation for 1 h with inhibitory 
antibodies or EGFR-modulating agents. For each condition, 
several areas of 2 × 5 µm were selected with 1000 recorded 
force–distance curves per area. Cell-free AFM measure-
ments were carried out with mica sheets (SPI Supplies, West 
Chester, USA) instead of cell monolayers, functionalized 
with either Dsg2-Fc or EGFR-Fc (Sino Biological). To pro-
duce comparable results, setpoint was adjusted to the same 
value as for cell-based experiments. For each condition, sev-
eral areas of 25 µm × 25 µm with 400 force–distance curves 
per area were measured using a z length of 0.3 µm and a 
pulling speed of 1 µm/s. Acquired AFM data were processed 
using the JPK processing software. Analysis of unbinding 
force distribution was performed with Origin Pro 2016, 93G 
(Northampton, MA, USA).
Hanging drop bead aggregation assay
Protein-G-coated polystyrene microbeads (Dynabeads, 
diameter 2.8 µm; Thermo Fisher Scientific) were coated 
with recombinant Dsg2- or EGFR-Fc and aggregation assays 
were carried out as described previously [95]. Briefly, beads 
were washed with 100 mM sodium phosphate buﬀer (pH 
8.1), blocked with 5% BSA for 1 h at RT, and incubated with 
0.15 mg/mL Dsg2-, EGFR-Fc or control-Fc part of human 
IgGs (Merck Millipore, Darmstadt, Germany) over night at 
4 °C under slow overhead rotation. Following washing steps, 
beads were incubated with 500 mM dimethyl adipimidate·2 
HCl (DMA, Thermo Fisher Scientific) for 45 min at RT to 
covalently cross-link protein-G with Fc parts. After incuba-
tion with 200 mM ethanolamine (pH 8.0) for 2 h at RT and 
several washing steps, about 0.3 µg beads were resuspended 
in 10 µL HBSS containing 1.8 mM  Ca2+. Then, beads were 
allowed to aggregate in a hanging drop on the underside of 
a culture dish lid at 37 °C for 1 h, followed by 1 h incubation 
with EGF. After shaking on an orbital shaker at 1000 rpm 
for 3 min, a ratio was calculated from of the area covered 
with beads and the area of total bead extent and expressed 
as density of bead colonies in percentage.
Calcium switch assay
Cells were incubated with 4 mM EGTA for 1 h, thereby 
inducing disruption of  Ca2+-dependent cell junctions. Ref-
ormation of cell junctions was induced by addition of 8 mM 
 CaCl2 supplemented with test reagents or the respective 
vehicle. Time course of junctional disassembly and reas-
sembly was monitored by measuring the transepithelial 
resistance (TER) of cells grown on eight-well electrode 
arrays (Ibidi, 8W10E) with an ECIS model Z theta (Applied 
Biophysics, Troy, NY, USA) at 800 Hz for DLD1 cells and 
400 Hz for Caco2 cells. In addition, cells were grown on fil-
ter inserts (Corning, PET membrane, pore size 0.4 µm) and 
measured with the ECIS 8W Trans-Filter Adapter. Stability 
of reformed cell junctions was analyzed using a dispase-
based cell dissociation assay.
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Dispase-based dissociation assay
Dissociation assays were performed in 24-well plates. After 
treatment with test reagents, cell monolayer were washed 
with Hank’s buﬀered saline solution (HBSS; Sigma-Aldrich) 
and incubated with 150 µL dispase II (2.4 U/mL in HBSS, 
Sigma-Aldrich) at 37 °C for 25 min. Reaction was stopped 
by adding 200 µL HBSS and a defined shear stress was 
applied by pipetting three times with an electrical pipet. 
Resulting fragments were counted using a binocular micro-
scope (Leica). Every condition was performed in duplicates 
and each experiment was repeated at least four times.
Proliferation assay
Cellular proliferation was ascertained by counting the num-
ber of cells using a Neubauer chamber (Laboroptik, Lancing, 
UK). 50,000 cells were seeded in 24-well plates in complete 
DMEM with erlotinib (2.5 µM) or DMSO and counted after 
24, 48, 72, and 96 h. Medium was changed every day.
Transfection with Dsg2–GFP
The plasmid encoding for human wild-type Dsg2 with a 
C-terminal eGFP tag [97] was kindly provided by Katja 
Gehmlich (University of Oxford, UK). 50,000 cells were 
seeded and transfected right away with 1 µg endotoxin-free 
Dsg2–GFP plasmid DNA or the GFP empty vector [98] 
(pDEST-eGFP-N1, Addgene plasmid # 31796, gift from 
Robin Shaw, Cedars-Sinai Heart Institute, Los Angeles, 
USA) using TurboFect™ (Life Technologies) according to 
the manufacturer’s protocol and incubated for 48 h. Medium 
was changed 8 h after transfection.
Statistics
All experiments were repeated at least three times. Band 
intensity was quantified using ImageJ (National Institutes of 
Health, Bethesda, MD, USA). For statistical analysis, two-
tailed Student’s t test was used to analyze two-sample groups 
and one-way ANOVA followed by Bonferroni correction 
was used for multiple sample groups. Results are shown as 
mean ± SE. A p value of < 0.05 was considered significant.
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Generation of Dsg2 knockout in Caco2 cells by using the CRISPR/Cas9 system 
Disruption of the Dsg2 gene was carried out with the CRISPR/Cas9 system. Two sgRNA targeting exon 
3 and exon 13 of human Dsg2 were designed using the Chopchop-web based sgRNA design tool [1] 
and subcloned into the lentiviral vectors pLentiCRISPR v2 (kind gift from Feng Zhang, Addgene 
plasmid # 52961) and pLKO5.sgRNA.EFS.GFP (kind gift from Benjamin Ebert, Addgene plasmid # 
57822) respectively. HEK293T cells were used for production of lentiviral particles employing the 
second generation lentiviral packaging system comprising pPAX and pMD2 packaging plasmids. Caco2 
cells were infected with viral supernatant containing both viral particles, CrisprV2 and LKO-sgRNA-
EFS GFP accompanied with the addition of polybrene. Infected cells were selected using Puromycin 
(15µg/ml) for 1 week and positive clones were sorted for GFP-expression using FACS. Deletion of the 
target gene in single clones was assessed by immunoblotting and qPCR. 
Table 1: Primers used for synthesis of the Dsg2 construct and used for qPCR  
Primer name Sequence 
hDSG2-1 f 
hDSG2-1 r 
hDSG2-2 f 
hDSG2-2 r 
 
caccgCTTTGGCGCCCTTTCCGCAA 
aaacTTGCGGAAAGGGCGCCAAAGc 
caccgCTAAACATCCTCATTTAGTG 
aaacCACTAAATGAGGATGTTTAGc 
 
qPCR primer Sequence 
DSG2 f 
DSG2 r 
 
Aattgcgctcatgattttgg 
Gcaatggcacatcagcagta 
 
 
 
Supplementary figure legends 
Fig. S1 (A) Immunostaining for Dsg2 and EGFR in confluent Caco2 cell monolayer displayed linear 
localization of Dsg2 and EGFR along the cell borders in Caco2 WT cells, which was not present in Dsg2 
deficient Caco2 cells. Bar 10 µm (B) Triton X-100 protein extraction revealed reduced amount of EGFR 
in the insoluble fraction upon loss of Dsg2 in Caco2 cells. GAPDH served as loading control. (C) Band 
intensity of detected EGFR was analyzed from 4 independent experiments, resulting in a significant 
reduction of EGFR in both fractions in Dsg2-deficient Caco2 cells. Results are shown as means ± SE * 
p < 0.05 (D) Total protein level of EGFR in Caco2 cells was assessed by Western blotting resulting in 
reduced levels of EGFR in Dsg2-deficient Caco2 cells. GAPDH served as loading control. (E) Band 
intensity of detected EGFR bands was quantified from 5 independent experiments, showing a significant 
reduction of total EGFR protein levels upon loss of Dsg2 in Caco2 cells. Results are shown as means ± 
SE. * p < 0.05 
Fig. S2 (A) Phosphorylation of EGFR at Y845 in Caco2 cells was analyzed via Western blot. Reduced 
level of phosphorylation were observed in cells deficient for Dsg2. (B) Band intensity for detected 
pEGFR was quantified and normalized to total EGFR. Shown are fold change values ± SE of 6 
independent experiments. * p < 0.05 (C) Immunostaining for Src in DLD1 cells deficient for Dsg2 
and/or Dsc2 revealed similar localization of Src at cell borders in all cell lines independent of Dsg2 
expression. Alexa-phalloidin was used to visualize cell borders. Bar 10 µm (D) Western blot analysis of 
whole cell lysates of DLD1 cells revealed unaltered protein levels of total Src as well as phosphorylated 
Src in all knockout cell lines. GAPDH was used as loading control. Shown is representative blot of 3 
independent experiments. (E) Src is present in the TritonX-100 insoluble fraction despite loss of Dsg2 
and similar in all DLD1 knockout cell lines. GAPDH was used as loading control. Shown is 
representative blot of 3 independent experiments. 
Fig. S3 (A) Barrier recovery of Caco2 cells after Ca2+-switch was monitored by measuring the TER  
showing impaired barrier recovery after inhibition of EGFR, Src and p38MAPK activity with respective 
inhibitors. Inhibitors were applied together with CaCl2 after 1 h depletion with EGTA. (B) TER values 
were quantified 10 h after repletion with respective inhibitors revealing significantly reduced TER 
values after repletion with Erlotinib, PP2 and SB202190 compared to control repletion with respective 
vehicle. Shown are fold change values ± SE of 6 independent experiments. * p < 0.05; n.s. = not 
significant (C) Barrier recovery of DLD1 WT cells grown on filter inserts was analyzed via TER 
measurements. Test reagents were applied together with CaCl2 from the apical or basolateral site of cell 
monolayer, which resulted in impaired barrier recovery after inhibition of apical as well as of basolateral 
localized EGFR. (D) TER values were quantified 8 h after repletion showing significantly decreased 
values in the presence of Erlotinib compared to control repletion. Shown are fold change values ± SE of 
4 independent experiments. * p < 0.05; n.s. = not significant (E) Barrier recovery of DLD1 cells deficient 
for Dsg2 and Dsc2 after Ca2+-switch was analyzed using TER measurements revealing impaired 
recovery after repletion with added inhibitors for EGFR, Src and p38MAPK activity. (F) TER values 
were quantified 10 h after repletion showing a significant reduction in the presence of Erlotinib, PP2 
and SB202190. Shown are fold change values ± SE of 6-8 independent experiments. * p < 0.05; n.s. = 
not significant (G) Ca2+-switch assay was performed with confluent cell monolayer of DLD1 WT cells 
grown on coverslips and formation of TJ was assessed 2 h after repletion with several test reagents by 
immunostaining for Cld4. Alexa488-phalloidin was used to visualize cell borders. Bar 10 µm. (H) DLD1 
double knockout cells and Caco2 Dsg2-deficient cells were transfected with Dsg2-GFP or the GFP 
empty vector resulting in linear localization of Dsg2-GFP along the cell borders. Bar 10 µm (I-J) Cell 
proliferation of Caco2 cells deficient for Dsg2 was determined by cell counting. 50000 cells were seeded 
and treated with Erlotinib (I) or transfected with Dsg2-GFP (J) and counted after 48 h. Shown is mean 
± SE of 4 (I) and 5 (J) independent experiments. GFP-ev = empty vector, * p < 0.05 
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Abstract:  
Desmosomes are the least understood intercellular junctions in the intestinal epithelia 
and provide cell-cell adhesion via the cadherins desmoglein (Dsg)2 and desmocollin 
(Dsc)2. We studied these cadherins in Crohn's disease (CD) patients and in newly 
generated conditional villin-Cre DSG2 and DSC2 knockout mice (DSG2ΔIEC; DSC2ΔIEC). 
CD patients exhibited altered desmosomes and reduced Dsg2/Dsc2 levels. The 
intestines of both transgenic animal lines were histopathologically inconspicuous. 
However, DSG2ΔIEC, but not DSC2ΔIEC mice displayed an increased intestinal 
permeability, a wider desmosomal space as well as alterations in desmosomal and tight 
junction components. After dextran sodium sulfate (DSS)-treatment and C. rodentium 
exposure, DSG2ΔIEC mice developed a more pronounced colitis, an enhanced intestinal 
epithelial barrier disruption leading to a stronger inflammation and activation of 
epithelial pSTAT3 signaling. No susceptibility to DSS-induced intestinal injury was 
noted in DSC2ΔIEC animals. Dsg2 interacted with the cytoprotective chaperone Hsp70. 
Accordingly, DSG2ΔIEC mice had lower Hsp70 levels in the plasma membrane 
compartment, whereas DSC2ΔIEC mice displayed a compensatory recruitment of galectin 
3, a junction-tightening protein. Our results demonstrate that Dsg2, but not Dsc2 is 
required for the integrity of the intestinal epithelial barrier in vivo.  
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Introduction  
Epithelial cell layers in general provide an efficient barrier against the hostile 
environment. The intestinal epithelium has to facilitate both, protection of the 
underlying tissue from invading microorganisms and efficient uptake of nutrients and 
solutes. Intercellular junctions constitute a crucial part of this barrier and consist of tight 
junctions (TJs), adherens junctions (AJs) and desmosomes that together form the apical 
junctional complex (AJC).1 TJ are the primary structures sealing the intercellular space. 
However, pro-inflammatory signaling in epithelial cells alters the TJ composition leading 
to reduced barrier function, thereby contributing to the pathogenesis of multiple 
prevalent intestinal disorders such as inflammatory bowel disease, celiac disease or 
infectious gastroenteritis. 2, 3 This process is driven by molecular remodeling that results 
in decreased levels of claudin 1 and occludin and increased amounts of claudins 2 and 
15.1, 4 AJs are established mediators of cell-cell adhesion and play an important role in 
cell polarization and differentiation via the associated Wnt/β-catenin pathway.1  
Desmosomes represent the least studied AJC component. They are, similar to AJs, 
important for cell adhesion and cytoskeletal anchorage.5 Their importance becomes 
evident in inherited cardiomyopathies that are caused by mutation in desmosomal genes 
and blistering skin disorders elicited by desmosomal autoantibodies. Desmosomes are 
also altered in microbial infections in that their constituents are cleaved by bacterial 
toxins and become targeted in adenoviral respiratory infections.6-8 Desmosomes bear 
structural similarities with hemidesmosomes that with the help of integrins connect the 
cells to the extracellular matrix. The crucial importance of hemidesmosomes was recently 
demonstrated in mice with intestinal epithelial cell-specific α6 integrin ablation that 
develop colitis with spontaneous progression into high-grade intestinal carcinoma.9  
To connect the cells, desmosomes comprise transmembrane proteins termed 
desmosomal cadherins. These are subdivided into the desmoglein and desmocollin type 
(gene names: DSGs/DSCs, protein names: Dsgs/Dscs). While homo- and heterophilic 
interactions between the extracellular Dsg and Dsc domains have been described, the 
latter are preferred and accordingly, both protein types are needed for cellular adhesion.5, 
10 Dsgs/Dscs are expressed in a cell type-specific pattern with Dsc2 and Dsg2 being the 
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most wide-spread family members and the major desmosomal cadherins of digestive 
epithelia.6 On the cytoplasmic side, Dsg2/Dsc2 are connected to the armadillo proteins 
plakoglobin (PG) and plakophilin 2 (Pkp2), which, together with desmoplakin (Dsp), 
facilitate the attachment to the keratin cytoskeleton.5, 6  
Despite their presumed biological importance, only in vitro studies addressed the role of 
desmosomal cadherins in the intestine so far. The data available up to date suggest that 
although they are both functionally and structurally similar, they also display unique 
properties. 6, 11-13 For example, DSG2 knockdown resulted in a compensatory up-
regulation of Dsc2, whereas DSC2 loss did not lead to alterations in Dsg2 protein levels. 
14 Moreover, Dsg2 but not Dsc2 was cleaved during intestinal epithelial cell apoptosis 
and DSG2 down-regulation inhibited this cell death pathway. 15 In addition to 
experimental data pointing towards a functional importance of desmosomes, a selective 
decrease of Dsg2 was reported in patients with Crohn´s disease. 16  In cultured epithelial 
cells, this down-regulation was associated with increased permeability that was prevented 
by stabilization of desmosomal adhesion.16 These disease-related changes coupled with 
their established in vitro biological function as well as the crucial importance of 
intercellular junctions 1, 9 prompted us to analyze the in vivo properties of desmosomal 
cadherins in the intestine. To that end, we generated conditional villin-Cre mediated 
DSG2 knockout and DSC2 knockout (DSG2ΔIEC/DSC2ΔIEC) mice and analyzed 
desmosomal alterations in Crohn´s disease patients.  
In summary, we demonstrate that intestinal DSG2 but not DSC2 is required for the 
integrity of the intestinal epithelial barrier in vivo. These data might be of human 
relevance, since Crohn´s disease patients display altered desmosomes as well as reduced 
desmosomal cadherin levels. 
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Results  
Since patients with Crohn’s disease were reported to have reduced intestinal Dsg2 
levels,16 we performed transmission electron microscopy that revealed an altered 
ultrastructure of the apical junctional complex (Suppl. Fig. 1A). In particular, TJs lacked 
proper membrane annealing, while desmosomes were sometimes missing and/or 
exhibited irregular or asymmetric plaques with reduced intermediate filament insertion. 
In contrast, AJ were largely unaltered (Suppl. Fig. 1A). In line with that and previous 
findings,16 a significant reduction in both desmosomal cadherins, i.e. Dsg2 and Dsc2, 
was seen, whereas no obvious alterations were detected in E-cadherin (Suppl. Fig. 1B, 
C).  
Next, we directly addressed the biological relevance of desmosomal cadherins in the 
newly generated intestinal-specific knockouts. In agreement with previous reports,6 Dsg2 
and Dsc2 were the only desmosomal cadherins expressed in the mouse intestine (Fig. 
1A). Both cadherins were abundantly expressed in the intestine, while lower amounts 
were seen in other organs such as the kidney (Fig. 1B). The newly generated intestine-
specific Dsg2 knockout (DSG2ΔIEC) displayed a selective and efficient deletion of Dsg2 
in both small and large intestine (Fig. 1C, D, Suppl. Fig. 2A-D) and no upregulation of 
other desmoglein and desmocollin isoforms was observed (Suppl. Fig. 3A). 
Immunofluorescence staining confirmed the loss of Dsg2 while Dsc2/plakoglobin 
staining was retained and demonstrated an unaltered desmosome distribution (Fig. 2A). 
DSG2ΔIEC mice developed normally, displayed normal weight gain and colon length 
(Suppl. Fig. 4). No diarrhea was observed. Histological examination revealed a 
morphologically inconspicuous small and large intestine with correctly differentiated and 
localized cell types (Fig. 2B, Suppl. Fig. 5A,B and data not shown). Unaltered levels of 
the stem cell markers LGR5 and R-spondin and no changes in the basal cell proliferation 
were noted (Suppl. Fig. 5C,D Suppl. Fig. 6). No inflammation was observed at any 
analyzed time point (Suppl. Fig. 7 and not shown). Electron microscopy revealed largely 
normal desmosomal plaques whereas the intercellular space between the junctions was 
significantly wider in the small and large intestine (Fig. 2C, Suppl. Fig. 8). Biochemical 
analysis illustrated profound changes in other desmosomal components with up-
regulation of Dsc2 and down-regulation of Dsp and PG, while the levels of Pkp2 and 
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keratin 8 (K8) were not altered (Fig. 2D, Suppl. Fig. 9). The same alterations were 
observed in small and large intestine and the changes likely occurred at the 
posttranscriptional level since the mRNA expression of all analyzed desmosomal genes 
was unaltered (Fig. 2E and data not shown). Immunoblotting revealed decreased levels 
of occludin and claudin 1 that are often reduced in situations leading to barrier 
dysfunction, while no differences were observed in the tight junction proteins claudin 7 
and 15 and the adherens junction protein E-cadherin (Suppl. Fig. 10A). 
Immunofluorescence staining revealed a normal distribution of tight and adherens 
junction proteins (Suppl. Fig. 10B). Myosin II regulatory light chain (MLC) 
phosphorylation, that constitutes a key regulator of tight junction permeability, did not 
differ between DSG2ΔIEC and DSG2fl/fl control mice (Suppl. Fig. 10C). In line with 
the described changes in epithelial junctions, DSG2ΔIEC mice had an increased 
intestinal permeability (Fig. 2F).  
Given that DSG2ΔIEC mice did not show a spontaneous intestinal injury, we tested their 
susceptibility to DSS colitis. Even at low DSS doses, DSG2ΔIEC animals developed a 
profound weight loss with bloody diarrhea and intestinal lesions (Fig. 3A-C). As an 
additional sign of tissue destruction, DSS-treated DSG2ΔIEC mice had shorter colons 
(Fig. 3C). The histological examination revealed a marked epithelial loss with an edema, 
inflammatory reaction and goblet cell loss that resulted in significantly higher injury 
scores (Fig. 3D). The pronounced inflammation was confirmed by increased intestinal 
myeloperoxidase activity as well as by higher pro-inflammatory cytokine levels (Fig. 
3E,F). Analysis of mesenteric lymph nodes demonstrated increased bacterial 
translocation (Fig. 3E).  
To further delineate the mechanisms underlying the observed phenotype, we analyzed 
the effects of short-term DSS administration that led to modest histological changes 
(Fig. 4A). Compared to controls, DSG2ΔIEC animals displayed a more profound epithelial 
cell loss into the intestinal lumen as demonstrated by higher levels of the epithelial 
marker K8 in the luminal content of the colon and by histological observation (Fig. 4A). 
In DSG2ΔIEC mice, DSS treatment resulted in a marked increase in intestinal 
permeability, while only a moderate DSS effect was seen in DSG2fl/fl mice (Fig. 2F, 
4B). In line with the more pronounced epithelial leakiness, molecular analyses 
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demonstrated an increased mRNA expression of pro-inflammatory cytokines and an 
activated IL-22-STAT3 signaling (Fig. 4C-E). Immunostaining revealed that STAT3 was 
phosphorylated in the epithelial cells and is most likely responsible for the increased 
production of the antimicrobial peptide RegIIIβ (Fig. 4D,F). As another consequence 
of the increased intestinal leakiness, we detected elevated levels of cleaved caspase 1 in 
DSS-treated DSG2ΔIEC mice suggesting enhanced inflammasome activation (Fig. 4E).  
To test the susceptibility of DSG2ΔIEC animals to infectious colitis, we exposed mice to 
the murine pathogen C. rodentium. In line with previous reports, the treatment did not 
lead to weight loss (Suppl. Fig. 11A).17 During the peak of infection, DSG2ΔIEC animals 
displayed higher fecal C. rodentium CFU counts, however, both genotypes successfully 
cleared the infection around day 18 (Suppl. Fig. 11B). Histological analysis demonstrated 
characteristic epithelial detachment, crypt elongation and hyperproliferation that were 
more pronounced in DSG2ΔIEC mice (Fig. 5A,B). The latter was confirmed by increased 
amounts of Ki-67 positive epithelial cells and higher PCNA expression (Fig. 5B,D, 
Suppl. Fig. 11C). No significant alterations in the amount of goblet cells were seen 
(Suppl. Fig. 11D). Among the C. rodentium-treated animals, DSG2ΔIEC mice displayed a 
stronger inflammatory reaction, higher expression of pro-inflammatory cytokines and a 
higher epithelial cell stress response with activation of the STAT3 signaling pathway and 
its antimicrobial product RegIIIβ (Fig. 5C,D). Immunostaining revealed that STAT3 was 
phosphorylated to a large extent in epithelial cells (Fig. 5D). In contrast to previous in 
vitro studies,18, 19 untreated DSG2ΔIEC mice displayed no obvious alteration in EGFR and 
p38 pathways (not shown). On the other hand, exposure of DSG2ΔIEC mice to DSS or 
C. rodentium resulted in diminished EGFR and p38 levels (Suppl. Fig. 12A,B).  
To better understand the biological significance of desmosomal cadherins, we also 
assessed the role of Dsc2. Similarly to DSG2ΔIEC mice, DSC2ΔIEC mice developed 
normally (Suppl. Figs. 13). Unlike in DSG2-deficient mice, no profound changes in other 
desmosomal or TJ components were observed (Fig. 6A,B, Suppl. Figs. 14) and 
plakoglobin immunofluorescence revealed an unaltered desmosomal distribution (Fig. 
6B). Additionally, no upregulation of other desmocollin and desmoglein isoforms was 
noticed (Suppl. Fig. 15). Electron microscopy indicated a normal desmosomal 
ultrastructure (Fig. 6C). In line with that, DSC2ΔIEC mice showed no alteration in 
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intestinal permeability (Fig. 6D). A morphologically inconspicuous small and large 
intestine with properly localized cell types was noted (Fig. 7A, Suppl. Fig. 16). In 
particular, the amount of goblet cells did not differ between DSC2ΔIEC and DSC2fl/fl mice 
(Suppl. Fig. 16). Moreover, in both genotypes, treatment with 2.4% DSS resulted in a 
comparable weight loss and a similar histological injury (Fig. 7A,B). In line with that, 
comparable levels of pro-inflammatory cytokines and antimicrobial peptides were noted 
(Fig. 7C and data not shown). To identify the mechanisms responsible for the different 
biological impact of DSG2 vs. DSC2 loss, we collected plasma membrane protein 
fractions. These identified reduced amounts of the cytoprotective chaperone Hsp70 in 
DSG2ΔIEC but not DSC2ΔIEC animals, while the established Dsg2-interacting protein 
Galectin 320 was enriched in the plasma membrane fractions of Dsc2-deficient, but not 
Dsg2-deficient animals (Fig. 7D). As a potential molecular explanation, Hsp70 co-
immunoprecipitated with Dsg2 but not with Dsc2 (Fig. 7E and data not shown).  
To further understand the ability of Dsg2/Dsc2 to compensate for the loss of its 
counterpart, we examined colorectal adenocarcinoma DLD1 cells lacking either one or 
both desmosomal cadherins.18, 21 Immunofluorescence and immunoblotting confirmed 
the knockout of both cadherins as well as a complete re-expression of full-length Dsc2 
(FL Dsc2) in the double-knockout line (Suppl. Figure 17A,C). A simultaneous knockout 
of both cadherins resulted in a marked loss of membranous Dsp/PG staining, that was 
maintained in the lines lacking only one cadherin (Suppl. Figure 17B). Immunoblotting 
demonstrated that the altered Dsp staining pattern is not due to altered protein levels 
(Suppl. Figure 17C). With regard to functional properties, a knockdown of both 
cadherins resulted in a stronger decrease in the transepithelial electrical resistance (TER) 
than the loss of Dsc2 only, while a re-expression of Dsc2 was not sufficient to rescue 
the TER phenotype of double-knockout cells (Suppl. Figure 17D).  
In summary, our findings uncover the differential biological relevance of the 
desmosomal cadherins Dsg2 and Dsc2 that are both reduced in the human intestinal 
injury (Fig. 1B, Fig. 7F). 
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Discussion  
Our study analyzed the in vivo biological role of desmosomal cadherins in the intestine. 
We showed that desmosomal alterations as well as loss of Dsg2/Dsc2 occur in patients 
with Crohn´s disease. Since these patients display a strong activation of TNFα 
signaling,22 our data are in line with previous findings implicating TNFα in the loss of 
Dsg2 signal.16 In that respect, the regulation of Dsg2 is reminiscent of the regulation of 
TJ proteins, which undergo a strong inflammation-induced remodeling.1, 3, 4 On the other 
hand, E-cadherin as a key component of adherens junctions remained unaltered in all 
conditions.  
With regard to the biological importance of the desmosomal cadherins, DSG2ΔIEC and 
DSC2ΔIEC mice displayed morphologically normal desmosomes. In case of DSG2ΔIEC 
animals, this is not surprising since previous reports demonstrated that Dsg2 is not 
essential for desmosomal assembly.23, 24 On the other hand, the previous data on Dsc2 
were somewhat contradictory. It was reported to be indispensable for desmosomal 
assembly in an in vitro study,24 however, Dsc2 knockdown in cancer cell lines did not 
result in altered Dsg2 levels.14 In addition to normal appearing desmosomes, neither 
DSG2ΔIEC nor DSC2ΔIEC animals show an obvious epithelial injury under basal 
conditions. This is in line with the intestinal desmoplakin KOs, that do not exhibit an 
obvious pathology either.25 In contrast, cardiomyocyte-specific DSG2 ablation resulted 
in spontaneous arrhythmogenic cardiomyopathy 23 whereas deletion/mutation of other 
desmosomal cadherins led to defects in oral epithelia, skin and hair follicles.26 
Collectively, these data suggest that desmosomal cadherins are essential for integrity of 
mechanically challenged tissues, but are more dispensable in single-layered epithelia.  
While untreated mice displayed no obvious phenotype, altered desmosomal and TJ 
protein composition, wider desmosomal space and increased intercellular permeability 
were noted in DSG2ΔIEC but not DSC2ΔIEC mice (Figure 7F). With regard to the 
desmosomal composition and permeability, our data are consistent with Dsg2/Dsc2 
knockdowns performed in cancer cell lines and suggest that Dsg2 loss has a more 
profound impact on intercellular junctions than Dsc2 ablation.18, 19, 23 A potential 
explanation is that homophilic Dsg2 bonds, but not Dsc2 bonds are able to at least 
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partially compensate the ablation of the partner protein. In support of the latter, cell 
lines that lacked both Dsg2 and Dsc2 displayed similar TER as cells lacking Dsg2 only 
(Suppl. Figure 17D). Notably, although homophilic interactions of cadherins occur in 
epithelial cells, formation of heterophilic Dsg-Dsc interactions is preferred.10, 27 In 
addition to the strength of homophilic complexes, interactions with associated proteins 
might be also responsible for the differences between DSG2ΔIEC and DSC2ΔIEC 
mice. In particular, Hsp70 was found to interact with Dsg2 but not Dsc2 and 
accordingly, Dsg2ΔIEC mice displayed lower Hsp70 levels in their plasma membrane 
protein fractions. This finding is intriguing since Hsp70 is an established stress-
protective protein that ameliorates the development of intestinal injury 28, 29 and is known 
to interact with keratins, i.e. structures that are functionally tightly linked to 
desmosomes.30, 31 However, further studies are needed to delineate the functional 
importance of the diminished Hsp70 levels in Dsg2ΔIEC mice.  
On the other hand, DSC2ΔIEC mice (but not DSG2ΔIEC mice) displayed an accumulation 
of galectin 3 in their plasma membrane fractions. Of note, galectin 3 constitutes an 
established Dsg2-binding protein and an important mediator of adhesive strength.20 
Therefore, a perturbation in Hsp70 might account for the phenotype seen in DSG2ΔIEC 
mice, whereas galectin 3 may functionally compensate for the Dsc2 loss (Figure 7F). The 
reduced p38 levels seen in DSG2ΔIEC mice exposed to DSS or C. rodentium might be also 
of importance, since p38 in intestinal epithelia protects from colitis development.32  
While the moderate impairment of intestinal barrier seen in untreated DSG2ΔIEC mice 
is not sufficient to induce epithelial injury, it becomes more evident in the analyzed stress 
models. Two key events likely contribute to this finding: (i) inflammatory cytokines, in 
particularly TNFα, that are induced in the stress models,33, 34 further weaken the 
desmosomal adhesion,16 (ii) the injuries increase the leakiness of TJs that are known to 
constitute the major component of the intestinal barrier. The weakening of TJs is both 
a direct effect of an exposure to DSS/C. rodentium as well as a consequence of the 
resulting inflammatory reaction.1, 3, 4, 35-37 Moreover, our findings indicate that Dsg2 
ablation promotes TJ leakiness by decreasing the levels of tightening TJ components. 
This is supported by previous in vitro studies in which loss of Dsg2-mediated adhesion 
led to disruption of TJ integrity.15, 38 Consequently, peptides strengthening desmosomal 
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adhesion may present a viable therapeutic strategy in situations with impaired 
desmosomes.16  
The above described loss of epithelial barrier resulted in stronger bacterial translocation 
that induced the observed intestinal inflammation (Figure 7F). Two classic inflammatory 
pathways have been prominently activated: (i) production of pro-inflammatory cytokines 
IL-1β and TNFα; (ii) activation of IL-22-pSTAT3 signaling. IL-1β/TNFα are known to 
be produced as a direct reaction to microbial components.39, 40 Their increased levels 
likely contribute to the stronger epithelial loss seen after DSS treatment thereby leading 
to a vicious cycle of inflammation and epithelial injury (Figure 7C).40, 41 On the other 
hand, IL-22 belongs to anti-inflammatory cytokines that protect from development of 
colitis in several models.40, 42, 43 It stimulates, via STAT3 activation, epithelial cell 
proliferation and regeneration and likely contributes to the hyperplasia that was observed 
in the Citrobacter rodentium model. Since both signaling pathways become activated as a 
consequence of increased epithelial permeability after Dsg2 loss, the balance between 
IL-1β/TNFα and IL-22-pSTAT3 activation presumably dictates, whether DSG2ΔIEC 
animals will display increased epithelial loss (as seen in the DSS model) or increased 
regeneration (Citrobacter model).  
In summary, our findings reveal desmosomal alterations in patients with Crohn´s disease 
and demonstrate the differential importance of the desmosomal cadherins Dsg2/Dsc2 
for the desmosomal structure and susceptibility to intestinal injury (Figure 7F). Given 
that a TJ stabilizing agent showed promise in a clinical trial of celiac disease,44 further 
studies are warranted to explore the therapeutic potential of desmosome-stabilizing 
peptides.16  
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Materials and Methods  
Mouse experiments  
Mice with conditional (intestine-specific) Desmoglein 2 (Dsg2) or Desmocollin 2 
deletion were generated by crossing previously described DSG2 exon4/5 floxed 
(DSG2fl/fl) and DSC2 exon2 floxed (DSC2fl/fl) mice with mice expressing Cre under the 
control of the villin promotor (DSG2ΔIEC/DSC2ΔIEC).23, 45-47 All mice were on C57BL/6 
background and kept under standardized conditions (12 hours day/night cycle, 21-24°C, 
humidity ~50%) with free access to food and water. To induce colitis, 10 weeks old sex-
matched mice were exposed to dextran sodium sulfate (DSS, MP Biochemicals, 
Heidelberg, Germany) in the drinking water and sacrificed after four days (short-term 
DSS). Alternatively, DSS was administered for five days with a change to normal water 
afterwards and killing of animals at day 7 (long-term DSS). For DSG2ΔIEC and DSC2ΔIEC 
mice, we used 1.6% and 2.4% DSS, respectively. For an infectious model, Citrobacter 
rodentium strain DBS100 48 was grown in Luria-Bertani (LB) medium at 37 °C overnight 
by shaking (200 rpm). 9-10 weeks old sex-matched mice were infected by oral gavage 
with 1x109 C. rodentium and analyzed 14 or 21 days thereafter. At indicated time points, 
stool was collected, homogenized in sterile phosphate buffered saline (PBS) (Digital 
Disruptor Genie, Scientific industries, New York, US) and plated in serial dilutions on 
MacConkey agar plates (Roth, Karlsruhe, Germany) to count colony forming units 
(CFU) of Citrobacter rodentium. Untreated, age- and sex-matched littermates were used as 
controls.  
To examine intestinal permeability, mice were fasted for three hours and gavaged with 
0.6 mg/g of body weight 4kD FITC-labelled dextran (Sigma-Aldrich, Steinheim, 
Germany). Four hours later, blood was collected retroorbitally and the fluorescence 
intensity in serum was measured (excitation: 492 nm; emission: 525 nm, Cytation3 
imaging reader, BioTek, Bad Friedrichshall, Germany). The samples were prepared in 
duplicates and the results calculated according to the standard curve. All animals were 
weighted and sacrificed by an isoflurane overdose. In selected animals, the distal colon 
was analyzed via a mini-endoscope (Karl Storz, Tuttlingen, Germany). Rectal bleeding 
was examined using commercial hemoCARE fecal occult blood Guajak test using a 
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semi-quantitative scoring from 0 to 3 (0: no bleeding, 1: mild bleeding, 2: moderate 
bleeding, 3: severe bleeding). Mesenteric lymph nodes were dissected and homogenates 
were plated on Columbia sheep blood agar plates (Oxoid/Thermo Scientific, Munich, 
Germany) to evaluate the translocation of bacteria into the lymph nodes. Proximal 
intestinal parts were washed and stored as Swiss rolls in 4% formaldehyde for 
histological evaluation or embedded in O.C.T. compound (Tissue-Tek, Sakura, Staufen, 
Germany) for cryosectioning. Distal parts were washed and snap frozen in liquid 
nitrogen for biochemical and RNA analysis.  
Human samples  
As described in detail previously,38 human specimens were obtained from terminal ileum 
of patients who suffered from refractory Crohn’s Disease (CD) and/or had a 
complication that required surgical resection, such as stenosis, fistula, or abscesses. 
Control tissue samples of the terminal ileum were from patients that required right 
hemicolectomy in which the surgical resection routinely involves a part of the healthy 
small intestine (for further information see Suppl. table 1). For Western blot analyses, 
mucosa was mechanically dissected from the tissue immediately after the resection and 
transferred into lysis buffer containing 25 mmol/L HEPES, 2 mmol/L EDTA, 25 
mmol/L NaF, and 1% sodium dodecyl sulfate. Specimens were homogenized with 
TissueLyzer (Qiagen, Hilden, Germany) and normalized with BCA assay (Thermo 
Fisher, Waltham, MA). Anti-Dsg2 (Invitrogen, Carlsbad, CA), anti-Dsc2 (Abcam, 
Cambridge, UK) and anti E-cadherin (BD Biosciences, Franklin Lakes, NJ) primary 
antibodies were combined with a horseradish peroxidase-labeled goat anti-mouse 
antibody (Dianova, Hamburg, Germany).  
A second part of the tissue samples was fixed in 4% paraformaldehyde, embedded in 
paraffin and cut into 1 μm thick sections. Immunostaining was performed as described 
previously 49 using rabbit anti-Dsg2 (Invitrogen), anti-Dsc2 (Abcam) and mouse anti-E-
cadherin (BD Biosciences) antibodies in combination with a Cy3-labeled goat anti-
mouse- and a Cy2-labeled goat anti-rabbit antibody (Both Dianova, Hamburg, 
Germany). To analyze the tissue architecture, all specimens were stained with 
Hematoxylin and Eosin (H&E).  
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Cell culture experiments  
For the described experiments, we used previously published DLD1 cells with 
CRISPR/Cas9-mediated knockdown of Dsc2 (ΔDsc2) or both desmosomal cadherins 
(ΔDsg2 ΔDsc2), as well as a cell line in that the knockout of both cadherins was followed 
by a re-expression of Dsc2 (ΔDsg2 ΔDsc2 + FL Dsc2).21 The cells were cultured in 
Dulbecco’s modified Eagle’s medium (Life Technologies, Carlsbad, CA) containing 10% 
fetal bovine serum (Biochrom, Berlin, Germany), 50 U/ml penicillin and 50 U/ml 
streptomycin (AppliChem, Darmstadt, Germany) in 5% CO2 atmosphere at 37°C until 
they reached confluence.18  
Biochemical methods  
Total tissue lysates were prepared by homogenization of tissues in 3% SDS-containing 
buffer with protease and phosphatase inhibitors. To determine luminal protein 
composition, colon was removed, opened longitudinally and vigorously inverted fifteen 
times in PBS. The solution containing epithelial cells was centrifuged at 5000 rpm for 10 
minutes at 4°C and the pellet was used for homogenization. DLD1 cells were grown in 
24-well plates and lysed using 1% SDS lysis buffer supplemented with a protease-
inhibitor cocktail (Roche, Mannheim, Germany). Same amounts of proteins were 
separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) followed by transfer 
to PVDF/nitrocellulose membranes or staining with 0.1% Coomassie Brilliant Blue G-
250. The membranes were incubated with specific primary and HRP-coupled secondary 
antibodies, which were then visualized by an enhanced chemiluminescence detection kit 
(GE Healthcare/Amersham Biosciences, UK). The antibodies used in this study are 
summarized in Suppl. table 3.  
To determine myeloperoxidase (MPO) activity, colonic tissue was homogenized in ice-
cold 50 mM potassium phosphate buffer containing 0.5% 
hexadecyltrimethylammonium bromide. Equal volume of cell lysis buffer was added and 
the homogenates were freeze-thawed twice. After centrifugation, supernatant was 
removed and supplemented with reaction buffer (with o-dianisidine hydrochloride and 
0.001% H2O2) or standard solution. After three minutes of reaction time, the absorbance 
was spectrophotometrically measured at 450 nm (Cytation3 imaging reader). The 
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samples were prepared in duplicates and the results were calculated according to the 
standards.  
Plasma membrane protein fractions from colon scrapings were extracted according to 
the manufacturer’s protocol (Abcam, ab65400). Briefly, scrapings were homogenized in 
an appropriate volume of homogenization buffer containing protease inhibitor cocktail. 
Following centrifugation, the pellet that contains plasma membrane proteins was re-
suspended in the provided upper phase solution. Plasma membrane proteins were 
purified by repeated addition of lower phase solution that was later on removed by 
centrifugation at low speed. Finally, the plasma membrane proteins were pelleted via 
high-speed centrifugation at +4°C. The membrane fraction was dissolved in 0.5% 
Triton-X-100/PBS that was supplemented with Laemmli buffer (0.2 M Tris pH 6.8, 40% 
glycerol, 8% sodium dodecyl sulfate, 7.2% β-mercaptoethanol, 0.02% bromophenol 
blue).  
Immunoprecipitation 
Total lysates were prepared by homogenization of colon scrapings in RIPA buffer (2.5 
mM Tris-HCl pH 7.4, 0.025% sodium deoxycholate, 150 mM NaCl, 2 mM EDTA, 
0.01% NP-40). After conjugation of Dsc2 or Dsg2 antibody to Protein G Dynabeads 
(Thermo Fisher) for 10 minutes, the lysates were added to the beads-antibody complex 
and the solution was incubated upon a gentle rotation for 2 hours at +4°C. A magnet 
was used to collect the beads that were washed three times with a supplied washing 
buffer. The supernatant was discarded, the proteins were eluted via heating in SDS-
containing Laemmli buffer for 5 minutes at 95°C and further analysed by SDS-PAGE.  
Histological analysis  
The formaldehyde-fixed tissues were paraffin-embedded, cut into 3 μm thick sections 
and stained with H&E or periodic acid-Schiff (PAS). For the latter, deparaffinized slides 
were oxidized in 2% periodic acid solution for 5 minutes. After washing in distilled water, 
a staining with Schiff reagent for 15 minutes was performed and followed by 
hematoxylin counterstaining. Finally, the sections were blued in 1M Tris buffer (pH 8). 
Images were recorded with a Zeiss light microscope (Zeiss, Germany) and AxioVision 
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Rel 4.8 software (Zeiss, Germany). PAS-positive cells were counted as a mean from at 
least thirty different crypts by ImageJ software.  
A previously described semi-quantitative histopathological score50 with minor 
modifications was used for evaluation of DSS-treated samples. The following parameters 
were assessed: (i) submucosa thickening/edema, (ii) inflammatory cell infiltration, (iii) 
goblet cell loss (each parameter with a score 0-3: 0: normal; 1: mild; 2: moderate; 3: 
severe), (iv) epithelial damage/erosion (0: normal; 2: <1/3 of total area with altered 
epithelial cell morphology; 4: >1/3 of total area with altered epithelial cell morphology 
and/or mild erosions; 6: <10% of ulcerative areas; 8: 10-20% of ulcerative areas, 10: 
>20% of ulcerative areas).  
The C. rodentium exposed colons were semi-quantitatively scored. Following criteria were 
assessed: (i) epithelial detachment (0: normal, 0,5: low, 1: high); (ii) hyperplasia (0: 
normal, 1: low hyperplasia, 2: high hyperplasia); (iii) inflammation (0: normal, 1: 
moderate, 2: severe). Lengths of colonic crypts were measured in longitudinal 
orientation. At least 10 crypts per mouse were analysed and the results are presented as 
means. All analyses were performed in a blinded manner by AG and an experienced 
pathologist (PB).  
Study approval  
The animal experiments were approved by the state of North Rhine-Westphalia in 
Germany and the University of Aachen animal care committee and were conducted in 
compliance with the German Law for Welfare of Laboratory Animals. All CD patients 
had given their informed consent before surgery, and the study was approved by the 
Ethical Board of the University of Würzburg (proposal numbers 113/13 and 46/11).  
Data analysis and statistical methods  
Image quantifications were performed with ImageJ (National Institutes of Health, 
Bethesda, USA). Data were analyzed with an unpaired two-tailed Student´s t-test or 
Mann-Whitney test where appropriate. P-values below 0.05 were considered as 
statistically significant.  
For additional materials, see supplementary section.  
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Figure 1. Dsg2 and Dsc2 are the major cadherins expressed in the intestine and 
DSG2-deficient animals (DSG2ΔIEC) display an intestine-specific Dsg2 loss. 
(A,B) Expression levels of DSG2, DSC2 as well as the other desmoglein and desmocollin 
family members were assessed by real time RT-PCR in the indicated mouse organs (n=4-
5). (C) DSG2 mRNA expression was quantified in the highlighted mouse organs of 
DSG2ΔIEC (ΔIEC) and DSG2fl/fl (fl/fl) mice (n=4) by real time RT-PCR. Colonic 
desmoglein 2 (Dsg2) protein levels were assessed in both groups by immunoblotting 
(n=5). L7 (mouse ribosomal protein) gene and β-tubulin (βTub) were used as an internal 
and a loading control, respectively. Dsg, desmoglein; Dsc, desmocollin; Liv, liver; B. 
duct, common bile duct; G.bl, gallbladder; Kid, kidney; Stom, stomach; Duo, duodenum; 
Jeju, jejunum; Ile, ileum; Col, colon. Two-tailed Student’s t test was used for statistical 
analyses. **p<0.01, ***p<0.001.   
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Figure 2. DSG2-deficient animals (DSG2ΔIEC) display an altered desmosomal 
protein composition, a wider desmosomal space width and increased intestinal 
permeability. (A) The distribution of Dsc2, plakoglobin (PG) and Dsg2 in the colon of 
DSG2ΔIEC (ΔIEC) and DSG2fl/fl (fl/fl) mice was visualized by immunofluorescence. 
Scale bar = 20 μm. (B) Hematoxylin and eosin (H&E) staining revealed an unperturbed 
overall colon architecture. (C) Desmosomal ultrastructure of colon samples was assessed 
by electron microscopy with subsequent quantification of the desmosomal intercellular 
space (IS) width and length of the desmosomal plaque (n=5). Scale bar = 200 nm. AJ, 
adherens junctions; De, desmosomes; TJ, tight junctions (D,E) Immunoblotting and 
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RT-PCR were employed to study the impact of Dsg2 loss on desmosomal composition 
in the colon (n=5). Dsc2, desmocollin 2; Dsp, desmoplakin; Pkp2, plakophilin 2; K8, 
keratin 8. (F) Administration of 4kD FITC-dextran with subsequent quantification of 
serum FITC levels was utilized as a measurement of intestinal permeability (n=5). 
Average mRNA expression in DSG2fl/fl mice was arbitrarily set as 1 and levels in 
DSG2ΔIEC mice are presented as ratio. L7 (mouse ribosomal protein) gene and β-tubulin 
(βTub) were used as an internal and a loading control, respectively. Data in C,F are 
shown as dot plots. Two-tailed Student’s t test was used for statistical analyses. *p<0.05 
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Figure 3. DSG2-deficient animals (DSG2ΔIEC) exhibit an enhanced susceptibility 
to dextran sodium sulfate (DSS)-induced colitis. (A) Relative body weights of 
DSG2ΔIEC (ΔIEC) mice (grey rectangles) and their floxed littermates (black circles, 
DSG2fl/fl, fl/fl, n=7 each) were determined daily starting at the time of first DSS 
administration. (B-D) Macroscopic images of the colon mucosa obtained by 
colonoscopy, stool guaiac test with semi-quantitative scoring (n=6), colonic length and 
hematoxylin and eosin (H&E) staining of colon sections with morphometric 
quantification were used to assess the severity of colitis at day 7 after DSS administration 
(n=6). (E,F) The extent of colonic inflammation 7 days after DSS exposure was 
evaluated by myeloperoxidase (MPO) activity and real-time RT-PCR for TNFα and IL-
1β (n=3-6). The low cytokine expression in non-treated animals (ctrl) was arbitrarily set 
as 1. L7 (mouse ribosomal protein) gene was used as an internal control. Bacterial 
translocation into mesenteric lymph nodes (MLN) was quantified as the amount of 
colonies grown from total MLN homogenates on blood agar plates (n=7-8). Data in 
C,D,E are presented as dot plots. Two-tailed Student’s t test was used for statistical 
analyses of DSS-treated animals. *p<0.05, ***p<0.001.  
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Figure 4. DSG2-deficient animals (DSG2ΔIEC) subjected to dextran sodium 
sulfate (DSS) for four days display higher intestinal permeability and enhanced 
STAT3 signaling. (A) Hematoxylin and eosin (H&E) staining of colon sections from 
DSG2ΔIEC (ΔIEC) mice and their floxed littermates (DSG2fl/fl or fl/fl) was performed. 
Western Blot depicts the epithelial cell marker keratin 8 (K8) in the colonic luminal 
content. (B) Serum FITC levels were measured following gavage of 4kD FITC-dextran 
and presented as dot plots (n=6). (C-E) RT-PCR for TNFα, IL-1β and IL-22 as well as 
the antimicrobial peptide REGIIIβ was performed (n=4-9). Activation of selected 
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signaling pathways was assessed by immunoblotting. The low cytokine expression in 
non-treated animals (ctrl) was arbitrarily set as 1. All other values are presented as ratio. 
L7 (mouse ribosomal protein) gene and β-tubulin (βTub) were used as an internal and a 
loading control, respectively. (F) Immunohistochemistry visualizes phosphorylated 
STAT3 in colon sections of DSS-treated mice. Scale bar (A,F) = 100 μm. Two-tailed 
Student’s t test was used for statistical analysis of DSS-treated animals.*p<0.05, 
**p<0.01, ***p<0.001.  
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Figure 5. DSG2-deficient (DSG2ΔIEC) mice exhibit enhanced susceptibility to 
Citrobacter rodentium (C. rod.)-induced colitis. (A) Hematoxylin and eosin (H&E) 
staining of colon sections with quantification of epithelial hyperplasia (Hypl), 
detachment (Detachm) and inflammatory immune cell infiltration (Inflm) as well as 
colon crypt length determination was performed in DSG2ΔIEC mice and their floxed 
littermates (DSG2fl/fl or fl/fl) 14 days after oral infection with C. rod. (n=7). Scale bar = 
200 μm. Data are shown as dot plots. (B) Ki-67 immunohistochemistry with 
morphometric quantification visualize the proliferation in colon sections 14 days post 
infection with C. rod. (n=7). (C,D) Real time RT-PCR for the highlighted cytokines and 
the antimicrobial product REGIIIβ as well as immunoblotting for the indicated 
signalling molecules were conducted in untreated and in C. rod.-infected mice (n=4-7). 
L7 (mouse ribosomal protein) gene and β-tubulin (βTub) were used as an internal and a 
loading control, respectively. mRNA expression in untreated fl/fl mice was arbitrarily 
set as 1 and other levels are presented as ratio. Immunohistochemistry illustrates 
phosphorylated STAT3 in colon sections of C. rod.- infected mice. Scale bar (B,D) = 
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100 μm. Two-tailed Student’s t test (A,B, upper panels in C) or Mann-Whitney test 
(lower panels in C) were used for statistical analyses of C.rod.-exposed mice.*p<0.05, 
**p<0.01.  
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Figure 6. DSC2-deficient animals (DSC2ΔIEC) show an unaltered desmosomal 
plaque and no increased intestinal permeability. (A) Immunoblotting was 
performed on total colon lysates from DSC2ΔIEC (ΔIEC) mice and their floxed littermates 
(DSC2fl/fl, fl/fl) (n=5). β-tubulin (βTub) was used as a loading control. (B) 
Immunofluorescence depicts the distribution of Dsc2 and plakoglobin (PG) in the 
colons of both genotypes. Scale bar = 20 μm. (C) Desmosomal ultrastructure was 
assessed on colon samples by electron microscopy with subsequent quantification of the 
desmosomal intercellular space width and desmosomal length (n=3). Scale bar = 200 
nm. IS = intercellular space. (D) 4kD FITC-dextran was administered and serum FITC 
levels were quantified as a measurement of intestinal permeability (n=4). Data in C,D 
are shown as dot plots. Cldn1, claudin 1; Dsp, desmoplakin; E-cad, E-cadherin; K8, 
keratin 8; PG, plakoglobin; Pkp2, plakophilin 2. 
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Figure 7. DSG2ΔIEC and DSC2ΔIEC mice display differential phenotypes as well as 
alterations in their plasma membrane proteome. (A) Overall colon architecture of 
DSC2ΔIEC mice and corresponding floxed mice (DSC2fl/fl) was evaluated prior to (ctrl) 
and 7 days after DSS exposure by hematoxylin and eosin (H&E) staining. Scale bar = 
200 μm. (B) The relative body weight of DSC2ΔIEC mice (red rectangles, ΔIEC) and their 
floxed littermates (blue circles, fl/fl) was measured daily starting at the day of the first 
DSS administration (n=7). (C) The mRNA levels of the pro-inflammatory cytokine 
TNFα and the antimicrobial peptide REGIIIβ were evaluated prior to (ctrl) and 7 days 
after DSS exposure by real time RT-PCR. The cytokine expression in ctrl animals was 
arbitrarily set as 1. L7 (mouse ribosomal protein) gene was used as an internal control. 
(D) Plasma membrane protein fractions were isolated from colons of both genotypes 
and subjected to immunoblotting. Coomassie blue staining of blots was used as loading 
control. Gal3, Galectin 3; Hsp70, heat shock protein 70. (E) Colonic mucosa lysates 
from fl/fl animals were used for co-immunoprecipitation with Dsg2 (left panel) and 
Dsc2 (right panel), that was followed by immunoblotting. IgG-conjugated beads (IgG) 
and total lysates (Total) were used as a control and an input, respectively. (F) Schematic 
illustrates the molecular changes seen in DSG2ΔIEC and DSC2ΔIEC mice.  
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Supplementary Materials and Methods  
Immunohistochemistry  
Deparaffinized sections were boiled in either citrate-based antigen unmasking solution 
pH 6 (Vector laboratories, Burlingame, USA) or EDTA-based retrieval solution pH 9 
(DAKO, Hamburg, Germany). To reduce the endogenous peroxidase activity, slides 
were incubated with 3% H2O2 for 10 minutes. Based on supplier recommendations, the 
sections were blocked either with 2% BSA (bovine serum albumin) in Tris Base Saline 
Buffer with 0.1% Tween-20 (TBST) or 5% normal goat serum in PBS for 30 minutes. 
Afterwards, sections were incubated with anti-pSTAT3 (Tyr705, #9131, Cell Signalling, 
Leiden, Netherlands), anti-Ki-67 (M7249, Dako, Hamburg, Germany) or anti-Lysozyme 
(sc27958 (C-19), Santa Cruz, Heidelberg, Germany) antibody overnight at 4°C. After 
washing, biotinylated secondary antibodies (Vector laboratories) were applied for 30 
minutes followed by incubation with the Vectastain working solutions as recommended 
by the manufacturer (Vectastain ABC Kit, Vector laboratories). Staining was developed 
with 3,3’-diaminobenzidine (DAB, Vector laboratories) and hematoxylin was used as a 
counterstain. Lysozyme-positive cells were counted as a mean in at least twenty different 
crypts.  
Immunofluorescence staining  
Immunofluorescence staining was performed on frozen, O.C.T.-embedded tissues, that 
were cut into 2-3 μm and 5 μm thick sections, respectively and DLD1 cells that were 
seeded on 12 mm glass cover slides and grown for 4 days after reaching full confluence. 
Tissue specimen and cells were fixed in pre-cooled acetone or 2% paraformaldehyde in 
PBST for 10 minutes, respectively. Paraformaldehyde-fixed samples were permeabilized 
with 0.5% Triton X-100 in PBST for another 10 minutes. Blocking was performed for 
30 minutes at room temperature in 2% normal goat serum, 1% BSA, 0.1% cold fish skin 
gelatine, 0.1% Triton X-100, 0.05% Tween 20 in 1x PBS (tissue) or 2% BSA in PBST 
(cells). Afterwards the slides were exposed to following primary antibodies: anti-
Desmoglein 2 (tissue),1 anti-Desmoglein 2 (cells, #610121 (rb5), Progen, Heidelberg, 
Germany), anti-Desmocollin 2 (see below for details), anti-Desmocollin 2/3 (#326200, 
clone 7G6, Thermo Scientific, Munich, Germany), anti-Desmoplakin (NW6, gift from 
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Kathleen J. Green, Chicago, USA), anti-Plakoglobin (#61005 (PG 5.1.), Progen, 
Hamburg, Germany), anti-ZO-1(Mid) (#402200, Life technologies, USA) and anti-E-
cadherin (#3195, Cell signaling, Leiden, Netherlands) overnight at 4°C. After washing 
and incubation with Cy3 or Alexa-Fluor 488/568-conjugated secondary antibodies 
(Dianova, Hamburg, Germany and Invitrogen, Molecular Probes, Eugene, OR, USA) 
for 1 hour in the dark, slides were washed and mounted. The immunofluorescence for 
γ-catenin (PG) was performed on paraffin-embedded colon sections. In brief, the 
sections were deparaffinized, washed and boiled in citrate-based antigen unmasking 
solution pH 6 (Vector laboratories). Anti-γ-catenin (PG) (sc30997 K-20, Santa Cruz, 
Heidelberg, Germany) and anti-goat Alexa-Fluor 568 (Invitrogen) were used as primary 
and secondary antibodies, respectively. The sections were covered with ProLong 
antifade reagent containing DAPI (Invitrogen). DLD1 cells were mounted with 60% 
glycerol in PBS containing 1.5% N-propyl gallate (Serva, Heidelberg, Germany). 
Fluorescence images were acquired with Zeiss microscope Axio Imager Z1 (Zeiss, Jena) 
or a Leica SP5 confocal microscope with a 63 x NA 1.4 PL APO objective (Leica, 
Wetzlar, Germany).  
Transmission electron microscopy  
Murine samples were cut into ~1 mm³ pieces and fixed by a three step process with the 
following fixatives: (i) 3.7% formaldehyde, 1% glutaraldehyde, 11.6 g NaH2PO4xH2O 
and 2.7 g NaOH per liter ddH2O for two hours; (ii) 1% OsO4 for one hour; (iii) 0.5% 
uranylacetate/0.05 N sodium hydrogen maleate buffer (pH 5.2) for 2 hours (all at room 
temperature). Subsequently, tissues were dehydrated, embedded in araldite for 48 hours 
at 60°C and cut into 75 nm ultrathin sections that were treated with 3% uranylacetate 
for four minutes and with 80 mM lead citrate for three minutes to enhance the contrast. 
Images were acquired with an EM 10 (Zeiss) plus digital camera (Olympus) and iTEM 
software (Olympus). The intercellular space width and length were determined as a mean 
from at least ten different desmosomes per mouse.  
Human samples were fixed with 2.5% glutaraldehyde and cut into ~1 mm³ pieces. After 
three washing steps with PBS, samples were incubated with 2% osmium tetroxide 
solution for 1 hour at 4°C and subsequently dehydrated through an ascending ethanol 
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series from 20 to 100%. Samples were embedded with epon for 24 hours at 80°C and 
ultrathin sections (60 - 80 nm) were cut with a diamond knife. Staining was performed 
with a saturated solution of uranyl acetate for 40 minutes and lead citrate for 5 minutes. 
Images were acquired with the transmission electron microscope Libra 120 (Zeiss, 
Oberkochen, Germany).  
Quantitative real-time PCR  
Total RNA was isolated using RNeasy Mini Kit (Qiagen, Hilden, Germany) according 
to the manufacturer’s instructions and 1 μg was reverse-transcribed into cDNA using 
M-MLV Reverse Transcriptase Kit (Promega, Mannheim, Germany). Quantitative real-
time PCR was performed with the 7300 Fast Real-Time PCR System (Applied 
Biosystems). Samples were analyzed in duplicates with the ΔΔCt method relative to L7 
ribosomal protein as an internal control. All levels are reported as means +/- SEM. The 
primers used in this study are summarized in Suppl. table 2.  
Transepithelial Resistance Measurements (TER)  
Cells were grown on 8-well electrode arrays (Ibidi, 8W10E) and baseline TER was 
measured with an ECIS model Z theta (Applied Biophysics, Troy, NY) at 800 Hz as 
described previously.2  
Desmocollin 2 antibody generation  
To generate a peptide-specific anti-Dsc2 antibody, an antigen was obtained by 
conjugation of the synthetic peptide with sequence SRRGAGYHHHTLDPC to 
ovalbumin. Guinea pigs were immunized by subcutaneous injection of 240 μg of the 
peptide diluted in complete Freund’s adjuvant followed by three boostings with the same 
amount of antigen diluted in incomplete Freund’s adjuvant being performed every two 
weeks. Serum was collected 14 days after the last immunization. To purify the Dsc2-
specific antibodies, the serum was purified over a column that was adsorbed with the 
immunogenic peptide. After washing with 10 mM sodium phosphate (pH 6.8), the 
antibodies were retrieved with IgG Elution Buffer (Thermo Scientific, #21004). At the 
end, the solution was neutralized with 2 M K2HP04.  
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Suppl. table 1: Overview of the analyzed human samples  
 
AZT=Azathioprin, MTX=Methotrexate  
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Suppl. table 2: Primers used for genotyping and quantitative Real Time PCR  
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Suppl. table 3: Antibodies used for Western Blotting 
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Supplementary Figure 1. Desmosomes are altered and desmosomal cadherins are 
reduced in patients with Crohn’s disease. (A) Transmission electron microscopy 
images of terminal ileum specimens from patients with Crohn’s disease (CD) and from 
a healthy control individual (ctrl). Scale bar = 500 nm (left panels) and 250 nm (right 
panels). (B,C) Terminal ileum specimens from patients with Crohn´s disease (CD) 
(n=12) as well as from control individuals (ctrl) (n=10) were stained with antibodies 
against Dsg2, Dsc2 and E-cadherin. The corresponding protein lysates were subjected 
to immunoblotting with subsequent morphometric quantification. Hematoxylin and 
eosin (H&E) staining highlights the overall intestinal architecture. Scale bar 
immunofluorescence = 20 μm, scale bar H&E = 50 μm. Two-tailed Student’s t test was 
used for statistical analyses. *p<0.05  
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Supplementary Figure 2. DSG2-deficient animals (DSG2ΔIEC) reveal an 
intestine-specific Dsg2 loss. (A-D) Desmoglein 2 (Dsg2) protein levels were assessed 
in the indicated mouse organs of DSG2ΔIEC (ΔIEC) and DSG2fl/fl (fl/fl) mice by 
immunoblotting. βActin was used as a loading control.  
 
Supplementary Figure 3. Knockout of DSG2 does not alter the expression of other 
desmoglein and desmocollin isoforms. Expression levels of the desmoglein family 
members DSG1a, DSG1b and DSG3 (A) as well as the desmocollin members DSC1 
and DSC3 (B) were assessed in the colon of DSG2ΔIEC (ΔIEC) and DSG2fl/fl (fl/fl) mice 
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by real time RT-PCR (n=3-4). Skin was used as a positive control (PC). L7 (mouse 
ribosomal protein) gene was used as an internal control. Average mRNA expression in 
fl/fl mice was arbitrarily set as 1 and levels in ΔIEC mice as well as the skin represent a 
ratio.  
 
 
 
Supplementary Figure 4. DSG2-deficient animals (DSG2ΔIEC) display normal 
body weight and colon length. The body weights and the colon lengths of 11 weeks 
(11w), 6 months (6M) and 11 months (11M) old DSG2ΔIEC (ΔIEC) mice and their floxed 
littermates (fl/fl) are displayed in form of dot plots (n=6-20).  
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Supplementary Figure 5. Small and large intestine of DSG2-deficient animals 
(DSG2ΔIEC) show no obvious defects in tissue morphology and differentiation. (A) 
Periodic acid-Schiff (PAS) staining demonstrated a similar amount of goblet cells in 
colons from DSG2ΔIEC (ΔIEC) mice and their floxed littermates (DSG2fl/fl or fl/fl). The 
results were confirmed by real time RT-PCR for mucin 2, a major goblet cell product 
(n=6). (B) Hematoxylin and eosin (H&E) staining demonstrates a regular architecture 
of the small intestine (SI). Immunohistochemistry for the small intestinal Paneth cell 
marker lysozyme with quantification of lysozyme-positive cells/crypt revealed no 
differences between both genotypes (n=4). Scale bar (A,B) = 100 μm (C,D) Real time 
RT-PCR demonstrated similar expression levels of the stem cell markers LGR5 and R-
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spondin 1 (Rspo1) in the transgenic animals. Small (SI) and large intestine (LI) were 
analysed (n=6-7). L7 (mouse ribosomal protein) gene was used as an internal control, 
respectively. Average mRNA expression in fl/fl mice was arbitrarily set as 1 and levels 
in ΔIEC mice represent a ratio.  
 
 
 
Supplementary Figure 6. DSG2-deficient animals (DSG2ΔIEC) show no changes 
in basal cell proliferation. To evaluate the proliferation grade in the small intestine (SI) 
and large intestine (LI) of DSG2ΔIEC (ΔIEC) mice and their floxed littermates (fl/fl), the 
S-phase marker PCNA was assessed by real time RT-PCR (n=7) and immunoblotting. 
L7 (mouse ribosomal protein) gene and β-tubulin (βTub) were used as an internal and a 
loading control, respectively. Average mRNA expression in fl/fl mice was arbitrarily set 
as 1 and levels in ΔIEC mice were presented as ratio.  
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Supplementary Figure 7. DSG2-deficient animals (DSG2ΔIEC) display no obvious 
inflammation under basal conditions. The inflammatory markers TNFα, IL-1β and 
IL-6 were evaluated in the small (SI; A) and large intestine (LI; B) of 11 weeks old 
DSG2ΔIEC (ΔIEC) mice and their floxed littermates (fl/fl) by real time RT-PCR (n=4-6). 
L7 (mouse ribosomal protein) gene was used as an internal control. Average mRNA 
expression in fl/fl mice was arbitrarily set as 1 and levels in ΔIEC mice were presented 
as ratio.  
 
 
Supplementary Figure 8. DSG2-deficient animals (DSG2ΔIEC) exhibit a wider 
desmosomal intercellular space in the small intestine. The desmosomal 
ultrastructure of small intestine samples from DSG2ΔIEC (ΔIEC) and DSG2fl/fl (fl/fl) 
mice was assessed by electron microscopy with quantification of the desmosomal 
intercellular space (IS) and the length of the desmosome (n=4). Data are shown as dot 
plots. Two-tailed Student’s t test was used for statistical analysis. *p<0.05  
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Supplementary Figure 9. DSG2-deficient animals (DSG2ΔIEC) display an altered 
desmosomal protein composition. The OD (optical density) values from the 
immunoblots of colonic tissues from DSG2ΔIEC (ΔIEC) mice and their floxed littermates 
(fl/fl) were normalized to the OD values of β-tubulin (n=3) (for representative pictures 
see Figure 2D). Average levels in fl/fl mice were arbitrarily set as 1 and the amounts in 
ΔIEC mice were presented as ratio. Dsp, desmoplakin; PG, plakoglobin; Pkp2, 
plakophilin 2; K8, keratin 8; Tub, β-tubulin. Two-tailed Student’s t test was used for 
statistical analyses. *p<0.05, **p<0.01, ***p<0.001.  
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Supplementary Figure 10. DSG2-deficient animals (DSG2ΔIEC) have altered levels 
of the tight junction proteins claudin 1 and occludin. (A,C) Immunoblotting was 
used to study the impact of Dsg2 deficiency on the composition of key tight/adherens 
junction proteins in the colons of DSG2ΔIEC mice and their floxed littermates (DSG2fl/fl). 
The activation of myosin II regulatory light chain (MLC) signalling as the regulator of 
tight junction permeability was also assessed. β-tubulin was used as a loading control. 
(B) The distribution of tight and adherens junctions in the colonic sections was visualized 
with antibodies against E-cadherin, ZO-1, Claudin 1 and Claudin 15, respectively. Scale 
bar = 20 μm. ZO-1, zonula occludens-1.  
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Supplementary Figure 11. DSG2-deficient animals (DSG2ΔIEC) infected with C. 
rodentium display higher PCNA levels. (A) The relative body weight of DSG2ΔIEC 
mice (red rectangles, ΔIEC) and their floxed littermates (blue circles, fl/fl) was measured 
(n=7). (B) Citrobacter rodentium colonization in the stool was quantified as the amount of 
colony forming units (CFUs) on MacConkey agar plates at the indicated days (n=5). (C) 
Colonic PCNA mRNA expression was assessed by real time RT-PCR (n=4-7). (D) 
Periodic acid-Schiff (PAS) staining with subsequent quantification of PAS-positive 
cells/crypt indicated a similar amount of goblet cells in colons from both genotypes 
(n=8). Real time RT-PCR and histological analysis were performed 14 days after oral 
infection with C. rodentium. L7 (mouse ribosomal protein) gene was used as an internal 
control. Average mRNA expression in fl/fl mice was arbitrarily set as 1 and levels in 
ΔIEC mice were presented as ratio. Two-tailed Student’s t test were used for statistical 
analyses.*p<0.05   
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Supplementary Figure 12. DSG2-deficient animals (DSG2ΔIEC) do not show an 
activation of the analyzed signaling pathways. Immunoblotting revealed no obvious 
activation of EGFR and p38 signaling pathways in colons of DSG2-deficient (ΔIEC) 
mice compared to their floxed littermates (fl/fl). Mice were analysed after 4 days of DSS 
treatment or 14 days after exposure to C. rodentium. β-tubulin (βTub) was used as a 
loading control. p, phospho. 
 
 
 
Supplementary Figure 13. DSC2-deficient animals (DSC2ΔIEC) demonstrate 
normal body weight and small and large intestinal lengths. (A) The body weights 
of 11 weeks old DSC2ΔIEC (ΔIEC) mice and their floxed littermates (fl/fl) were analysed 
(n=12). (B) The large (LI) and small intestinal (SI) lengths were measured in both 
genotypes (n=8). Data are shown as dot plots. 
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Supplementary Figure 14. DSC2-deficient animals (DSC2ΔIEC) show no obvious 
alterations in the desmosomal and tight junction protein composition. (A,B) The 
OD (optical density) values were determined from the immunoblots of colonic tissues 
from DSC2ΔIEC (ΔIEC) mice and control littermates (fl/fl). The values were normalized 
to the OD values of β-tubulin (n=5) (for representative pictures see Figure 6A,B). The 
values in fl/fl mice were arbitrarily set as 1 and levels in ΔIEC mice were presented as 
ratio. Cldn1, claudin 1; Dsp, desmoplakin; PG, plakoglobin; Pkp2, plakophilin 2; K8, 
keratin 8. Two-tailed Student’s t test was used for statistical analyses. ***p<0.001.  
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Supplementary Figure 15. Knockout of DSC2 does not alter the expression of 
other desmoglein and desmocollin isoforms. mRNA levels of the desmoglein family 
members DSG1a, DSG1b, DSG2 and DSG3 (A) as well as the desmocollin members 
DSC1 and DSC3 (B) were analyzed in the colon of DSC2ΔIEC (ΔIEC) and DSC2fl/fl (fl/fl) 
mice by real time RT-PCR (n=4). Skin was used as a positive control (PC) and L7 (mouse 
ribosomal protein) as an internal control. Average mRNA expression in fl/fl mice was 
arbitrarily set as 1 and levels in ΔIEC mice as well as the skin represent a ratio.  
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Supplementary Figure 16. DSC2-deficient animals (DSC2ΔIEC) display no 
alteration in the goblet cell amount. Periodic acid-Schiff (PAS) staining with 
subsequent quantification of PAS-positive cells/crypt showed a similar amount of goblet 
cells in colons of DSC2ΔIEC (ΔIEC) and floxed control mice (DSG2fl/fl or fl/fl) (n=4). 
Scale bar = 200 μm. 
 
 
Supplementary Figure 17. Knockout DLD1 cells lacking both desmoglein 2 
(Dsg2) and desmocollin 2 (Dsc2) display a loss of membranous desmoplakin 
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(Dsp) and plakoglobin (PG) staining and exhibit a decreased transepithelial 
electrical resistance (TER). (A, B) The distribution of Dsc2, Dsg2, plakoglobin (PG) 
and desmoplakin (Dsp) in DLD1 wildtype (WT) and knockout cell lines was visualized 
by immunofluorescence. Scale bar = 10 μm. ΔDsg2 ΔDsc2 = knockout of both 
Dsg2/Dsc2, ΔDsg2 ΔDsc2 + FL Dsc2 = Dsg2/Dsc2 knockout + re-introduction of 
full length Dsc2, ΔDsc2 = Dsc2 knockout. (B) Immunoblotting was employed to study 
the impact of desmosomal cadherin loss on desmosomal protein levels. α-tubulin (αTub) 
was used as a loading control. (C) TER values were assessed in DLD1 WT and the 
corresponding knockout cells (n ≥ 10), **p < 0,001, ***p < 0,001 compared to control.
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2.4 Glial cell-line derived neutrotrophic factor (GDNF) regulates 
intestinal barrier function in inflammatory bowel diseases by 
stabilization of desmoglein 2 
__________________________________________________________ 
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Abstract 
Background / Aim 
Breakdown of the intestinal epithelial barrier (IEB) is a hallmark in the pathogenesis of 
inflammatory bowel diseases (IBD). Glial cell line derived neurotrophic factor (GDNF) 
secreted by enteric glial cell promotes IEB function by undefined mechanisms. We 
hypothesized a critical contribution of GDNF on loss of IEB in IBD and investigated 
the underlying mechanism.  
Methods 
Gut specimen of patients suffering from IBD were analyzed. In vitro, conventional cell 
biology methods in Caco2 cells and human intestinal enteroids were applied. In vivo, 
Dextran Sodium Sulfate (DSS) was used to induce colitis in C57Bl6 mice. 
Results 
In intestinal specimen from IBD patients GDNF was significantly reduced in inflamed 
parts of the tissues. This reduction was paralleled by a loss of desmosomal junctional 
protein desmoglein2 (Dsg2), changes of the intermediate filament (IF) system, increased 
phosphorylation of p38 mitogen-activated protein kinase (MAPK) and cytokeratins. In 
Caco2 cells GDNF recruited Dsg2 to the cell borders and augmented Dsg2-mediated 
intercellular adhesion. The specificity of these effects on Dsg2 was proven in Dsg2-
deficient cells that did not respond to GDNF. Incubation of Caco2 cells and enteroids 
with TNFα led to impaired IEB function with reduced Dsg2, which was mediated by 
p38MAPK-dependent phosphorylation of cytokeratins. TNFα-induced changes were 
blocked by GDNF. Similarly, in mice with DSS-colitis loss of Dsg2, breakdown of IEB, 
phosphorylation of p38MAPK and cytokeratins were all attenuated by treatment with 
GDNF. 
Conclusion 
GDNF attenuated inflammation-induced breakdown of IEB caused by p38MAPK-
dependent cytokeratin phosphorylation leading to loss of Dsg2. Reduced GDNF in IBD 
patients indicates a disease-relevant contribution to breakdown of IEB.  
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desmosomes, desmoglein2, intermediate filaments, cytokeratins, keratin 
phosphorylation, p38MAPK enterocyte 
Introduction 
Inflammatory bowel diseases (IBD) i.e. Crohn’s disease (CD) and ulcerative colitis (UC) 
are caused by a complex interplay between environmental factors, the composition of 
gut microbiota and an inappropriate immune response in genetically predisposed 
individuals (Geremia et al., 2014; Uhlig, 2013). In addition, recent evidence suggests that 
dysregulation of the intestinal epithelial barrier (IEB) plays a major role in the 
development and perpetuation of IBD (Martini et al., 2017).   
Under normal conditions, the IEB is built by a monolayer of polarized enterocytes, 
which are sealed and held together by different junctional proteins such as tight 
junctions, adherens junctions and desmosomes (Farquhar and Palade, 1963b; Luissint et 
al., 2016). Previously it was shown that besides profound changes in tight junction 
integrity, loss of the desmosomal cadherin desmoglein2 (Dsg2) in intestinal epithelium 
plays a critical role in the pathogenesis of barrier dysfunction in patients with CD 
(Vielmuth et al., 2015). Desmosomes in intestinal epithelium consist of the cadherin-
type adhesion molecules desmoglein 2 (Dsg2) and desmocollin 2 (Dsc2), which are 
tethered to the intermediate filament cytoskeleton through specific desmosomal plaque 
proteins. Therefore, desmosomal function is dependent from dynamics in the 
intermediate filament system which is known to be regulated by p38 mitogen-activated 
protein kinase (p38MAPK) (Berkowitz et al., 2005; Kitajima, 2014). The pro-
inflammatory cytokine tumor necrosis factor D (TNFD) which is regarded as the critical 
link between increased intestinal permeability and immune reaction in IBD (Sanders, 
2005) was shown to increase intestinal epithelial permeability by p38MAPK-dependent 
loss of Dsg2-mediated adhesion (Vielmuth et al., 2015).   
It is known that the enteric nervous system (ENS) and factors secreted by enteric glial 
cells are critically involved in the regulation of IEB and therefore may be an 
unappreciated pathogenicity factor in the development of IBD (Neunlist et al., 2003). In 
support of this idea, it was reported that enteric glial cells in specimen of patients 
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suffering from IBD were reduced and experimental studies showed that toxic or 
autoimmune ablation of enteric glial cells lead to loss of the IEB (Bush et al., 1998; 
Cornet et al., 2001). A potential key player that is secreted by enteric glial cells is Glial 
cell-line derived neurotrophic factor (GDNF). Loss of GDNF in experimental models 
leads to morphological and functional abnormalities of IEB similar to those seen in IBD 
patients (Brun et al., 2013; Steinkamp et al., 2003). Furthermore, GDNF shows anti-
inflammatory effects in a murine model of colitis (Zhang et al., 2010a) and was 
previously shown to exert direct effects on enterocytes in vitro which lead to the 
maturation of tight junctions in the IEB by largely unknown mechanisms (Meir et al., 
2015a; Meir et al., 2016). 
Based on this, we tested the hypothesis that GDNF critically regulates Dsg2-dependent 
integrity of the intestinal barrier and is thereby involved in the pathogenesis of barrier 
dysfunction in IBD.  
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Materials and Methods 
Test reagents 
Caco2 cells and human enteroids were treated with 100ng/ml recombinant human 
GDNF (PeproTech, Hamburg, Germany)(Meir et al., 2015a). TNFα (Biomol, Hamburg, 
Germany) was used at 100ng/ml (Vielmuth et al., 2015). The p38MAPK inhibitor 
SB202190 was used at 30µM (Callbiochem, Darmstadt, Germany) and anisomycin 
(Sigma-Aldrich, Munich, Germany) was used at 60 Pmol/l to activate p38MAPK (Meir 
et al., 2015a).  
Human tissue samples 
Human tissue samples derived from patients suffering from IBD with an indication for 
surgical resection. Tissue samples from patients with Crohn’s disease (n= 9) derived 
from the terminal ileum. They were taken from the center of the inflamed parts of the 
resection specimen and from the periphery were no inflammation was seen. During the 
surgical procedure the extent of inflammation in the resection specimen was estimated 
by the surgeon using a semi-quantitative score according to the macroscopic impression 
(+ major inflammation, - minor inflammation). In patients with ulcerative colitis (n= 9) 
a sample of the affected colon was taken. Control tissue samples (colon or terminal 
ileum) from patients not suffering from IBD derived from patients that required right 
or left hemi-colectomy due to colon carcinoma in which the surgical resection routinely 
involves a part of the healthy small intestine or colon, respectively. All patients had given 
their informed consent before surgery, and ethical approval was given by the Ethical 
Board of the University of Würzburg (proposal numbers 113/13, 46/11, 42/16).  
For Western blot analyses, samples of the mucosa and whole gut wall were taken 
immediately after resection from each specimen and then snap frozen in liquid nitrogen 
and processed for Western Blot analyses. A second part of the tissue samples was fixed 
in 4% paraformaldehyde embedded in paraffin, sectioned (1 Pm) and immunostaining 
was performed as described previously(Vielmuth et al., 2015) and in supplementary methods. 
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Cell Culture 
Caco2 cells were acquired from ATCC (Wesel, Germany) and were cultured in Eagle’s 
Minimum Essential Medium (EMEM, ATCC, Wesel, Germany) supplemented with 50 
U/ml Penicillin-G, 50µg Streptomycin and 10% fetal calf serum (FCS, Biochrom, Berlin, 
Germany). Cultures were used for experiments when grown to confluent monolayers. 
For experiments, cells were serum-starved for 24h. 
Generation of CRISPR/Cas9-mediated gene knockout for Dsg2 in Caco2 cells 
Caco2 cells deficient for Dsg2 were generated using the CRISPR/Cas9 technique as 
described in the supplementary methods. 
Enteroids 
IECs were isolated from human whole gut wall resections, 1cm² in size as described in 
the supplementary methods and as described previously (Schweinlin et al., 2016).  
Animal experiments 
After animal care committee approval (Laboratory Animal Care and Use Committee of 
the district of Unterfranken; AZ 2-272), experiments were performed on male 
C57BL/6J mice. Animals were kept under conditions that conformed to the National 
Institutes of Health “Guide for the Care and Use of Laboratory Animals” approved by 
the Government of Unterfranken and Germany as well as for those of the US National 
Institutes of Health. Animals were kept on a standard diet at 12h day-and-night cycles.  
Experimental setup 
We used Dextran Sulfate Sodium (DSS) as a murine model for induction of colitis. 8 
weeks old male mice received 2.5% DSS in autoclaved drinking water ad libitum. Mice 
were monitored daily to document a disease activity index (DAI) for body weight, 
changes of stool consistency and presence of blood in the stool using Haemocult (Care 
diagnostica, Voerde, Germany) as suggested previously using following scoring 
system(Chassaing et al., 2014): Normal stool consistency with negative haemoccult (0); 
soft stools with positive haemoccult (1); very soft stools with traces of blood (2); watery 
stools with visible rectal bleeding (3). Animals were randomized in two groups. GDNF 
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treated animals (n=9) received 5µg/kg bodyweight of GDNF in 100µl 0.9% NaCl 
intraperitoneally, while DSS-alone animals (n = 9) received 100µl 0.9 % NaCl every 24 
hours.  
Measurement of intestinal permeability and tissue harvesting 
After 6 days, the mice were anaesthetized using isoflurane (Forene, Abbott, Wiesbaden, 
Germany). In deep anesthesia, a median laparotomy was performed and the colon was 
mobilized and opened at the ileocaecal valve and at the upper rectum.  
After a flush with warm PBS to remove blood and stool the colon was ligated and 200µl 
of 4kDa FITC dextran (1mg/ml) was injected in the ligated colon to determine intestinal 
permeability by measuring the translocation of 4 kDa FITC dextran in the blood. For 
this, blood from the inferior vena cava was taken after 1h and centrifuged at 13.400 rpm 
for 10 minutes at 4°C. Afterwards the luminescence of the serum was quantified using 
Genios Pro Reader (Tecan, Maennedorf, Switzerland). 
Thereafter mice were sacrificed by exsanguination. The complete colon was harvested 
and Colon length was measured. The ligations of the colon were loosened and afterwards 
the Colon was cut into two pieces. One part was fixed in 4% paraformaldehyde 
embedded in paraffin and sectioned. Two blinded investigators quantified the 
inflammation of the tissue in H.E.-stained sections of the colon using the following 
inflammation score(Erben et al., 2014): Extent of inflammatory cell infiltration (none 
=1, mucosal infiltration =2, submucosal infiltration =3 transmural infiltration =4) and 
severity of epithelial damage (no epithelial damage =1, focal lesions =2, multiple lesions 
=3, extended ulcerations =4), resulting in a total scoring range of 2 –8 per mouse. The 
other half of the colon was lyzed and homogenized with a Tissue Lyzer (Quiagen, 
Hilden, Germany) in a SDS lysis buffer and used for Western Blot analysis and 
quantification of GDNF concentrations using GDNF ELISA (Promega, Mannheim, 
Germany). The GDNF ELISA is described in the supplementary methods. 
Immunocytochemistry 
Immuncytochemistry is described in the supplementary methods in detail.  
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Western Blotting 
Cells, human and animal tissue lysates were prepared and processed for Western Blots 
as described in the supplementary methods. 
Membrane Protein Extraction Assay 
Protein fractionation was carried out using Mem-Per Plus Kit (Thermo Fischer, 
Waltham, MA, USA). Cells were harvested in growth media by scraping them from the 
bottom with a cell scraper. After centrifugation at 300rpm for 5 minutes and washing 
three times, the cells were permeabilized with a permeabilisation buffer to release the 
cytosolic fraction. The cytosolic fraction was separated by centrifugation at 16000rpm 
for 15 minutes. The pellet containing the membrane-associated proteins was then re-
suspended in a solubilisation buffer. The suspension was centrifuged another time at 
16000rpm for 15 minutes to remove particulate material. Then the cytosolic and 
membrane-associated supernatants were used for Western Blot analysis. 
Atomic Force Microscopy (AFM) 
Cells were grown on glass coverslips and treated with GDNF (100ng/ml) 1 day before 
getting confluent or with 4mM EGTA for 30 min after finished control measurements. 
For analysis of Dsg2 interactions on the surface of living cells, a Nanowizard III AFM 
(JPK Instruments, Berlin, Germany) mounted on an optical microscopy (Carl Zeiss, 
Jena, Germany) was used. The approach of AFM force spectroscopy on living cells was 
described in detail before (Vielmuth et al., 2015) and was carried out as described in the 
supplementary methods. 
Dispase-based enterocyte dissociation assays 
As described previously (Vielmuth et al., 2015), confluent cells in 24-well plates were 
exposed to the test reagents as indicated below, washed with Hank’s buffered saline 
solution (HBSS, Sigma-Aldrich, Munich, Germany) and incubated with Dispase-II 
(Sigma-Aldrich, Munich, Germany) for 30 minutes to release the monolayer from the 
well bottom. Afterwards, the cell sheet was exposed to shear stress by pipetting 5 times. 
Four fields of view were photographed with BZ-9000 (BIOREVO, Keyence, Osaka, 
Japan) and numbers were quantified. 
146  Under revision in J Clin Invest 
 
Measurements of Transepithelial Electrical Resistance (TER) 
To measure transepithelial electrical resistance (TER) we used ECIS trans-Filter Adapter 
for ECIS 1600R across cell monolayers (Applied Biophysics, Ibidi GmBH, Martinsried, 
Germany). Cells were seeded on 24-well transwell chambers and measurement started 
immediately. At confluency of monolayers cells were treated with or without mediators 
as indicated below. 
Statistics 
Statistical analysis was performed using Prism (GraphPad Software, La Jolla, CA, USA). 
Data are presented as means ± SE. Statistical significance was assumed for p<0.05. 
Paired Student's t-test was performed for two-sample group analysis after checking for 
a Gaussian distribution. Analysis of variance (ANOVA) followed by Tukey’s multiple 
comparisons test and Bonferroni correction was used for multiple sample groups. 
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Results  
Reduced GDNF in the terminal ileum and colon of IBD patients is associated 
with loss of barrier function  
Western Blot analyses of specimen from patients suffering from CD or UC showed a 
significant loss of GDNF in full wall lysates when compared to control lysates. This was 
not observed in uninflamed parts of the tissues of CD patients (Figure 1A). Loss of 
GDNF in CD and UC was paralleled by loss of the desmosomal adhesion protein Dsg2 
at the cell borders in immunostaining of inflamed terminal ileum of CD patients (Figure 
1Bc, d) or inflamed colon of UC patients (Figure 1Bk, l) compared to healthy controls 
of the terminal ileum (Figure 1Ba, b) and colon (Figure 1Bi, j) where Dsg2 was regularly 
distributed along the cell borders. The intermediate filament system as revealed by 
cytokeratin 18 staining was profoundly deranged in both CD and UC samples (Figure 
1Bg, h, o, p) when compared to healthy controls (Figure 1Bm, n). Western blot analyses 
showed a significant reduction of Dsg2 in CD and UC samples (Figure 1C). Because 
Dsg2 is known to be regulated by p38MAPK (Ungewiss et al., 2017) and we observed 
alterations of cytokeratins in immunostaining we tested whether phosphorylation of 
these proteins was altered in IBD. In CD and in CU samples phosphorylation of 
p38MAPK as well as phosphorylation of cytokeratins 18 and 8 were significantly 
increased in Western Blot analyses (Figure 1C). The activation of p38MAPK and the 
phosphorylation of cytokeratin appeared to be dependent on the extent of inflammation 
(Suppl. Fig. 1 and 2). 
GDNF effects on IEB are mediated via Dsg2 
These observations in patients led to the hypothesis that GDNF might be critically 
involved in the regulation of Dsg2 and thereby contribute to loss of barrier function in 
IBD. In a first step, the effects of GDNF on Dsg2 were evaluated in Caco2 monolayers. 
Immunostaining showed that application of 100 ng/ml recombinant GDNF in 
confluent monolayers resulted in augmented staining patterns of Dsg2 at the cell borders 
(Figure 2A). While GDNF application did not increase total protein levels of Dsg2 
(Figure 2B), triton extraction assays showed Dsg2 to be significantly increased in the 
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insoluble fraction which is considered to contain cytoskeleton-bound proteins following 
GDNF treatment (Figure 2C).  
To explore the functional effect of GDNF on Dsg2 binding properties and distribution 
on the cell surface atomic force microscopy (AFM) was applied on living enterocytes 
similar to recent studies (Schinner et al., 2017; Ungewiss et al., 2017; Vielmuth et al., 
2015). Imaging of the cell surface topography revealed a microvillus covered surface 
typical for polarized Caco2 cells and elevated cell-cell borders which allowed specific 
measurements at these areas (Fig. 2D). To examine Dsg2 binding properties, adhesion 
measurements with a Dsg2-coated tip of a flexible AFM cantilever on living cells were 
performed. For this purpose, 2 cell-cell border containing areas were selected for each 
condition with 1000 recorded force-distance curves for each area. To ensure 
comparability between different conditions, measurements under control conditions and 
on cells incubated with GDNF or EGTA were always performed with the same AFM 
cantilever. Under control conditions, binding events were detected with an unbinding 
force of around 29 pN as revealed by peakfit analysis (Fig. 2E) which resembles the 
values of previously measured Dsg2 specific unbinding forces on the surface of living 
enterocytes (Ungewiss et al., 2017). Application of GDNF significantly increased the 
amount of measured binding events by around 50 % (Fig. 2F, G). Additionally, EGTA 
was applied to demonstrate specificity of measured binding events as Ca2+ depletion 
disrupts Ca2+--dependent cadherin binding. After 30 min of EGTA-mediated Ca2+ 
depletion, binding frequency was significantly reduced by around 40 % compared to 
control conditions (Fig. 2G). Since measured binding events after incubation with 
GDNF appeared to be more prominent at cell-cell borders (Fig. 2F), it was examined 
next whether the localization of Dsg2 specific binding events was altered compared to 
control conditions. Therefore, a distribution ratio defined as the percentage of measured 
binding events along the cell borders (cb) versus measured binding events on the cell 
surface was calculated (cs) (Fig. 2H). Indeed, the distribution ratio was significantly 
increased after incubation with GDNF.  Together, these data indicate that application 
of GDNF either results in a redistribution of existing Dsg2-specific interactions or 
promotes the emergence of new Dsg2-specific interactions along the cell borders. 
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To verify that effects of GDNF on the IEB were primarily mediated by its effects on 
Dsg2 a Dsg2-deficient Caco2 (Dsg2 (-/-)) cell line was generated using the 
CRISPR/CAS9 technique (Figure 2I). In Caco2 cells transfected with nonsense vectors 
application of 100 ng/ml recombinant GDNF led to increased TER values of 1.5-fold 
compared to untreated controls (Figure 2J). In Dsg2 (-/-) Caco2 cells application GDNF 
did not show any effect on TER (Figure 2K) which confirmed that GDNF effects were 
dependent on Dsg2.  
TNFD-induced cytokeratin retraction and loss of Dsg2 are blocked by GDNF 
TNFD was used to mimic inflammation-induced alterations in differentiated Caco2 
monolayers. Application of TNFD induced a significant reduction of TER to 0.73r0.05-
fold of baseline values after 8h (Figure 3A). Combined treatment of monolayers with 
TNFD and GDNF completely blocked TNFD-induced loss of TER. Following 
application of GDNF Dsg2 was significantly reduced in triton extraction assays in the 
insoluble fraction i.e. in the cytoskeleton-bound fraction compared to controls. 
Combined treatment of cells with TNFD and GDNF inhibited loss of Dsg2 in the triton-
insoluble fraction (Figure 3B; Suppl. Figure 3A). This observation was confirmed in 
immunostaining when Dsg2 which was regularly distributed at the cell borders in 
differentiated Caco2 cells (Figure 3Ca, arrows) and in enteroids (Figure 3Da, arrows) 
under control conditions was reduced after application of TNFD (Figure 3Cc and 3Dc). 
The loss of Dsg2 from the cell borders was attenuated by simultaneous application of 
TNFD and GDNF in Caco2 monolayers (Figure 3Ce, arrows) and in enteroids (Figure 
3De, arrows).  
Intermediate filaments visualized by cytokeratin18 immunostaining were present as a 
keratinring in the cell periphery under control conditions (Figure 3Cd, arrows). 
Application of TNFD led to a significant retraction of the intermediate filament ring 
(Figure 3Cd, arrows) which was diminished after combined treatment of cells with 
TNFD and GDNF (Figure 3Cf). The visual impression of changes within the 
intermediate filament system were quantified und thereby confirmed by measurements 
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of fluorescence intensity at the cell borders and distance of retraction of the keratinring 
from the cell borders (Suppl. Figure 3B, C).  
In human intestinal enteroids, comparable observations were made for cytokeratin18: 
The keratinring was present in the cell periphery under control conditions (Figure 3Dd) 
and was profoundly deranged after TNFD application (Figure 3Dd). Following 
application of TNFD and GDNF attenuated TNFD-induced changes of intermediate 
filaments (Figure 3Df). 
In dispase-based enterocyte dissociation assays incubation of differentiated Caco2 
(Caco2 Dsg2 (+/+)) cells with TNFD led to a significantly increased number of cell 
fragments which was completely blocked by simultaneous application of TNFD and 
GDNF (Figure 3E). In Caco2 Dsg2 (-/-) we found increased cell dissociation compared 
to Caco2 Dsg2 (+/+) under basal conditions which was significantly augmented after 
application of TNFD. However, in the absence of Dsg2 increased cell dissociation was 
not blocked by application of GDNF (Figure 3F). Application of GDNF alone had no 
effect on basal cell dissociation in both cell lines. 
Inflammation-induced effects on Dsg2 are mediated by activation of p38MAPK 
and phosphorylation of cytokeratin18 
Given the alternating activation or inactivation of p38MAPK by TNFD and GDNF, we 
hypothesized that epithelial barrier protection by GDNF is mediated by affecting 
p38MAPK followed by modulation of the intermediate filament system. Accordingly, 
phosphorylation of p38MAPK was significantly increased following incubation with 
TNFD in Caco2 cells and in enteroids (Figure 4A, B). Simultaneous application of TNFD 
and GDNF significantly attenuated phosphorylation of p38MAPK while GDNF alone 
did not alter phosphorylation of p38MAPK significantly below baseline levels (Figure 
4A, B, suppl. Figure 4A, B).  
Because a correlation of phosphorylated cytokeratins with intestinal barrier function was 
suggested previously (Majumdar et al., 2012) phosphorylation of cytokeratins 18 and 8 
were analyzed following treatment with TNFD or TNFD and GDNF, respectively. In 
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both, Caco2 cells and in enteroids application of TNFD resulted in significantly 
augmented phosphorylation of cytokeratin 18 at serin52 and cytokeratin 8 at serin74 in 
Caco2 cells and in enteroids (Figure 4A, B, suppl. Figure 4B, C, D). In contrast, no 
changes of phosphorylation patterns were detected for cytokeratin 18 at serin33 (suppl. 
Figure 5C, D). Application of TNFD together with GDNF blocked phosphorylation of 
both cytokeratin 18 and cytokeratin 8 (Figure 4A, B, suppl. Figure 4B, C, D).  
Further experiments showed that increased phosphorylation of cytokeratin 18 and 8 by 
TNFD was inhibited by simultaneous treatment of cells with p38MAPK inhibitor 
SB202190. Application of SB202190 alone resulted in reduced phosphorylation of 
cytokeratin 18 and 8 below control levels (Figure 4C; suppl. Figure 5A, B). Vice versa, 
activation of p38MAPK by incubating Caco2 cells with anisomycin (Vielmuth et al., 
2015) resulted in significantly increased phosphorylation of cytokeratin 18 and 8. These 
experiments demonstrated that cytokeratin phosphorylation in intestinal epithelial cells 
is mediated by activation of p38MAPK. 
In immunostaining of Caco2 monolayers application of TNFD and SB202190 blocked 
TNFD-induced loss of Dsg2 at the cell borders (Figure 4Dc, e) and cytokeratin retraction 
as revealed by cytokeratin 18 immunostaining was not detectable any more (Figure 4Dd, 
f). While treatment of cells with SB2021090 alone did not induce visible alterations of 
Dsg2 and cytokeratin staining (Figure 4Dg, h), application of anisomycin to activate 
p38MAPK showed a strong increase in phosphorylation of both cytokeratins 18 and 8 
which resulted in loss of Dsg2 at the cell borders in immunostaining and cytokeratin 
retraction, comparable to the effects observed after TNFD treatment (Figure 4Di, j). 
GDNF attenuates loss of IEB and inflammation in DSS-colitis 
To determine the effects of GDNF on IEB in an in vivo model of intestinal inflammation 
we induced acute colonic injury with 2.5% DSS in mice. C57Bl6 mice (n=18) received 
2.5% DSS in autoclaved drinking water ad libitum, while control mice received normal 
drinking water. The DSS mice were divided into two groups. One group (n=9) was 
treated daily with 5µg/kg bodyweight of GDNF in 100µl 0.9% NaCl intraperitoneally 
(DSS + GDNF) whereas the other group received 100µl of 0.9% NaCl (DSS). The 
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effective administration of GDNF had been verified in preliminary experiments in 
ELISA-based measurements of GDNF serum concentrations and in tissue lysates of the 
colon (suppl. Figure 6A, B). 
Following DSS application, a significant increase to 2.11±0.26 of the DAI was obvious 
after 5 days (Figure 5A). This was attenuated in the DSS+GDNF group where DAI was 
significantly lower at 1.22±0.15. Measurements of colon length was 70.05± 1.48mm in 
the control group. Due to DSS-induced inflammation the colon length was significantly 
reduced to 49.11± 0.84mm (suppl. Figure 6D). GDNF application in the DSS+GDNF 
group led to a significantly less reduction of colon length to 55.1±1.7mm. Intestinal 
permeability as revealed by measurements of 4 kDa FITC-dextran flux across the IEB 
was significantly increased to 9.9± 1.3-fold of controls (Figure 5B). Treatment of animals 
with GDNF (DSS+GDNF) significantly attenuated inflammation-induced loss of the 
intestinal barrier.  
Histological analyses of H.E.-staining revealed an acute inflammation of the colon 
following DSS administration with an inflammation score of 6.7± 0.8 (Figure 5Ca-c, D). 
Treatment of animals with GDNF resulted in a visible reduction of inflammation in 
H.E.-staining (Figure 5Cc) which was reflected by a significant reduction of the 
inflammation score (Figure 5D). Comparable to observation made in patients with IEB, 
in Caco2 monolayers and in enteroids immunostaining of animals with DSS-colitis 
showed significant loss of Dsg2 at the cell borders which was attenuated by treatment 
of DSS animals with GDNF (Figure 5Cd-f suppl. Figure 6 E). Similarly, deranged 
organization patterns of cytokeratin 18, which was observed in DSS animals were 
blunted by treatment of animals with GDNF (Figure 5Cg-i). In Western Blot analyses 
phosphorylation of p38MAPK and cytokeratin18 was significantly increased in DSS-
colitis, which was both attenuated by treatment with GDNF (Figure 5E, suppl. Figure 6 
F). 
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Discussion 
In the present study, we show a novel mechanism which contributes to the loss of IEB 
in patients with IBD: The neurotrophic factor GDNF was reduced in samples from IBD 
patients, which correlated with loss of Dsg2 and alterations of the intermediate filament 
system. In vitro experiments in Caco2 cells showed that GDNF acts via stabilization of 
desmosomal protein Dsg2, which was proven by the fact that Caco2 cells deficient for 
Dsg2 showed no response when stimulated by GDNF. In Caco2 cells and in human 
enteroids GDNF was effective to protect against inflammation-induced loss of Dsg2 
and breakdown of intestinal barrier function as revealed by measurements of TER, 
immunostaining and dispase-based enterocyte dissociation assays. Inflammation-
induced loss of IEB by application of TNFD was mediated by activation i.e. 
phosphorylation of p38MAPK which then augmented phosphorylation of cytokeratins 
8 and 18 and consecutively reduced Dsg2 at the cell borders, which is a newly 
characterized mechanism in this context. Protective effects of GDNF on IEB were 
mediated by inhibiting TNFD-induced phosphorylation of p38MAPK and cytokeratins. 
The relevance of this mechanism in vivo was confirmed in a murine model of DSS-
induced colitis where we observed increased phosphorylation of p38MAPK and 
cytokeratins followed by loss of Dsg2. Breakdown of IEB in DSS-colitis was 
demonstrated by increased flux of 4 kDa FITC dextran across the intestinal barrier. All 
inflammation-induced effects were attenuated by therapeutic administration of 
recombinant GDNF. Finally, the strong correlation of all these findings i.e. loss of 
GDNF and Dsg2, increased phosphorylation of p38MAPK and cytokeratins in samples 
from patients with CD and UC point to a disease-relevant role and mechanism of 
GDNF-dependent effects in IBD.  
Loss of GDNF in IBD contributes to inflammation-induced breakdown of the 
IBD 
Our present data clearly show that GDNF was significantly reduced in Western blot 
analyses in samples from patients with CD and UC. In a previous study, which 
investigated endoscopically collected colon samples from patients with IBD, GDNF was 
found to be significantly increased in immunostaining (von Boyen et al., 2011). Given 
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that patients in the latter study and in our study both displayed severe inflammation this 
difference of GDNF levels can hardly be explained by different stages of the diseases in 
the two studies. Rather, the fact that in the latter study endoscopic samples which usually 
comprise very small sections including only parts of the gut wall were analyzed whereas 
in our study larger samples of the whole gut wall that derived from surgical resection 
were analyzed it can be assumed that specimen in our study led to more representative 
results.  
Since uninflamed parts of the terminal ileum of patients with CD showed no reduction 
of GDNF compared to healthy controls argues against a primary loss of GDNF in the 
context of IBD at a first glance. However, it can be speculated that there may be 
increased susceptibility of enteric glial cells leading to alterations of GDNF secretion. 
This is supported by previous data from biopsies of patients with IBD and animal 
models of IBD consistently suggested a role of inflammatory effects on the ENS in the 
generation of symptoms associated with IBD (Lakhan and Kirchgessner, 2010). The 
significant role for enteric glial cells and especially GDNF in the context of inflammatory 
response was pointed out by a study in which TLR2-deficient mice displayed disturbed 
architecture of the ENS, which resulted in reduced GDNF expression and caused 
breakdown of the IEB (Brun et al., 2013). In the latter study, application of GDNF led 
to reconstitution of the ENS but potentially direct effects of GDNF on enterocytes 
remained unexplored (Brun et al., 2013). In contrast to these observations recent studies 
demonstrated that enteric glial cells are not required for maintenance of the epithelium 
in mice (Rao et al., 2017) and do not acutely effect gut permeability (Grubisic and 
Gulbransen, 2017). While this is still under discussion, it must be considered that in 
addition to alterations of enteric glial cells in IBD smooth muscle cells in the gut wall 
and even enterocytes represent an additional source of GDNF which both may be 
critically involved in the regulation of intestinal GDNF levels in health and disease (Brun 
et al., 2015; Meir et al., 2015a). This idea conforms to the observation of Steinkamp et 
al., which observed an increase of solely epithelial GDNF in immunostaining in 
specimen of patients with IBD and proposed that increased epithelial GDNF may be a 
rescue mechanism following inflammation (Steinkamp et al., 2003).  
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GDNF attenuated all inflammation-induced effects in intestinal epithelial cells 
Previous studies suggested that IEB is stabilized by GDNF indirectly by inducing anti-
apoptotic effects on colonic enterocytes and immunomodulation (Langness et al., 2017; 
Reinshagen et al., 2000; Steinkamp et al., 2003; Zhang et al., 2010a). According to our in 
vitro data in Caco2 cells and in human enteroids application of GDNF resulted in direct 
effects on enterocytes, which prevented inflammation-induced loss of IEB. In previous 
studies, we and other groups confirmed the presence of GDNF receptors and 
responsiveness to GDNF in enterocytes (Meir et al., 2015a; Steinkamp et al., 2003). For 
the first time, we provide evidence that GDNF effects are primarily mediated by 
strengthening Dsg2 function, which was shown by the fact that Dsg2-deficient cells 
showed no response to GDNF. The effects on Dsg2 by GDNF were substantiated by 
immunostaining, triton-extraction and AFM where application of GDNF resulted in 
increased Dsg2 at cell borders and augmented Dsg2-mediated adhesion. Furthermore 
inflammation-induced loss of Dsg2 at the cell borders was restored by GDNF in vivo and 
in vitro while increased cell-cell adhesion was observed in dispase-based enterocyte 
dissociation assays. Again, in Dsg2-deficient Caco2 cells GDNF was not effective to 
restore TNFD-induced loss of cell-cell adhesion underlining the importance of Dsg2 in 
this context. In summary, all these data not only show a novel target of GDNF-induced 
effects in enterocytes but also support the growing evidence for the importance of 
desmosomal integrity to maintain the IEB in health and disease (Jiang et al., 2014; 
Kamekura et al., 2014; Kamekura et al., 2015; Schlegel et al., 2010; Vielmuth et al., 2015). 
p38MAPK-dependent phosphorylation of intermediate filaments induces loss of 
IEB in inflammation 
Regulation of desmosomal adhesion has been extensively investigated in the context of 
the skin blistering disease pemphigus in keratinocytes where autoantibody-induced loss 
of desmoglein3 (Dsg3)-mediated adhesion results in activation of p38MAPK and keratin 
filament reorganization (Berkowitz et al., 2005; Kitajima, 2014). Additionally, it was 
recently shown that adhesive forces of Dsg3 in keratinocytes are mediated by keratin-
dependent regulation of p38MAPK (Vielmuth et al., 2017). Our present data 
demonstrate that p38MAPK was phosphorylated in both CU and in CD, which 
156  Under revision in J Clin Invest 
 
correlated with loss of Dsg2. While our own study detected loss of Dsg2 in CD in our 
previous study (Vielmuth et al., 2015) this was not described for patients with CU before. 
The barrier destabilizing effect of phosphorylated p38MAPK by TNFα in intestinal 
epithelium is also supported by our previous study in which inflammatory stimuli 
induced strong activation of p38MAPK followed by loss of Dsg2-mediated adhesion 
(Vielmuth et al., 2015), so that p38MAPK activation appears to be detrimental for 
intestinal barrier integrity. On the other hand, it was reported that a proper balance of 
p38MAPK activation is important since activation of p38MAPK was also required for 
barrier recovery following Ca2+-depletion in a cell culture model of enterocytes 
(Ungewiss et al., 2017). It must be considered however that in the latter study Dsg2-
mediated adhesion was directly targeted by Ca2+ depletion or antibodies directed against 
the extracellular domain of Dsg2 (Ungewiss et al., 2017). In contrast, in the present study 
a cytokine stimulus i.e. TNFD via its receptor led to activation of p38MAPK, which 
obviously resulted in barrier-compromising effects. Therefore, the role of p38MAPK in 
intestinal barrier regulation may differ depending on the type of activation. 
Following p38MAKP activation we observed the phenomenon of keratin retraction as 
has amply been described in keratinocytes after stimulation with pemphigus 
autoantibodies directed against Dsg3 which then led to internalization of Dsg3 (Calkins 
et al., 2006). In the context of inflammatory bowel diseases, it was recognized earlier that 
patients with CD or UC have missense mutations in keratin 8 (Owens et al., 2004) which 
led to the assumption that his may lead to augmented susceptibility in intestinal 
epithelium. In support of this it was shown that interleukin6-dependent expression of 
keratin 8 protected the intestinal barrier from inflammatory stimuli (Wang et al., 2007). 
Cytokeratin8 phosphorylation at Ser74 has previously been identified as a substrate for 
phosphorylation by p38MAPK and it was observed that under certain conditions of 
inflammation increased keratin 8 phosphorylation occurs which was linked to increased 
susceptibility of the IEB by unknown mechanisms (Majumdar et al., 2012). This 
hypothesis is now substantiated by our present data where cytokeratin 8 and 18 
phosphorylation is indeed critically involved in the process IEB regulation most likely 
by affecting desmosomal integrity. In general, it is known that phosphorylation of 
keratins changes the distribution of keratins in the cell, alters its polymerization behavior, 
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and is associated with keratin granule formation (Fois et al., 2013; Magin et al., 2007). 
Moreover, it was shown in keratinocytes that keratins control intercellular desmosomal 
adhesion since desmosomes that lack the tethering to intermediate filaments by adapter 
proteins undergo a more rapid endocytosis with consecutive loss of intercellular 
adhesion (Kroger et al., 2013). A comparable mechanism can be assumed in our present 
data in enterocytes since phosphorylation of keratins led to retraction of the peripheral 
keratinring. This may reduce tethering of Dsg2 to the intermediate filaments with 
consecutive loss of desmosomal adhesion and intestinal barrier function. 
In summary, inflammation-induced cytokeratin phosphorylation by activation of 
p38MAPK which led to loss of Dsg2 as shown here in vitro, in vivo and in patients’ 
samples suffering from IBD points to a novel and important pathomechanism for 
barrier dysregulation in CD and UC. GDNF-induced inhibition of this pathway as 
outlined above rises not only a novel view for its role in the pathogenesis of barrier 
dysregulation in IBD but also implies an interesting potential for novel therapeutic 
options.  
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Figure 1: Reduction of GDNF correlated with loss of Dsg2, activation of 
p38MAPK and alteration of intermediate filaments in patients with IBD  
A In Western Blot analyses resection specimen from patients with Crohn’s Disease (CD) 
(n= 9) and ulcerative colitis (n= 9) were analyzed for GDNF levels. In inflamed parts of 
the terminal ileum of CD patients (left) and colon from CU patients, (right) GDNF was 
significantly reduced. B Immunostaining was performed for Dsg2 (a-d, i-l) or cytokeratin 
18 (e-h, m-p) from resection specimen of patients with CD from the terminal ileum (a-
h) or patients with CU (from the colon (i-p). In controls of the terminal ileum (a, b) or 
the colon (i,j) Dsg2 is regularly distributed along the cell borders and cytokeratin18 
staining shows a regular peripheral intermediate filament ring under control conditions 
(e,f, m,n). Patients with CD (c,d) and CU (k, l) showed loss of Dsg2 at the cell borders 
which was paralleled by a profoundly deranged cytokeratin18 staining pattern (g,h, o, p). 
Scale bar is 20 µm. C In Western Blot analyses of CD and UC samples significant loss 
of Dsg2, augmented phosphorylation of p38MAPK, cytokeratin18 and cytokeratin8 
were found. Western Blots are representative for n= 9 patients for each group. OD= 
optical density values normalized to β-actin or to total p38MAPK, cytokeratin18 or 8 are 
indicated below the Western Blots, * p<0.05 compared to control, # p<0.05 compared 
to uninflamed tissue. 
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Figure 2: GDNF stabilizes the intestinal barrier via Dsg2 
A Immunostaining of Caco2 monolayers at confluence showed faint Dsg2 staining 
patterns (a) at the cell borders which was augmented by application of 100 ng/ml GDNF 
for 24h (b). Images shown are representative for n>5 experiments. B In Western Blot 
analyses application of GDNF did not result in significantly increased protein amounts; 
OD= optical density values normalized to β-actin; representative for n>5 experiments. 
C In triton extraction experiments GDNF led to augmented Dsg2 in the triton-insoluble 
fraction; representative for n>5 experiments. D AFM measurements were performed 
on living Caco2 cells at 37°C. Cell topography images were created for selection of 
specific areas at cell borders (left panel). Force measurements with a Dsg2 coated AFM 
cantilever revealed binding events on the surface of Caco2 cells with each white dot 
representing one binding event (right panel).  E Analysis of measured Dsg2-specific 
unbinding forces resulted in a distribution-peak of 29,3 pN.  F Cell topography of Caco2 
cells was imaged after incubation with GDNF (left panel). Force maps of Dsg2 adhesion 
measurements display more binding events along the cell border (right panel) after 
application of GDNF.  G Quantification of measured binding events points out a 
significantly increased binding frequency after application of GDNF and a significantly 
decreased binding frequency after EGTA mediated Ca2+ depletion (means ± SEM, n = 
6 for GDNF, n = 3 for EGTA; * p < 0.05).  H Distribution ratio of Dsg2-specific 
binding events was calculated as the quotient of measured binding events along the cell 
border (cb) and measured binding events on the surrounding cell surface (cs) (shown are 
means ± SE, n= 6, * p < 0.05). I Western Blot analyses for Dsg2 is shown to 
demonstrate the effective knock-out of Dsg2 in the Caco2 Dsg2 (-/-) cell line in 
comparison to Caco2wt (control) and Caco2 cells transfected with nonsense plasmids; 
OD= optical density values normalized to β-actin; representative for n>5 experiments. 
J, K TER measurements of Caco2 Dsg2 (+/+) cells transfected with nonsense plasmids 
(J) and Caco2 Dsg2 (-/-) following application of 100 ng/ml GDNF are shown. While 
in of Caco2 Dsg2 (+/+) GDNF application resulted in a significant increase of TER 
values no effect on TER was observed in Caco2 Dsg2 (-/-); n=6 experiments for each 
condition; *p<0.05. 
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Figure3: GDNF attenuated all inflammation-induced effects in Caco2 cells and 
in human enteroids 
A In TER measurements application of TNFα resulted in significant reduction of TER 
which was attenuated by simultaneous application of GDNF; n=6 experiments for each 
condition; *p<0.05 compared to control. B In triton extraction experiments TNFα led 
to a reduction of Dsg2 in the triton-insoluble fraction. Simultaneous application of 
GDNF blocked TNFα-induced loss of Dsg2 and application of GDNF alone 
augmented Dsg2 in the triton-insoluble fraction; representative for n>5 experiments; 
OD= optical density values normalized to β-actin; representative for n>5 experiments, 
p<0.05 compared to control. C, D Immunostaining was performed in Caco2 cells (C) 
and in human enteroids for Dsg2 (Ca,c,e, Da, c, e) and for cytokeratin18 (Cb, f, h, Db, 
f, h). Under control conditions Dsg2 and cytokeratin 18 were both found regularly at the 
cell borders (arrowheads) in Caco2 (C) and in enteroids (D). TNFα induced loss of Dsg2 
at the cell borders (arrowheads) in Caco2 (Cc) and in enteroids (Dc) which was blocked 
by simultaneous application of GDNF (arrowhead in Ce, De). TNFα led to retraction 
of the cytokeratin ring from the cell borders in Caco2 cells (arrowheads Cd) which was 
attenuated by GDNF (Cf). In enteroids, cytokeratin18 architecture was profoundly 
deranged following TNFα (arrowhead Dd) which was blocked by simultaneous 
application of GDNF (arrowhead Df). Images are representatives; for n>6 experiments; 
scale bar is 20 µm. E, F Dispase-based enterocyte dissociation assays were performed in 
Caco2 Dsg2 (+/+) (E) transfected with nonsense plasmids or Caco2 Dsg2 (-/-) (F), 
respectively. Application of TNFα to Caco2 Dsg2 (+/+) cells (E) resulted in a 
significantly increased number of fragments which was blocked when cells were treated 
with GDNF. No effect was observed when cells were treated with GDNF alone. In 
Caco2 Dsg2 (-/-) (E) an increased number of fragments compared to Dsg2 (+/+) was 
observed under baseline conditions which was further increased following incubation 
with TNFα. Co-incubation with GDNF and GDNF had no influence on the number of 
fragments. n>6 individual experiments. 
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Figure 4: TNFα-induced cytokeratin phosphorylation is p38MAPK-dependent 
A, B, C Western Blot analyses were performed in Caco2 cells (A, C) and in enteroids 
(B). Following application of TNFα phosphorylation of p38MAPK, cytokeratin18 and 
8 were significantly increased. Co-incubation of GDNF blocked TNFα-induced 
phosphorylation in Caco2 and in enterocytes while application of GDNF alone did not 
change phosphorylation compared to controls. Inhibition of p38MAPK using SB202190 
attenuated TNFα-induced phosphorylation of cytokeratin 18 and 8 whereas activation 
of p38MAPK using anisomycin augmented phosphorylation of both cytokeratin above 
control levels. OD= optical density values normalized to loading controls; representative 
for n>5 experiments, *p<0.05 compared to control; # p<0.05 compared to TNFα. 
D Immunostaining of Dsg2 (a,c,e,g,i) and cytokeratin 18 (b, d, f, h, i) were performed in 
Cacp2 monolayers. Application of TNFα resulted in loss of Dsg2 at the cell borders (c) 
and induced cytokeratin retraction (d). This was blocked by co-incubation of TNFα with 
SB202190 when Dsg2 (e) was regularly distributed at cell borders and cytokeratin 
retraction was blunted (f). SB202190 (g,h) alone did not show changes when compared 
to controls (a, b)  whereas anisomycin induced loss of Dsg2 at the cell borders (i) and 
cytokeratin retraction (j). Experiments shown are representative for n>6; scale bar is 20 
µm. 
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Figure 5 GDNF stabilizes intestinal barrier function in DSS-colitis 
A Disease activity index (DAI) for DSS animals is shown. Application of GDNF led to 
significant reduction of DAI; *p< 0.05 compared to DSS alone B Intestinal permeability 
was measured by translocation of 4kDa FITC-dextran from the intestinal lumen into the 
blood. In DSS-colitis intestinal permeability was significantly increased which was 
attenuated by treatment with GDNF. C H.E. staining of representative images of colon 
sections from mice are shown for controls (a), DSS-colitis (b) and DSS colitis with 
GDNF treatment (c). Inflammation was reduced by GDNF treatment. Immunostaining 
of Dsg2 (d-f) showed reduced Dsg2 at the cell borders in DSS-colitis (e) which was 
restored following application of GDNF (f). Immunostaining for cytokeratin18 (g-i) was 
deranged in DSS-colitis which was not observed after treatment of GDNF (i). Scale bar 
is 20 µm.  D Inflammation score was evaluated in H.E. staining. In DSS-colitis 
inflammation score was significantly increased above control values. Treatment with 
GDNF resulted in significantly reduced inflammation scores. E Western Blots from 
colon tissue lysates of animals are shown. Dsg2 reduction in DSS-colitis was blocked by 
application of GDNF. Augmented phosphorylation of p38MAPK, cytokeratin18 and 
cytokeratin8 in DSS-colitis was attenuated by treatment with GDNF.  OD= optical 
density values normalized to loading controls; representative for n>5 experiments, 
*p<0.05 compared to control; # p<0.05 compared to DSS. 
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Supplemental Figure 1 
A Western blot analyses of resection specimen of patients suffering from Crohn’s disease 
showed a significant loss of Dsg2, an augmented phosphorylation of p38 MAPK, 
cytokeratin 18 at Serin 52 and cytokeratin 8 at Serin 74 in the inflamed parts of the tissue. 
These changes were not seen in the uninflamed resection margins. (- uninflamed; + 
inflamed). B Analysis of Dsg2 protein levels, through measurements of the optical 
density of western blots, demonstrated a reduction of Dsg2 in the inflamed parts of the 
specimen to 0.33± 0.10 (equates 0.21± 0.05 of controls) compared to 1.91± 0.56 in 
control specimen. In the uninflamed resection, margins of the specimen no changes 
compared to controls were observed when OD was 0.66 ± 0.22. (OD = optical density, 
n=9) C Quantification of the optical density resulted in a significant increase of 
phosphorylation of p38 MAPK to 2.37± 0.42 (-fold of controls) in the inflamed areas 
of the tissue that was not seen in the non-inflamed specimen when OD was 0.76± 0.22 
(OD = optical density, n=9).  D In inflamed tissue phosphorylation of cytokeratin 18 at 
Serin 52 was increased to 1.92± 0.15 compared to 1.29± 0.36 in the non-inflamed tissue 
(OD = optical density, n=9). E Increased phosphorylation of cytokeratin 8 at Serin 74 
was observed dependent in inflamed tissue specimen (OD = optical density, n=9). 
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Supplemental Figure 2 
A Western blot analyses of resection specimen of patients suffering from ulcerative 
colitis revealed a significant loss of Dsg2, an increased phosphorylation of p38 MAPK, 
cytokeratin 18 at Serin 52 and cytokeratin 8 at Serin 74 compared to non-inflamed colon 
of control specimen. B Statistic analysis of optical density of Dsg2 demonstrated a 
significant reduction of Dsg2 in inflamed colon specimen of patients suffering from 
ulcerative colitis (OD = optical density, n=9) C- E The loss of desmoglein2 in specimen 
of ulcerative colitis was paralleled by an increase in phosphorylation of p38MAPK, 
cytokeratin18 at Serin52 and cytokeratin 8 at Serin74 as shown by an augmented optical 
density of western blots (OD = optical density, n=9). 
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Supplemental Figure 3 
A Quantification of the optical densities of Dsg2 western blot signaling in Caco2 cells 
after Triton assay are shown. TNFα led to a reduced signal in the triton-insoluble 
fraction. In contrast incubation with GDNF increased the intensity of Dsg2 in the triton-
insoluble fraction and blocked the effects of TNFα (OD = optical density, n=5). B 
Analyses of the cytokeratin immunostaining revealed a shift of the intensity peak away 
from the cell border after incubation with TNFα. Co-incubation with GDNF attenuated 
the effect of TNFα (n = 6). C The distance of keratin retraction is shown. The distance 
between the highest intensities and the cell borders was determined. TNFα increased the 
keratin retraction to 43.52± 4.48 pixel compared to 9.84± 1.14 after co-incubation of 
TNFα with GDNF (n=6) 
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Supplemental Figure 4 
A, C, E Measurements of the western blot intensity after application of TNFα and 
GDNF in Caco2 cells demonstrate that TNFα showed increased phosphorylation of 
p38MAPK, cytokeratin18 at Serin 52 and cytokeratin 8 at Serin 74. This was attenuated 
following co-incubation of TNFα with GDNF, where phosphorylation patterns were 
comparable to control levels (OD = optical density, n=6). B, D, F TNFα enhanced 
phosphorylation of p38MAPK and cytokeratin 18 at Serin 52 in human enteroids, which 
was not that strong for cytokeratin 8 at serin 74. Application of GDNF reduced this 
effect of TNFα-induced phosphorylation (OD = optical density, n=6). 
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Supplemental Figure 5 
A Phosphorylation of cytokeratin 18 at Serin 52 was altered following modulation with 
p38MAPK inhibitor SB202190 and p38MAPK activator anisomycin. Anisomycin led to 
a significant increase in phosphorylation, while Sb202190 attenuated phosphorylation of 
cytokeratin 18 at Serin 52 (OD = optical density, n=6). B Anisomycin increased 
phosphorylation of cytokeratin 8 at Serin 74 and vice versa Sb202190 reduced this 
phosphorylation (OD = optical density, n=6). C In contrast, TNFα and GDNF did not 
influence the phosphorylation of cytokeratin 18 at Serin 33 (OD = optical density, n=4). 
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Supplemental Figure 6 
A The concentration of GDNF in murine lysates of the colon was determined with a 
GDNF ELISA. The application of 100µg GDNF intraperitoneally led to a significant 
increase of GDNF after 24h (n=4). B In murine serum concentration of GDNF 
increased after 1h following the intraperitoneal injection of 100µg GDNF (n=4). C 
Dextran Sodium Sulfate in the drinking water of the mice led to a significant reduction 
of their bodyweight compared to controls. Intraperitoneal application of 100µg GDNF 
did not block this effect of Dextran Sodium Sulfate (n=9). D The colon of the mice was 
significantly shortened following the application of Dextran Sodium Sulfate in mice. 
Intraperitoneal injection of GDNF for 6 days attenuated this effect on the colon length 
(n=9). E Western blots of murine colon lysates showed a significant increase of the 
signal of Dsg2 in the Dextran Sodium Sulfate mice that were treated with GDNF 
compared to the Dextran Sodium Sulfate alone group (n=6). F Quantification of the 
phosphorylation of p38MAPK is shown. In SDD animals phosphorylation of 
p38MAPK was significantly increased which was blocked by treatment with GDNF 
(OD = optical density, n=6). 
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Generation of CRISPR/Cas9-mediated gene knockout for Dsg2 in Caco2 cells 
sgRNA for SpCas9-mediated genome editing were designed using the Chopchop-web 
based sgRNA design tool (Labun et al., 2016). Two oligos targeting exon 3 and exon 13 
of human Dsg2 were designed and subcloned into two lentiviral vectors; sgRNA 
targeting exon 3 into pLentiCRISPR v2 (was a gift from Feng Zhang, Addgene plasmid 
# 52961) and sgRNA targeting exon 13 in pLKO5.sgRNA.EFS.GFP (was a gift from 
Benjamin Ebert, Addgene plasmid # 57822). Lentiviral particles were produced using 
HEk293T cells utilising second generation lentiviral packaging system comprising pPAX 
and pMD2 packaging plasmids. Caco-2 cells were seeded in 6 well plates and 24h later 
infected in the presence of polybrene, with viral supernatant comprising both viral 
particles, LKO-sgRNA-EFS GFP and CrisprV2.  
3 days post infection infected cells were selection with Puromycin (15ug/ml) for 1 week 
with medium changes every two days. Puromycin-positive clones were FACS sorted for 
GFP-expression and reseeded as single cells in a 24 well plate. Single clones were 
propagated and loss of Dsg2 was assessed in single clones by western blot and qPCR.  
Primer name Sequence 
hDSG2-1 f 
hDSG2-1 r 
hDSG2-2 f 
hDSG2-2 r 
 
caccgCTTTGGCGCCCTTTCCGCAA 
aaacTTGCGGAAAGGGCGCCAAAGc 
caccgCTAAACATCCTCATTTAGTG 
aaacCACTAAATGAGGATGTTTAGc 
 
qPCR primer Sequence 
DSG2 f 
DSG2 r 
 
Aattgcgctcatgattttgg 
Gcaatggcacatcagcagta 
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Enteroids 
IECs were isolated from human full-wall gut resections, 1cm² in size as described 
previously (Schweinlin et al., 2016). Briefly, villi were scraped off the muscle-free mucosa 
using a sterile glass slide. The remaining tissue was transferred into a 50mL falcon tube 
with 20mL 4°C cold HBSS (Sigma-Aldrich, St. Louis, MO, USA), vortexed for 5s and 
the supernatant discarded. This washing step was repeated until the supernatant was 
completely cleared of cell debris. Afterward, the tissue was incubated in 4°C cold 2 mM 
EDTA/HBSS solution (Sigma- Aldrich, St. Louis, MO, USA) for 30min at 4°C under 
gentle rotation on a shaker. Subsequently, the tissue was washed once in 20 mL HBSS 
by manually inverting the tube five times. The mucosa was transferred in a new tube 
with 10mL HBSS and manually shaken five times. This shaking procedure was repeated 
four times always using a new tube. Each cell fraction was checked for the amount and 
size of crypts within small drops under the microscope. The supernatants containing the 
most vital appearing crypts were pooled and centrifuged at 350g for 3 min at room 
temperature (RT). Pellet was resuspended in 10mL basal medium, DMEM-F12 
Advanced (Invitrogen, Carlsbad, CA, USA) supplemented with N2, B27, Anti-Anti, 
10mM HEPES, 2 mM GlutaMAX-I (all from Invitrogen, Carlsbad, CA, USA), 1 mM 
N-acetylcysteine (Sigma-Aldrich,St. Louis, MO, USA),and the crypt number was 
estimated in a 10µL drop by microscopy. Crypts were centrifuged in a nonstick 1.5 mL 
tube at 350g for 3 min at RT and the supernatant was removed. The tube with the cell 
pellet was placed on ice until further use. The pellet was resuspended in an appropriate 
amount of cold Matrigel (Corning, Hickory, NC, USA) that is, 5000 crypts/mL Drops 
of 50µl per well were seeded in a 24- well plate and incubated for 10–20 min until the 
Matrigel was well solidified. The culture medium contained a mixture of 50% fresh basal 
medium and 50% Wnt3A-conditioned medium. 
Furthermore, the following growth factors were added: 500 ng/mL hR-Spondin 1 
(PeproTech, Rocky Hill, NY, USA), 100 ng/mL IECs were isolated from human small 
intestinal tissue and expanded as organoid culture for 3–4 weeks.  
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GDNF-ELISA 
GDNF ELISA was performed according to manufacturer’s protocol (Promega, 
Mannheim, Germany). The assay is an antibody sandwich ELISA in which 96-well plates 
are coated with anti-GDNF monoclonal antibody, which binds soluble GDNF. 
Nonspecific bindings were blocked with block & sample buffer. 100µl GDNF standard 
or test samples were added to the 96-well plate and incubated with shaking for 6h. As 
test samples either mouse serum or tissue lysates of mouse gut were used. Mouse serum 
was collected during the animal surgery as described above. 10µl serum was diluted in 
40µl PBS. Tissue lysates were obtained from the mouse gut by homogenization using 
tissue lyzer in 500µl buffer. After centrifugation (30min, 4°C, 13.000g), the supernatant 
was used for the ELISA measurements. After several wash steps, an anti-human GDNF 
primary antibody was added to the 96-well plate followed by incubation at 4°C overnight 
and by several washing steps. Next, anti-Chicken IgY HRP conjugate was incubated for 
2 hours. As a final step, TMB One solution was added, reaction was stopped with 1N 
hydrochloric acid and color change was detected with an ELISA reader at 450nm.  
Immuncytochemistry 
Cultured cell monolayers were prepared for immunostaining as described previously 
(Schlegel et al., 2012). In brief, epithelial cells were grown to confluence on coverslips or 
transwell chambers (0.4 µm pore size, Falcon, Heidelberg, Germany). After incubation 
with or without different mediators, cells were fixated with 2% formaldehyde for 10 
minutes and treated with 0.1% Triton-X for 15 minutes afterwards, at room temperature. 
The human and animal tissue samples and enteroids embedded in paraffin were 
sectioned in 1µm slices. Immunostaining was performed after removal of paraffin as 
described for epithelial monolayers (Schlegel et al., 2010). Then monolayers and tissue 
slides were incubated at 4° C overnight using following primary antibodies at 1:100 in 
phosphate-buffered saline (PBS): rabbit anti-Desmoglein2 (Merck Milipore, Darmstadt, 
Germany); mouse anti-Cytokeratin 18 and 8 (both Santa Cruz Biotechnology, 
Heidelberg, Germany). As secondary antibodies, we used Cy3- or 488- labeled goat anti-
mouse, goat anti-rabbit, or mouse anti-goat (all diluted 1:600, Dianova, Hamburg, 
Germany). Coverslips and filters were mounted on glass slides with Vector Shield 
186  Under revision in J Clin Invest 
 
Mounting Medium as anti-fading compound, which included DAPI to stain cell nuclei 
additionally (Vector Laboratories, Burlingham, CA). Representative experiments were 
photographed with a fluorescence microscope BZ-9000 (BIOREVO, Keyence, Osaka 
Japan) and a confocal microscope (Leica TCS SP2, Wetzlar, Germany). . 
Western blot 
For Western blot analysis cells were grown on 6-well plates and homogenized in SDS 
lysis buffer containing 25mmol/l HEPES, 2mmol/l EDTA, 25mmol/l NaF and 1% 
sodium dodecyl sulfate. To analyze human enterocytes, the mucosa was mechanically 
dissected from the underlying tissue immediately after the resection. Full wall specimen 
were used for analyses of the animal experiments. 
Then the specimens were lyzed in a SDS lysis buffer using TissueLyzer (Quiagen, Hilden 
Germany). In similar fashion, a part of the distal murine colon was lyzed in SDS lysis 
buffer with TissueLyzer.  
SDS gel electrophoresis and blotting were carried out after normalization of the protein 
amount using BCA assay (Thermo Fisher, Waltham, MA), as described previously 
(Schlegel et al., 2011).  Antibodies against pp38MAPK and p38MPAK (Cell Signaling 
Technology, Cambridge, UK), Phospho-Cytokeratin18 Serin52 (abcam, Cambridge, 
UK), Phospho-Cytokeratin18 Serin33 (abcam, Cambridge, UK), Cytokeratin 18 (Santa 
Cruz biotechnology, Heidelberg, Germany), Phospho-Cytokeratin 8 Serin74 (Thermo 
Fisher, Waltham, MA), Desmoglein2 goat anti-mouse (Life technologies, Carlsbad, CA) 
and GDNF (R+D Systems, Abingdon, UK) were used at a dilution of 1:1000 in 5% 
bovine serum albumin (BSA) and 0.1% Tween. As secondary antibodies horseradish 
peroxidase-labeled goat anti-rabbit IgG, goat anti-mouse IgG (all Santa Cruz 
Biotechnology, Heidelberg, Germany) were used (1:3000 in 5% BSA, 0.1% Tween). To 
validate normalization Peroxidase-labeled β-Actin and GAPDH (both Sigma-Aldrich, 
Munich, Germany) antibodies were applied. Chemiluminescence signal detection and 
quantification were performed by densitometry (ChemicDoc Touch Bio-Rad 
Laboratories GmbH, Munich, Germany). Optical densities (OD) were quantified in each 
Western Blot using Image Lab ChemicDoc Touch Bio-Rad Laboratories GmbH, 
Munich, Germany)  for statistical evaluation.  
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Atomic force microscopy 
Cells were grown on glass coverslips and treated with GDNF (100ng/ml) 1 day before 
getting confluent or with 4mM EGTA for 30 min after finished control measurements. 
For analysis of Dsg2 interactions on the surface of living cells, a Nanowizard III AFM 
(JPK Instruments, Berlin, Germany) mounted on an optical microscopy (Carl Zeiss, 
Jena, Germany) was used. The approach of AFM force spectroscopy on living cells was 
described in detail before (Vielmuth et al., 2015). Imaging and force measurements were 
performed in cell culture medium using flexible Si3N4 AFM cantilevers (MLCT probes, 
Bruker, Calle Tecate, CA, USA) coated with a flexible bifunctional polyethylene glycol 
linker (Gruber Lab, Institute of Biophysics, Linz, Austria) and recombinant Dsg2-Fc 
containing the complete extracellular domain (ED) of Dsg2, as outlined elsewhere 
(Andreas et al., 2007). At first, AFM topography images of 50 x 50 µm and 128 x 128 
pixels were created using a force curve-based imaging mode (QI-mode) with a setpoint 
adjusted to 0,5 nN, a z-length of 1500 nm and a pulling speed of 50 µm/s. For adhesion 
measurements, a small area of 2 x 5 µm was selected and 1000 force-distance curves 
were recorded for each area using the force mapping mode with a relative setpoint of 
0,5 nN, a z-length of 3 µm and a pulling speed 5 µm/s. JPK data processing software 
(JPK instruments) was applied for processing AFM images and analysis of force distance 
curves and Origin 9.1 (Originlab, Northampton, MA, USA) was used for peakfit analysis 
of measured unbinding force curves. 
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3 Discussion 
 
3.1 Cultured enterocytes as suitable model for the human intestinal 
epithelium 
Aim of this study was to analyze the adhesive and signaling function of Dsg2 in the 
intestinal epithelium. The usage of in vitro cell culture represents a convenient and low 
cost approach that is suitable for genetic manipulation and allows easy stimulation with 
activators, inhibitors, cytokines or growth factors (Fig. 8). In contrast, in vivo studies are 
cost-expensive, difficult to manipulate without inducing physiological complications and 
can raise ethical concerns. In addition, some techniques are not applicable in an in vivo 
or ex vivo model of the intestine, such as the AFM to measure binding properties of 
desmosomal cadherins. Here, two human colon carcinoma cell lines were used, DLD1 
and Caco2 cells, which were derived from different patients (Caro et al., 1995; Chen et 
al., 1995; Dexter et al., 1981). A thorough characterization revealed that both cell lines 
were polarized after growing for four (DLD1) or six (Caco2) days post confluence, with 
mature cell junctions at the apical side, characteristic microvilli on the cell surface and 
fully developed desmosomes similar as seen in human tissue samples. Moreover, they 
form a cell monolayer that physically and functionally resemble an intestinal epithelial 
barrier, with a steady transepithelial resistance that was maintained over days. This is in 
line with previous studies that also reported the development of a mature epithelial 
barrier (Artursson et al., 1993; Matsumoto et al., 1990; Schlegel et al., 2010; Wang et al., 
2008; Wilson et al., 1990; Zweibaum A., 1991). Furthermore, several results obtained in 
cell culture, were also reproducible in an in vivo mouse model, organoid cultures and 
human tissue samples, which suggests that cultured enterocytes represent a suitable 
model to investigate the biological functions of Dsg2. However, one has to consider that 
the human intestinal epithelium is composed of several different cell types and 
differences in gene expression profiles are present along the crypt-villus axis as well as 
along the diverse sections of the gastrointestinal tract (Anderle et al., 2005). Although 
enterocytes make up the largest portion in the intestinal epithelium, the specific 
functions of other cell types shape the environment of the intestinal epithelium, which 
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is missing in the enterocyte cell culture. For instance, Caco2 as well as DLD1 cells 
produce no or only moderate amounts of mucus (Dexter et al., 1981; Engle et al., 1998), 
which might affect the binding properties of Dsg2 on the cell surface. Hence, a co-
culture system of enterocytes and goblet cells could provide further insights into the real 
physiological situation and should be tested in future studies. However, complex 
interactions with the immune system highly influences the barrier properties in vivo 
(Luissint et al., 2016), which cannot or only partly be simulated in a cell culture system. 
Furthermore, some considerations must be taken into account when choosing a cell line 
for studies. Since the various available cell lines derived from different carcinomas, they 
differ in their genetic profiles (Ahmed et al., 2013), which might influence the outcome 
of a study and could explain contradictory results of the same investigation in different 
labs. For instance, in this study using Caco2 and DLD1 cells, loss of Dsg2 had a 
proproliferative effect, while another study conducted in SW480 cells reported the 
opposite (Kamekura et al., 2014). A constitutive active β-catenin signaling and 
deregulated expression of pro-proliferative genes that are present in SW480 but not in 
DLD1 cells (Rowan et al., 2000; Yang et al., 2006) might be an explanation. Hence, it is 
reasonable to conduct a study in different cell lines to assure that the outcome is 
universal, as it has been done in this thesis. All in all, cultured enterocytes represent a 
suitable model to study functions of proteins in the intestinal epithelium. 
Figure 8. Advantages 
and disadvantages of 
intestinal cell culture 
model. Several 
advantages argue in 
favor of using cultured 
enterocytes (confluent 
Caco2 cells are shown) 
as model system to 
study functions of 
proteins in the 
intestinal epithelium. 
Disadvantages such as 
diverging genetic 
profiles should be 
considered when 
choosing a cell line and 
co-culture systems 
with multiple cell types 
might provide more 
insights.  
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3.2 Dsg2 as cell surface receptor for signal transduction of 
environmental stimuli 
Dsg2 constitutes the adhesive core of desmosomes (Owen and Stokes, 2010), which 
until recently have been considered to provide first and foremost the mechanical 
strength to intercellular cohesion (Green and Simpson, 2007). In the mature intestinal 
epithelium, desmosomes are located beneath the TJ and AJ, thereby sealing the 
paracellular space, which is also referred to as the “terminal bar “ (Capaldo et al., 2014; 
Farquhar and Palade, 1963a). A previous study reported that a specific antibody targeting 
the ED of Dsg2 impaired barrier function and led to rupture of TJ (Schlegel et al., 2010). 
However, the underlying mechanism was not investigated. The authors speculated that 
the antibody might bind to Dsg2 present outside of desmosomes, thus inducing signaling 
events, rather than passing the AJC and interfering with desmosomal Dsg2. From studies 
on pemphigus, it is already known that binding of desmoglein-specific autoantibodies to 
extradesmosomal desmoglein molecules on the cell surface of keratinocytes, activates 
intracellular signaling cascades, leading to impaired desmoglein-mediated cell adhesion 
(Berkowitz et al., 2008a; Kawasaki et al., 2006; Saito et al., 2012; Spindler et al., 2013; 
Tsunoda et al., 2011; Waschke et al., 2005). However, nothing was known about 
extradesmosomal Dsg2 on the surface of intestinal epithelial cells. This study 
demonstrates for the first time that extradesmosomal Dsg2 is present on the surface of 
cultured polarized enterocytes. Moreover, immunostaining of human tissue samples and 
enteroids revealed extradesmosomal Dsg2 on the cell surface, as well. Binding of an 
antibody directed against the ED of Dsg2 led to impaired cell adhesion, which was 
preceded by p38MAPK activation, indicating that Dsg2 transmits the extracellular 
stimuli thereby activating signaling events that control intercellular adhesion. Along this 
line, Dsg2 has been reported as a receptor utilized by adenoviruses to infect intestinal 
epithelial cells. Adenovirus interaction with Dsg2 activated intracellular signaling 
cascades such as PI3K and Erk1/2, resulting in the opening of intercellular junctions 
(Wang et al., 2011). Since desmosomal Dsg2 in polarized epithelial cells is inaccessible 
for adenoviruses, this underlines the appearance of extradesmosomal Dsg2 on the cell 
surface. In accordance to the present study, in which binding of the Dsg2-specific 
antibody to the ED 3 activates p38MAPK signaling, Dsg2 ED 3 is also critical for 
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adenovirus binding thereby inducing activation of the MAPK pathway (Vassal-Stermann 
et al., 2018; Wang et al., 2011). Similarly, in keratinocytes an antibody targeting the Dsg3 
ED 3 and 4 caused p38MAPK-mediated endocytosis of Dsg3 (Saito et al., 2012). Hence, 
beside its adhesive function, Dsg2 can transmit extracellular signals through ED 3. At 
present, it is unclear how this function is achieved. Given that no enzymatic activity of 
the cytoplasmic Dsg2 tail is known to date, interaction with enzymatic active proteins 
might be involved. A possible candidate is the RTK EGFR.  
 
3.2.1 Direct interaction of Dsg2 and EGFR via their extracellular domains 
regulates cell adhesion and proliferation 
In this study, a direct interaction between the extracellular part of Dsg2 and EGFR has 
been shown for the first time. Dsg2 is required for localization of EGFR to the cell 
borders where it is phosphorylated at Y845, which is catalyzed by the kinase Src. In 
Dsg2-deficient cells, phosphorylation at Y845 is reduced and EGFR is retracted from 
cell borders. Moreover, proliferation is drastically increased upon loss of Dsg2 and can 
be restored by inhibition of EGFR activity as well as by reintroduction of Dsg2. These 
findings led us to propose a new mechanism that Dsg2 interacts directly with its 
extracellular domain with EGFR, shapes EGFR function towards adhesion, and 
suppresses proliferation (Fig. 9). In concordance, reduced phosphorylation of EGFR 
Y845 upon loss of Dsg2 was also reported in other studies (Kamekura et al., 2014; 
Overmiller et al., 2016). EGFR phosphorylation at Y845 activates a series of downstream 
events, thus regulating various cellular functions (Biscardi et al., 1999; Maa et al., 1995; 
Sato et al., 1995). Enhanced cell transformation, motility and invasion have been linked 
to Y845 phosphorylation-mediated signaling and increased levels of EGFR and Src are 
observed in several cancer cells (Chung et al., 2009; Jung et al., 2011; Jung et al., 2013; 
Kannangai et al., 2006; Maa et al., 1995). Furthermore, Src-mediated phosphorylation at 
Y845 has been shown to inhibit apoptosis and to promote proliferation (Ray et al., 2007; 
Tice et al., 1999). Along this line, recent studies reported that reduced levels of EGFR 
Y845 phosphorylation upon loss of Dsg2 result in decreased cell proliferation 
(Kamekura et al., 2014; Overmiller et al., 2016). This is contradictory to our data, 
showing that reduced phosphorylation at EGFR Y845 upon loss of Dsg2 enhances cell 
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proliferation. However, and in support of our data, Y845 phosphorylation is also known 
to induce cell-cycle arrest and to inhibit growth (Godek et al., 2011; Sato et al., 2003). 
Several reasons are conceivable for the diverging outcomes that are triggered by the same 
phosphorylation site. First of all, EGFR signaling is spatially compartmentalized (Bakker 
et al., 2017). EGFR is activated upon ligand binding at the cell surface, which is followed 
by its internalization and passage of different routes of the endosome network, whereby 
signaling continues (Francavilla et al., 2016; Haugh et al., 1999; Vieira et al., 1996; Wu et 
al., 2012). Thus, different mechanisms leading to the observed EGFR Y845 
phosphorylation might explain diverging outcomes. Consistently, the study reporting a 
decreased proliferation after loss of Dsg2, suggests EGFR activation through Dsg2-
mediated displacement of EGFR from lipid rafts (Overmiller et al., 2016), while our data 
propose direct interaction of Dsg2 and EGFR that suppress proliferation. In addition, 
we demonstrate that antibodies targeting the ED of Dsg2 or of EGFR inhibit the 
interaction. In line with this, another study shows that Dsg2 ED fragments capable of 
binding to the same region as the inhibitory antibody, disrupt intercellular adhesion and 
enhance proliferation of IECs (Kamekura et al., 2015), thus underpinning our hypothesis 
that Dsg2-EGFR interaction fosters adhesion and suppresses proliferation. In addition, 
Dsg2 has been shown to support differentiation and thus acts as tumor suppressor gene 
in gastric cancer (Yashiro et al., 2006), which also points to an anti-proliferative function 
of Dsg2. Moreover, beside our results from experiments with cultured cells, we observed 
a close co-localization of Dsg2 and EGFR also in human tissue samples and enteroids, 
which supports the physiological relevance of this newly discovered complex. 
Furthermore, our collaboration-study on intestine-specific Dsg2 knockout mice revealed 
increased proliferation under inflammatory conditions in the Dsg2-KO. This further 
indicates that Dsg2 might inhibit EGFR-mediated proliferation under normal conditions 
and that loss of Dsg2-EGFR interaction enables proliferation for instance to induce 
wound healing during inflammation. Although EGFR is generally thought to be located 
in the basolateral membrane of polarized epithelial cells (Bishop and Wen, 1994; 
Scheving et al., 1989), several studies report its presence also in the apical membrane in 
IECs (Gonnella et al., 1987; Kelly et al., 1992; Yoo et al., 2011). Hence, a receptor 
complex consisting of Dsg2 and EGFR at the apical cell surface is plausible. Recently, a 
similar complex consisting of EGFR and the AJ component Ecad was reported, which 
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likewise suppresses EGFR activity and stabilizes cell adhesion (Rubsam et al., 2017b). 
Furthermore, apical and basolateral located EGFR has been demonstrated to exert 
differential functions (Kuwada et al., 1998), which might also explain diverging outcomes 
of EGFR phosphorylation at Y845.  
 
 
 
Figure 9. Schematic model of Dsg2-mediated signaling functions through direct binding to 
Dsg2. Direct interaction with RTK and binding of adenoviruses or Dsg2-specific antibodies (ab) to 
Dsg2 molecules can induce signaling cascades that modulate intercellular adhesion. Mechanisms include 
Dsg2-mediated inhibition of the canonical EGFR-triggered proliferation pathway. Adenovirus-binding 
leads to activation of downstream signaling molecules such as PI3K and Erk1/2, resulting in opening of 
other junctions (Wang et al., 2011) and activation of MMPs and ADAM proteins that cleave Dsg2 ED 
(Wang et al., 2015). Dsg2-specific antibody binding results in activation of p38MAPK.  
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3.2.2 Indirect activation of Dsg2 signaling function through environmental 
stimuli 
Here, we suggest that Dsg2 functions as receptor on the cell surface and that direct 
binding to Dsg2, such as binding of other receptors, autoantibodies or adenoviruses, 
activates intracellular signaling pathways. However, there is evidence that Dsg2 signaling 
is activated through environmental stimuli, such as cytokines or growth factors, in an 
indirect manner, as well (Fig 10).  
 Activation of Dsg2 signaling function through inflammatory cytokines 
Inflammatory cytokines such as TNFα, INFγ or IL-1β are known to alter epithelial 
barrier function and to be increased in IBD (Koch and Nusrat, 2012; Nava et al., 2010; 
Rogler and Andus, 1998; Sanders, 2005), which also display deregulated Dsg2 function 
(Spindler et al., 2015). Cytokines influence Dsg2 function by activation of MMPs and 
ADAM proteins, whose activities are known to be enhanced in IBD (Baugh et al., 1999; 
Rogler and Andus, 1998). Activated proteinases cleave the ED of Dsg2, which on the 
one hand reduces intercellular adhesion through disruption of the adhesive core of 
desmosomes, on the other hand the fragments can serve as ligands for other receptors. 
For instance, soluble Dsg2 fragments have been demonstrated to bind to HER2 and 
HER3 receptors, resulting in activation of the Akt/mTOR and MAPK pathway and 
subsequently enhanced proliferation (Kamekura et al., 2015). Although, in this case 
proliferation was induced through Dsg2 fragment-mediated activation of HER2 and 
HER3, Dsg2 ED fragments can likewise bind homophilic to Dsg2 and thus might 
possibly lead to disruption of Dsg2-EGFR binding that induces EGFR-mediated 
proliferation. In addition, it is not clear whether desmosomal or extradesmosomal Dsg2 
is cleaved. In this study, we observed ultrastructural changes of desmosomes in samples 
from CD patients, or found them to be completely missing, indicating that desmosomal 
Dsg2 molecules might be cleaved under inflammatory conditions, which results in loss 
of functional desmosomes. In this line, endocytosis of desmosomal Dsg2 has been 
reported to be regulated by ADAM proteins (Klessner et al., 2009). However, direct 
binding of adenoviruses to Dsg2 has been reported to induce Dsg2 ED shedding, as 
well (Wang et al., 2015). Since desmosomal Dsg2 is not accessible to the virus, it is likely 
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that the virus binds to extradesmosomal Dsg2. One could speculate that cleavage of 
desmosomal and extradesmosomal Dsg2 induces different signaling events. In addition, 
it is not clarified whether the cleaved Dsg2 fragments induce autocrine signaling, or act 
on neighboring cells. A recently published study propose that cleaved Dsg2 fragments, 
resulting from apoptotic stimuli, induce proliferation of neighboring cells to promote 
wound closure (Yulis et al., 2018). In case of adenovirus-mediated Dsg2 shedding, it is 
more likely that shedding-mediated signaling occurs in the same cell, as the goal of 
adenovirus binding to Dsg2 is to increase access to receptors trapped in intercellular 
junctions (Wang et al., 2015; Wang et al., 2011). 
 Activation of Dsg2 signaling function through growth factors 
We demonstrated a direct interaction of Dsg2 and EGFR in this study, hence activation 
of Dsg2 signaling via growth factor binding to EGFR, is expectable. In line with the 
above findings, we observed that EGF inhibits the interaction and induces 
internalization of both, EGFR as well as Dsg2. Thus, it is likely that interaction with 
EGFR stabilizes Dsg2 at the cell surface. A possible mechanism for stabilizing Dsg2 
might involve tyrosine phosphorylation of Dsg2 that has been shown to be blocked by 
EGFR tyrosine kinase inhibitors (Lorch et al., 2004). Furthermore, EGFR mediated 
phosphorylation of Dsg2 associated plaque proteins such as PG, upon stimulation with 
growth factors, has been assumed critical in modulating the association of the cadherin-
catenin complex with the cytoskeleton (Gaudry et al., 2001; Kanai et al., 1995; Shibamoto 
et al., 1994; Valles et al., 1990), which supports stability of desmogleins at cell borders. 
Moreover, EGF stimulation is known to activate p38MAPK (Frey et al., 2004; 
Vergarajauregui et al., 2006) that is a well-known modulator of Dsg2 signaling. Finally, 
EGFR activity has also been shown to induce MMPs (Lochter et al., 1997; McCawley et 
al., 1998), which cleave Dsg2 molecules as described above.  
Recently, another growth factor was identified to regulate intestinal barrier functions, 
namely the GDNF that enhances barrier properties of IECs (Meir et al., 2015b). A 
further objective of this thesis was, to address the impact of GDNF on Dsg2 function, 
which was part of a study investigating how GDNF regulates intestinal barrier function 
in IBD. Here, AFM analyses revealed that GDNF increases Dsg2 binding at cell-cell 
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borders, either through redistribution of existing Dsg2 molecules or through formation 
of new Dsg2 interactions at cell borders. In line with this, decreased levels of GDNF 
have been associated with a barrier breakdown of the intestinal epithelial barrier in mice, 
underlining its beneficial function for barrier properties (Brun et al., 2013). Moreover, 
analyses of immunostainings for cytokeratin18 after stimulation with the cytokine TNFα 
and GDNF revealed a significant retraction of the keratin cytoskeleton after TNFα-
stimulation, which was prevented by simultaneous application of GDNF. Furthermore, 
the data suggest that this protective effect is mediated via reduced p38MAPK and 
cytokeratin phosphorylation. This is in line with a previous study, showing that 
stimulation with TNFα induced p38MAPK phosphorylation and subsequent loss of 
Dsg2-mediated adhesion (Spindler et al., 2015). However, the role of p38MAPK activity 
in barrier regulation seems to differ depending on the type of activation, since Dsg2-
deficient enterocytes show impaired barrier properties despite reduced p38MAPK 
activity and activation of p38MAPK enhanced barrier formation. Thus, p38MAPK has 
a central role in regulating intercellular adhesion and a proper balance of its activity is 
required. Furthermore, stimulation with GDNF alone did not alter phosphorylation of 
p38MAPK, but enhanced Dsg2 binding frequency as well as its distribution at cell 
borders in AFM experiments. In conclusion, this data indicates that GDNF prevents 
p38MAPK-mediated keratin retraction and subsequent loss of cell adhesion but also 
directly enhances Dsg2-mediated cell adhesion at cell borders. Since GDNF is clearly 
reduced in samples from patients suffering from CD or UC, our data points to a new 
pathomechanism for barrier dysregulation in IBD and offers new possibilities for 
therapeutic approaches. Accordingly, GDNF has already been proposed to serve as 
rescue mechanism during inflammation (Steinkamp et al., 2003).  
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Figure 10. Schematic model of indirect activation of Dsg2-mediated signaling functions. Dsg2 
mediated signaling function is induced indirectly via extracellular stimuli such as growth factors and 
cytokines. EGF binding to EGFR blocks its interaction with Dsg2 and induces the canonical signaling 
cascade resulting in cell proliferation. In addition, activated EGFR results in phosphorylation of the 
Dsg2 cytoplasmic tail (Lorch et al., 2004) or plaque proteins such as PG (Gaudry et al., 2001; Shibamoto 
et al., 1994), thus modulating anchorage to the cytoskeleton. GDNF has protective function by inhibiting 
phosphorylation of p38MAPK and keratins but also influences Dsg2 distribution at cell borders. 
Cytokines induce Dsg2 ED shedding, resulting in reduced adhesion and increased proliferation 
(Kamekura et al., 2015). 
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3.3 Tissue dependent function of desmogleins 
In previous studies, our group has characterized what mechanisms regulate desmosomal 
adhesion in keratinocytes. In this context, several key players were identified that play 
also a role in regulating cell adhesion in IECs. However, the functional mechanism in 
keratinocytes differs from that in IECs. For instance, in keratinocytes Dsg2 has been 
found to be less important for cell cohesion than Dsg3 and does not influence 
p38MAPK activity. Moreover, activated p38MAPK was shown to reduce intercellular 
cohesion and was found in a complex with Dsg3 but not Dsg2 (Hartlieb et al., 2013; 
Hartlieb et al., 2014; Spindler et al., 2013). In contrast, this study demonstrates that IECs 
require p38MAPK activity for barrier formation and maintenance. Furthermore, Dsg2 
is indispensable for cell cohesion and regulates the activity of p38MAPK. Collectively, 
these results point towards a tissue-specific function of desmosomal cadherins. 
Although p38MAPK activity is known to be dependent on the cell type and stimulus, as 
its signaling has been shown to promote cell death in some cell lines, while enhancing 
survival, cell growth and differentiation in different cell lines (Cuenda and Rousseau, 
2007), the diverging mechanisms that regulate cell adhesion pathways might also come 
from tissue-specific expression pattern of desmogleins. Simple epithelia, like the 
intestinal epithelium, comprises only two desmosomal cadherin isoforms, Dsg2 and 
Dsc2. In contrast, seven desmosomal cadherin isoforms can be found in multilayered 
stratified epithelia like the human epidermis, with a differential distribution between the 
specific layers and very low levels of Dsg2 and Dsc2 (Dusek et al., 2007; Garrod and 
Chidgey, 2008; Mahoney et al., 2006) (Fig. 11). In one individual cell, several isoforms 
are expressed and various isoforms can be found in one single desmosome (North et al., 
1996; Nuber et al., 1996; Shimizu et al., 1995). Thus, functions associated with 
desmosomal cadherins can be distributed on several isoforms in keratinocytes, whereas 
in IECs they have to be combined in Dsg2 and Dsc2. In keratinocytes, desmosomal 
cadherin isoforms have specific functions in epithelial differentiation. For instance, Dsg2 
is concentrated in basal layers where proliferation takes place and is absent in suprabasal 
layers, whereas Dsg1 gets expressed on initiation of differentiation that is paralleled by 
cell movement into the first suprabasal layer and shows highest expression rates in 
suprabasal layers (Johnson et al., 2014).  
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Figure 11. Schematic outline of tissue-dependent expression of desmosomal cadherins in simple 
and stratified epithelial tissue. While simple columnar epithelial cells express only two desmosomal 
cadherin isoforms, seven isoforms are expressed in stratified epithelia in a differentiation dependent 
pattern. Dsg2, which is the only desmoglein in simple epithelia, is concentrated in basal proliferative 
layers in stratified epithelia and is absent in suprabasal layers where Dsg1 levels are at their highest. 
 
 
Their distinct functions become clear when expression of a desmosomal cadherin is 
forced in the wrong layer. Hence, it has been shown that ectopic expression of Dsg2 in 
the suprabasal skin layer acts contrarily to Dsg1 and induces enhanced proliferation as 
well as activation of growth and survival pathways (Brennan et al., 2007). Therefore, it 
is not surprising that loss of Dsg2 has diverging effects on signaling pathways, depending 
on tissue type. In keratinocytes, loss of Dsg2 has been reported to reduce the 
phosphorylation level of EGFR resulting in decreased cell proliferation (Overmiller et 
al., 2016), while our data from IECs revealed an enhanced proliferation. Furthermore, 
Dsg2-deficient pancreatic cells display increased levels of EGFR phosphorylation at 
Y845 (Hutz et al., 2017), which is also in contrast to IECs, showing decreased levels of 
Y845 phosphorylation. The manifold functions of Dsg2 become even more apparent 
when it comes to its role in human cancer. Several studies report Dsg2 expression to be 
downregulated in diffuse-type gastric cancer, prostate cancer and pancreatic cancer 
(Barber et al., 2014; Ramani et al., 2008; Yashiro et al., 2006). In human breast cancer 
cells, Dsg2 is believed to be a putative tumor suppressor and to reduce cell aggregation, 
invasion and motility (Davies et al., 1997). In contrast, other studies suggest an 
oncogenic function of Dsg2, as it has been shown to be overexpressed in non-small cell 
lung cancer, skin squamous cell carcinoma as well as basal cell carcinoma and its loss 
suppressed colon cancer proliferation (Brennan and Mahoney, 2009; Fukuoka et al., 
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2007; Kamekura et al., 2014). Hence, it is likely that desmosomal cadherin functions in 
a spatiotemporal fashion, which implies the involvement of specific interaction partners 
or protein modifications that modulate their function.   
3.4 Differential biological functions of Dsg2 and Dsc2 
In this study, we investigated the adhesive and signaling functions of Dsg2 in IECs. 
However, beside Dsg2, a second desmosomal cadherin is expressed in the intestinal 
epithelium, namely Dsc2, which raises the question whether and, if so, how their 
functions differ. Although, both homo- and heterophilic interactions between Dsg2 and 
Dsc2 ED can be found in desmosomes, heterophilic interactions have been reported to 
be preferred and that both protein types are required for cell cohesion (Harrison et al., 
2016; Nekrasova and Green, 2013). Moreover, it is assumed that a specific ratio of 
desmogleins and desmocollins is essential to maintain intercellular adhesion (Getsios et 
al., 2004). In contrast, another study reported that Dsc2 alone is sufficient to form 
functional desmosomes in IECs (Fujiwara et al., 2015), while a study on pancreatic cells 
revealed that silencing of Dsg2 but not Dsc2 results in loss of cell cohesion (Hutz et al., 
2017). 
Our data demonstrate that both proteins have unique properties. We observed that 
Dsg2, but not Dsc2, regulates activity of p38MAPK. Furthermore, we detected co-
localization between Dsg2 and EGFR, which did not appear between Dsc2 and EGFR. 
In line with this, loss of Dsc2 had no effect on localization as well as protein levels of 
EGFR, while loss of Dsg2 led to decreased EGFR levels, decreased EGFR 
phosphorylation at Y845 and EGFR redistribution away from cell borders. Moreover, 
loss of Dsg2 increased cell proliferation of IECs via EGFR signaling, whereas loss of 
Dsc2 resulted in similar proliferation as seen in WT cells. In addition, we participated in 
a study that explored the properties of Dsg2 and Dsc2 in the intestinal epithelium with 
regard to their importance under inflammatory conditions. Comparison of TER values 
from different KO cell lines revealed a lower resistance for cells deficient for both 
desmosomal cadherins, which was not restored by reintroduction of Dsc2. Along this 
line, that study shows that mice deficient for Dsg2 in the intestinal epithelium, display 
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increased intestinal permeability, which was not noted in Dsc2 deficient mice. However, 
we observed that loss of Dsc2 in cultured IECs resulted in reduced TER values, as well, 
albeit the values were not as much reduced as upon loss of Dsg2. In addition, 
unpublished data from our lab shows a significantly reduced intercellular cohesion in 
DLD1 cells lacking Dsc2 compared to cells lacking Dsg2. Collectively, these data 
indicates that Dsc2 is required to provide strong cohesion, while Dsg2 might exert rather 
regulatory functions. This hypothesis is supported by a study, reporting that a global 
Dsg2 knockout in mice is not viable, while Dsc2 knockout mice do not display any 
defects (Eshkind et al., 2002). Hence, this points to a crucial signaling function of Dsg2, 
whereas the adhesive function of Dsc2 might be compensated more easily. However, a 
compensatory up-regulation has been observed for Dsc2 upon loss of Dsg2, but not for 
Dsg2 upon loss of Dsc2 (Kolegraff et al., 2011). In addition, another study reports a 
signaling function for Dsc2, as well, and proposes Dsg2 and Dsc2 to act in an opposing 
way (Kamekura et al., 2014). Hence, this issue is still an open question and awaits further 
investigation. A possible starting point could be the analysis of putative interaction 
partners that might specifically shape the Dsg2 and Dsc2 function. In this study, we 
identified EGFR as interaction partner for Dsg2 and that its function is influenced by 
loss of Dsg2 but not Dsc2. Data from our cooperation study, investigating the properties 
of Dsg2 and Dsc2 in knockout mice, show an interaction of the chaperone heat shock 
protein 70 (Hsp70) with Dsg2 but not with Dsc2. Furthermore, comparison of so far 
known interaction partners for Dsg2 and Dsc2 using the BioGRID Database (Stark et 
al., 2006) revealed 52 physical interactors for Dsg2 and 26 physical interactors for Dsc2, 
of which only 10 interaction partners overlap, pointing towards different interactomes 
that might regulate specifically the functions of Dsg2 and Dsc2 (Fig. 12). 
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Figure 12. Overview of up to date known interactomes of Dsg2 and Dsc2. Comparison of physical 
interaction partners of Dsg2 and Dsc2, published on the BioGRID Database (Stark et al., 2006) reveals 
different interactomes for Dsg2 and Dsc2, with 52 interaction partners for Dsg2, 26 interaction partner 
for Dsc2 and only 10 interaction partners found in both datasets.  
 
 
In conclusion, this study reveals new functional properties for Dsg2, beside its adhesive 
function and suggests a receptor like mechanism to transmit extracellular stimuli. In the 
rapidly renewing intestinal epithelium, Dsg2 might act as a sensor to regulate the switch 
between adhesive and proliferative or apoptotic state for instance to enable cell shedding 
of senescent cells at the villus tip or to promote wound healing in response to 
inflammatory stimuli. Furthermore, this study demonstrates that Dsg2 and Dsc2 have 
unique properties and are likely to be regulated differentially. Thus, identification of 
interactomes specific for Dsg2 or Dsc2 might unveil new targets for protein regulation 
that could be useful for the development of therapeutic approaches for diseases such as 
IBD that evince dysregulated Dsg2 function.   
  
204  Discussion 
 
 
  
Annex  205 
4 Annex 
4.1 References 
Abdo, H., Derkinderen, P., Gomes, P., Chevalier, J., Aubert, P., Masson, D., Galmiche, J.P., 
Vanden Berghe, P., Neunlist, M., and Lardeux, B. (2010). Enteric glial cells protect neurons 
from oxidative stress in part via reduced glutathione. FASEB J 24, 1082-1094. 
Adams, C.L., Chen, Y.T., Smith, S.J., and Nelson, W.J. (1998). Mechanisms of epithelial 
cell-cell adhesion and cell compaction revealed by high-resolution tracking of E-cadherin-
green fluorescent protein. J Cell Biol 142, 1105-1119. 
Ahmed, D., Eide, P.W., Eilertsen, I.A., Danielsen, S.A., Eknæs, M., Hektoen, M., Lind, G.E., 
and Lothe, R.A. (2013). Epigenetic and genetic features of 24 colon cancer cell lines. 
Oncogenesis 2, e71. 
Al-Ghadban, S., Kaissi, S., Homaidan, F.R., Naim, H.Y., and El-Sabban, M.E. (2016). 
Cross-talk between intestinal epithelial cells and immune cells in inflammatory bowel 
disease. Sci Rep 6, 29783. 
Allen, S.J., Watson, J.J., Shoemark, D.K., Barua, N.U., and Patel, N.K. (2013). GDNF, NGF 
and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther 138, 155-175. 
Amagai, M., Matsuyoshi, N., Wang, Z.H., Andl, C., and Stanley, J.R. (2000). Toxin in bullous 
impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 6, 
1275-1277. 
Amagai, M., and Stanley, J.R. (2012). Desmoglein as a target in skin disease and beyond. 
J Invest Dermatol 132, 776-784. 
Amasheh, S., Meiri, N., Gitter, A.H., Schoneberg, T., Mankertz, J., Schulzke, J.D., and 
Fromm, M. (2002). Claudin-2 expression induces cation-selective channels in tight junctions 
of epithelial cells. J Cell Sci 115, 4969-4976. 
Anderle, P., Sengstag, T., Mutch, D.M., Rumbo, M., Praz, V., Mansourian, R., Delorenzi, 
M., Williamson, G., and Roberts, M.A. (2005). Changes in the transcriptional profile of 
transporters in the intestine along the anterior-posterior and crypt-villus axes. BMC 
Genomics 6, 69. 
Andl, C.D., Mizushima, T., Oyama, K., Bowser, M., Nakagawa, H., and Rustgi, A.K. (2004). 
EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in 
primary esophageal keratinocytes. Am J Physiol Gastrointest Liver Physiol 287, G1227-
1237. 
Andreas, E., Linda, W., M., K.A.S., Christian, R., Jürgen, W., D., H.C., Martin, H., Rong, Z., 
Ferry, K., Dieter, B., et al. (2007). A new simple method for linking of antibodies to atomic 
force microscopy tips. Bioconjugate Chem 18, 1176−1184. 
206  Annex 
 
Arimoto, K., Burkart, C., Yan, M., Ran, D., Weng, S., and Zhang, D.E. (2014). Plakophilin-
2 promotes tumor development by enhancing ligand-dependent and -independent 
epidermal growth factor receptor dimerization and activation. Mol Cell Biol 34, 3843-3854. 
Artursson, P., Ungell, A.L., and Lofroth, J.E. (1993). Selective paracellular permeability in 
two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells 
and rat intestinal segments. Pharm Res 10, 1123-1129. 
Bagrodia, S., Derijard, B., Davis, R.J., and Cerione, R.A. (1995). Cdc42 and PAK-mediated 
signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J Biol 
Chem 270, 27995-27998. 
Bakker, J., Spits, M., Neefjes, J., and Berlin, I. (2017). The EGFR odyssey - from activation 
to destruction in space and time. J Cell Sci. 
Barber, A.G., Castillo-Martin, M., Bonal, D.M., Rybicki, B.A., Christiano, A.M., and Cordon-
Cardo, C. (2014). Characterization of desmoglein expression in the normal prostatic gland. 
Desmoglein 2 is an independent prognostic factor for aggressive prostate cancer. PLoS 
One 9, e98786. 
Baselga, J., and Hammond, L.A. (2002). HER-targeted tyrosine-kinase inhibitors. Oncology 
63 Suppl 1, 6-16. 
Baugh, M.D., Perry, M.J., Hollander, A.P., Davies, D.R., Cross, S.S., Lobo, A.J., Taylor, 
C.J., and Evans, G.S. (1999). Matrix metalloproteinase levels are elevated in inflammatory 
bowel disease. Gastroenterology 117, 814-822. 
Bech-Serra, J.J., Santiago-Josefat, B., Esselens, C., Saftig, P., Baselga, J., Arribas, J., and 
Canals, F. (2006). Proteomic identification of desmoglein 2 and activated leukocyte cell 
adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel 
electrophoresis. Mol Cell Biol 26, 5086-5095. 
Bektas, M., Jolly, P.S., Berkowitz, P., Amagai, M., and Rubenstein, D.S. (2013). A 
pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis. J Biol 
Chem 288, 9447-9456. 
Ben-Ze'ev, A., Shtutman, M., and Zhurinsky, J. (2000). The integration of cell adhesion with 
gene expression: the role of beta-catenin. Exp Cell Res 261, 75-82. 
Berkowitz, P., Chua, M., Liu, Z., Diaz, L.A., and Rubenstein, D.S. (2008a). Autoantibodies 
in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated 
protein kinase-dependent signaling in the skin. Am J Pathol 173, 1628-1636. 
Berkowitz, P., Diaz, L.A., Hall, R.P., and Rubenstein, D.S. (2008b). Induction of p38MAPK 
and HSP27 phosphorylation in pemphigus patient skin. J Invest Dermatol 128, 738-740. 
Berkowitz, P., Hu, P., Liu, Z., Diaz, L.A., Enghild, J.J., Chua, M.P., and Rubenstein, D.S. 
(2005). Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-
induced cytoskeleton reorganization. J Biol Chem 280, 23778-23784. 
Annex  207 
Bertocchi, C., Vaman Rao, M., and Zaidel-Bar, R. (2012). Regulation of adherens junction 
dynamics by phosphorylation switches. J Signal Transduct 2012, 125295. 
Bevins, C.L., and Salzman, N.H. (2011). Paneth cells, antimicrobial peptides and 
maintenance of intestinal homeostasis. Nat Rev Microbiol 9, 356-368. 
Biscardi, J.S., Maa, M.C., Tice, D.A., Cox, M.E., Leu, T.H., and Parsons, S.J. (1999). c-Src-
mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 
is associated with modulation of receptor function. J Biol Chem 274, 8335-8343. 
Bishop, W.P., and Wen, J.T. (1994). Regulation of Caco-2 cell proliferation by basolateral 
membrane epidermal growth factor receptors. Am J Physiol 267, G892-900. 
Blair, S.A., Kane, S.V., Clayburgh, D.R., and Turner, J.R. (2006). Epithelial myosin light 
chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab 
Invest 86, 191-201. 
Blay, J., and Brown, K.D. (1985). Epidermal growth factor promotes the chemotactic 
migration of cultured rat intestinal epithelial cells. J Cell Physiol 124, 107-112. 
Bouyain, S., Longo, P.A., Li, S., Ferguson, K.M., and Leahy, D.J. (2005). The extracellular 
region of ErbB4 adopts a tethered conformation in the absence of ligand. Proc Natl Acad 
Sci U S A 102, 15024-15029. 
Brand, T.M., Iida, M., Luthar, N., Starr, M.M., Huppert, E.J., and Wheeler, D.L. (2013). 
Nuclear EGFR as a molecular target in cancer. Radiother Oncol 108, 370-377. 
Brennan, D., Hu, Y., Joubeh, S., Choi, Y.W., Whitaker-Menezes, D., O'Brien, T., Uitto, J., 
Rodeck, U., and Mahoney, M.G. (2007). Suprabasal Dsg2 expression in transgenic mouse 
skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J Cell 
Sci 120, 758-771. 
Brennan, D., and Mahoney, M.G. (2009). Increased expression of Dsg2 in malignant skin 
carcinomas: A tissue-microarray based study. Cell Adh Migr 3, 148-154. 
Brun, P., Giron, M.C., Qesari, M., Porzionato, A., Caputi, V., Zoppellaro, C., Banzato, S., 
Grillo, A.R., Spagnol, L., De Caro, R., et al. (2013). Toll-like receptor 2 regulates intestinal 
inflammation by controlling integrity of the enteric nervous system. Gastroenterology 145, 
1323-1333. 
Brun, P., Gobbo, S., Caputi, V., Spagnol, L., Schirato, G., Pasqualin, M., Levorato, E., Palu, 
G., Giron, M.C., and Castagliuolo, I. (2015). Toll like receptor-2 regulates production of glial-
derived neurotrophic factors in murine intestinal smooth muscle cells. Mol Cell Neurosci 68, 
24-35. 
Buck, V.U., Hodecker, M., Eisner, S., Leube, R.E., Krusche, C.A., and Classen-Linke, I. 
(2018). Ultrastructural changes in endometrial desmosomes of desmoglein 2 mutant mice. 
Cell Tissue Res. 
208  Annex 
 
Burgess, A.W., Cho, H.S., Eigenbrot, C., Ferguson, K.M., Garrett, T.P., Leahy, D.J., 
Lemmon, M.A., Sliwkowski, M.X., Ward, C.W., and Yokoyama, S. (2003). An open-and-
shut case? Recent insights into the activation of EGF/ErbB receptors. Mol Cell 12, 541-552. 
Bush, T.G., Savidge, T.C., Freeman, T.C., Cox, H.J., Campbell, E.A., Mucke, L., Johnson, 
M.H., and Sofroniew, M.V. (1998). Fulminant jejuno-ileitis following ablation of enteric glia 
in adult transgenic mice. Cell 93, 189-201. 
Cadwell, C.M., Su, W., and Kowalczyk, A.P. (2016). Cadherin tales: Regulation of cadherin 
function by endocytic membrane trafficking. Traffic 17, 1262-1271. 
Calkins, C.C., Setzer, S.V., Jennings, J.M., Summers, S., Tsunoda, K., Amagai, M., and 
Kowalczyk, A.P. (2006). Desmoglein endocytosis and desmosome disassembly are 
coordinated responses to pemphigus autoantibodies. J Biol Chem 281, 7623-7634. 
Capaldo, C.T., Farkas, A.E., and Nusrat, A. (2014). Epithelial adhesive junctions. 
F1000Prime Rep 6, 1. 
Caro, I., Boulenc, X., Rousset, M., Meunier, V., Bourrié, M., Julian, B., Joyeux, H., Roques, 
C., Berger, Y., Zweibaum, A., et al. (1995). Characterisation of a newly isolated Caco-2 
clone (TC-7), as a model of transport processes and biotransformation of drugs. 
International Journal of Pharmaceutics 116, 147-158. 
Cereijido, M., Valdes, J., Shoshani, L., and Contreras, R.G. (1998). Role of tight junctions 
in establishing and maintaining cell polarity. Annu Rev Physiol 60, 161-177. 
Ceresa, B.P., and Peterson, J.L. (2014). Cell and molecular biology of epidermal growth 
factor receptor. International review of cell and molecular biology 313, 145-178. 
Cerf-Bensussan, N., and Gaboriau-Routhiau, V. (2010). The immune system and the gut 
microbiota: friends or foes? Nat Rev Immunol 10, 735-744. 
Chassaing, B., Aitken, J.D., Malleshappa, M., and Vijay-Kumar, M. (2014). Dextran sulfate 
sodium (DSS)-induced colitis in mice. Current protocols in immunology / edited by John E 
Coligan  [et al] 104, Unit 15 25. 
Chen, J., Nekrasova, O.E., Patel, D.M., Klessner, J.L., Godsel, L.M., Koetsier, J.L., Amargo, 
E.V., Desai, B.V., and Green, K.J. (2012). The C-terminal unique region of desmoglein 2 
inhibits its internalization via tail-tail interactions. J Cell Biol 199, 699-711. 
Chen, T.R., Dorotinsky, C.S., McGuire, L.J., Macy, M.L., and Hay, R.J. (1995). DLD-1 and 
HCT-15 cell lines derived separately from colorectal carcinomas have totally different 
chromosome changes but the same genetic origin. Cancer Genet Cytogenet 81, 103-108. 
Chiasson-MacKenzie, C., and McClatchey, A.I. (2018). Cell-Cell Contact and Receptor 
Tyrosine Kinase Signaling. Cold Spring Harb Perspect Biol 10. 
Cho, H.S., and Leahy, D.J. (2002). Structure of the extracellular region of HER3 reveals an 
interdomain tether. Science 297, 1330-1333. 
Annex  209 
Chung, B.M., Dimri, M., George, M., Reddi, A.L., Chen, G., Band, V., and Band, H. (2009). 
The role of cooperativity with Src in oncogenic transformation mediated by non-small cell 
lung cancer-associated EGF receptor mutants. Oncogene 28, 1821-1832. 
Chung, Y., Law, S., Kwong, D.L., and Luk, J.M. (2011). Serum soluble E-cadherin is a 
potential prognostic marker in esophageal squamous cell carcinoma. Dis Esophagus 24, 
49-55. 
Citalan-Madrid, A.F., Garcia-Ponce, A., Vargas-Robles, H., Betanzos, A., and Schnoor, M. 
(2013). Small GTPases of the Ras superfamily regulate intestinal epithelial homeostasis 
and barrier function via common and unique mechanisms. Tissue Barriers 1, e26938. 
Clevers, H. (2013). The intestinal crypt, a prototype stem cell compartment. Cell 154, 274-
284. 
Clevers, H.C., and Bevins, C.L. (2013). Paneth cells: maestros of the small intestinal crypts. 
Annu Rev Physiol 75, 289-311. 
Cliffe, L.J., Humphreys, N.E., Lane, T.E., Potten, C.S., Booth, C., and Grencis, R.K. (2005). 
Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. 
Science 308, 1463-1465. 
Cohen, B.L., Torres, J., and Colombel, J.F. (2012). Immunosuppression in inflammatory 
bowel disease: how much is too much? Curr Opin Gastroenterol 28, 341-348. 
Collins, J.T., and Bhimji, S.S. (2018). Anatomy, Abdomen, Small Intestine. In StatPearls 
(Treasure Island (FL)). 
Conte, A., and Sigismund, S. (2016). Chapter Six - The Ubiquitin Network in the Control of 
EGFR Endocytosis and Signaling. Prog Mol Biol Transl Sci 141, 225-276. 
Cornet, A., Savidge, T.C., Cabarrocas, J., Deng, W.L., Colombel, J.F., Lassmann, H., 
Desreumaux, P., and Liblau, R.S. (2001). Enterocolitis induced by autoimmune targeting of 
enteric glial cells: a possible mechanism in Crohn's disease? Proc Natl Acad Sci U S A 98, 
13306-13311. 
Cox, H.M. (2016). Neuroendocrine peptide mechanisms controlling intestinal epithelial 
function. Curr Opin Pharmacol 31, 50-56. 
Cuenda, A., and Rousseau, S. (2007). p38 MAP-kinases pathway regulation, function and 
role in human diseases. Biochim Biophys Acta 1773, 1358-1375. 
Daly, J.M., Olayioye, M.A., Wong, A.M., Neve, R., Lane, H.A., Maurer, F.G., and Hynes, 
N.E. (1999). NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour 
cells: role of PI3 kinase and p38 MAP kinase pathways. Oncogene 18, 3440-3451. 
Davies, E., Cochrane, R., Hiscox, S., Jiang, W., Sweetland, H., and Mansel, R. (1997). The 
role of desmoglein 2 and E-cadherin in the invasion and motility of human breast cancer 
cells. Int J Oncol 11, 415-419. 
210  Annex 
 
De Maio, A., Vega, V.L., and Contreras, J.E. (2002). Gap junctions, homeostasis, and injury. 
J Cell Physiol 191, 269-282. 
Delva, E., Jennings, J.M., Calkins, C.C., Kottke, M.D., Faundez, V., and Kowalczyk, A.P. 
(2008). Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal 
disassembly are mediated by a clathrin- and dynamin-independent mechanism. J Biol 
Chem 283, 18303-18313. 
Den, Z., Cheng, X., Merched-Sauvage, M., and Koch, P.J. (2006). Desmocollin 3 is required 
for pre-implantation development of the mouse embryo. J Cell Sci 119, 482-489. 
Derycke, L., De Wever, O., Stove, V., Vanhoecke, B., Delanghe, J., Depypere, H., and 
Bracke, M. (2006). Soluble N-cadherin in human biological fluids. Int J Cancer 119, 2895-
2900. 
Dexter, D.L., Spremulli, E.N., Fligiel, Z., Barbosa, J.A., Vogel, R., VanVoorhees, A., and 
Calabresi, P. (1981). Heterogeneity of cancer cells from a single human colon carcinoma. 
Am J Med 71, 949-956. 
Dieckgraefe, B.K., Weems, D.M., Santoro, S.A., and Alpers, D.H. (1997). ERK and p38 
MAP kinase pathways are mediators of intestinal epithelial wound-induced signal 
transduction. Biochem Biophys Res Commun 233, 389-394. 
Dieding, M., Debus, J.D., Kerkhoff, R., Gaertner-Rommel, A., Walhorn, V., Milting, H., and 
Anselmetti, D. (2017). Arrhythmogenic cardiomyopathy related DSG2 mutations affect 
desmosomal cadherin binding kinetics. Sci Rep 7, 13791. 
Dusek, R.L., Getsios, S., Chen, F., Park, J.K., Amargo, E.V., Cryns, V.L., and Green, K.J. 
(2006). The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel 
caspase-3 target that regulates apoptosis in keratinocytes. J Biol Chem 281, 3614-3624. 
Dusek, R.L., Godsel, L.M., and Green, K.J. (2007). Discriminating roles of desmosomal 
cadherins: beyond desmosomal adhesion. J Dermatol Sci 45, 7-21. 
Engle, M.J., Goetz, G.S., and Alpers, D.H. (1998). Caco-2 cells express a combination of 
colonocyte and enterocyte phenotypes. J Cell Physiol 174, 362-369. 
Enslen, H., Raingeaud, J., and Davis, R.J. (1998). Selective activation of p38 mitogen-
activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J 
Biol Chem 273, 1741-1748. 
Erben, U., Loddenkemper, C., Doerfel, K., Spieckermann, S., Haller, D., Heimesaat, M.M., 
Zeitz, M., Siegmund, B., and Kuhl, A.A. (2014). A guide to histomorphological evaluation of 
intestinal inflammation in mouse models. Int J Clin Exp Pathol 7, 4557-4576. 
Esaki, C., Seishima, M., Yamada, T., Osada, K., and Kitajima, Y. (1995). Pharmacologic 
evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-
trisphosphate generation, intracellular calcium increase, and plasminogen activator 
secretion in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 105, 329-333. 
Annex  211 
Escobar, D.J., Desai, R., Ishiyama, N., Folmsbee, S.S., Novak, M.N., Flozak, A.S., 
Daugherty, R.L., Mo, R., Nanavati, D., Sarpal, R., et al. (2015). alpha-Catenin 
phosphorylation promotes intercellular adhesion through a dual-kinase mechanism. J Cell 
Sci 128, 1150-1165. 
Eshkind, L., Tian, Q., Schmidt, A., Franke, W.W., Windoffer, R., and Leube, R.E. (2002). 
Loss of desmoglein 2 suggests essential functions for early embryonic development and 
proliferation of embryonal stem cells. Eur J Cell Biol 81, 592-598. 
Fabre-Lafay, S., Garrido-Urbani, S., Reymond, N., Goncalves, A., Dubreuil, P., and Lopez, 
M. (2005). Nectin-4, a new serological breast cancer marker, is a substrate for tumor 
necrosis factor-alpha-converting enzyme (TACE)/ADAM-17. J Biol Chem 280, 19543-
19550. 
Farquhar, M.G., and Palade, G.E. (1963a). JUNCTIONAL COMPLEXES IN VARIOUS 
EPITHELIA. The Journal of Cell Biology 17, 375. 
Farquhar, M.G., and Palade, G.E. (1963b). Junctional complexes in various epithelia. The 
Journal of cell biology 17, 375-412. 
Feakins, R.M. (2014). Ulcerative colitis or Crohn's disease? Pitfalls and problems. 
Histopathology 64, 317-335. 
Ferguson, K.M., Berger, M.B., Mendrola, J.M., Cho, H.S., Leahy, D.J., and Lemmon, M.A. 
(2003). EGF activates its receptor by removing interactions that autoinhibit ectodomain 
dimerization. Mol Cell 11, 507-517. 
Fois, G., Weimer, M., Busch, T., Felder, E.T., Oswald, F., von Wichert, G., Seufferlein, T., 
Dietl, P., and Felder, E. (2013). Effects of keratin phosphorylation on the mechanical 
properties of keratin filaments in living cells. FASEB J 27, 1322-1329. 
Foltz, I.N., Lee, J.C., Young, P.R., and Schrader, J.W. (1997). Hemopoietic growth factors 
with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase 
pathway. J Biol Chem 272, 3296-3301. 
Francavilla, C., Papetti, M., Rigbolt, K.T., Pedersen, A.K., Sigurdsson, J.O., Cazzamali, G., 
Karemore, G., Blagoev, B., and Olsen, J.V. (2016). Multilayered proteomics reveals 
molecular switches dictating ligand-dependent EGFR trafficking. Nat Struct Mol Biol 23, 
608-618. 
Frey, M.R., Dise, R.S., Edelblum, K.L., and Polk, D.B. (2006). p38 kinase regulates 
epidermal growth factor receptor downregulation and cellular migration. EMBO J 25, 5683-
5692. 
Frey, M.R., Golovin, A., and Polk, D.B. (2004). Epidermal growth factor-stimulated intestinal 
epithelial cell migration requires Src family kinase-dependent p38 MAPK signaling. J Biol 
Chem 279, 44513-44521. 
212  Annex 
 
Fujiwara, M., Nagatomo, A., Tsuda, M., Obata, S., Sakuma, T., Yamamoto, T., and Suzuki, 
S.T. (2015). Desmocollin-2 alone forms functional desmosomal plaques, with the plaque 
formation requiring the juxtamembrane region and plakophilins. J Biochem 158, 339-353. 
Fukuoka, J., Dracheva, T., Shih, J.H., Hewitt, S.M., Fujii, T., Kishor, A., Mann, F., Shilo, K., 
Franks, T.J., Travis, W.D., et al. (2007). Desmoglein 3 as a prognostic factor in lung cancer. 
Hum Pathol 38, 276-283. 
Funderburg, N., Lederman, M.M., Feng, Z., Drage, M.G., Jadlowsky, J., Harding, C.V., 
Weinberg, A., and Sieg, S.F. (2007). Human -defensin-3 activates professional antigen-
presenting cells via Toll-like receptors 1 and 2. Proc Natl Acad Sci U S A 104, 18631-18635. 
Furness, J.B. (2012). The enteric nervous system and neurogastroenterology. Nat Rev 
Gastroenterol Hepatol 9, 286-294. 
Furuse, M., Fujimoto, K., Sato, N., Hirase, T., Tsukita, S., and Tsukita, S. (1996). 
Overexpression of occludin, a tight junction-associated integral membrane protein, induces 
the formation of intracellular multilamellar bodies bearing tight junction-like structures. J Cell 
Sci 109 ( Pt 2), 429-435. 
Gallicano, G.I., Kouklis, P., Bauer, C., Yin, M., Vasioukhin, V., Degenstein, L., and Fuchs, 
E. (1998). Desmoplakin is required early in development for assembly of desmosomes and 
cytoskeletal linkage. J Cell Biol 143, 2009-2022. 
Garcia-Gras, E., Lombardi, R., Giocondo, M.J., Willerson, J.T., Schneider, M.D., Khoury, 
D.S., and Marian, A.J. (2006). Suppression of canonical Wnt/beta-catenin signaling by 
nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular 
cardiomyopathy. J Clin Invest 116, 2012-2021. 
Garrod, D., and Chidgey, M. (2008). Desmosome structure, composition and function. 
Biochim Biophys Acta 1778, 572-587. 
Garrod, D.R., Berika, M.Y., Bardsley, W.F., Holmes, D., and Tabernero, L. (2005). Hyper-
adhesion in desmosomes: its regulation in wound healing and possible relationship to 
cadherin crystal structure. J Cell Sci 118, 5743-5754. 
Gaudry, C.A., Palka, H.L., Dusek, R.L., Huen, A.C., Khandekar, M.J., Hudson, L.G., and 
Green, K.J. (2001). Tyrosine-phosphorylated plakoglobin is associated with desmogleins 
but not desmoplakin after epidermal growth factor receptor activation. J Biol Chem 276, 
24871-24880. 
Ge, B., Gram, H., Di Padova, F., Huang, B., New, L., Ulevitch, R.J., Luo, Y., and Han, J. 
(2002). MAPKK-independent activation of p38alpha mediated by TAB1-dependent 
autophosphorylation of p38alpha. Science 295, 1291-1294. 
Geremia, A., Biancheri, P., Allan, P., Corazza, G.R., and Di Sabatino, A. (2014). Innate and 
adaptive immunity in inflammatory bowel disease. Autoimmun Rev 13, 3-10. 
Annex  213 
Getsios, S., Amargo, E.V., Dusek, R.L., Ishii, K., Sheu, L., Godsel, L.M., and Green, K.J. 
(2004). Coordinated expression of desmoglein 1 and desmocollin 1 regulates intercellular 
adhesion. Differentiation 72, 419-433. 
Getsios, S., Simpson, C.L., Kojima, S., Harmon, R., Sheu, L.J., Dusek, R.L., Cornwell, M., 
and Green, K.J. (2009). Desmoglein 1-dependent suppression of EGFR signaling promotes 
epidermal differentiation and morphogenesis. J Cell Biol 185, 1243-1258. 
Gialeli, C., Theocharis, A.D., and Karamanos, N.K. (2011). Roles of matrix 
metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278, 
16-27. 
Giepmans, B.N. (2004). Gap junctions and connexin-interacting proteins. Cardiovasc Res 
62, 233-245. 
Godek, J., Sargiannidou, I., Patel, S., Hurd, L., Rothman, V.L., and Tuszynski, G.P. (2011). 
Angiocidin inhibits breast cancer proliferation through activation of epidermal growth factor 
receptor and nuclear factor kappa (NF-kB). Exp Mol Pathol 90, 244-251. 
Godsel, L.M., Dubash, A.D., Bass-Zubek, A.E., Amargo, E.V., Klessner, J.L., Hobbs, R.P., 
Chen, X., and Green, K.J. (2010). Plakophilin 2 couples actomyosin remodeling to 
desmosomal plaque assembly via RhoA. Mol Biol Cell 21, 2844-2859. 
Gonnella, P.A., Siminoski, K., Murphy, R.A., and Neutra, M.R. (1987). Transepithelial 
transport of epidermal growth factor by absorptive cells of suckling rat ileum. J Clin Invest 
80, 22-32. 
Grace, M.P., Kim, K.H., True, L.D., and Fuchs, E. (1985). Keratin expression in normal 
esophageal epithelium and squamous cell carcinoma of the esophagus. Cancer Res 45, 
841-846. 
Granholm, A.C., Reyland, M., Albeck, D., Sanders, L., Gerhardt, G., Hoernig, G., Shen, L., 
Westphal, H., and Hoffer, B. (2000). Glial cell line-derived neurotrophic factor is essential 
for postnatal survival of midbrain dopamine neurons. J Neurosci 20, 3182-3190. 
Green, K.J., and Simpson, C.L. (2007). Desmosomes: new perspectives on a classic. J 
Invest Dermatol 127, 2499-2515. 
Grubisic, V., and Gulbransen, B.D. (2017). Enteric glial activity regulates secretomotor 
function in the mouse colon but does not acutely affect gut permeability. The Journal of 
physiology. 
Gunzel, D., and Yu, A.S. (2013). Claudins and the modulation of tight junction permeability. 
Physiol Rev 93, 525-569. 
Han, J., Lee, J.D., Bibbs, L., and Ulevitch, R.J. (1994). A MAP kinase targeted by endotoxin 
and hyperosmolarity in mammalian cells. Science 265, 808-811. 
214  Annex 
 
Hanakawa, Y., Schechter, N.M., Lin, C., Garza, L., Li, H., Yamaguchi, T., Fudaba, Y., 
Nishifuji, K., Sugai, M., Amagai, M., et al. (2002). Molecular mechanisms of blister formation 
in bullous impetigo and staphylococcal scalded skin syndrome. J Clin Invest 110, 53-60. 
Hanks, S.K., and Hunter, T. (1995). Protein kinases 6. The eukaryotic protein kinase 
superfamily: kinase (catalytic) domain structure and classification. FASEB J 9, 576-596. 
Harris, R.C., Chung, E., and Coffey, R.J. (2003). EGF receptor ligands. Exp Cell Res 284, 
2-13. 
Harrison, O.J., Brasch, J., Lasso, G., Katsamba, P.S., Ahlsen, G., Honig, B., and Shapiro, 
L. (2016). Structural basis of adhesive binding by desmocollins and desmogleins. Proc Natl 
Acad Sci U S A 113, 7160-7165. 
Hartlieb, E., Kempf, B., Partilla, M., Vigh, B., Spindler, V., and Waschke, J. (2013). 
Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion. PLoS One 8, 
e53739. 
Hartlieb, E., Rotzer, V., Radeva, M., Spindler, V., and Waschke, J. (2014). Desmoglein 2 
compensates for desmoglein 3 but does not control cell adhesion via regulation of p38 
mitogen-activated protein kinase in keratinocytes. J Biol Chem 289, 17043-17053. 
Hattrup, C.L., and Gendler, S.J. (2008). Structure and function of the cell surface (tethered) 
mucins. Annu Rev Physiol 70, 431-457. 
Haugh, J.M., Huang, A.C., Wiley, H.S., Wells, A., and Lauffenburger, D.A. (1999). 
Internalized epidermal growth factor receptors participate in the activation of p21(ras) in 
fibroblasts. J Biol Chem 274, 34350-34360. 
Heidenreich, K.A., and Kummer, J.L. (1996). Inhibition of p38 mitogen-activated protein 
kinase by insulin in cultured fetal neurons. J Biol Chem 271, 9891-9894. 
Helander, H.F., and Fandriks, L. (2014). Surface area of the digestive tract - revisited. Scand 
J Gastroenterol 49, 681-689. 
Heller, F., Florian, P., Bojarski, C., Richter, J., Christ, M., Hillenbrand, B., Mankertz, J., 
Gitter, A.H., Burgel, N., Fromm, M., et al. (2005). Interleukin-13 is the key effector Th2 
cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell 
restitution. Gastroenterology 129, 550-564. 
Hofmann, I., Casella, M., Schnolzer, M., Schlechter, T., Spring, H., and Franke, W.W. 
(2006). Identification of the junctional plaque protein plakophilin 3 in cytoplasmic particles 
containing RNA-binding proteins and the recruitment of plakophilins 1 and 3 to stress 
granules. Mol Biol Cell 17, 1388-1398. 
Hollander, D. (1999). Intestinal permeability, leaky gut, and intestinal disorders. Curr 
Gastroenterol Rep 1, 410-416. 
Annex  215 
Hollander, D., Vadheim, C.M., Brettholz, E., Petersen, G.M., Delahunty, T., and Rotter, J.I. 
(1986). Increased intestinal permeability in patients with Crohn's disease and their relatives. 
A possible etiologic factor. Ann Intern Med 105, 883-885. 
Holthofer, B., Windoffer, R., Troyanovsky, S., and Leube, R.E. (2007). Structure and 
function of desmosomes. International review of cytology 264, 65-163. 
Honegger, A.M., Kris, R.M., Ullrich, A., and Schlessinger, J. (1989). Evidence that 
autophosphorylation of solubilized receptors for epidermal growth factor is mediated by 
intermolecular cross-phosphorylation. Proc Natl Acad Sci U S A 86, 925-929. 
Hoschuetzky, H., Aberle, H., and Kemler, R. (1994). Beta-catenin mediates the interaction 
of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 127, 
1375-1380. 
Hoy, B., Geppert, T., Boehm, M., Reisen, F., Plattner, P., Gadermaier, G., Sewald, N., 
Ferreira, F., Briza, P., Schneider, G., et al. (2012). Distinct roles of secreted HtrA proteases 
from gram-negative pathogens in cleaving the junctional protein and tumor suppressor E-
cadherin. J Biol Chem 287, 10115-10120. 
Hughes, R.C. (2001). Galectins as modulators of cell adhesion. Biochimie 83, 667-676. 
Huguenin, M., Muller, E.J., Trachsel-Rosmann, S., Oneda, B., Ambort, D., Sterchi, E.E., 
and Lottaz, D. (2008). The metalloprotease meprinbeta processes E-cadherin and weakens 
intercellular adhesion. PLoS One 3, e2153. 
Hulpiau, P., and van Roy, F. (2009). Molecular evolution of the cadherin superfamily. Int J 
Biochem Cell Biol 41, 349-369. 
Hutz, K., Zeiler, J., Sachs, L., Ormanns, S., and Spindler, V. (2017). Loss of desmoglein 2 
promotes tumorigenic behavior in pancreatic cancer cells. Mol Carcinog 56, 1884-1895. 
Hynes, N.E., and Lane, H.A. (2005). ERBB receptors and cancer: the complexity of targeted 
inhibitors. Nat Rev Cancer 5, 341-354. 
Itoh, M., Tsukita, S., Yamazaki, Y., and Sugimoto, H. (2012). Rho GTP exchange factor 
ARHGEF11 regulates the integrity of epithelial junctions by connecting ZO-1 and RhoA-
myosin II signaling. Proc Natl Acad Sci U S A 109, 9905-9910. 
Jager, S., Stange, E.F., and Wehkamp, J. (2013). Inflammatory bowel disease: an impaired 
barrier disease. Langenbecks Arch Surg 398, 1-12. 
Ji, H., Wang, J., Nika, H., Hawke, D., Keezer, S., Ge, Q., Fang, B., Fang, X., Fang, D., 
Litchfield, D.W., et al. (2009). EGF-induced ERK activation promotes CK2-mediated 
disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin. Mol 
Cell 36, 547-559. 
216  Annex 
 
Jiang, K., Rankin, C.R., Nava, P., Sumagin, R., Kamekura, R., Stowell, S.R., Feng, M., 
Parkos, C.A., and Nusrat, A. (2014). Galectin-3 regulates desmoglein-2 and intestinal 
epithelial intercellular adhesion. J Biol Chem 289, 10510-10517. 
Johansson, M.E., Sjovall, H., and Hansson, G.C. (2013). The gastrointestinal mucus system 
in health and disease. Nat Rev Gastroenterol Hepatol 10, 352-361. 
Johnson, G.L., Dohlman, H.G., and Graves, L.M. (2005). MAPK kinase kinases (MKKKs) 
as a target class for small-molecule inhibition to modulate signaling networks and gene 
expression. Curr Opin Chem Biol 9, 325-331. 
Johnson, J.L., Najor, N.A., and Green, K.J. (2014). Desmosomes: regulators of cellular 
signaling and adhesion in epidermal health and disease. Cold Spring Harb Perspect Med 
4, a015297. 
Jung, J., Kim, H.Y., Kim, M., Sohn, K., Kim, M., and Lee, K. (2011). Translationally 
controlled tumor protein induces human breast epithelial cell transformation through the 
activation of Src. Oncogene 30, 2264-2274. 
Jung, O., Choi, Y.J., Kwak, T.K., Kang, M., Lee, M.S., Ryu, J., Kim, H.J., and Lee, J.W. 
(2013). The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form 
invasive protrusions via EGFR Tyr845 phosphorylation. Biochim Biophys Acta 1833, 629-
642. 
Kamekura, R., Kolegraff, K.N., Nava, P., Hilgarth, R.S., Feng, M., Parkos, C.A., and Nusrat, 
A. (2014). Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell 
proliferation through EGFR signaling. Oncogene 33, 4531-4536. 
Kamekura, R., Nava, P., Feng, M., Quiros, M., Nishio, H., Weber, D.A., Parkos, C.A., and 
Nusrat, A. (2015). Inflammation-induced desmoglein-2 ectodomain shedding compromises 
the mucosal barrier. Mol Biol Cell 26, 3165-3177. 
Kamio, T., Shigematsu, K., Sou, H., Kawai, K., and Tsuchiyama, H. (1990). 
Immunohistochemical expression of epidermal growth factor receptors in human 
adrenocortical carcinoma. Hum Pathol 21, 277-282. 
Kanai, Y., Ochiai, A., Shibata, T., Oyama, T., Ushijima, S., Akimoto, S., and Hirohashi, S. 
(1995). c-erbB-2 gene product directly associates with beta-catenin and plakoglobin. 
Biochem Biophys Res Commun 208, 1067-1072. 
Kannangai, R., Sahin, F., and Torbenson, M.S. (2006). EGFR is phosphorylated at Ty845 
in hepatocellular carcinoma. Mod Pathol 19, 1456-1461. 
Kaplan, M., Narasimhan, S., de Heus, C., Mance, D., van Doorn, S., Houben, K., Popov-
Celeketic, D., Damman, R., Katrukha, E.A., Jain, P., et al. (2016). EGFR Dynamics Change 
during Activation in Native Membranes as Revealed by NMR. Cell 167, 1241-1251 e1211. 
Katayama, M., Hirai, S., Kamihagi, K., Nakagawa, K., Yasumoto, M., and Kato, I. (1994). 
Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 69, 
580-585. 
Annex  217 
Kawasaki, Y., Aoyama, Y., Tsunoda, K., Amagai, M., and Kitajima, Y. (2006). Pathogenic 
monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK 
phosphorylation in human squamous carcinoma cell line. Autoimmunity 39, 587-590. 
Keil, R., Rietscher, K., and Hatzfeld, M. (2016). Antagonistic Regulation of Intercellular 
Cohesion by Plakophilins 1 and 3. J Invest Dermatol 136, 2022-2029. 
Kelly, D., McFadyen, M., King, T.P., and Morgan, P.J. (1992). Characterization and 
autoradiographic localization of the epidermal growth factor receptor in the jejunum of 
neonatal and weaned pigs. Reprod Fertil Dev 4, 183-191. 
Kim, Y.S., and Ho, S.B. (2010). Intestinal goblet cells and mucins in health and disease: 
recent insights and progress. Curr Gastroenterol Rep 12, 319-330. 
Kitajima, Y. (2014). 150(th) anniversary series: Desmosomes and autoimmune disease, 
perspective of dynamic desmosome remodeling and its impairments in pemphigus. Cell 
Commun Adhes 21, 269-280. 
Klessner, J.L., Desai, B.V., Amargo, E.V., Getsios, S., and Green, K.J. (2009). EGFR and 
ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal 
cadherin desmoglein 2. Mol Biol Cell 20, 328-337. 
Kloth, M.T., Catling, A.D., and Silva, C.M. (2002). Novel activation of STAT5b in response 
to epidermal growth factor. J Biol Chem 277, 8693-8701. 
Koch, P.J., Goldschmidt, M.D., Zimbelmann, R., Troyanovsky, R., and Franke, W.W. 
(1992). Complexity and expression patterns of the desmosomal cadherins. Proc Natl Acad 
Sci U S A 89, 353-357. 
Koch, P.J., Walsh, M.J., Schmelz, M., Goldschmidt, M.D., Zimbelmann, R., and Franke, 
W.W. (1990). Identification of desmoglein, a constitutive desmosomal glycoprotein, as a 
member of the cadherin family of cell adhesion molecules. Eur J Cell Biol 53, 1-12. 
Koch, S., and Nusrat, A. (2012). The life and death of epithelia during inflammation: lessons 
learned from the gut. Annu Rev Pathol 7, 35-60. 
Kolegraff, K., Nava, P., Helms, M.N., Parkos, C.A., and Nusrat, A. (2011). Loss of 
desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation 
of Akt/beta-catenin signaling. Mol Biol Cell 22, 1121-1134. 
Koval, M. (2013). Differential pathways of claudin oligomerization and integration into tight 
junctions. Tissue Barriers 1, e24518. 
Kowalczyk, A.P., and Nanes, B.A. (2012). Adherens junction turnover: regulating adhesion 
through cadherin endocytosis, degradation, and recycling. Subcell Biochem 60, 197-222. 
Kroger, C., Loschke, F., Schwarz, N., Windoffer, R., Leube, R.E., and Magin, T.M. (2013). 
Keratins control intercellular adhesion involving PKC-alpha-mediated desmoplakin 
phosphorylation. The Journal of cell biology 201, 681-692.
218  Annex 
 
Krug, S.M., Schulzke, J.D., and Fromm, M. (2014). Tight junction, selective permeability, 
and related diseases. Semin Cell Dev Biol 36, 166-176. 
Kubota, K., Furuse, M., Sasaki, H., Sonoda, N., Fujita, K., Nagafuchi, A., and Tsukita, S. 
(1999). Ca(2+)-independent cell-adhesion activity of claudins, a family of integral 
membrane proteins localized at tight junctions. Curr Biol 9, 1035-1038. 
Kuwada, S.K., Lund, K.A., Li, X.F., Cliften, P., Amsler, K., Opresko, L.K., and Wiley, H.S. 
(1998). Differential signaling and regulation of apical vs. basolateral EGFR in polarized 
epithelial cells. Am J Physiol 275, C1419-1428. 
Kyriakis, J.M., and Avruch, J. (2001). Mammalian mitogen-activated protein kinase signal 
transduction pathways activated by stress and inflammation. Physiol Rev 81, 807-869. 
Labun, K., Montague, T.G., Gagnon, J.A., Thyme, S.B., and Valen, E. (2016). CHOPCHOP 
v2: a web tool for the next generation of CRISPR genome engineering. Nucleic Acids Res 
44, W272-276. 
Lakhan, S.E., and Kirchgessner, A. (2010). Neuroinflammation in inflammatory bowel 
disease. J Neuroinflammation 7, 37. 
Langness, S., Kojima, M., Coimbra, R., Eliceiri, B.P., and Costantini, T.W. (2017). Enteric 
glia cells are critical to limiting the intestinal inflammatory response after injury. American 
journal of physiology Gastrointestinal and liver physiology 312, G274-G282. 
Laskin, J.J., and Sandler, A.B. (2004). Epidermal growth factor receptor: a promising target 
in solid tumours. Cancer Treat Rev 30, 1-17. 
Lee, J.C., Laydon, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S., Green, D., McNulty, 
D., Blumenthal, M.J., Heys, J.R., Landvatter, S.W., et al. (1994). A protein kinase involved 
in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746. 
Lemmon, M.A., and Schlessinger, J. (2010). Cell signaling by receptor tyrosine kinases. 
Cell 141, 1117-1134. 
Lochter, A., Galosy, S., Muschler, J., Freedman, N., Werb, Z., and Bissell, M.J. (1997). 
Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that 
leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in 
mammary epithelial cells. J Cell Biol 139, 1861-1872. 
Lopez-Posadas, R., Becker, C., Gunther, C., Tenzer, S., Amann, K., Billmeier, U., Atreya, 
R., Fiorino, G., Vetrano, S., Danese, S., et al. (2016). Rho-A prenylation and signaling link 
epithelial homeostasis to intestinal inflammation. J Clin Invest 126, 611-626. 
Lorch, J.H., Klessner, J., Park, J.K., Getsios, S., Wu, Y.L., Stack, M.S., and Green, K.J. 
(2004). Epidermal growth factor receptor inhibition promotes desmosome assembly and 
strengthens intercellular adhesion in squamous cell carcinoma cells. J Biol Chem 279, 
37191-37200. 
Annex  219 
Luissint, A.C., Parkos, C.A., and Nusrat, A. (2016). Inflammation and the Intestinal Barrier: 
Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair. 
Gastroenterology 151, 616-632. 
Maa, M.C., Leu, T.H., McCarley, D.J., Schatzman, R.C., and Parsons, S.J. (1995). 
Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: 
implications for the etiology of multiple human cancers. Proc Natl Acad Sci U S A 92, 6981-
6985. 
MacDonald, T.T., Biancheri, P., Sarra, M., and Monteleone, G. (2012). What's the next best 
cytokine target in IBD? Inflamm Bowel Dis 18, 2180-2189. 
Magin, T.M., Vijayaraj, P., and Leube, R.E. (2007). Structural and regulatory functions of 
keratins. Experimental cell research 313, 2021-2032. 
Mahoney, M.G., Hu, Y., Brennan, D., Bazzi, H., Christiano, A.M., and Wahl, J.K., 3rd (2006). 
Delineation of diversified desmoglein distribution in stratified squamous epithelia: 
implications in diseases. Exp Dermatol 15, 101-109. 
Majumdar, D., Tiernan, J.P., Lobo, A.J., Evans, C.A., and Corfe, B.M. (2012). Keratins in 
colorectal epithelial function and disease. Int J Exp Pathol 93, 305-318. 
Mankertz, J., and Schulzke, J.D. (2007). Altered permeability in inflammatory bowel 
disease: pathophysiology and clinical implications. Curr Opin Gastroenterol 23, 379-383. 
Mao, X., Choi, E.J., and Payne, A.S. (2009). Disruption of desmosome assembly by 
monovalent human pemphigus vulgaris monoclonal antibodies. J Invest Dermatol 129, 908-
918. 
Maretzky, T., Reiss, K., Ludwig, A., Buchholz, J., Scholz, F., Proksch, E., de Strooper, B., 
Hartmann, D., and Saftig, P. (2005). ADAM10 mediates E-cadherin shedding and regulates 
epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci 
U S A 102, 9182-9187. 
Martin-Padura, I., Lostaglio, S., Schneemann, M., Williams, L., Romano, M., Fruscella, P., 
Panzeri, C., Stoppacciaro, A., Ruco, L., Villa, A., et al. (1998). Junctional adhesion 
molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular 
junctions and modulates monocyte transmigration. J Cell Biol 142, 117-127. 
Martini, E., Krug, S.M., Siegmund, B., Neurath, M.F., and Becker, C. (2017). Mend Your 
Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory 
Bowel Disease. Cell Mol Gastroenterol Hepatol 4, 33-46. 
Matsumoto, H., Erickson, R.H., Gum, J.R., Yoshioka, M., Gum, E., and Kim, Y.S. (1990). 
Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell 
line Caco-2. Gastroenterology 98, 1199-1207. 
Mayhew, T.M., Myklebust, R., Whybrow, A., and Jenkins, R. (1999). Epithelial integrity, cell 
death and cell loss in mammalian small intestine. Histol Histopathol 14, 257-267. 
220  Annex 
 
McCawley, L.J., and Matrisian, L.M. (2001). Matrix metalloproteinases: they're not just for 
matrix anymore! Curr Opin Cell Biol 13, 534-540. 
McCawley, L.J., O'Brien, P., and Hudson, L.G. (1998). Epidermal growth factor (EGF)- and 
scatter factor/hepatocyte growth factor (SF/HGF)- mediated keratinocyte migration is 
coincident with induction of matrix metalloproteinase (MMP)-9. J Cell Physiol 176, 255-265. 
McClatchey, A.I., and Yap, A.S. (2012). Contact inhibition (of proliferation) redux. Curr Opin 
Cell Biol 24, 685-694. 
McCrea, P.D., and Gumbiner, B.M. (1991). Purification of a 92-kDa cytoplasmic protein 
tightly associated with the cell-cell adhesion molecule E-cadherin (uvomorulin). 
Characterization and extractability of the protein complex from the cell cytostructure. J Biol 
Chem 266, 4514-4520. 
McCrea, P.D., Maher, M.T., and Gottardi, C.J. (2015). Nuclear signaling from cadherin 
adhesion complexes. Curr Top Dev Biol 112, 129-196. 
McLachlan, R.W., and Yap, A.S. (2007). Not so simple: the complexity of phosphotyrosine 
signaling at cadherin adhesive contacts. J Mol Med (Berl) 85, 545-554. 
Meir, M., Flemming, S., Burkard, N., Bergauer, L., Metzger, M., Germer, C.T., and Schlegel, 
N. (2015a). Glial cell line-derived neurotrophic factor (GDNF) promotes barrier maturation 
and wound healing in intestinal epithelial cells in vitro. American journal of physiology 
Gastrointestinal and liver physiology, ajpgi 00357 02014. 
Meir, M., Flemming, S., Burkard, N., Bergauer, L., Metzger, M., Germer, C.T., and Schlegel, 
N. (2015b). Glial cell line-derived neurotrophic factor promotes barrier maturation and 
wound healing in intestinal epithelial cells in vitro. Am J Physiol Gastrointest Liver Physiol 
309, G613-624. 
Meir, M., Flemming, S., Burkard, N., Wagner, J., Germer, C.T., and Schlegel, N. (2016). 
The glial cell-line derived neurotrophic factor: a novel regulator of intestinal barrier function 
in health and disease. American journal of physiology Gastrointestinal and liver physiology 
310, G1118-1123. 
Menzel, K., Hausmann, M., Obermeier, F., Schreiter, K., Dunger, N., Bataille, F., Falk, W., 
Scholmerich, J., Herfarth, H., and Rogler, G. (2006). Cathepsins B, L and D in inflammatory 
bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo. 
Clin Exp Immunol 146, 169-180. 
Mertens, C., Kuhn, C., and Franke, W.W. (1996). Plakophilins 2a and 2b: constitutive 
proteins of dual location in the karyoplasm and the desmosomal plaque. J Cell Biol 135, 
1009-1025. 
Michels, C., Buchta, T., Bloch, W., Krieg, T., and Niessen, C.M. (2009). Classical cadherins 
regulate desmosome formation. J Invest Dermatol 129, 2072-2075. 
Annex  221 
Miguel, J.C., Maxwell, A.A., Hsieh, J.J., Harnisch, L.C., Al Alam, D., Polk, D.B., Lien, C.L., 
Watson, A.J., and Frey, M.R. (2017). Epidermal growth factor suppresses intestinal 
epithelial cell shedding through a MAPK-dependent pathway. J Cell Sci 130, 90-96. 
Mineta, K., Yamamoto, Y., Yamazaki, Y., Tanaka, H., Tada, Y., Saito, K., Tamura, A., 
Igarashi, M., Endo, T., Takeuchi, K., et al. (2011). Predicted expansion of the claudin 
multigene family. FEBS Lett 585, 606-612. 
Moog, F. (1981). The lining of the small intestine. Sci Am 245, 154-158, 160, 162 et 
passiom. 
Morandell, S., Stasyk, T., Skvortsov, S., Ascher, S., and Huber, L.A. (2008). Quantitative 
proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of 
the EGFR signaling network. Proteomics 8, 4383-4401. 
Moro, L., Dolce, L., Cabodi, S., Bergatto, E., Boeri Erba, E., Smeriglio, M., Turco, E., Retta, 
S.F., Giuffrida, M.G., Venturino, M., et al. (2002). Integrin-induced epidermal growth factor 
(EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of 
specific EGF receptor tyrosines. J Biol Chem 277, 9405-9414. 
Mowat, A.M. (2003). Anatomical basis of tolerance and immunity to intestinal antigens. Nat 
Rev Immunol 3, 331-341. 
Muise, A.M., Walters, T.D., Glowacka, W.K., Griffiths, A.M., Ngan, B.Y., Lan, H., Xu, W., 
Silverberg, M.S., and Rotin, D. (2009). Polymorphisms in E-cadherin (CDH1) result in a mis-
localised cytoplasmic protein that is associated with Crohn's disease. Gut 58, 1121-1127. 
Muller, E.J., Williamson, L., Kolly, C., and Suter, M.M. (2008). Outside-in signaling through 
integrins and cadherins: a central mechanism to control epidermal growth and 
differentiation? J Invest Dermatol 128, 501-516. 
Muniz, L.R., Knosp, C., and Yeretssian, G. (2012). Intestinal antimicrobial peptides during 
homeostasis, infection, and disease. Front Immunol 3, 310. 
Munoz, W.A., Lee, M., Miller, R.K., Ahmed, Z., Ji, H., Link, T.M., Lee, G.R., Kloc, M., 
Ladbury, J.E., and McCrea, P.D. (2014). Plakophilin-3 catenin associates with the 
ETV1/ER81 transcription factor to positively modulate gene activity. PLoS One 9, e86784. 
Nagar, B., Overduin, M., Ikura, M., and Rini, J.M. (1996). Structural basis of calcium-
induced E-cadherin rigidification and dimerization. Nature 380, 360-364. 
Nava, P., Kamekura, R., and Nusrat, A. (2013). Cleavage of transmembrane junction 
proteins and their role in regulating epithelial homeostasis. Tissue Barriers 1, e24783. 
Nava, P., Koch, S., Laukoetter, M.G., Lee, W.Y., Kolegraff, K., Capaldo, C.T., Beeman, N., 
Addis, C., Gerner-Smidt, K., Neumaier, I., et al. (2010). Interferon-gamma regulates 
intestinal epithelial homeostasis through converging beta-catenin signaling pathways. 
Immunity 32, 392-402. 
222  Annex 
 
Navid, F., Boniotto, M., Walker, C., Ahrens, K., Proksch, E., Sparwasser, T., Muller, W., 
Schwarz, T., and Schwarz, A. (2012). Induction of regulatory T cells by a murine beta-
defensin. J Immunol 188, 735-743. 
Nekrasova, O., and Green, K.J. (2013). Desmosome assembly and dynamics. Trends Cell 
Biol 23, 537-546. 
Neunlist, M., Rolli-Derkinderen, M., Latorre, R., Van Landeghem, L., Coron, E., 
Derkinderen, P., and De Giorgio, R. (2014). Enteric glial cells: recent developments and 
future directions. Gastroenterology 147, 1230-1237. 
Neunlist, M., Toumi, F., Oreschkova, T., Denis, M., Leborgne, J., Laboisse, C.L., Galmiche, 
J.P., and Jarry, A. (2003). Human ENS regulates the intestinal epithelial barrier permeability 
and a tight junction-associated protein ZO-1 via VIPergic pathways. American journal of 
physiology Gastrointestinal and liver physiology 285, G1028-1036. 
Niessen, C.M., Leckband, D., and Yap, A.S. (2011). Tissue organization by cadherin 
adhesion molecules: dynamic molecular and cellular mechanisms of morphogenetic 
regulation. Physiol Rev 91, 691-731. 
Noah, T.K., Donahue, B., and Shroyer, N.F. (2011). Intestinal development and 
differentiation. Exp Cell Res 317, 2702-2710. 
Noe, V., Fingleton, B., Jacobs, K., Crawford, H.C., Vermeulen, S., Steelant, W., Bruyneel, 
E., Matrisian, L.M., and Mareel, M. (2001). Release of an invasion promoter E-cadherin 
fragment by matrilysin and stromelysin-1. J Cell Sci 114, 111-118. 
North, A.J., Chidgey, M.A., Clarke, J.P., Bardsley, W.G., and Garrod, D.R. (1996). Distinct 
desmocollin isoforms occur in the same desmosomes and show reciprocally graded 
distributions in bovine nasal epidermis. Proc Natl Acad Sci U S A 93, 7701-7705. 
Nuber, U.A., Schafer, S., Stehr, S., Rackwitz, H.R., and Franke, W.W. (1996). Patterns of 
desmocollin synthesis in human epithelia: immunolocalization of desmocollins 1 and 3 in 
special epithelia and in cultured cells. Eur J Cell Biol 71, 1-13. 
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.H., Saito, K., Sakamoto, 
A., Inoue, M., Shirouzu, M., et al. (2002). Crystal structure of the complex of human 
epidermal growth factor and receptor extracellular domains. Cell 110, 775-787. 
Olayioye, M.A., Neve, R.M., Lane, H.A., and Hynes, N.E. (2000). The ErbB signaling 
network: receptor heterodimerization in development and cancer. EMBO J 19, 3159-3167. 
Oshima, T., and Miwa, H. (2016). Gastrointestinal mucosal barrier function and diseases. J 
Gastroenterol 51, 768-778. 
Overmiller, A.M., McGuinn, K.P., Roberts, B.J., Cooper, F., Brennan-Crispi, D.M., Deguchi, 
T., Peltonen, S., Wahl, J.K., 3rd, and Mahoney, M.G. (2016). c-Src/Cav1-dependent 
activation of the EGFR by Dsg2. Oncotarget 7, 37536-37555. 
Annex  223 
Overmiller, A.M., Pierluissi, J.A., Wermuth, P.J., Sauma, S., Martinez-Outschoorn, U., 
Tuluc, M., Luginbuhl, A., Curry, J., Harshyne, L.A., Wahl, J.K., 3rd, et al. (2017). Desmoglein 
2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes. 
FASEB J 31, 3412-3424. 
Owen, G.R., and Stokes, D.L. (2010). Exploring the Nature of Desmosomal Cadherin 
Associations in 3D. Dermatology research and practice 2010, 930401. 
Owens, D.W., Wilson, N.J., Hill, A.J., Rugg, E.L., Porter, R.M., Hutcheson, A.M., Quinlan, 
R.A., van Heel, D., Parkes, M., Jewell, D.P., et al. (2004). Human keratin 8 mutations that 
disturb filament assembly observed in inflammatory bowel disease patients. J Cell Sci 117, 
1989-1999. 
Padmanabhan, A., Rao, M.V., Wu, Y., and Zaidel-Bar, R. (2015). Jack of all trades: 
functional modularity in the adherens junction. Curr Opin Cell Biol 36, 32-40. 
Pal, M., Bhattacharya, S., Kalyan, G., and Hazra, S. (2018). Cadherin profiling for 
therapeutic interventions in Epithelial Mesenchymal Transition (EMT) and tumorigenesis. 
Exp Cell Res 368, 137-146. 
Peeters, M., Geypens, B., Claus, D., Nevens, H., Ghoos, Y., Verbeke, G., Baert, F., 
Vermeire, S., Vlietinck, R., and Rutgeerts, P. (1997). Clustering of increased small intestinal 
permeability in families with Crohn's disease. Gastroenterology 113, 802-807. 
Perez-Moreno, M., and Fuchs, E. (2006). Catenins: keeping cells from getting their signals 
crossed. Dev Cell 11, 601-612. 
Pokutta, S., Herrenknecht, K., Kemler, R., and Engel, J. (1994). Conformational changes of 
the recombinant extracellular domain of E-cadherin upon calcium binding. Eur J Biochem 
223, 1019-1026. 
Polk, D.B. (1998). Epidermal growth factor receptor-stimulated intestinal epithelial cell 
migration requires phospholipase C activity. Gastroenterology 114, 493-502. 
Prasad, A., and Pedigo, S. (2005). Calcium-dependent stability studies of domains 1 and 2 
of epithelial cadherin. Biochemistry 44, 13692-13701. 
Raingeaud, J., Gupta, S., Rogers, J.S., Dickens, M., Han, J., Ulevitch, R.J., and Davis, R.J. 
(1995). Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated 
protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 
270, 7420-7426. 
Ramani, V.C., Hennings, L., and Haun, R.S. (2008). Desmoglein 2 is a substrate of kallikrein 
7 in pancreatic cancer. BMC Cancer 8, 373. 
Rao, M., Rastelli, D., Dong, L., Chiu, S., Setlik, W., Gershon, M.D., and Corfas, G. (2017). 
Enteric Glia Regulate Gastrointestinal Motility but Are Not Required for Maintenance of the 
Epithelium in Mice. Gastroenterology. 
224  Annex 
 
Ravi, A., Garg, P., and Sitaraman, S.V. (2007). Matrix metalloproteinases in inflammatory 
bowel disease: boon or a bane? Inflamm Bowel Dis 13, 97-107. 
Ray, R.M., Bhattacharya, S., and Johnson, L.R. (2007). EGFR plays a pivotal role in the 
regulation of polyamine-dependent apoptosis in intestinal epithelial cells. Cell Signal 19, 
2519-2527. 
Reinshagen, M., Rohm, H., Steinkamp, M., Lieb, K., Geerling, I., Von Herbay, A., Flamig, 
G., Eysselein, V.E., and Adler, G. (2000). Protective role of neurotrophins in experimental 
inflammation of the rat gut. Gastroenterology 119, 368-376. 
Reiss, K., Maretzky, T., Ludwig, A., Tousseyn, T., de Strooper, B., Hartmann, D., and Saftig, 
P. (2005). ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-
catenin nuclear signalling. EMBO J 24, 742-752. 
Rietscher, K., Keil, R., Jordan, A., and Hatzfeld, M. (2018). 14-3-3 proteins regulate 
desmosomal adhesion via plakophilins. J Cell Sci 131. 
Rocks, N., Paulissen, G., El Hour, M., Quesada, F., Crahay, C., Gueders, M., Foidart, J.M., 
Noel, A., and Cataldo, D. (2008). Emerging roles of ADAM and ADAMTS 
metalloproteinases in cancer. Biochimie 90, 369-379. 
Rodriguez-Garcia, M., Oliva, H., Climent, N., Escribese, M.M., Garcia, F., Moran, T.M., 
Gatell, J.M., and Gallart, T. (2009). Impact of alpha-defensins1-3 on the maturation and 
differentiation of human monocyte-derived DCs. Concentration-dependent opposite dual 
effects. Clin Immunol 131, 374-384. 
Rodriguez, J.M., Murphy, K., Stanton, C., Ross, R.P., Kober, O.I., Juge, N., Avershina, E., 
Rudi, K., Narbad, A., Jenmalm, M.C., et al. (2015). The composition of the gut microbiota 
throughout life, with an emphasis on early life. Microb Ecol Health Dis 26, 26050. 
Rogler, G., and Andus, T. (1998). Cytokines in inflammatory bowel disease. World J Surg 
22, 382-389. 
Rosenblatt, J., Raff, M.C., and Cramer, L.P. (2001). An epithelial cell destined for apoptosis 
signals its neighbors to extrude it by an actin- and myosin-dependent mechanism. Curr Biol 
11, 1847-1857. 
Roskoski, R., Jr. (2014). The ErbB/HER family of protein-tyrosine kinases and cancer. 
Pharmacol Res 79, 34-74. 
Rotzer, V., Hartlieb, E., Vielmuth, F., Gliem, M., Spindler, V., and Waschke, J. (2015). E-
cadherin and Src associate with extradesmosomal Dsg3 and modulate desmosome 
assembly and adhesion. Cell Mol Life Sci 72, 4885-4897. 
Rouse, J., Cohen, P., Trigon, S., Morange, M., Alonso-Llamazares, A., Zamanillo, D., Hunt, 
T., and Nebreda, A.R. (1994). A novel kinase cascade triggered by stress and heat shock 
that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. 
Cell 78, 1027-1037. 
Annex  225 
Rowan, A.J., Lamlum, H., Ilyas, M., Wheeler, J., Straub, J., Papadopoulou, A., Bicknell, D., 
Bodmer, W.F., and Tomlinson, I.P. (2000). APC mutations in sporadic colorectal tumors: A 
mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci U S A 97, 
3352-3357. 
Rubsam, M., Broussard, J.A., Wickstrom, S.A., Nekrasova, O., Green, K.J., and Niessen, 
C.M. (2017a). Adherens Junctions and Desmosomes Coordinate Mechanics and Signaling 
to Orchestrate Tissue Morphogenesis and Function: An Evolutionary Perspective. Cold 
Spring Harb Perspect Biol. 
Rubsam, M., Mertz, A.F., Kubo, A., Marg, S., Jungst, C., Goranci-Buzhala, G., Schauss, 
A.C., Horsley, V., Dufresne, E.R., Moser, M., et al. (2017b). E-cadherin integrates 
mechanotransduction and EGFR signaling to control junctional tissue polarization and tight 
junction positioning. Nat Commun 8, 1250. 
Rutgeerts, P., Vermeire, S., and Van Assche, G. (2009). Biological therapies for 
inflammatory bowel diseases. Gastroenterology 136, 1182-1197. 
Saito, M., Stahley, S.N., Caughman, C.Y., Mao, X., Tucker, D.K., Payne, A.S., Amagai, M., 
and Kowalczyk, A.P. (2012). Signaling dependent and independent mechanisms in 
pemphigus vulgaris blister formation. PLoS One 7, e50696. 
Samuelov, L., and Sprecher, E. (2015). Inherited desmosomal disorders. Cell Tissue Res 
360, 457-475. 
Sanders, D.S. (2005). Mucosal integrity and barrier function in the pathogenesis of early 
lesions in Crohn's disease. J Clin Pathol 58, 568-572. 
Sato, K., Nagao, T., Iwasaki, T., Nishihira, Y., and Fukami, Y. (2003). Src-dependent 
phosphorylation of the EGF receptor Tyr-845 mediates Stat-p21waf1 pathway in A431 cells. 
Genes Cells 8, 995-1003. 
Sato, K., Sato, A., Aoto, M., and Fukami, Y. (1995). c-Src phosphorylates epidermal growth 
factor receptor on tyrosine 845. Biochem Biophys Res Commun 215, 1078-1087. 
Scheving, L.A., Shiurba, R.A., Nguyen, T.D., and Gray, G.M. (1989). Epidermal growth 
factor receptor of the intestinal enterocyte. Localization to laterobasal but not brush border 
membrane. J Biol Chem 264, 1735-1741. 
Schinner, C., Vielmuth, F., Rotzer, V., Hiermaier, M., Radeva, M.Y., Co, T.K., Hartlieb, E., 
Schmidt, A., Imhof, A., Messoudi, A., et al. (2017). Adrenergic Signaling Strengthens 
Cardiac Myocyte Cohesion. Circulation research 120, 1305-1317. 
Schlegel, N., Leweke, R., Meir, M., Germer, C.T., and Waschke, J. (2012). Role of NF-
kappaB activation in LPS-induced endothelial barrier breakdown. Histochemistry and cell 
biology 138, 627-641. 
Schlegel, N., Meir, M., Heupel, W.M., Holthofer, B., Leube, R.E., and Waschke, J. (2010). 
Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity. Am J 
Physiol Gastrointest Liver Physiol 298, G774-783. 
226  Annex 
 
Schlegel, N., Meir, M., Spindler, V., Germer, C.T., and Waschke, J. (2011). Differential role 
of Rho GTPases in intestinal epithelial barrier regulation in vitro. Journal of cellular 
physiology 226, 1196-1203. 
Schulze, K., Galichet, A., Sayar, B.S., Scothern, A., Howald, D., Zymann, H., Siffert, M., 
Zenhausern, D., Bolli, R., Koch, P.J., et al. (2012). An adult passive transfer mouse model 
to study desmoglein 3 signaling in pemphigus vulgaris. J Invest Dermatol 132, 346-355. 
Schweinlin, M., Wilhelm, S., Schwedhelm, I., Hansmann, J., Rietscher, R., Jurowich, C., 
Walles, H., and Metzger, M. (2016). Development of an Advanced Primary Human In Vitro 
Model of the Small Intestine. Tissue Eng Part C Methods 22, 873-883. 
Segretain, D., and Falk, M.M. (2004). Regulation of connexin biosynthesis, assembly, gap 
junction formation, and removal. Biochim Biophys Acta 1662, 3-21. 
Seishima, M., Esaki, C., Osada, K., Mori, S., Hashimoto, T., and Kitajima, Y. (1995). 
Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular 
calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line. J 
Invest Dermatol 104, 33-37. 
Shapiro, L., Fannon, A.M., Kwong, P.D., Thompson, A., Lehmann, M.S., Grubel, G., 
Legrand, J.F., Als-Nielsen, J., Colman, D.R., and Hendrickson, W.A. (1995). Structural 
basis of cell-cell adhesion by cadherins. Nature 374, 327-337. 
Sharma, G.D., He, J., and Bazan, H.E. (2003). p38 and ERK1/2 coordinate cellular 
migration and proliferation in epithelial wound healing: evidence of cross-talk activation 
between MAP kinase cascades. J Biol Chem 278, 21989-21997. 
Shibamoto, S., Hayakawa, M., Takeuchi, K., Hori, T., Oku, N., Miyazawa, K., Kitamura, N., 
Takeichi, M., and Ito, F. (1994). Tyrosine phosphorylation of beta-catenin and plakoglobin 
enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma 
cells. Cell Adhes Commun 1, 295-305. 
Shimizu, F., Sano, Y., Saito, K., Abe, M.A., Maeda, T., Haruki, H., and Kanda, T. (2012). 
Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of 
claudin-5 in the blood-brain barrier and the blood-nerve barrier. Neurochem Res 37, 401-
409. 
Shimizu, H., Masunaga, T., Ishiko, A., Kikuchi, A., Hashimoto, T., and Nishikawa, T. (1995). 
Pemphigus vulgaris and pemphigus foliaceus sera show an inversely graded binding 
pattern to extracellular regions of desmosomes in different layers of human epidermis. J 
Invest Dermatol 105, 153-159. 
Shinoda, T., Shinya, N., Ito, K., Ohsawa, N., Terada, T., Hirata, K., Kawano, Y., Yamamoto, 
M., Kimura-Someya, T., Yokoyama, S., et al. (2016). Structural basis for disruption of 
claudin assembly in tight junctions by an enterotoxin. Sci Rep 6, 33632. 
Shoelson, S.E. (1997). SH2 and PTB domain interactions in tyrosine kinase signal 
transduction. Curr Opin Chem Biol 1, 227-234. 
Annex  227 
Shore, E.M., and Nelson, W.J. (1991). Biosynthesis of the cell adhesion molecule 
uvomorulin (E-cadherin) in Madin-Darby canine kidney epithelial cells. J Biol Chem 266, 
19672-19680. 
Singh, A.B., and Harris, R.C. (2005). Autocrine, paracrine and juxtacrine signaling by EGFR 
ligands. Cell Signal 17, 1183-1193. 
Singh, P.K., and Hollingsworth, M.A. (2006). Cell surface-associated mucins in signal 
transduction. Trends Cell Biol 16, 467-476. 
Spindler, V., Eming, R., Schmidt, E., Amagai, M., Grando, S., Jonkman, M.F., Kowalczyk, 
A.P., Muller, E.J., Payne, A.S., Pincelli, C., et al. (2018). Mechanisms Causing Loss of 
Keratinocyte Cohesion in Pemphigus. J Invest Dermatol 138, 32-37. 
Spindler, V., Meir, M., Vigh, B., Flemming, S., Hutz, K., Germer, C.T., Waschke, J., and 
Schlegel, N. (2015). Loss of Desmoglein 2 Contributes to the Pathogenesis of Crohn's 
Disease. Inflamm Bowel Dis 21, 2349-2359. 
Spindler, V., Rotzer, V., Dehner, C., Kempf, B., Gliem, M., Radeva, M., Hartlieb, E., Harms, 
G.S., Schmidt, E., and Waschke, J. (2013). Peptide-mediated desmoglein 3 crosslinking 
prevents pemphigus vulgaris autoantibody-induced skin blistering. J Clin Invest 123, 800-
811. 
Spindler, V., and Waschke, J. (2014). Desmosomal cadherins and signaling: lessons from 
autoimmune disease. Cell Commun Adhes 21, 77-84. 
Staehelin, L.A. (1972). Three types of gap junctions interconnecting intestinal epithelial cells 
visualized by freeze-etching. Proc Natl Acad Sci U S A 69, 1318-1321. 
Stark, C., Breitkreutz, B.-J., Reguly, T., Boucher, L., Breitkreutz, A., and Tyers, M. (2006). 
BioGRID: a general repository for interaction datasets. Nucleic Acids Research 34, D535-
D539. 
Steinkamp, M., Geerling, I., Seufferlein, T., von Boyen, G., Egger, B., Grossmann, J., 
Ludwig, L., Adler, G., and Reinshagen, M. (2003). Glial-derived neurotrophic factor 
regulates apoptosis in colonic epithelial cells. Gastroenterology 124, 1748-1757. 
Stevenson, B.R., Siliciano, J.D., Mooseker, M.S., and Goodenough, D.A. (1986). 
Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction 
(zonula occludens) in a variety of epithelia. J Cell Biol 103, 755-766. 
Sudol, M. (1998). From Src Homology domains to other signaling modules: proposal of the 
'protein recognition code'. Oncogene 17, 1469-1474. 
Sumigray, K., Zhou, K., and Lechler, T. (2014). Cell-cell adhesions and cell contractility are 
upregulated upon desmosome disruption. PLoS One 9, e101824. 
228  Annex 
 
Sun, H., Charles, C.H., Lau, L.F., and Tonks, N.K. (1993). MKP-1 (3CH134), an immediate 
early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in 
vivo. Cell 75, 487-493. 
Sweeney, G., Somwar, R., Ramlal, T., Volchuk, A., Ueyama, A., and Klip, A. (1999). An 
inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose 
transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. 
J Biol Chem 274, 10071-10078. 
Takahashi, M. (2001). The GDNF/RET signaling pathway and human diseases. Cytokine 
Growth Factor Rev 12, 361-373. 
Takekawa, M., Maeda, T., and Saito, H. (1998). Protein phosphatase 2Calpha inhibits the 
human stress-responsive p38 and JNK MAPK pathways. EMBO J 17, 4744-4752. 
Terry, S.J., Zihni, C., Elbediwy, A., Vitiello, E., Leefa Chong San, I.V., Balda, M.S., and 
Matter, K. (2011). Spatially restricted activation of RhoA signalling at epithelial junctions by 
p114RhoGEF drives junction formation and morphogenesis. Nat Cell Biol 13, 159-166. 
Tice, D.A., Biscardi, J.S., Nickles, A.L., and Parsons, S.J. (1999). Mechanism of biological 
synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci U S 
A 96, 1415-1420. 
Tinkle, C.L., Pasolli, H.A., Stokes, N., and Fuchs, E. (2008). New insights into cadherin 
function in epidermal sheet formation and maintenance of tissue integrity. Proc Natl Acad 
Sci U S A 105, 15405-15410. 
Tong, J., Taylor, P., and Moran, M.F. (2014). Proteomic analysis of the epidermal growth 
factor receptor (EGFR) interactome and post-translational modifications associated with 
receptor endocytosis in response to EGF and stress. Mol Cell Proteomics 13, 1644-1658. 
Tsang, S.M., Brown, L., Gadmor, H., Gammon, L., Fortune, F., Wheeler, A., and Wan, H. 
(2012). Desmoglein 3 acting as an upstream regulator of Rho GTPases, Rac-1/Cdc42 in 
the regulation of actin organisation and dynamics. Exp Cell Res 318, 2269-2283. 
Tsukita, S., and Furuse, M. (2000). Pores in the wall: claudins constitute tight junction 
strands containing aqueous pores. J Cell Biol 149, 13-16. 
Tsukita, S., Furuse, M., and Itoh, M. (2001). Multifunctional strands in tight junctions. Nat 
Rev Mol Cell Biol 2, 285-293. 
Tsunoda, K., Ota, T., Saito, M., Hata, T., Shimizu, A., Ishiko, A., Yamada, T., Nakagawa, 
T., Kowalczyk, A.P., and Amagai, M. (2011). Pathogenic relevance of IgG and IgM 
antibodies against desmoglein 3 in blister formation in pemphigus vulgaris. Am J Pathol 
179, 795-806. 
Tucker, D.K., Stahley, S.N., and Kowalczyk, A.P. (2014). Plakophilin-1 protects 
keratinocytes from pemphigus vulgaris IgG by forming calcium-independent desmosomes. 
J Invest Dermatol 134, 1033-1043. 
Annex  229 
Turner, J.R. (2006). Molecular basis of epithelial barrier regulation: from basic mechanisms 
to clinical application. Am J Pathol 169, 1901-1909. 
Uhlig, H.H. (2013). Monogenic diseases associated with intestinal inflammation: 
implications for the understanding of inflammatory bowel disease. Gut 62, 1795-1805. 
Ullrich, A., and Schlessinger, J. (1990). Signal transduction by receptors with tyrosine 
kinase activity. Cell 61, 203-212. 
Ungewiss, H., Vielmuth, F., Suzuki, S.T., Maiser, A., Harz, H., Leonhardt, H., Kugelmann, 
D., Schlegel, N., and Waschke, J. (2017). Desmoglein 2 regulates the intestinal epithelial 
barrier via p38 mitogen-activated protein kinase. Scientific reports 7, 6329. 
Valles, A.M., Tucker, G.C., Thiery, J.P., and Boyer, B. (1990). Alternative patterns of 
mitogenesis and cell scattering induced by acidic FGF as a function of cell density in a rat 
bladder carcinoma cell line. Cell Regul 1, 975-988. 
van der Flier, L.G., and Clevers, H. (2009). Stem cells, self-renewal, and differentiation in 
the intestinal epithelium. Annu Rev Physiol 71, 241-260. 
Van Itallie, C.M., and Anderson, J.M. (2014). Architecture of tight junctions and principles 
of molecular composition. Semin Cell Dev Biol 36, 157-165. 
Van Itallie, C.M., Colegio, O.R., and Anderson, J.M. (2004). The cytoplasmic tails of 
claudins can influence tight junction barrier properties through effects on protein stability. J 
Membr Biol 199, 29-38. 
Vasioukhin, V., Bauer, C., Degenstein, L., Wise, B., and Fuchs, E. (2001a). 
Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-
catenin in skin. Cell 104, 605-617. 
Vasioukhin, V., Bowers, E., Bauer, C., Degenstein, L., and Fuchs, E. (2001b). Desmoplakin 
is essential in epidermal sheet formation. Nat Cell Biol 3, 1076-1085. 
Vassal-Stermann, E., Mottet, M., Ducournau, C., Iseni, F., Vragniau, C., Wang, H., Zubieta, 
C., Lieber, A., and Fender, P. (2018). Mapping of Adenovirus of serotype 3 fibre interaction 
to desmoglein 2 revealed a novel 'non-classical' mechanism of viral receptor engagement. 
Sci Rep 8, 8381. 
Vergarajauregui, S., San Miguel, A., and Puertollano, R. (2006). Activation of p38 mitogen-
activated protein kinase promotes epidermal growth factor receptor internalization. Traffic 
7, 686-698. 
Vieira, A.V., Lamaze, C., and Schmid, S.L. (1996). Control of EGF receptor signaling by 
clathrin-mediated endocytosis. Science 274, 2086-2089. 
Vielmuth, F., Hartlieb, E., Kugelmann, D., Waschke, J., and Spindler, V. (2015). Atomic 
force microscopy identifies regions of distinct desmoglein 3 adhesive properties on living 
keratinocytes. Nanomedicine 11, 511-520. 
230  Annex 
 
Vielmuth, F., Wanuske, M.T., Radeva, M.Y., Hiermaier, M., Kugelmann, D., Walter, E., 
Buechau, F., Magin, T.M., Waschke, J., and Spindler, V. (2017). Keratins Regulate the 
Adhesive Properties of Desmosomal Cadherins Through Signaling. J Invest Dermatol. 
Vielmuth, F., Wanuske, M.T., Radeva, M.Y., Hiermaier, M., Kugelmann, D., Walter, E., 
Buechau, F., Magin, T.M., Waschke, J., and Spindler, V. (2018). Keratins Regulate the 
Adhesive Properties of Desmosomal Cadherins through Signaling. J Invest Dermatol 138, 
121-131. 
Vinken, M., Vanhaecke, T., Papeleu, P., Snykers, S., Henkens, T., and Rogiers, V. (2006). 
Connexins and their channels in cell growth and cell death. Cell Signal 18, 592-600. 
von Boyen, G.B., Schulte, N., Pfluger, C., Spaniol, U., Hartmann, C., and Steinkamp, M. 
(2011). Distribution of enteric glia and GDNF during gut inflammation. BMC 
gastroenterology 11, 3. 
von Boyen, G.B., Steinkamp, M., Reinshagen, M., Schafer, K.H., Adler, G., and Kirsch, J. 
(2004). Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric 
glia. Gut 53, 222-228. 
Walsh, D., McCarthy, J., O'Driscoll, C., and Melgar, S. (2013). Pattern recognition 
receptors--molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine 
Growth Factor Rev 24, 91-104. 
Walter, E., Vielmuth, F., Rotkopf, L., Sardy, M., Horvath, O.N., Goebeler, M., Schmidt, E., 
Eming, R., Hertl, M., Spindler, V., et al. (2017). Different signaling patterns contribute to loss 
of keratinocyte cohesion dependent on autoantibody profile in pemphigus. Sci Rep 7, 3579. 
Wang, H., Ducournau, C., Saydaminova, K., Richter, M., Yumul, R., Ho, M., Carter, D., 
Zubieta, C., Fender, P., and Lieber, A. (2015). Intracellular Signaling and Desmoglein 2 
Shedding Triggered by Human Adenoviruses Ad3, Ad14, and Ad14P1. J Virol 89, 10841-
10859. 
Wang, H., Hughes, I., Planer, W., Parsadanian, A., Grider, J.R., Vohra, B.P., Keller-Peck, 
C., and Heuckeroth, R.O. (2010). The timing and location of glial cell line-derived 
neurotrophic factor expression determine enteric nervous system structure and function. J 
Neurosci 30, 1523-1538. 
Wang, H., Li, Z.Y., Liu, Y., Persson, J., Beyer, I., Moller, T., Koyuncu, D., Drescher, M.R., 
Strauss, R., Zhang, X.B., et al. (2011). Desmoglein 2 is a receptor for adenovirus serotypes 
3, 7, 11 and 14. Nat Med 17, 96-104. 
Wang, L., Srinivasan, S., Theiss, A.L., Merlin, D., and Sitaraman, S.V. (2007). Interleukin-
6 induces keratin expression in intestinal epithelial cells: potential role of keratin-8 in 
interleukin-6-induced barrier function alterations. J Biol Chem 282, 8219-8227. 
Wang, Q., Guo, X.L., Wells-Byrum, D., Noel, G., Pritts, T.A., and Ogle, C.K. (2008). 
Cytokine-induced epithelial permeability changes are regulated by the activation of the p38 
mitogen-activated protein kinase pathway in cultured Caco-2 cells. Shock 29, 531-537. 
Annex  231 
Waschke, J. (2008). The desmosome and pemphigus. Histochem Cell Biol 130, 21-54. 
Waschke, J., Bruggeman, P., Baumgartner, W., Zillikens, D., and Drenckhahn, D. (2005). 
Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without 
blocking desmoglein 1 transinteraction. J Clin Invest 115, 3157-3165. 
Waschke, J., and Spindler, V. (2014). Desmosomes and extradesmosomal adhesive 
signaling contacts in pemphigus. Med Res Rev 34, 1127-1145. 
Waschke, J., Spindler, V., Bruggeman, P., Zillikens, D., Schmidt, G., and Drenckhahn, D. 
(2006). Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol 175, 721-
727. 
Weiske, J., Schoneberg, T., Schroder, W., Hatzfeld, M., Tauber, R., and Huber, O. (2001). 
The fate of desmosomal proteins in apoptotic cells. J Biol Chem 276, 41175-41181. 
Wilson, G., Hassan, I.F., Dix, C.J., Williamson, I., Shah, R., Mackay, M., and Artursson, P. 
(1990). Transport and permeability properties of human Caco-2 cells: An in vitro model of 
the intestinal epithelial cell barrier. Journal of Controlled Release 11, 25-40. 
Wilson, K.J., Gilmore, J.L., Foley, J., Lemmon, M.A., and Riese, D.J., 2nd (2009). 
Functional selectivity of EGF family peptide growth factors: implications for cancer. 
Pharmacol Ther 122, 1-8. 
Windoffer, R., Borchert-Stuhltrager, M., and Leube, R.E. (2002). Desmosomes: 
interconnected calcium-dependent structures of remarkable stability with significant integral 
membrane protein turnover. J Cell Sci 115, 1717-1732. 
Wong, V., and Gumbiner, B.M. (1997). A synthetic peptide corresponding to the 
extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 
136, 399-409. 
Wu, P., Wee, P., Jiang, J., Chen, X., and Wang, Z. (2012). Differential regulation of 
transcription factors by location-specific EGF receptor signaling via a spatio-temporal 
interplay of ERK activation. PLoS One 7, e41354. 
Wu, Z., Nybom, P., and Magnusson, K.E. (2000). Distinct effects of Vibrio cholerae 
haemagglutinin/protease on the structure and localization of the tight junction-associated 
proteins occludin and ZO-1. Cell Microbiol 2, 11-17. 
Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., and Greenberg, M.E. (1995). Opposing 
effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331. 
Yamada, S., and Nelson, W.J. (2007). Localized zones of Rho and Rac activities drive 
initiation and expansion of epithelial cell-cell adhesion. J Cell Biol 178, 517-527. 
Yang, J., Zhang, W., Evans, P.M., Chen, X., He, X., and Liu, C. (2006). Adenomatous 
polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination 
in colon cancer cells. J Biol Chem 281, 17751-17757. 
232  Annex 
 
Yarden, Y., and Sliwkowski, M.X. (2001). Untangling the ErbB signalling network. Nat Rev 
Mol Cell Biol 2, 127-137. 
Yashiro, M., Nishioka, N., and Hirakawa, K. (2006). Decreased expression of the adhesion 
molecule desmoglein-2 is associated with diffuse-type gastric carcinoma. Eur J Cancer 42, 
2397-2403. 
Yoo, B.K., He, P., Lee, S.J., and Yun, C.C. (2011). Lysophosphatidic acid 5 receptor 
induces activation of Na(+)/H(+) exchanger 3 via apical epidermal growth factor receptor in 
intestinal epithelial cells. Am J Physiol Cell Physiol 301, C1008-1016. 
Yu, Y.B., and Li, Y.Q. (2014). Enteric glial cells and their role in the intestinal epithelial 
barrier. World J Gastroenterol 20, 11273-11280. 
Yulis, M., Quiros, M., Hilgarth, R., Parkos, C.A., and Nusrat, A. (2018). Intracellular 
Desmoglein-2 cleavage sensitizes epithelial cells to apoptosis in response to pro-
inflammatory cytokines. Cell Death Dis 9, 389. 
Zarubin, T., and Han, J. (2005). Activation and signaling of the p38 MAP kinase pathway. 
Cell Res 15, 11-18. 
Zeissig, S., Burgel, N., Gunzel, D., Richter, J., Mankertz, J., Wahnschaffe, U., Kroesen, 
A.J., Zeitz, M., Fromm, M., and Schulzke, J.D. (2007). Changes in expression and 
distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction 
in active Crohn's disease. Gut 56, 61-72. 
Zhang, D.K., He, F.Q., Li, T.K., Pang, X.H., Cui de, J., Xie, Q., Huang, X.L., and Gan, H.T. 
(2010a). Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and 
inflammation and is therapeutic for murine colitis. The Journal of pathology 222, 213-222. 
Zhang, D.K., He, F.Q., Li, T.K., Pang, X.H., Cui, D.J., Xie, Q., Huang, X.L., and Gan, H.T. 
(2010b). Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and 
inflammation and is therapeutic for murine colitis. J Pathol 222, 213-222. 
Zhang, S., Han, J., Sells, M.A., Chernoff, J., Knaus, U.G., Ulevitch, R.J., and Bokoch, G.M. 
(1995). Rho family GTPases regulate p38 mitogen-activated protein kinase through the 
downstream mediator Pak1. J Biol Chem 270, 23934-23936. 
Zweibaum A., L.M., Grasset E., Louvard D. (1991). Use of cultured cell lines in studies of 
intestinal cell differentiation and function. In Handbook of physiology: the gastrointestinal 
system, intestinal absorption and secretion (American Physiological Society), pp. 223-255. 
  
Annex  233 
4.2 Abbreviations 
% per cent 
(Co-) IP (Co-) Immunoprecipitation 
°C degree Celsius 
µl microliter, 10-6 l 
µM micromolar, 10-6 M 
ADAM A disintegrin and metalloproteinase domain-containing protein 
AFM Atomic force microscopy 
AJ Adherens junctions 
AJC Apical junctional complex 
AMP Antimicrobial peptides 
APC Adematous polyposis coli 
Ca2+ Calcium 
CaCl2 Calcium chloride 
CD Crohn’s disease 
Cld4 Claudin 4 
Cld2 Claudin 2 
CNS Central nervous sytem 
C.rod Citrobacter rodentium 
Cxs Connexins 
DP Desmoplakin 
Dsc2 Descmocollin 2 
Dsg2 Desmoglein 2 
DSS Dextran sodium sulphate 
DTD Desmoglein terminal domain 
DUR Desmoglein unique region 
EA Extracellular anchoring domain 
EC Extracellular cadherin repeat 
Ecad E-cadherin 
ED Extracellular domain 
EGC Enteric glial cell 
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EGF Epidermal growth factor 
EGFR Epidermal growth factor receptor 
EGTA Ethylene glycol tetraacetic acid 
ENS Enteric nervous system 
Fc Constant effector-determining region 
Fig. Figure 
FL Full-length 
GAPDH Glycerinaldehyd-3-phosphat-Dehydrogenase 
GDNF Glial-derived neurotrophic factor 
GFP Green Fluorescent Protein 
GJ Gap junctions 
h Hour 
HER2 Human epidermal growth factor receptor 2 
HER3 Human epidermal growth factor receptor 3 
Hsp70 Heat shock protein 70 
Hz Hertz 
IA Intracellular anchoring domain 
IBD Inflammatory bowel disease 
ICS Intracellular cadherin-like sequence 
IEC Intestinal epithelial cells 
IF Immunofluorescence 
IgG Immunoglobulin G 
IL-1β Interleukin 1 beta 
INFγ Interferon gamma 
IPL Proline rich linker region 
JAMs Junctional adhesion molecules 
kD kilo dalton 
KO Knockout 
MAPK Mitogen-activated protein kinase 
min Minute 
MLCK Myosin light chain kinase 
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MMP Matrix metallo protease 
Ncad N-cadherin 
nm nanometer 
n.s. not significant 
PG Plakoglobin 
Pkp Plakophilin 
pN pico newton 
RTK Receptor tyrosine kinase 
RUD Repeat unit domain 
SE Standard error 
SIM Structured illumination microscopy 
siRNA small interefering ribonucleic acid 
Src Rous sarcoma kinase 
STAT3 Signal transducer and activator of transcription 3 
STED Stimulated emission depletion microscopy 
Suppl. Supplementary 
TER Transepithelial resistance 
TGF Transforming growth factor 
TJ Tight junctions 
TM Transmembrane domain 
TNFα Tumor nucrose factor alpha 
UC Ulcerative colitis 
WT Wildtype 
ZO1 Zonula occludens 1 
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